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SUMMARY 
The generic term 'esterases' broadly represents enzymes that hydrolyse aliphatic or 
aromatic esters. and within this definition is a group of esterases that show a preference 
for short acyl chain esters such as a-naphthyl acetate, propionate or butyrate. These are 
often collectively referred to as 'non-specific esterases' (NSE), but a more accurate and ti  
descriptive designation is according to the substrate used. The demonstration of esterases 
by azo-dye techniques has found particular applications in haematological cytochemistry, 
and, with specific reference to normal myeloid cells, a-naphthyl acetate esterase (ANAE) 
0 	 cytochemical reactions of moderate-strong diffuse type are typically associated with cells 
of monocyte/macrophage lineage. In contrast. granulocytes at all levels of morphological 
differentiation are cytochemically ANAE negative. Isoelectric focusing (IEF) studies of 
ANAE isoenzymes have further revealed the existence of two species with apparent 
differences in lineage affiliation. The first (ComEst) is expressed by both granulocytes 
and monocytes, and comprises a series of isoenzymes with isoelectric points (p1) ranging 
from 6.3 to 7.9, whereas a second (MonEst) species that is specifically expressed by 
haemopoietic cells of monocytic/macrophage origin is seen on IEF zymograms as a series 
of isoforms within a relatively narrow pI range of 5.5-6.2. 
These present studies were undertaken in order to extend what is cuiTently known of the 
cellular, kinetic and molecular features of the two main myeloid esterase species. It was 
considered that these investigations were necessary to clarify the nature of atypical 
cytochemical reactions in leukaemic and dyshaemopoietic myeloid cells, to establish 
whether or not the two species were related or distinct enzymes, to gain further insights 
into their possible functional role(s), and to provide molecular details of relevance for the 
longer term aim of cloning MonEst protein in particular. 
Studies reported here of normal myeloid cells confirmed the lineage affiliation of the two 
main esterase species, and analysis of a large number of acute myeloid leukaemias also 
resolved the nature of atypical ANAE cytochemistries. Abnormally increased focal and 
granular reactions of myeloid blasts was shown to be due to over-expression of ComEst, 
and the lack of ANAE cytochemical staining in a significant proportion of monocytic 
leukaemias was shown to result from a failure to synthesise MonEst. As a prelude to the 
biochemical purification of myeloid esterases, the ComEst and MonEst species were also 
investigated to determine their chromatographic characteristics. This involved an 
evaluation of a wide range of column gels including ion-exchange, hydrophobic 
interaction, affinity, and gel filtration. The purification protocol resulting from these 
evaluations successfully permitted the purification of ComEst to a highly enriched state 
and MonEst to homogeneity. Subsequent molecular and kinetic analyses revealed that 
enzymatically active MonEst exists in its native state as an apparent trimer which, under 
non-reducing conditions, dissociates to inactive 63 kDa monomers. In contrast, native 
ComEst was shown to be a 68 kDa monomer which retained enzymatic activity following 
SDS treatment, and was not dissociated under reducing conditions. Lectin affinity studies 
confirmed that both esterase species were glycoproteins but differed in that MonEst 
contained oligomannosidic-type glycan(s) whilst ComEst contained a mixture of 
fucosylated and non-fucosylated biantennary N-acetyllactosamine-type glycan(s). 
Neuraminidase, a-mannosidase, a-L-fucosidase, and endoglycosidase H were shown to 
have no effect on the pI distribution of individual ComEst or MonEst isoforms, but 
endoglycosidase treatment did reduce the Mr of MonEst from 63 to 60 kDa. Enzyme 
kinetic studies also revealed that purified ComEst preferentially hydrolysed esters of short 
acyl chain length (C2 and C3) whilst MonEst hydrolysed esters of higher acyl chain 
length (butyrate > propionate > acetate). However, MonEst failed to hydrolyse a wide 
range of natural and synthetic peptidase substrates thus tending to exclude its functional 
role in peptide processing. Possible differences in reaction mechanisms of the two 
esterase species were also evaluated by examining the inhibitory effects of representative 
enzyme inhibitors which demonstrated that serine and histidine residues were required. for 
MonEst but not ComEst activity. N-terminus amino acid sequencing of purified MonEst 
indicated almost complete identity with human alveolar macrophage esterase. differing 
only in a Val-Thr substitution at position 12, and close similarities with rabbit liver 
carboxylesterase. 
In summary, substrate and inhibitor studies strongly suggested that the MonEst and 
ComEst species should be classified as carboxylesterases (EC 3.1.1.1) and 
acetylesterases (EC 3.1.1.6) respectively and that, together with distinct differences in 
their molecular and biochemical characteristics, it is concluded that these are unrelated 
myeloid enzymes which share only the ability to hydrolyse a-naphthyl acetate. Although 
yet to be established, the kinetic and molecular differences reported here may have 
fundamental relevance with respect to the biofunctional role(s) of these enzymes. 
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CHAPTER ONE 
GENERAL INTRODUCTION 
2 
1.1 INTRODUCTION  
Cytochemical analyses of leucocyte enzyme systems represent an important supplement to 
traditional morphological classifications of leukaemic cells. Since the early part of this 
century, many cytochemical techniques have evolved for the demonstration of leucocyte 
lineage-associated enzymes. One of the enzyme groups of normal and neoplastic blood 
cells that has been extensively studied by cytochemical techniques, and more recently 
with biochemical and electrophoretic methodologies is the so-called "non-specific 
esterase" system. 
Nonspecific esterases (NSE) are widely distributed in numerous cell types and in 
leucocytes they are demonstrated by the hydrolysis of short acyl chain esters of alpha-
naphthol. Although their physiological role remains poorly understood, the cytochemical 
demonstration of esterase activity represents an integral part of the classification of acute 
leukaemia. In particular, recent biochemical studies provide substantial evidence that the 
specific monocytic maturational commitment from pluripotential myeloid precursors is 
associated with the synthesis and expression of distinct esterase isoenzyme forms. This 
Chapter will discuss the general concepts of myeloid cell maturation, the known 
cytochemical and biochemical characteristics of leucocyte esterases and the theoretical 
aspects of isoenzymes. Subsequent Chapters analyse the cytochemical and molecular 
(electrophoretic and chromatographic) characteristics of myeloid esterases, including their 
purification, and discuss the findings in the context of current concepts of myeloid cell 
differentiation programmes. 
1.2 NORMAL AND LEUKAEMIC MYELOID CELL MATURATION  
1.2.1 Myeloid maturation: General Concepts Conventional morphological 
features have proved useful for establishing cell function (particularly at the ultrastructural 
level) as well as for delineating patterns of maturation for normal and neoplastic cells. 
Traditional morphological boundaries are defined by criteria such as cell size, ratio of size 
of nucleus to cytoplasm, fineness of chromatin, shape of nucleus, the presence or 
3 
absence of nucleoli, the presence and type of cytoplasmic granules, and the cytoplasmic 
colouration of Romanowsky-stained cells. Since changes in nuclear chromatin and cell 
size occur during each replication stage, and as the formation of granules and other 
cytoplasmic constituents occur gradually during the stages of cell development, 
morphological definitions are necessarily arbitrary and do not always parallel biochemical 
or physiological changes. In some cases, it is difficult to classify a cell into one category 
or another, since cell development does not occur as step-like transformations but by 
gradual transition. Consequently, the individual myeloid differentiation stages described 
below should be regarded simply as 'snap-shots' of a maturational continuum. One other 
basic consideration is that since a cell is composed of several component parts, each must 
undergo transformation. In normal haemopoiesis, these transformations are simultaneous 
and closely associated (i.e. developmental 'synchronism'). However, abnormal and 
neoplastic process may be characterised by differential maturation between, particularly, 
the nucleus and cytoplasm. This aberrant process is referred to as 'asynchronism' or 
'maturation asynchrony'. 
1.2.2 Granulocytic differentiation: The earliest recognisable granulocyte 
precursor is the myeloblast. With progressive maturation this sequentially develops to the 
promyelocyte, myelocyte, metamyelocyte, 'band' form and finally the mature, functional 
granulocyte (polymorphonuclear neutrophil). The transformation of a myeloblast to a 
mature granulocyte takes 10-15 days, the greater part of this process being in the bone 
marrow, resulting in an eight fold increase in their number. Cellular division occurs up to 
and including the myelocyte stage, and this is followed by unidirectional maturation to the 
neutrophil. It is generally agreed that neutrophil, eosinophil and basophil precursors are 
indistinguishable by light microscopy until the myelocyte stage, when specific granules 
(i.e. neutrophilic, eosinophilic and basophilic) are formed. 
1.2.2.1 Myeloblast:  These cells are often indistinguishable from lymphoid precursors 
and comprise approximately 1-5 percent of normal marrow cells. Morphologically, the 
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cytoplasm is moderate in quantity and deeply basophilic due to the presence of RNA. 
Cytoplasmic granulation is usually insignificant but some granules may occasionally be 
seen in more mature myeloblast forms. As myeloblasts are mitotic and represent one of 
the earliest stages of myeloid development, their morphological and cytochemical 
appearances show considerable variation. This is particularly true in acute leukaemia 
where the proliferating myeloblasts may show different levels of 'maturation arrest'. 
Another morphological feature associated with leukaemic myeloblasts, is the presence of 
rod-shaped cytoplasmic inclusions derived from primary granules [White, 1967; Wetzel, 
1970]. These distinctive structures, which are widely known as Auer bodies (rods), 
share the cytochemical characteristics of primary granules [Harada, 1951; Goldberg, 
1964] . 
1.2.2,2 Pronuelocyte: Developmental stages following the myeloblast have been 
classically differentiated on the basis of the number and type of granules. The 'non-
specific azurophilic' or primary granules are predominantly synthesised at the 
promyelocyte stage and have been identified by fine structural studies as being a common 
characteristic of the neutrophil, eosinophil and basophil series [Ackerman, 1968; Scott & 
Horn 1970; Bainton et al., 1971]. Morphologically, the promyelocyte is the largest of the 
granulocyte precursors. The nucleus has a similar chromatin pattern to the myeloblast but 
the nucleoli tend to be less conspicuous. Cytoplasmic granulation is however distinctive 
and although the synthesis of these primary granules is restricted to promyelocytes, 
primary granules persist through all subsequent developmental levels including mature 
polymorphonuclear forms [Bainton & Farquhar, 1966; Scott & Horn 1970; Bainton et 
al., 1971]. Primary granules characteristically contain lysosomal enzymes such as acid 
phosphatase, myeloperoxidase, esterases, lysozyme, and beta-glucuronidase [Bainton & 
Farquhar, 1966, 1968a, b; Wetzel et al., 1967; Zeya & Spitznagel, 1969; Bainton et al., 
1971]. Compared to their normal counterparts, the promyelocytes of most acute 
promyelocytic leukaemias (APL-M3) are typically hypergranular; the cytoplasm of these 
cells being densely populated with coarse, intensely staining azurophilic granules, which 
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tend to obscure the nuclear border. In addition, the nuclear contour is frequently irregular 
and in some cells the nucleus may be folded, bilobed or reniform in appearance, 
resembling an immature monocyte nucleus [Hillestad, 1957; Bernard et al., 1963; Sultan 
et al., 1973; Bennett et al., 1976]. The cytoplasm often exhibits randomly distributed 
bundles of Auer rods (faggots') characteristic of a leukaemic process [Breton-Gorius & 
Houssay, 1973; Sultan et g., 1973; Bennett et al., 1976; McKenna et al., 1982]. A 
variant form of acute promyelocytic leukaemia (M3-Hypo), in which the promyelocytes 
show relatively little cytoplasmic granulation has also been described [Golomb et al., 
1980; Bennett et al., 1980]. In common with the hypergranular form of APL-M3 
however, these hypogranular promyelocytes exhibit distinctive nuclear lobulation or 
convolutions and patients with M3-Hypo also show a chromosomal 15:17 translocation, 
[Rowley et al., 1977; Van Den Berghe et g., 1979; Golomb et al., 1980]. 
1.2.2.3 myelocyte: The myelocyte may be defined as the stage of granulocytic 
differentiation at which specific (secondary) granules appear in the cytoplasm. 
Consequently, these cells can be identified as being neutrophilic, eosinophilic or 
basophilic depending on lineage commitment. Concomitant with the production of 
secondary granules, the active synthesis of primary granules ceases at this maturational 
stage and their numbers decrease with successive mitotic divisions (mitodilution) 
[Ackerman & Bell los, 1955; Bainton & Farquhar, 1966]. Neutrophilic secondary 
(specific) granules are smaller than primary granules and are formed in increasing 
numbers on the convex surface and lateral borders of the somewhat less prominent Golgi 
cisternae [Bainton & Farquhar, 1966; Ackerman, 1968]. These granules show little 
peroxidase or acid phosphatase activity but do contain aminopeptidases, lysozyme, 
collagenase and other basic proteins [Wetzel el al., 1967; Zeya & Spitznagel, 1969; 
Bainton et al., 1971]. 
1.2.2.4 Metarnyelocyte and 'Band' Forms:  As the myelocyte matures to the non-mitotic 
metamyelocyte, the cytoplasm assumes the characteristics of mature granulocytes. The 
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nuclear chromatin becomes coarser, the nucleus indented and cytoplasmic granulation 
becomes particularly evident. The intermediate stage between the metamyelocyte and the 
mature polymorphonuclear granulocyte is variously described as the 'band', 'stab' or 
'juvenile' form. In these granulocytes, the nuclear chromatin is further condensed but the 
nuclear shape, which may be curved (horseshoe) or coiled, remains non-segmented. The 
cytoplasm becomes progressively less basophilic and the number of organelles, other 
than secondary granules, decrease. This cell type is the most immature cell of the 
granulocyte series that may be seen in normal peripheral blood. 
1.2.2.5 Po4ymolphonuclear Granulocytes: The mature neutrophilic granulocyte is 
essentially differentiated from its immediate (non-segmented) precursor by distinct 
nuclear lobulation. The cytoplasm lacks basophilia and contains fine secondary granules. 
The primary function of a mature neutrophil is phagocytosis of small foreign particles 
such as bacteria. The neutrophil, being a migratory cell, performs most if not all of its 
functions after leaving the blood stream; which it achieves via the endothelial cells of 
venules [De Vargas-Linares & Burgos, 1964]. Neutrophil migration is stimulated by 
chemotactic factors, produced in response to formation of antigen-antibody complexes, 
leucocyte debris and many other physiological factors. This migration occurs 
continuously into sites such as the oral cavity, lungs, and gastro-intestinal tract [Ambrus 
& Ambrus, 1959]. Neutrophil phagocytosis can occur in the absence of antibody or 
complement protein although, the process is greatly enhanced if the foreign particle is 
opsonised (i.e. coated by antibody or complement). 
1.2.3 Monocvtic differentiation: Monocytes develop from immature myeloid 
precursors in the bone marrow. Mature monocytes migrate from the blood to tissue sites 
such as the liver, spleen, lung, and lymph nodes where they function in their terminally 
differentiated state as free or fixed macrophages. Promonocytes are the earliest 
recognisable precursors of monocytes found in normal bone marrow. The immediate 
precursor of the promonocyte is not known although possible candidates include the 
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hypothetical monoblast, myeloblast or promyelocyte. Morphologically, the promonocyte 
cytoplasm is relatively basophilic, containing peroxidase positive azurophilic granules and 
the nucleus is folded with fine chromatin and prominent nucleoli. Granule numbers 
decrease with subsequent division and they are not replaced by specific granules [Hirsch 
& Fedorko, 1970]. 
Mature monocytes may be readily discriminated from other cells in Romanowsky-stained 
preparations. The nuclear chromatin is moderately condensed, the nucleus is indented or 
folded and no nucleoli are observed. Cytoplasm is abundant, grey-blue in colour and 
contains fine dust-like peroxidase positive granules, which give the monocyte cytoplasm 
its characteristic ground-glass appearance. Monocyte granules contain acid phosphatase, 
beta-glucuronidase and cathepsin [Cohn & Benson, 1965]. Other hydrolases such as 
esterase, acid ribonuclease and lysozyme are also found in monocytes though their sub-
cellular location is unclear. Lysosomes (dense granules) arise by a process in which 
enzyme-containing vesicles (primary lysosomes budding from the Golgi apparatus) fuse 
with pinocytic vacuoles. They differ from the specific granules of granulocytes, which 
are formed at the promyelocyte stage and represent primary lysosomes. Synthesis of 
lysosomal enzymes by monocytes is stimulated by activation of the cell, for example 
during phagocytosis of biological material [Cohn & Benson, 1965; Cohn, 1970]. 
1.3 LEUCOCYTE ESTERASES  
1.3.1 Cvtochemical characteristics 
1,3.1.1 Evolution of cytochemical methods: Esterases are a group of enzymes capable 
of hydrolysing a variety of aliphatic and aromatic esters. 'Tweens' were introduced as 
substrates in 1945 [Gomori, 1945] for the demonstration of esterases in fixed tissue 
sections, but these gave crude results and received only cursory descriptive studies. 
Several years later, the first azo dye coupling method for esterases, adapted from earlier 
methodology by Menten et al., [19441 for alkaline phosphatase, was introduced by 
Nachlas & Seligman 11949]. This involved the hydrolysis of beta-naphthyl acetate by 
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esterases present in acetone-fixed tissue sections with the simultaneous capture of the 
liberated naphthol by a diazonium salt. Although this resulted in a brightly coloured and 
insoluble azo-dye-product complex, the staining was not topographically precise as lateral 
diffusion occurred due to slow coupling. Gomori 119521 subsequently recommended 
that beta-naphthyl acetate be replaced by the alpha-isomers or by naphthol AS acetate (2- 
acetoxy-3 naphthoic anilide) in order to minimise diffusion artefacts. Naphthol AS 
acetate in particular was hydrolysed more slowly than the simpler naphthyl acetate, but 
yielded a highly insoluble and substantive azo-dye product, with a corresponding 
improvement in localisation. Other investigators [Pearse, 1954; Burstone, 1957: 
Gossner, 1958] achieved somewhat more precise localisation of azo-dyes, in relation to 
sites of enzymatic activity, by substituting the more insoluble naphthol AS derivatives for 
the parent compound. Wachstein & Wolf 11958] later used naphthol AS acetate as 
substrate and demonstrated esterase activity in all types of human blood and marrow 
cells. However, when using alpha-naphthyl acetate as substrate, Braunstein 119591 was 
able to demonstrate esterase activity only in monocytes. Subsequently, Fischer and 
Schmalzl [1964] showed that the esterase activity of monocytes was sensitive to sodium 
fluoride (NaF) inhibition whilst that of granulocytes was relatively resistant to NaF. 
Additionally, Gomori [1953] reported the use of chloroacyl esters as histochemical 
substrates for the demonstration of chloroacetate esterases. Consequently, the differing 
reaction patterns with various substrates, together with the observation that the 
predominant esterase species in monocytes but not granulocytes was NaF sensitive, 
strongly suggested the existence of multiple esterase forms in human blood cells. 
1.3.1.2 Demonstration of cellular esterases - Reaction Principles: The cytochemical 
visualisation of esterases is achieved by the formation of insoluble coloured precipitates 
at, or near, the site of substrate hydrolysis. The most commonly employed substrates 
currently used for the demonstration of leucocyte esterases are acetate, propionate and 
butyrate esters of alpha-naphthol (ANA, ANP and ANB respectively) and naphthol AS-D 
chloroacetate (NASDCA). Alpha-naphthyl acetate, propionate and butyrate substrates 
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show progressive increases in acyl chain lengths of C2, (CO.CH3), C3, (CO.C2H5) and 
C4, (CO.C3H7) respectively and are produced by reactions between alpha-naphthol and 
acetic, propionic or butyric acid. As a result of enzymic hydrolysis, free alpha-naphthol 
is liberated and this subsequently forms an insoluble coloured (azo-dye) product through 
its spontaneous coupling with a suitable and soluble diazonium salt (e.g. hexazotised 
pararosaniline, New Fuchsin or Fast Blue BB; Table 1.1). As diazonium salts are 
unstable compounds, which readily form more stable but inactive isodiazotates [Pearse, 
1968], active salts need to be prepared immediately prior to use by diazotising base dyes 
with nitrous acid. Figure 1.1 schematically illustrates the hydrolysis of alpha-naphthyl 
acetate and subsequent capture of liberated alpha-naphthol by the diazonium salt to 
produce an insoluble azo-dye. Similar reaction principles are applicable to the hydrolysis 
of propionate and butyrate esters. 
1.3.13 Esterase cytochemistiy: Leucocyte esterases are divided into two main groups; 
the chloroacetate esterases and the so-called 'non-specific' esterases (NSE). NSE 
enzymes hydrolyse simple esters of alpha-naphthol although they may also act on amide 
derivatives [Myers, 1960] and fatty acid esters [Pearse, 1972]. In haematological 
cytochemistry, esterases are commonly referred to by the substrates used for their 
demonstration, hence the terms alpha-naphthyl acetate esterase (ANAE) and chloroacetate 
esterase (CAE). The NSE reaction is routinely performed using either alpha-naphthyl 
acetate or butyrate as substrate [Yam et al., 1971; Li et al., 1973, 1986], both of which 
are hydrolysed by esterases associated with cells of monocytic-lineage, megakaryocytes, 
platelets, lymphocytes and plasma cells (Table 1.2). The butyrate substrate has been 
reported to show a more specific reaction for monocytic esterases [Ainsley et al., 1971; Li 
et al., 19731, although macrophages, megakaryocytes and mature T-lymphocytes may 
also show positive reactions. Some hydrolysis of alpha-naphthyl esters by chloroacetate 
esterase may occur although this is only observed following prolonged incubation at an 
alkaline pH [Li et al., 1973; 1986]. 
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Compared to the normally unreactive mature granulocytic elements, some myeloblasts 
tend to show weak cytoplasmic ANAE staining, of granular or diffuse type, which may 
be very weak or absent with the butyrate substrate. Monocytes and macrophages usually 
exhibit intense diffuse cytoplasmic staining with both acetate and butyrate substrates, the 
reaction being relatively sensitive to sodium fluoride (NaF) inhibition [Li et al., 1973]. 
Electron microscopic (EM) studies have revealed that the distinctive esterases of 
monocytes are localised on the external surface of the plasma membrane and are thus 
ectoenzymes [Monahan et al., 1981]. In contrast to monocyte esterases, lymphocyte 
esterases appear to be associated with clusters of smooth membrane vesicles in the 
cytoplasm [Marec et al., 1981; Monahan et al., 1981; Zicca et al., 19811, and 
cytochemical reactivity of T-lymphocytes is usually seen as one to three discrete 'dots' in 
the cytoplasm. This dot or focal type reaction observed in lymphocytes has been 
correlated with mature helper-T-lymphocytes, exhibiting CD2, CD3 and helper-T-ce]l 
antigen (CD4) [Zicca et al., 1981; Bernard & Dufer, 19831. B-lymphocytes usually 
show negligible NSE cytochemical staining as do leukaemic B- and T-Iymphoblasts. 
Megakaryocytes may also show an intense diffuse cytoplasmic reaction with the acetate 
ester but a much weaker reaction with the butyrate substrate [Li et al., 1973J. Platelets 
show similar ANAE staining patterns to monocytes; again the reaction products have been 
shown by EM to be localised to the external surface of the plasma membrane [Bozdech & 
Bainton, 1981; Boesen, 1984]. 
13,1.4 Diagnostic value of NSE cytochemistry in leukaemia: The cytochemical 
demonstration of leucocyte alpha-naphthyl acetate (ANAE) or butyrate (ANBE) esterase 
reactivity is widely used for the delineation of haemopoietic cells showing monocytic 
differentiation. ANAE/ANBE reactivity of normal and leukaemic monocytes is 
characteristically of a moderate to strong diffuse type and is invariably weak or absent in 
normal granulocytic components. Consequently, this cytochemical procedure is widely 
used for the identification of monocytic components in acute monocytic leukaemia 
(AMoL-M5), acute myelomonocytic leukaemia (AMML-M4) and chronic 
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myelomonocytic leukaemia (CMML). Although these enzymes are reliable markers for 
the demonstration of monocytic involvement in myeloid leukaemias, recent studies have 
shown that monocytic components in approximately 15% of morphologically and 
immunologically defined AMoL-M5 cases show weak or negative ANAE and ANBE 
reactions [Hayhoe & Cawley, 1972; Rodgers et al., 1982; Scott et al., 1983. 1985, 1987; 
Milligan et al., 1984]. Furthermore, whilst normal myeloblasts and cells of granulocytic 
lineage typically lack demonstrable ANAE or ANBE activity, weak to moderate ANAE 
reactivity is often seen in leukaemic myeloblasts and the promyelocytes of acute 
promyelocytic leukaemia (APL-M3 hypergranular variant) [Bennett et al., 1976, 1980; 
Scott et al., 1989]. As atypical esterase cytochemistry in acute leukaemias may be 
difficult to interpret, in terms of diagnostic classification and assessment of lineage, a 
number of modifications to standard cytochemical procedures have been introduced. 
These include both the use of alternative short acyl chain (C2-C4) substrates and the 
incorporation of enzyme inhibitors. For example, it has been suggested that the use of 
alpha-naphthyl butyrate may be more definitive than acetate for the demonstration of 
monocytic esterase activity [Ainsley et al., 1971; Li et al., 1973], and the incorporation of 
sodium fluoride in the staining procedure has been promoted as a specific inhibitor of 
monocytic esterase activity [Li et al., 1973; Hayhoe & Quaglino, 1980]. 
In addition to standard esterase (NSE) cytochemical procedures, it is also possible to 
simultaneously demonstrate ANAE and chloroacetate esterase (CAE) on the same blood 
or bone marrow film. This is most effectively achieved by sequentially staining for the 
two esterase enzyme types with different colours in two separate incubation mixtures 
[Yam et al., 1971]. The technique is of particular value in observing the atypical esterase 
staining of granulocytes in the hypergranular variant of acute promyelocytic leukaemia 
and some myelodysplastic syndromes (MDS). In hypergranular AML-M3, the 
promyelocytes often stain for both ANAE and CAE [Grusovin & Castoldi, 1976; Rydell, 
1979; Bennett et al., 1980; Stavem et al., 1981; Scott et al., 1983; Tomonaga et al., 
1985], a phenomenon rarely observed in other leukaemias. 
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1.3.2 	 Biochemica I c ha racteristics,  
1.32.1 Introduction: Early attempts at classifying esterases were largely based on their 
ability to hydrolyse aliphatic (ali-esterases) or aromatic (arom-esterases) esters. Aldridge 
[1953] subsequently extended this by proposing the categorisation of esterases based on 
their relative resistance or sensitivity to organophosphorous compounds. In this way, 
esterases which were not inhibited by organophosphates were designated 'A-esterases' 
and those that were sensitive were classified as 'B-esterases'. Additionally, a third type 
known as PC-esterases' were described [Kirsch, 1971] and these were defined by both 
their resistance to organophosphates and their preferential hydrolysis of acetic acid esters. 
The biochemically-based Enzyme Commission [IUPAC-IUB, 1978] classification for 
enzymes acting on ester bonds has recommended their subdivision into various parent 
groups (EC 3.1.1 through 3.1.31) depending on the chemical nature of the ester bond 
being hydrolysed. The histochemically important esterases are grouped under the generic 
title, 'carboxylic ester hydrolases' (EC 3.1.1) and are further categorised into three main 
groups; carboxylesterases (EC 3.1.1.1), arylesterases (EC 3.1.1.2) and acetylesterases 
(EC 3.1.1.6) based on the type of substrate being hydrolysed and sensitivity to various 
inhibitors (Tables 1.3 and 1.4). In general, ali- or B-esterases are broadly represented by 
the carboxylesterases, the arom- or A-esterases by arylesterases and the C-esterases by 
acetylesterases. In addition, carboxylesterases characteristically hydrolyse straight-chain 
(aliphatic) esters, as well as naphthol esters, arylesterases hydrolyse cyclic (aromatic) 
esters and (strictly speaking) esters of phenol, whereas acetylesterases preferentially 
hydrolyse esters of acetic acid and are resistant to the action of organophosphates and 
sulphydryl blocking agents. 
Classifications based on substrate characteristics are clearly valid for most enzyme 
systems. However, due to their wide substrate specificity, the sub-categorisation of 
esterases may be of limited value [Pen & Beintema, 1986; Wienker & Deimling, 1987]. 
According to the recommendations of the IUB [1978], most leucocyte esterases would be 
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categorised as carboxylesterases (EC 3.1.1.1) as they hydrolyse carboxylic esters and do 
not share the inhibitor/activator characteristics of the other groups of histological esterases 
described by EC 3.1.1 (Table 1.3 and 1.4) [Holmes & Masters. 1967; Oertel & Kastner, 
1984]. In haematological terms, the rather vague term 'nonspecific esterase' (NSE) is 
applied to all enzymes which hydrolyse simple esters (e.g. alpha-naphthyl acetate), even 
though their cellular origins and cytochemical reactivities may vary considerably. For the 
purposes of this current study, and in order to avoid unnecessary confusion, the so-called 
'nonspecific' and 'specific' leucocyte esterases described in the text will subsequently be 
referred to as alpha-naphthyl acetate (or butyrate) esterases (ANAE/ANBE) and 
'chloroacetate esterases' (CAE) respectively. The other groups of carboxylic ester 
hydrolases such as acetylcholinesterases (EC 3.1.1.7) and cholinesterases (EC 3.1.1.8) 
may be of some histochemical interest, but their concentration in leucocytes is generally 
low [Zajicek et al., 1954]. 
1.3.2.2 Substrate reactivities of esterases: Using the combined techniques of zone 
electrophoresis and histochemical staining [Hunter & Markert, 1957], multiple isoenzyme 
forms of esterases have been shown to occur in the human liver [Paul & Fottrell, 196 1], 
brain [Barron et al., 1963; Lagnado & Hardy, 1967], muscle [Ecobichon & Kalow, 
1965], kidney [Ecobichon & Kalow, 1964], red cells [Tashian, 1961, 1969], leucocytes 
[Shows, 1972a; Li et al., 1973; Radzun et al., 1980; Yourno & Mastropaolo, 1981] and 
plasma [Harris et al., 1962]. In certain cases, these isoenzymes are relatively specific for 
particular substrates and are identified as tissue-specific enzymes (e.g. cholinesterases 
and acetylcholinesterases). However, the majority of esterases exhibit broad and 
frequently overlapping inhibitor and substrate reactivities (Tables 1.3 and 1.4). Indeed, 
not only do esterases act on ester bonds but they may also catalyse the hydrolysis of 
amide bonds and be involved in processes of transacylation [Myers et al., 1957: Mentlein 
et al., 1980]. Consequently, there may occasionally be difficulties in assigning an 
esterase to a particular enzyme group since it may display properties characteristic of more 
than one group. For example, some proteolytic enzymes such as trypsin (EC 3.4.21.4) 
14 
and chymotrypsin (EC 3.4.21.1) are capable of hydrolysing carboxylic esters and can be 
inhibited by esterase inhibitors such as diisopropyl fluorophosphate and diethyl-p- 
nitrophenyl phosphate [Dixon et 
	 1958]. 
Leucocyte-associated esterases in their strictest sense catalyse the hydrolysis of uncharged 
carboxylic esters [Kirsch, 1971] but may also act on esters of fatty acids or glycerol 
INachlas & Seligman, 1949], a property usually associated with lipases. Despite these 
overlaps in substrate specificity, carboxylesterases may be regarded, in general terms, as 
enzymes which act on esters of short-chain glyceryl and simple monoesters (acyl chain-
lengths of C2-C4) whereas lipases act on longer chain (fatty acid) esters (C8 or more) 
[Khoo & Steinberg, 1975]. 
13.2,3 Inhibitor studies of esterases: Due to the heterogeneous nature of esterases and 
lack of knowledge of physiological substrates, their characterisation has been additionally 
dependent on inhibitor studies. The classification of arylesterases, carboxylesterases and 
acetylesterases is traditionally based on their activities in presence of organophosphates 
such as diisopropyl fluorophosphate (DFP) or diethyl p-nitrophenyl phosphate (E600) 
[Dixon & Webb, 1964; Chayen 41., 1969]. Organophosphate inhibition appear to 
result from the ability of these compounds to compete with the ester substrate for binding 
to the active site of the enzyme. Thereafter, instead of an enzyme-acyl complex 
formation, as is the case with the normal substrate, the enzyme becomes phosphorylated. 
The rate at which the phosphorylated enzyme can be hydrolysed is much slower than the 
acylated form consequently, resulting in inhibition. With weaker inhibitors, this 
hydrolysis does occur at a measurable rate and the enzyme may eventually become fully 
active again. On the basis of organophosphate inhibition, carboxylesterases are generally 
sensitive whereas acetylesterases and arylesterases are resistant. For comparison, 
trypsin, chymotrypsin, plasmin and thrombin are also sensitive to these organophosphate 
compounds. 
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Sodium fluoride (NaF) is the most widely investigated inhibitor of esterase cytochemical 
activity. Early observations indicated that the inhibitory action of this compound could be 
used to specifically differentiate cells of monocytic lineage. However, the atypical 
esterase cytochemical activity of some myeloblastic leukaemias may also be inhibited at 
higher NaF concentrations (1.0mg/m1) [Li et al., 1973], even though there are clear 
differences in monocytic and non-monocytic reactions when examined according to 
relative inhibitor sensitivity. Indeed, detailed inhibition studies of monocytic esterase 
isoenzymes, separated by electrophoretic techniques, indicate a thirteen-fold increased 
sensitivity of these isoenzymes to NaF as compared to isoenzyme forms of higher IA 
(Section 1.3.2.4) common to both monocytes and granulocytes [Scott et al., 1984a, b, 
c]. Consequently, the specificity of NaF inhibition for monocytic esterases should be 
regarded as a 'relative' (rather than specific) phenomenon because both myeloid esterase 
activities (monocyte-associated and common) have been demonstrated to be inhibited by 
this compound [Scott et al., 1984a, b, c; Drexler et al., 1985]. NaF inhibition of myeloid 
esterase activity has been found to be reversible, but it is not known whether NaF directly 
inactivates the 'native' esterase or acts on the acylated enzyme [Scott et al., 1984c]. For 
comparison, chloroacetate esterases are resistant to NaF inhibition [Moloney et al., 1959; 
1960]. 
Other compounds, such as sodium taurocholate, have been used [Burstone, 1962] to 
differentiate (by activation rather than inhibition) lipases and esterases, and 
cholinesterases may be further characterised by their relative sensitivity to eserine [Pearse, 
1972]. Sulphydryl blocking reagents such as p-Hydroxymercuribenzoic acid (HMBA) 
and related compounds have also been reported to inhibit arylesterases and activate 
acetylesterases [Burstone, 1962; Webb, 1966; Holmes & Masters, 1967; Bulmer & 
Fisher, 1970]. 
1.3.2.4 Haemopoietic cell esterase isoenzymes:  Distinct differences in the esterase 
cytochemical staining patterns of normal and neoplastic blood cells stimulated a number 
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of biochemical and electrophoretic investigations which were designed to assess whether 
or not these variable cytochemistries could be attributed to differences in esterase 
isoenzyme distributions. 
Li et al., [1973] first detailed the substrate specificity and cellular distribution of leucocyte 
esterases separated by polyacrylamide gel electrophoresis (PAGE) at pH 4.0. A total of 
nine different enzyme bands, displaying esterolytic activity, were resolved using this 
technique. Bands 1, 2, 7, 8 and 9 were best demonstrated with naphthol AS-D 
chloroacetate as substrate (CAE activity), and bands 3, 4, 5, and 6 preferentially 
hydrolysed alpha-naphthyl esters. With the recognition of multiple isoenzyme forms, 
alternative methods were applied in an attempt to clarify the esterase isoenzyme 
distribution of normal and neoplastic cell lineages. Other investigators, using the 
techniques of vertical or horizontal PAGE confirmed and extended the findings of Li and 
colleagues [Kass & Peters, 1978; Yourno & Mastropaolo, 19811. These standard 
electrophoretic techniques, while demonstrating for the first time major differences 
between esterases of different normal and leukaemic cell types, also revealed areas of 
diffuse staining suggesting the possible occurrence of additional unresolved components 
[Kass & Munster, 1979a; 1979bJ. 
The introduction of isoelectric focusing (IEF), using ampholyte carriers to generate pH 
gradients within a polyacrylamide gel, considerably improved the resolution of individual 
isoenzyme components which were otherwise not resolved by conventional 
electrophoretic methods. Using the high-resolution IEF technique, multiple esterase 
isoenzymes with differing isoelectric points (p1) have been demonstrated and shown to 
exist in a cell-associated manner [Radzun gt 1., 1980; Radzun & Parwaresch, 1980; Scott 
1984a; Oertel & Kastner, 1984; Cohn e_t al., 1987]. Composite IEF zymograms 
for most haemopoietic elements have been documented by a number of independent 
investigators [Radzun ell., 1980; Parwaresch e_t al., 1981; Scott ei al., 1984a, b; Cohn 
et al., 1987]. Whilst minor discrepancies have been reported in esterase isoenzyme 
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distribution profiles, these differences could largely be attributed to differences in 
experimental procedures. Of particular importance, was the finding that the cytochemical 
esterase activity of normal and leukaemic monocytes (and macrophages) was specifically 
associated with a group of acidic esterase isoenzymes within a narrow pI range of 5.5 to 
6.2. In contrast. esterase zymograms of purified granulocytes were reported to show up 
to 11 isoenzyme forms displaying a broader pl range of 6.3 to 8.3. These latter 
isoenzymes were additionally found to be expressed by other myeloid cell types [Radzun 
et al., 1980]. 
Fractionation of esterases from leukaemic monocytes, by a combination of anion-
(DEAE, pH 7.5) cation-exchange (CM, pH 5.0) chromatography, has been reported to 
result in four peaks of enzyme activity, each displaying differing substrate specificities 
[Lam et al., 1978]. Attempts have also been made to determine the molecular weights of 
different esterase enzyme species, using various electrophoretic and gel filtration 
techniques. However, many of the initial studies examined animal liver carboxylesterases 
and molecular weights of 160-170 kDa are frequently quoted [reviewed by Krisch, 
1971]. Considerably lower molecular weights, in the region of 50-60 kDa, have also 
been reported for animal carboxylesterases [Barker & Jencks, 1969; Ecobichon, 1969; 
Heymann et al., 1971; Cohn et al., 1987] but inter-relationships between the two 
molecular weight species remains poorly understood. 
1.4 ISOENZYMES; THEORETICAL CONSIDERATIONS,  
1.4.1 Introduction: Enzymes often occur as various molecular forms, each of which 
may display differing physicochemical properties. The original terminology used to 
describe these different forms of the same enzyme was isozymes [Markert & Moller, 
1959], this was later changed to isoenzymes [Wroblewski & Gregory, 1961]. 
Isoenzymes essentially describe enzyme molecular and/or biochemical heterogeneity. 
This protein heterogeneity can occur as a result of various factors and these may be 
categorised into two main types; (a) genetic or primary factors, where multiple genes 
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encoding different enzyme subunits are present, or (b) post-translational or secondary 
factors, where homogeneous enzymes or subunits comprising the active enzyme, are 
modified differentially leading to the synthesis of multiple isoenzyme forms from a single 
gene product. The current definition recommended by the Commission of Biological 
Nomenclature [1977] states that the term isoenzyme should only be used to describe 
multiple forms of enzymes arising within a single species from genetically determined 
differences in the primary structure. Strictly speaking, this therefore excludes multiple 
enzyme forms derived from post-transcriptional or post-translational modifications, 
which are often referred to as secondary isoenzymes. 
L4.2 Primary isoenzymes:  Primary isoenzymes are genetically derived, either as a 
result of multiple allelism at a single gene locus, determining structurally distinct versions 
of a particular polypeptide chain, or as a result of multiple gene loci, coding for 
structurally distinct polypeptide chains of the enzyme. 
1.4.2.1 Multiple allelisrn: In a diploid genome, each gene locus possesses two alleles for 
which an individual may be homozygous (both alleles identical) or heterozygous (both 
alleles different). Homozygous individuals will produce a single species of protein, this 
enzyme varying from individual to individual. depending on the alleles present at the 
locus in question [Harris & Hopkinson, 1976i. In the heterozygous individual the two 
different allelic variants encode two different polypeptide chains thus in heterozygous 
individuals monomeric enzymes can be present as two different isoenzyme forms, 
dimeric enzymes as three isoenzyme forms, trimeric as four forms and so on assuming 
unrestricted random association of subunits. Within any individual, the degree of enzyme 
heterogeneity resulting from multiple allelism is limited. However, intra-species 
variations may be considerable depending on the variety of allelic forms, for the locus, 
present in the species gene pool. Isoenzymes resulting from multiple allelism are also 
referred to as "allozymes". 
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1.4.2.2 Multiple gene loci: Although multiple gene loci coding for structurally distinct 
isoenzymes are well established for many enzyme systems, their occurrence defies to 
some extent the normal biological regulatory mechanisms which occur during gene 
duplication [Marken, 1987]. For example, it is known that mutations can arise during 
gene duplication, resulting in the formation of variant genes. In general however, only 
one copy of each structural gene is allowed to be present in the genome and consequently, 
the replicate variant is destroyed through specific degradation if it is not a perfect copy of 
the original gene. In the case of multilocus isoenzyme systems these replicate variant 
genes are preserved and furthermore, are thought to acquire the status of independent 
regulation. Survival of the replicated genes appears to be enhanced by translocation to a 
different part of the genome, either within the same chromosome or to a different 
chromosome. It is possible that a new genomic position facilitates independent 
regulation. Isoenzymes derived by way of multiple gene loci therefore may not only 
display structural and physicochemical differences but, more significantly, may be 
synthesised in a cell or tissue specific manner [Markert & Moller, 1959; Markert, 1963; 
1964]. These characteristics are attributed to the belief that replicate genes acquire the 
status of independent regulation. 
In a multilocus isoenzyme system, each gene locus encodes a related but distinct 
polypeptide chain. For monomeric enzymes, the isoenzyme forms generated are usually 
distributed in different cellular compartments; examples of this include cytoplasmic and 
mitochondrial isoenzyme forms of malate dehydrogenase, isocitrate dehydrogenase, 
superoxide dimutase, glutamate oxaloacetate transaminase and fumarate hydratase [Harris 
& Hopkinson, 1976]. In all these cases the cytoplasmic and mitochondria! forms are 
encoded by separate genes and the gene loci for these enzymes may be located on 
different chromosomes, as in the case of human isocitrate dehydrogenase. For this 
particular enzyme, the soluble cytoplasmic form is encoded by a gene on chromosome 2 
and the mitochondrial form by a gene on chromosome 15 [Shows, 1972b; Turner et al., 
1974]. 
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For oligomeric enzymes. each different gene locus encodes a distinct subunit of the 
functionally active enzyme. The subunit associations in these enzymes can then lead to 
variant forms of true isoenzymes displaying different biochemical and physicochemical 
properties [Moss, 1982]. The number of isoenzyme forms generated effectively depends 
on the number of gene loci in the particular multilocus system, and also the numbers of 
subunits required to produce an active enzyme molecule. For example, in the multilocus 
system encoding the isoenzymes of lactate dehydrogenase (LDH), which is a tetrameric 
enzyme, there are three separate gene loci which give rise to 15 different isoenzymes (i.e. 
three homogeneous and 12 heterogeneous). Thus, if the subunits of LDH are designated 
A, B, and C, the subunit composition of the possible isoenzymes (assuming random 
subunit association) would be A4, A3B, A2B2, AB3, B4, A3C, A2C2, AC3, C4, B3C. 
B2C2, BC3, ABC2, A2BC, and AB2C. 
The complexity of isoenzyme forms may be further compounded if allelic variation occurs 
in addition to multiple loci. Again using vertebrate LDH as an example, there are allelic 
variants of subunits A and B. An organism doubly heterozygous for these variants could 
synthesise five different subunits and consequently a much larger range of tetrameric 
isoenzymes. 
The main difference between multiple allelism and gene loci as causes of isoenzyme 
formation is that multiple allelism results in differences in the pattern of isoenzymes of 
individual members of a species, while multiple gene loci are in general, common to all 
members of a species. 
1.4.3 Secondary isoenzymes: Isoenzymes generated by modification at post-
translational level, rather than at genetic level, are not true isoenzymes and are generally 
referred to as secondary isoenzymes [Shaw, 1969]. These post-synthetic modifications, 
either by addition of carbohydrate residues, limited proteolysis, or covalent modification 
of amino acid side chains may all lead to the generation of multiple molecular enzyme 
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forms with apparent differences in molecular charge, molecular weight, substrate 
specificity, and inhibitor characteristics. Post-synthetic alterations, leading to 
heterogeneity in homogeneous proteins, is a well documented phenomenon [Multiple 
Molecular Forms of Enzymes, 1968; Williamson et al., 19731 and the Sections below 
briefly outlines some of the most commonly encountered post-translational modifications 
which can lead to secondary isoenzyme formation. 
1.4.3.1 Decttnidation: Secondary isoenzymes may be derived from deamidation (- 
CONH2 ---> -COO-) of asparagine or glutamine residues. This alteration causes a change 
in the net negative charge and consequently, isoenzymes resulting from deamidation may 
be detected by electrophoretic techniques (particularly isoelectric focusing). 
Microheterogeneity observed for muscle aldolase fully illustrates secondary isoenzyme 
generation as a result of deamidation. In vertebrates, aldolase is encoded by three genetic 
loci and although only one of these, the alpha locus, is expressed in skeletal muscle, two 
closely related but different subunits alpha and beta can be isolated from the tissue on the 
basis of charge. Tryptic maps of separated peptides show extensive regions of homology 
for the two subunits [Koida et al., 1969] and the alpha subunit is thought to be the 
original gene product which is converted, with time, to the beta subunit by deamidation of 
an asparagine residue near the C-terminus 1Koida et al., 1969; Lai et al., 1970; Midelfort 
& Mehler, 19721. Deamidation of glutamine residues may occur in other enzyme systems 
including L-amylase [Lehrner & Malacinski, 1975; Karn et al., 1975; Doane et al., 
19751, lysozyme [Robinson & Tedro, 1973], arginine kinase [Blethen, 19721, and 
carbonic anhydrase C [Lin & Deutsch, 19721. Human L-amylase is encoded by two 
different gene loci; AmyA is demonstrated as being active in the salivary glands and 
AmyB in pancreatic cells. The salivary form is both deamidated and deglycosylated and 
shows different electrophoretic and gel filtration profiles from the pancreatic enzyme, 
which is deamidated only. 
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1.4.3.2 Proteolysis: Multiple molecular enzyme forms, resulting from limited 
proteolysis of the parent enzyme protein, may also be considered as secondary 
isoenzymes. In most instances, trypsin is the enzyme involved in proteolytic cleavage. 
Isoenzymes derived by way of limited proteolysis, which occur in higher and lower 
molecular weight forms, include those of the enzyme galactosyl transferase [Magee et al., 
1974], neuraminidase [Francus et at, 1975], pyruvate kinase [Marie et al., 1977] and 
beta-glucuronidase [Dean, 1974; Keller & Touster, 1975; Stahl & Touster, 1971]. The 
enzyme system of beta-glucuronidase has been extensively studied with respect to its 
molecular structure and genetics. The active mammalian enzyme exists as a tetrameric 
glycoprotein of molecular weight 300 kDa. However, six different isoenzyme forms 
have been demonstrated exhibiting molecular weights ranging from 260 to 470 kDa 
[Swank & Paigen, 1973]. These differences in molecular weights have been shown to be 
due to varying amounts of a glycoprotein, egasyn which is associated with the enzyme 
[Swank & Paigen, 1973]. This glycoprotein is thought to be complexed with 
glucuronidase when the enzyme is membrane-bound and is removed by tryptic 
proteolysis when the enzyme is lysosomal [Lusis & Paigen, 1977]. Cleavage of single 
amino acid residues may also lead to the generation of secondary isoenzymes, as 
illustrated by the alkaline phosphatase isoenzymes in E. coli. Here, three isoenzymes of 
alkaline phosphatase have been demonstrated, each derived by step-wise proteolysis of 
the amino-terminal arginine residue from each of the identical subunits of the active 
dimer. 
1.4.3.3 Glycosylation: Secondary isoenzymes resulting from variations in the 
carbohydrate content may be subdivided into (a) isoenzymes displaying different 
electrophoretic or charge characteristics and (b) isoenzymes displaying different affinity 
chromatography binding characteristics. Enzyme heterogeneity in the first group of 
isoenzymes results from the differential presence of acidic or basic carbohydrate moieties, 
especially neuraminic (sialic) acid, whereas in the second group enzyme heterogeneity is 
caused by differences in the incorporation of neutral sugar residues (glucose, fucose and 
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mannose). Numerous isoenzyme systems exist which can be associated with differences 
in sialic acid content. In general, an increase in the number of sialic acid residues per 
molecule leads to an increase in net negative charge. Conversely, treatment with 
neuraminidase leads to a decrease in the number of sialic acid residues producing an 
increase in the net positive charge and, consequently, a higher isoelectric point (pI). This 
effect has been demonstrated for the isoenzyme systems of acid phosphatase [Smith & 
Whitby, 1968; Ostrowski et al., 1970] and catalase [Jones & Masters, 1972]. However, 
even though variations in sialic acid content can result in marked charge heterogeneity, the 
molecular weight differences are usually negligible. 
Numerous multiple molecular forms of enzymes differ in their content of neutral sugars, 
such as glucose and mannose [Swallow. 1977]. Isoenzymes resulting from differences 
in the content of neutral sugar residues can be demonstrated using affinity 
chromatography media (e.g. Concanavalin-A, Lentil lectin and Wheatgerm lectin). Some 
of these isoenzyme forms have been shown to be tissue restricted; for example, adenosine 
deaminase and esterase extracted from human liver and several other organs bind to Con-
A, whereas both enzymes from erythrocytes do not [Swallow, 1977]. 
1.4.3.4 avidationlreduction Qf thiol groups: The oxidation or reduction of thiol groups 
(SH 	 S-), situated either within or outside the active site of an enzyme, may lead to 
the generation of secondary isoenzymes. Modification of thiol groups which are part of 
the active site will usually cause changes to enzyme activities (substrate 
specificities/inhibitor susceptibilities). Thiol groups located away from the active site may 
undergo several different reactions with no apparent change in enzymic activity. Such 
reactions include the formation of intramolecular S-S bonds and the reaction of SH 
groups with low-molecular weight disulphides. The formation of mixed disulphides 
between a low-molecular weight thiol compound such as glutathione and free SH groups 
of an enzyme may lead to alteration of molecular charge and weight. The formation of 
intramolecular S-S bonds can lead to polymerisation and hence a considerable 
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heterogeneity of both molecular charge and weight. The enzyme activity may also be 
altered in these isoenzymes depending on the accessibility of substrate to the active sites 
of the polymerised molecule. 
1,43i Other post-translational changes: When the post-translational modification 
process is very active in some tissues, compared to others, the result will be an apparent 
tissue specific distribution of secondary isoenzymes (mimicking the effect of multilocus 
isoenzymes). An example of this type of post-translational modification is seen with 
pyruvate kinase (PK). The subunits of PK are encoded at three independent genetic loci 
in mammals and the active enzyme is a tetramer. One of the subunits, the L-type (also 
referred to as type I), is localised in liver and erythrocytes. As the liver L-type PK 
subunit, but not the erythrocyte form, undergoes rapid proteolytic cleavage, the L-type 
isoenzymes associated with these two tissue sites differ from each other in molecular size 
(gel filtration chromatography) and electrophoretic charge (isoelectric focusing) [Ibsen, 
1977]. As PK plays an important role in the regulation of glycolysis, these two L-type 
subunits which show different regulatory properties are likely to be of physiological 
relevance. 
Conformational isomerism has also been suggested as a possible cause of isoenzyme 
formation. In this particular case, multiple molecular forms have identical primary 
structures but differ in their tertiary and quaternary structures because their polypeptide 
chains can exist in more than one stable configuration. If several multiple molecular 
forms represent a series of conformers, it may be assumed that any single member of the 
series could generate the complete set of isoenzymes. Mitochondria] malate 
dehydrogenase and erythrocyte acid phosphatase both provide possible examples of this 
phenomenon [Epstein & Schechter, 1968; Schechter & Epstein, 1968]. 
When interpreting electrophoretic (isoelectric focusing and gradient gel electrophoresis) 
and chromatographic (ion-exchange, gel filtration and affinity) characteristics of 
secondary isoenzymes it is of fundamental importance to establish that the apparent 
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observed heterogeneity is genuine (present in-vivo) and not artefactual (resulting from in-
vitro extraction procedures). For example, extraction techniques which involve 
subcellular organelle disruption may expose the enzyme of study to proteases or 
glycosidases, thus leading to apparent heterogeneity which would not be observed in-
vivo in their compartmentalised state. In addition, extraction procedures that utilise 
agents such as detergents may lead to artefactual heterogeneity as a result of differences in 
solubilisation. 
1.5 PRESENT STUDY 
Previous studies of myeloid cell esterases suggest that granulocytic and monocytic 
myeloid differentiation is associated with the expression of distinct isoenzyme 
zymograms. Traditional histochemical assessments, together with analyses of their 
biochemical characteristics following partial purification, provide further indications of 
differences in both the reactivity of these isoenzymes with substrate esters of short acyl 
chain lengths and their sensitivity to inhibitors. Whilst these observations provide 
circumstantial evidence that granulocyte- and monocyte-associated esterases are of 
different origin and possibly encoded by separate structural genes, more definitive proof 
requires studying the molecular and biochemical characteristics of extensively purified 
enzyme forms. Indeed, it has been suggested [Yourno et al., 19841 that these various 
esterase isoenzyme components could result from post-translational modifications of a 
common gene product which 'inter-converts' as a consequence of changes in myeloid 
differentiation programmes. In order to further investigate these possibilities, this study 
proposes to undertake an extensive analysis of normal and leukaemic myeloid cell 
esterases in order to (a) confirm the relationships between myeloid cell differentiation and 
esterase isoenzyme patterns, and (b) to specifically analyse by chromatographic, 
molecular and kinetic techniques whether or not the esterase isoenzyme species that are 
expressed by granulocytic and monocytic cells represent different gene products or are 
variant post-translational forms derived from the same gene product. 
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To achieve this, the study is divided into three main Sections. In the first part, a 
representative number of normal and leukaemic granulocytic and monocytic cell fractions 
will be investigated to assess the distribution of esterase isoenzymes with respect to cell-
lineage and level of maturation. Comparisons will be then be undertaken to establish 
potential correlations between esterase isoenzyme distributions and cytochemical staining 
patterns; an area or particular importance both to the understanding of esterase regulation 
and for diagnostic interpretation. 
The second part of the study will extensively evaluate the chromatographic characteristics 
of esterase isoenzyme species. This will include gel filtration, ion-exchange (anion and 
cation), lectin and non-lectin affinity chromatography, and hydrophobic interaction. The 
recognition of molecular differences between the various myeloid esterase isoenzyme 
forms by such techniques is particularly relevant to the final Section which applies these 
procedures to the full-scale purification of the main esterase species. Purified esterase 
components will then be characterised with respect to their molecular, biochemical, and 
kinetic (including inhibition) properties. Where possible, these studies will include the 
determination of a limited N-terminal amino acid sequence of the purified protein, which 
could subsequently enable the design of specific DNA probes for a more discriminating 
approach to the classification myeloid leukaemias. Additionally, as myeloid esterases are 
glycoproteins [Cohn at al., 19871, the study will also include analysis of the glycan 
structure of the two esterase species through specific lectin affinity binding. Collectively, 
the molecular and biochemical studies will enable a better understanding of the inter-
relationships between myeloid esterase isoenzyme forms. 
CHAPTER 1  
Figure 1.1 and Tables 1.1 to 1.4 
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Table 1.1 	 Esterase substrates and diazonium salt couplers commonly used for the 
cytochemical demonstration of esterases in haemopoietic cells 
Optimum pH 	 Substrate 	 Coupler 
(diazonium salt) 
6.0-6.3 Alpha-naphthyl acetate HPR 
6.0-6.3 Alpha-naphthyl butyrate HPR 
7.0-7.6 Naphthol AS-D chloroacetate HNF or 
Fast Blue BB 
Esterase 
IF ANAE ANBE 
CAE 
0 
Abbreviations: ANAE, alpha-naphthyl acetate esterase; ANBE, alpha-naphthyl butyrate 
esterase; CAE, chloroacetate esterase; HPR, hexazotised pararosaniline; HNF, 
hexazotised New Fuchsin. 
Table 1.2 Esterase cytochemistry of normal and leukaemic blood elements 
Leucocyte Esterase a 
Leucocyte-type 	 ANAE 	 ANBE 
	 CAE 
Normal myeloid elements 
Ncutrophils 
r Eosinophils Basophils Monocytes Megakaryocytes 
0 
0 
0 
++/+++ 
++/+++ 
0 
0 
0 
++/-H-+ 
01+ 
+++ 
0 
0/+ 
01+ 
0 
Normal lymphoid elements 
T-helper +/++ ( F) +/++ (F) 0 
T-suppressor 0 0 0 
B-cells 0 0 0 
Plasma cells ++/+++ + 0 
Leukaemic myeloid elements h 
AML-MO 0 0 0 
AML-M l (1 0 0 
AML-M2 0 0 0/+/++ 
APL-M3 Hyper 0/+/++/+++ (G) 0 +++ 
APL-M3 Hypo 0 0 0/+ 
AMML-M4 +/++ c +/++ C +/++ 
AMoL-M5 ++/+++ ++/+++ 0 
AML-M6 +++ 0 0 
AML-M7 +++ 01+ 0 
Leukaemic lymphoid elements 
T-lymphoblasts 0/+(F) 0/+(F) 0 
B-Iymphoblasts 0 0 0 
a Leucocyte esterase ANAE (alpha-naphthyl acetate esterase). ANBE (alpha-naphthyl 
butyrate esterase) and CAE (chloroacetate esterase) reactivities graded from 0 (negative) 
to 	 (strong.); (F) indicates a focal reaction and G indicates granular reactivity. 
h 	 Leukaemic myeloid cells categorised in accordance with the FAB classification 1Bennen et al.. 
1976. 1980]. 
ANAL and ANBE reactivities in AMML are predominantly restricted to the monocytic 
component of the lcukacmic population. 
Table 1.3 	 Inhibition characteristics of histochemically important carboxylic ester 
hydro.lases 
INHIBITORS a 
DFP 	 HMBA 	 Eserine 	 Ach I 
(10-4M) 	 (10-3M) 	 (10-5M) 	 (10-3M) 
Carboxylesterases (EC 3.1.1.1) 
Arylesterases (EC 3.1.1.2) 
Acetylesterases (EC 3.1.1.6) 	 A 
Acetylcholinesterases (EC 3.1.1.7) + 
Cholinesterases (EC 3.1.1.8) 
a Inhibitors: DFP, diisopropyl fluorophosphate; HMBA, p-hydroxymercuribenzoic 
acid; and Ach I, acetylcholine iodide. + indicates enzyme inhibited: - indicates 
enzyme resistant; and A indicates enzyme activated. 
Table 1.4 	 Hydrolysis of alpha-naphthyl esters of increasing chain length (C2-C4) 
by histochemically important carboxylic ester hydrolases 
ALPHA-NAPHTHYL ESTER 
Acetate 	 Propionate 
	 Butyrate 
Carboxylesterases (EC 3.1.1.1) +++ ++ ++ 
Arylesterases (EC 3.1.1.2) +++ + + 
Acetylesterases (EC 3.1.1.6) +++ - _ 
Acetylcholinesterases (EC 3.1.1.7) +++ +++ +++ 
Cholinesterases (EC 3.1.1.8) +++ +++ +++ 
Reaction intensities shown as negative (-), weak (+). moderate (++) and strong (+++). 
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CHAPTER TWO 
MYELOID CELL ESTERASE ISOENZYME EXPRESSION:  
QUALITATIVE AND QUANTITATIVE STUDIES  
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2.1 INTRODUCTION  
This Chapter primarily deals with the characterisation of myeloid cell esterase isoenzymes 
by isoelectric focusing (IEF), and the relationships between IEF esterase zymograms and 
cytochemical staining patterns. Evaluation of these features is important to the 
understanding of myeloid cell differentiation, as maturational commitment from 
pluripotential myeloid precursors appears to be associated with the synthesis and 
expression of distinct esterase isoenzyme forms. These investigations are also important 
in helping to define the criteria used for the subsequent purification of myeloid esterase 
species (Chapters 3 and 4). The various components involved in this Chapter, 
sequentially detail the theoretical aspects of cellular enzyme extraction/solubilisation and 
IEF, the techniques used for preparation and characterisation of normal and leukaemic cell 
fractions, cytochemical and immunophenotypic methodologies, esterase zymogram 
studies of myeloid cells, and the quantitative expression of myeloid esterases. 
2.1.1 Extraction of cellular enzymes;  
2,1.1,1 General extraction principles: In practice, extraction procedures for the 
solubilisation of any given protein need to be experimentally optimised and are designed 
to result in a high recovery with minimal denaturation. Extraction of soluble cytoplasmic 
enzymes is achieved with relative ease, by disruption of the plasma membrane in an 
isotonic buffer at physiological pH. Disruption of the plasma membrane may be achieved 
by homogenisation (organelles remain intact), alternate freezing and thawing, or by 
ultrasonication (plasma and subcellular membranes disrupted). 
Procedures employed for the extraction of membrane bound enzymes, are governed by 
the type of protein-membrane association involved for the particular enzyme of interest. 
There are two major groups of membrane proteins; the integral (intrinsic) proteins and 
peripheral (extrinsic) proteins [Singer & Nicolson, 1972; Singer, 1974]. Integral 
proteins are strongly associated with the membrane through hydrophobic interactions 
between the proteins and the 'core' of the membrane. They possess hydrophilic 
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domains, formed by ionic and polar groups (including carbohydrates) and hydrophobic 
domains, rich in apolar amino acid residues. The polar groups are ultimately exposed to 
an aqueous environment at the surface of the membrane while the apolar residues form a 
strong hydrophobic association with the core of the membrane lipid bilayer 'Lenard & 
Singer, 1966; Wallach & Zahler, 1966]. Consequently, the distribution of hydrophobic 
and hydrophilic regions of a protein determines its orientation within the membrane 
structure. Integral proteins assume three positions within the lipid bilayer; spanning or 
transmembrane proteins have hydrophilic regions which interact with the aqueous phase 
on both sides of the membrane, whereas a second type of integral protein does not span 
the membrane and has hydrophilic regions exposed to an aqueous phase on only one side 
of the membrane. The third type of integral protein is totally immersed within the 
hydrophobic phase of the bilayer and does not interact with the aqueous phase [Singer & 
Nicolson, 1972]. 
2.1.1.2 Extraction of peripheral proteins: Peripheral proteins located on membrane 
surfaces are fundamentally different from integral proteins in that their attachments are 
strictly polar in nature (electrostatic or hydrogen-bonding). Peripheral proteins are 
associated either with the polar heads of the lipid bilayer or with the hydrophilic regions 
of integral proteins [Singer & Nicolson, 1972]. Some of these proteins show restricted 
binding to the cytoplasmic side of the bilayer [Kant & Steck, 19731, which may infer the 
involvement of specific binding sites. Whatever the nature of the association, 
solubilisation of peripheral proteins in general can be achieved by a number of techniques 
involving chelating agents, or manipulation of ionic strength and pH. These procedures 
effectively decrease electrostatic interactions between the peripheral protein and charged 
lipids or integral proteins. Once in solution, peripheral proteins generally resemble 
soluble proteins although some degree of aggregation may occur [Steck, 1974]. 
2.1.1.3 Extraction of integral proteins:  Solubilisation, by definition, involves the 
disintegration of the lipid bilayer, which may be achieved using various membrane- 
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solubilising agents. Amongst the most widely used reagents are detergents, which 
solubilise the membrane and also act as a solvent medium for stabilising membrane 
proteins [Helenius & Simons, 1975]. 
Detergents used for membrane solubilisation may be subdivided into three types; (a) 
nonionic, such as octylglucoside and the polyoxyethylenes (which include Triton X-100, 
Lubrol PX and Nonidet P-40); (b) zwitterionic, such as 3-[(3-cholamidopropyl) 
dimethyl-ammonio1-1-propanesulphonate (CHAPS) and sulphobetaine; and (c) ionic, 
such as cetylammonium bromide and sodium dodecyl sulphate (SDS), which possess 
strongly acidic or basic polar head groups. Naturally occurring bile salts, such as 
cholate, tauracholate and deoxycholate also act as ionic detergents. Detergents are 
amphiphilic molecules and in aqueous solutions exist as monomers and micelles, 
providing the monomer concentration exceeds the 'critical micellar concentration' (CMC) 
[Mukerjee & Mysels, 1971; Tanford, 1973; Helenius & Simons, 1975]. Above the 
CMC, both monomers and micelles exist in equilibrium; below the CMC, detergent 
molecules exist as monomers only. Micelles are fairly monodisperse compact aggregates 
of detergent monomers, where the apolar groups of the molecules are sequestered into the 
centre and the polar groups are exposed to the aqueous phase. The micellar dimensions 
and the CMC of a given detergent are dependent on the apolar moiety of the detergent 
molecule [Helenius et al., 19791. 
In devising an approach for the isolation of a specific membrane protein, one must 
consider the nature of subsequent requirements for the purification and characterisation of 
the isolated molecule. For example, it is of paramount importance when isolating 
membrane enzymes that the extraction procedure does not result in a loss of biological 
activity because enzymatic activity is usually required for both, monitoring the 
fractionation procedure and for the subsequent characterisation of the purified product. 
Consequently, nonionic and zwitterionic detergents are generally used for solubilisation 
of functional proteins. 
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The mechanisms by which detergents interact with membrane lipids and proteins vary 
considerably. The nature of the detergent-membrane association is fairly complex and is 
reviewed in greater depth by Helenius and Simons [1975]. Briefly, detergent monomers 
substitute for membrane lipids at low detergent concentrations (below CMC), the degree 
of substitution increasing with increasing detergent concentration. At the CMC, sufficient 
lipid displacement by detergent occurs to allow disruption of the lamellar membrane 
structure [Bout et al., 1969; Tanford, 1972; Helenius & Soderlund, 1973]. This 
disruption (solubilisation) results in the generation of mixed detergent-lipid and detergent-
protein-lipid micelles which co-exist with the pure detergent micelles already present in 
solution. When higher concentrations of detergent are added to the mixed micelle 
populations, than are required to induce the lamellar-micellar phase transition, lipids are 
separated from proteins (delipidation) resulting in two separate populations, detergent-
protein and detergent-lipid, of mixed micelles. The quantities of detergents required 
depend both on the composition of the membrane and on the type of detergent used. The 
mixed micellar size, buoyant density, charge and binding affinity will vary, depending on 
the constituents of the micelles, and these properties may therefore be used to separate 
different mixed micelles in a heterogeneous population. Gel filtration is the technique 
most frequently chosen for the separation of protein-free and protein-containing micelles, 
as it results in high protein recovery and allows easy monitoring of the separation. The 
technique exploits the differential micellar dimensions (molecular weight and shape) 
exhibited by the mixed and homogeneous micelles. It is important to recognise that a 
micelle, mixed or homogeneous, is a fluid, noncovalently linked aggregate and as such its 
size and shape are susceptible to environmental changes. Therefore, in order to achieve 
reproducible results with detergent-solubilised proteins, it is imperative to standardise 
parameters such as ionic strength, pH, temperature, detergent and protein concentration. 
Lipids and proteins of native membranes interact with each other in complex fashions that 
differ depending on the nature of the membrane. Furthermore, protein structures are 
often affected by their environment and, consequently, the ability to retain biological 
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activity during and following extraction also varies from protein to protein. In general. 
nonionic detergents are most widely used for the solubilisation of leucocyte membrane 
enzymes, as these have several advantages over ionic detergents when used for extracting 
integral membrane enzymes. These rarely cause enzyme inactivation and, as they are 
electrically neutral, they do not interfere with subsequent separation procedures based on 
protein charged groups (e.g. ion-exchange chromatography, chromatofocusing or 
isoelectric focusing techniques). An additional advantage of using nonionic detergents is 
that although they are efficient in breaking membrane lipid-lipid and lipid-protein 
interactions, they do not disrupt protein-protein interactions. Consequently, the subunit 
structure of a native enzyme usually remains unaltered [Helenius & Simons, 1972]. One 
disadvantage in the use of such detergents however is that they may be difficult to remove 
from proteins, due to the formation of stable high molecular weight mixed detergent-
protein micelles [Furth et al., 1984; Renswoude & Kempf, 1984]. However, if removal 
of the detergent becomes necessary for further protein characterisation and providing the 
extracted enzyme proves to be stable in an aqueous environment, then low molecular 
weight nonionic detergents may be used (i.e. octylglucoside). These low molecular 
weight detergents often have a higher CMC and are readily dialysed out of a protein-
detergent mixture [Keesey, 1987]. One other factor that is important to the design of an 
enzyme purification procedure is that some detergents may absorb strongly in the 260- 
280nm range and may limit the ability to monitor chromatographic fractionation using a 
conventional UV flow cell. Triton X-100 is such a detergent but in instances where 
absorption profiles are required, alternative nonionic detergents including Thesit or 
isotridecylpoly (ethylene glycol ether) may be used. 
2.1.2 Isoelectric focusing;  
Isoelectric focusing (IEF) involves the electrophoretic migration of ampholytes (i.e. 
polypeptides and proteins) in a pH gradient. Biomolecules possessing a net positive or 
negative charge migrate in an electric field towards the pH where they are isoelectric (i.e. 
possess no net charge). This pH is referred to as the isoelectric point (pI) and at this 
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position in the pH gradient, they have zero electrophoretic mobility and concentrate in 
narrow zones. The principle of this so-called focusing effect is essentially a steady-state 
equilibrium between electrophoretic migration towards the isoelectric point and diffusion 
in the opposite direction. IEF plates for flat bed electrophoresis are commercially 
available as two main types; (a) Ampholine plates (Pharmacia), which consist of an inert 
support matrix (polyacrylamide or agarose) containing a mixture of low molecular weight 
ampholytes (synthetic and natural amino acids and peptides); and (b) Immobiline plates 
(Pharmacia), consisting of an inert matrix which has a preformed, immobilised pH 
gradient generated by covalently bonded buffering groups. In an electric field, the 
ampholytes incorporated into ampholine plates migrate rapidly to their isoelectric points 
and form a stable pH gradient [Svenson, 19621. The larger sample protein molecules 
undergo a slower migration, governed by the initial pH environment, and this migration 
continues until the pI has been reached. The technique has an extremely high and 
reproducible resolving power and can differentiate between proteins with pI differences 
of as little as 0.01 pH units [O'Farrell 1975; Radola, 1984]. As a result it has become 
increasingly employed in the characterisation of isoenzyme forms. Furthermore, if 
individual isoenzyme forms are stable at their pI, they can be visualised by simply 
immersing the plate in an appropriate substrate reaction mixture. 
2.2 METHODS, 
2.2.1 Preparation of normal and letikaemic cell fractions:,  
2.2.I.1 Preparation of normal blood granulocyte lneutrophil) fractions: Peripheral 
blood granulocytes were prepared from whole blood of 11 different normal individuals 
by sequential removal of erythrocytes, followed by density sedimentation on 
Lymphoprep (Nyegaard). The first part of this procedure involved the preparation of 
leucocyte-rich plasma by selective removal of erythrocytes. To achieve this, 40m1 of 
whole blood was mixed with a 1:5 volume of Plasmagel (Laboratoire Roger Bellon). 
Following rapid sedimentation at lg in a narrow bore tube, the leucocyte-rich supernate 
was removed and the cells washed three times in Hanks balanced-salt solution (HBSS; 
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Flow Laboratories). These cells were then resuspended in 10m1 of autologous cell-free 
plasma and layered onto an equal volume of Lymphoprep (density 1.077g/m1) in 
siliconised glass tubes of 22mm internal diameter. The tubes were subsequently 
centrifuged at 600g for 30 mins at room temperature after which the leucocytes separated 
into an interface, containing mononuclear cells (lymphocytes, monocytes) and platelets, 
and a pellet comprising granulocytes and a small number of residual erythrocytes. The 
interface was carefully removed, ensuring no mixing with the pellet, and this was 
subsequently used for the monocyte enrichment procedure described below (Section 
2.2.1.2). The cell pellet was then removed, and contaminating erythrocytes lysed with 
10m1 of 0.86% aqueous ammonium chloride at 37°C. Following erythrolysis, the red 
cell free, granulocyte-rich fraction was washed in HBSS and resuspended in the same 
prior to further processing. 
2,2.1.2 Preparation of normal blood monocyte fractions: In this study, two different 
types of blood monocyte fractions were prepared. The first comprised a cell suspension 
containing both lymphocytes and monocytes with approximate relative frequencies of 
80% and 20% respectively, which was used to examine correlations between the 
expression of membrane CD14 and cytoplasmic alpha-naphthyl acetate esterase (ANAE) 
activity by normal blood monocytes. The second cell suspension was specifically 
prepared for chromatographic and electrophoretic analyses of cellular esterases and 
comprised a predominance (mean 77%) of monocytes with the remaining cells being of 
lymphoid origin. 
Monocyte enrichment for cvtochemical and phenotypic studies: Peripheral blood 
mononuclear cells (lymphocytes and monocytes) were prepared from 19 individual 
normal EDTA-anticoagulated blood samples. Preliminary studies indicated that platelet 
removal prior to leucocyte fractionation was desirable because of their tendency to adhere 
to monocytes and cause clumping. Their removal was facilitated by centrifugation of 
EDTA blood at 60g for 5 min; the platelet-rich plasma, containing few leucocytes, was 
35 
removed and the platelets pelleted by high speed centrifugation. The resulting platelet-
free plasma was re-mixed with the packed cells and the procedure repeated twice more. 
The platelet-depleted blood was then layered onto an equal volume of Lymphoprep and 
centrifuged at 600g for 30 min. The resulting interface comprised 10-25% 
morphologically-defined monocytic cells, with the remainder being of lymphoid origin. 
Monocyte enrichment for esterase isoenzyme studies: Nine different mononuclear cell 
fractions, obtained from the Lymphoprep stage of the granulocyte fractionation procedure 
(Section 2.2.1.1), were washed twice and resuspended to a volume of 10m1 in HBSS. 
This was then layered onto 10m1 of Percoll solution (Phau-macia), diluted to give a density 
of 1.054g/ml, and centrifuged at 600g for 15 mins at room temperature. After 
centrifugation, the Percoll interface, primarily consisting of platelets, was discarded and 
the cell pellet containing monocytes and lymphocytes was washed twice and resuspended 
to 10m1 in HBSS. This mononuclear cell fraction was subsequently layered onto an 
equal volume of Percoll solution of density 1.062g/m1 and centrifuged at 600g for 30 
mins at room temperature. The resulting monocyte-rich interface was carefully removed, 
washed with HBSS and resuspended in the same prior to further processing. 
22.1.3 Fractionation of myeloid leukaemia blasts: Peripheral blood and/or bone 
marrow samples from a total of 204 patients with acute myeloid leukaemia were layered 
onto equal volumes of Lymphoprep and centrifuged at 600g for 30 min at room 
temperature. In each case the interface, which comprised high proportions of leukaemic 
blasts, was removed and washed in phosphate-buffered saline (PBS) pH 6.8 containing 
0.01% sodium azide prior to further studies. 
2.2.2 	 Characterisation of normal and leukaemic cell fractions:  
2.2.2.1 Preliminary studies of normal blood myeloid cell fractions:  Enriched normal 
blood granulocyte (neutrophil) and inonocyte fractions were examined morphologically 
(Romanowsky stain) and cytochemically (alpha-naphthyl acetate esterase, ANAE stain) 
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following cytocentrifugation at 100g for 5 min onto clean glass slides. Morphological 
examination, by means of a 200 cell differential, was undertaken to assess the 
proportions of individual leucocyte components present in each fraction. ANAE 
cytochemical staining permitted an assessment of the proportions of monocytic cells in 
both the monocyte-enriched fractions and, as a potential contaminate, in the granulocyte-
enriched fractions. The monocyte fractions were additionally tested by immunological 
procedures (Section 2.2.4) for the proportions of cells expressing membrane monocyte-
associated CD14 (63D3 and My4 monoclonal antibodies) determinants. 
2.22,2 Characterisation of lettkaemic blast cell fractions: Fractionated leukaemia blasts 
(Section 2.2.1.3) were examined morphologically, following cytocentrifugation, to 
determine the proportions of blasts. Only those cases with >80% blasts, together with 
high viability, were subsequently processed for electrophoretic and chromatographic 
isoenzyme analysis. All myeloid leukaemias studied were diagnostically classified by the 
following criteria: 
Morphology: Leukaemic peripheral blood/bone marrow smears were fixed in methanol 
and stained by a standard Romanowsky technique (May-Grunwald-Giemsa). 
Morphological assessments of the acute leukaemias were based on previously published 
standardised features, as defined by the French-American-British (FAB) Group [Bennett 
et al., 1976; Bennett et al., 1985J, and leukaemias were thus categorised as acute 
myeloblastic (AML- MI or M2), acute promyelocytic (APL- M3), acute myelomonocytic 
(AMML- M4) or acute monocytic (AMoL- M5). Further sub-categorisation of the M3 
cases into hypergranular (M3-hyper) and hypogranular (M3-hypo) variants was based on 
the degree of cytoplasmic granulation [Bennett gt al., 1976; Bennett gt al., 1980; Golomb 
et al., 1980], and further division of the M5 cases into M5a and M5b was based on the 
level of blast cell maturation [Bennett gt al., 1976]. 
Cytochemistry: All acute leukaemias studied were additionally examined by conventional 
cytochemical techniques for the presence of various myeloid and/or monocyte-associated 
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staining patterns (Table 2.1). These included Sudan Black B (SBB), myeloperoxidase 
(MPO), chloroacetate esterase (CAE) and alpha-naphthyl acetate esterase (ANAE), the 
reaction procedures for which are outlined in Section 2.2.3. 
Immunophenotyping: All cases of myeloid leukaemia included in this investigation were 
examined for the presence of myeloid lineage-associated membrane CD13 and/or CD33 
determinants, defined by My7 (Coulter Electronics) and My9 (Coulter Electronics) 
monoclonal antibodies respectively. In addition, expression of membrane monocyte-
associated CD14 determinants was assessed with at least two different monoclonal 
antibodies from a panel comprising FMC17 (Sera-Lab), FMC32 (Sera-Lab), Mot 
(Coulter Electronics), My4 (Coulter Electronics), LeuM3 (Becton-Dickinson), UCHMI 
(University College Hospital, London), and 61D3 (Bethesda Research Laboratories). 
The full monoclonal antibody panel used for the routine immunophenotypic 
characterisation of myeloid leukaemias analysed in this study is summarised in Table 2.2. 
2.2.3 	 Cytochemical techniques:  
2.2.3.1 Sudan Black B ‘SBB): Peripheral blood/bone marrow smears were fixed in 
formaldehyde vapour and stained according to the method of Sheehan and Storey [19471. 
Following incubation in the staining solution, the slides were destred twice with 70% 
ethanol and counterstained by Romanowsky procedure. 
2.23.2 Myeloperoxidase (MPO):  Peripheral blood/bone marrow smears were fixed 
with cold buffered fomol-acetone and stained for myeloperoxidase using a modification 
of the ICSH method [Elias, 1980: ICSH, 19851. Slides were immersed in an incubation 
mixture comprising 1.7mM diaminobenzidine tetrahydrochloride (Sigma) and 0.12% 
hydrogen peroxide in 50mM tris/HC1 pH 7.5. After incubation at room temperature for 
15 minutes, the slides were counterstained with 0.6% neutral red. 
22.3.3. Chloroacetate esterase (CAE):  Peripheral blood/bone marrow smears were 
fixed with cold buffered formol-acetone and stained according to the method of Yam et 
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al., [1971]. Slides were immersed in a staining solution containing 0.35mM naphthol 
AS-D chloroacetate substrate (Sigma) and hexazotised New Fuchsin (Sigma) in 
phosphate buffer at pH 7.2 for 20 minutes. After incubation at room temperature, the 
slides were counterstained with Haematoxylin. 
2.2.3.4 Alpha -naphthol acetate and butyrate esterase (ANAE/ANBE): 
 Peripheral 
blood/bone marrow smears were fixed with buffered formol-acetone and stained for 60 
minutes in a reaction mixture comprising 5.0mM alpha-naphthyl acetate, or alpha-
naphthyl butyrate (Sigma), and hexazotised pararosaniline (Sigma) [Yarn et al., 1971] in 
50mM phosphate buffer at pH 6.2 (ANAE) or 6.4 (ANBE). After completion of 
staining, the slides were counterstained with aqueous methyl green_ 
2,2.4 	 Immunophenol ping techniques:  
Various different immunophenotyping procedures were used to characterise membrane 
antigen expression by normal myeloid cells and leukaemic blasts in this study. Included 
among these are techniques for the determination of antigen expression, either as single or 
multiple analyses, as well as a combined immunophenotyping/cytochemical procedure 
specifically designed to correlate membrane CD14 and cytoplasmic ANAE expression at 
the single cell level (Section 2.2.4.4). 
2.2.4.1 Indirect (manual) immunolluorescence: Fractionated cell suspensions were 
adjusted to a concentration of approximately 5.0 x 106/ml in PBS containing 0.1% azide. 
50111 of each cell suspension was incubated at 40C with a pre-determined amount of 
appropriate primary monoclonal antibody for 30 min. Following incubation, the cell 
suspension was washed twice with PBS-azide and 25111 of fluorescein isothiocyanate 
(FITC) or rhodamine (TRITC) conjugated goat anti-mouse immunoglobulin (TAGO) was 
added. Primary and secondary antibody working concentrations were pre-determined by 
titration against antigen expressing and non-expressing cells (data not shown). The 
suspension was incubated for a further 30 min, the cells washed twice and the labelled 
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cells examined under a fluorescent microscope for membrane fluorescence. In each case, 
the proportion of cells expressing any given determinant was recorded. Control studies 
using irrelevant monoclonal antibodies of the same isotypes and second antibodies alone 
were routinely carried out. 
2.2.42 Indirect imnumorosetting: 
 Fractionated leukaemic myeloid blasts were adjusted 
to a concentration of approximately 5.0 x 106/m1 in PBS-azide. IOW of cell suspension 
was then incubated for 30 min at 4°C with a predetermined amount of appropriate 
primary antibody. Following incubation, the cells were washed twice with PBS-azide 
and resuspended to a volume of 100W. An equal volume of 1% ox erythrocytes (oxE), 
coated with goat anti-mouse immunoglobulin (GAM-Ig, TAGO) by a chromic chloride 
coupling technique [MacKarill et al., 1987], was added to the cell suspension and the 
mixture centrifuged at 350g for 1 min. Following centrifugation, the leucocyte/oxE pellet 
was gently resuspended in a dilute solution of acridine orange/ethidium bromide and 
examined under a fluorescent microscope. Viable leukaemic blasts were considered 
antigen-positive when more than three oxE were seen to be clearly bound to the cell 
membrane. Control studies, comprising blasts incubated with irrelevant monoclonal 
antibodies, were routinely undertaken. 
2.2.4.3 Automated flovt. cytome ►y: Acute myeloid leukaemias were examined for the 
expression of lineage-associated determinants by flow cytometry using two-colour 
combinations of FITC and phycoerythrin (PE) conjugated monoclonal reagents (Table 
2.2). For this, fractionated myeloid blasts were examined by direct immunofluorescent 
techniques using flow cytometry as described by Richards & Scott [1990]. Briefly, l0-
20µ1 of each cell suspension (containing 106 cells) was incubated at 4°C with a 
predetermined amount of appropriate FITC- or PE-conjugated primary antibody in 
microtitre plates [Campana & Janossy, 1986] for five minutes. Following incubation, the 
cell-antibody mixture was pelleted and the cells washed twice with 150p1 of PBS-azide to 
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remove excess antibody. The cells were resuspended in 500111 of Isoton (Coulter 
Electronics) prior to analysis by flow cytometry. 
Analyses were carried out with a FACSCAN flow cytometer (Becton-Dickinson) using 
Consort 30 software as previously described (Richards & Scott, 1990; Scott et al., 
19901. Forward scatter (FSC), side scatter (SSC), FITC (FL1) and PE (FL2) data were 
acquired and stored in list mode files. Single and dual antigen-positive components were 
determined using contour (quadrant) graphs of FL1 versus FL2. By utilising appropriate 
gate settings, the antigenic characteristics of the blast cell populations could be assessed. 
2.2.4.4 Combined ANAE cywchemisny and CD14 immunophenotvping: The CD14 
monoclonal antibodies used for these particular experiments were LeuM3 (Becton 
Dickinson), My4 (Coulter Electronics) and 61D3 (Bethesda Research Laboratories), and 
a total of 19 normal blood mononuclear fractions (Section 2.2.1.2) were investigated. To 
simultaneously analyse membrane CD I4 expression and cytoplasmic ANAE staining, a 
pre-determined amount of CD14 monoclonal antibody (LeuM3, My4 or 61D3) was added 
to 2.0 x 106 of mononuclear cells and incubated at 40C for 30 min. Following 
incubation, the cells were washed twice with complement fixation diluent (CFD) buffer 
(Oxoid) at pH 7.2 and resuspended to a concentration of 1.0 x 106/ml. 100111 of this cell 
suspension was added to an equal volume of 1% ox erythrocytes (oxE) coated with goat 
anti-mouse immunoglobulin (GAM-Ig) and the mixture centrifuged at 350g for 1 min 
[MacKarin a At • 19871. Following centrifugation, the leucocyte/oxE pellet was gently 
resuspended and cytocentrifuged (50g for 5 min) onto clean glass slides. The resulting 
cell (leucocyte/oxE) monolayers were stained by either a conventional Romanowsky 
technique or for ANAE (Section 2.2.3.4) activity. ANAE-stained cytocentrifuge 
preparations were examined for monocytes expressing cytoplasmic ANAE reactivity 
and/or membrane CD14 determinants. Typical monocytes showed moderate/strong M-
type ANAE reactions (defined as ANAE4); mononuclear cells with granular or 'dot' type 
reactions were excluded, as were cells displaying non-monocytic cytology. 
41 
Morphologically characterised monocytes binding a minimum of three oxE were defined 
as being CD14+ and, for each sample analysed, a minimum of 103 cells were examined. 
In this way, it was possible to subdivide normal monocytic components into three sub-
populations; (a) monocytes expressing both membrane CD14 and cytoplasmic ANAE 
(CD14+ANAE+), (b) monocytes lacking membrane CD14 but showing typical 
cytoplasmic M-type ANAE activity ( +), and (c) monocytes expressing membrane CD14 
but showing insignificant cytoplasmic ANAE staining (CD14+ANAE-). Cells with 
monocytoid morphology but lacking both membrane CD14 and cytoplasmic ANAE were 
occasionally seen although, in all mononuclear fractions studied, these represented only a 
minor proportion of those cells assessed. 
2,2•5 	 Extraction of cellular esterases;  
2.25.1 Optimisation qf cellular esterase utraction: In order to determine the efficiency 
of cellular esterase extraction, an artificially prepared mixture of normal monocytes and 
granulocytes (50:50) was tested with a variety of extraction procedures and detergents. 
In this way, the quantitative and qualitative features of liberated esterases could be 
determined. The five solubilising agents investigated were: (a) 0.25M potassium chloride 
(ICC1); (b) a zwitterionic detergent, 10mM 3-1(3-cholamidopropyl)dimethyl-ammonio}-1- 
propanesulphonate (CHAPS); (c) the nonionic detergent isotridecylpoly(ethylene glycol 
ether) (IEGE) at a concentration of 10mg/m1; (d) the nonionic detergent n-octylglucoside 
(30mM); and (e) the nonionic detergent Triton X-100 (10mg/mi). These agents were all 
made up in 20mM morpholino-ethane sulphonic acid (MES) pH 6.4 and their solubilising 
efficiency, compared with this buffer alone. Zwitterionic and nonionic detergents (all 
obtained from a single commercial source, Boehringer) were chosen for the extraction 
procedures as they are generally non-denaturing and do not interfere with many of the 
chromatographic and electrophoretic fractionation procedures subsequently evaluated in 
this study. They are also known to help preserve enzyme activity, particularly in cases 
where native enzymes are membrane bound. The degree of solubilisation of esterases 
was assessed by carrying out (a) quantitative (fluorimetric) enzyme assays using 4- 
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methylumbelliferyl acetate (4MB-Ac; Koch-Light) as substrate; and (b) qualitative 
analytical isoelectric focusing (TEF), with histochemical staining of the gel for ANAE. 
To carry out this experiment, the monocyte/granulocyte cell mixture was pre-cooled in an 
ice bath and disrupted by ultrasonication (MSE Soniprep 150) for 30 secs. The sonicated 
sample was then aliquoted into six fractions and each diluted with an equal volume of one 
of the above extraction reagents. These cell fractions were then incubated in the presence 
of extraction reagents at 37°C for 15 min, following which the cell debris was pelleted by 
centrifugation at 104g for 30 min. The supernates, containing extracted solubilised 
proteins, were removed and the cell pellets resuspended to the original sonicate volume in 
20mM MES pH 6.4. 
The volumes of sonicate supernate and the resuspended pellet from each of the extracted 
fractions were then measured and 20111 of each analysed for acetate esterase activity by 
fluorimetric assay (Section 2.3.6.4) using 4MB-Ac as substrate. Total acetate esterase 
activity was calculated and the percentage enzyme extracted by each procedure 
determined. The supemates from each extracted fraction were also electrophoresed on pl 
range 3.5 - 9.5 IEF plates (Section 2.2.6.1) and stained for ANAE activity. The resulting 
ANAE isoenzyme profiles were compared and the relative staining intensities of each 
isoenzyme form (defined by differences in pl) assessed. 
2.2.5.2 Effect of different Triton X-100 concentrations on the relative molecular weight 
species of raw sonicate esteutses:  Based on the results of the above procedures, 
Triton X-100 was selected to supplement 20mM MES (pH 6.4) in the extraction reagent. 
As detergents often promote micelle formation, with consequent effects on the apparent 
distribution of molecular weight species, it was necessary to establish whether the relative 
concentration of Triton X-100 in the extraction system could affect or contribute to the 
presence of different esterase molecular weight forms. 
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Fractionated leukaemic blasts from a case of AMML-M4, known to express the full 
complement of myeloid esterase isoenzyme forms as defined by IEF, were sonicated by 
standard procedures in 20mM MES pH 6.4 and the sonicate subsequently divided into six 
equal fractions. Triton X-100 was then added to each fraction to give final concentrations 
of: (a) 0%; (b) 0.25%; (c) 0.5%; (d) 1.0%; (e) 5.0%; or (f) 10.0%. These sonicate-
detergent mixtures were then incubated at 370C for 15 min, following which, the cell 
debris was removed by centrifugation at 104g for 30 min. The supernates, containing 
solubilised proteins, were then individually examined for the presence of different 
esterase molecular weight species by Fast Protein Liquid Chromatography (FPLC) gel 
filtration using a Superose-12 column (Pharmacia) as described in Section 3.2. Briefly, 
1001..11 of each sample was passaged through the Superose-12 column, at a flow rate of 
0.35m1/rain, in 50mM phosphate buffer (p1-1 7.2) containing the appropriate concentration 
(0 to 10%) of Triton X-100. One minute (0.35m1) fractions were collected and 100111 of 
each assayed by fluorimetry for esterase activity with a substrate mixture of 0.25mM 
4MB-acetate and 0.25mM 4-methylumbelliferyl-butyrate (Section 2.3.6.4). 
Isoelectric focusing (IEF) of myeloid cell esterases:  
2.2.6.1 Cases studied and standard electrvilaretic procedure: A total of 11 normal 
blood granulocyte-enriched and nine monocyte-enriched fractions were examined in this 
study, in addition to blast cell fractions from 204 cases of acute myeloid leukaemia. 
These leukaemias comprised 85 cases of AML-M 1/M2, 11 cases of APL-M3, 63 cases of 
AMML-M4, and 45 cases of AMoL-M5. Normal and leukaemic myeloid cells were 
initially isolated by the appropriate fractionation procedures outlined earlier (Section 
2.2.1) and esterases extracted by ultrasonication and detergent solubilisation (Section 
2.2.5). 
Esterase isoenzymes were fractionated by analytical isoelectric focusing (IEF) and the 
isoenzyme patterns of cell extracts examined following alpha-naphthyl acetate esterase 
(ANAE) histochemical staining. To achieve this, 30-5041 aliquots of normal or 
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leukaemic cell extracts were applied, using micracloth sample application pads, to 5% 
polyacrylamide gels (pH 3.5-9.5 PAG plates., Pharmacia) containing 2.5% w/v 
ampholine. The samples were focused for 1400 volt hours (Vhrs) at a constant current of 
20mA and the gel temperature kept at approximately 5-100C by carrying out the 
electrophoresis on a water cooled glass plate. Commercial, pre-stained protein standards 
(Sigma) of known isoelectric points (pI) were simultaneously focused with the extract 
samples. On completion of electrophoresis, the relative migratory positions of the protein 
standards were measured, and additionally, the pH gradient across the gel determined by 
use of a surface pH electrode (Philips). Focusing was considered complete when a linear 
pH gradient, ranging from 3.5-9.5, was generated across the gel. Gels were 
subsequently immersed in a staining solution containing alpha-naphthyl acetate and 
hexazotised pararosaniline at a pH of 6.2 (Section 2.2.3.4) and the pI of individual 
ANAE isoenzyme forms calculated with respect to both standard proteins and the gel 
surface pH measurements. 
2,2.6.2 Substrate specificity of myeloid esterase isoenzymes: In order to determine the 
relative substrate affinities of the various myeloid isoenzyme components, five AMML-
M4 and two AMoL-M5 leukaemic cell extracts expressing the full of complement myeloid 
isoenzyme forms were prepared. Three replicate IEF snips were run for each cell extract 
and on completion of electrophoresis, the individual lanes were cut and immersed in 
esterase staining solutions containing either (a) 5.0mM alpha-naphthyl acetate (ANA), (b) 
5.0mM alpha-naphthyl propionate (ANP), or (c) 5.0mM alpha-naphthyl butyrate (ANB). 
Hexazotised pararosaniline was employed as coupler in each reaction mixture and a 
standard pH of 6.3 was used. The relative staining intensities of esterase isoenzymes, 
with respect to the three substrates examined, were subjectively assessed after a 30 
minute staining period. 
2.2.6.3 Inhibitor studies of myeloid esterase isoenzymes:  To determine the relative 
sensitivity of the major myeloid esterase isoenzymes to various inhibitors, an AMML-M4 
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leukaemic cell extract containing all the major myeloid isoenzyme forms was 
electrophoresed (IEF) in multiple lanes. On completion, the individual lanes were 
segmented and pre-incubated for 10 min in a 50mM pH 6.4 phosphate buffer containing 
one of the inhibitors being investigated. This was followed by immersion in an ANAE 
reaction mixture also containing the same inhibitor. The inhibitors examined in this study 
were 5.0mM phenylmethylsulphonyl fluoride (PMSF; Boehringer), 2.4mM sodium 
fluoride (NaF: Sigma), 10mM neostigmine (Sigma), O. I mM eserine (Sigma) and 1.0mM 
p-hydroxymercuribenzoic acid (HMBA; Sigma). In addition, the inhibitory effects of 
NaF and PMSF were examined over a series of concentrations (ranging from 0.0 to 
1.5ing/m1 for NaF and 0.0 to 10.0mM for PMSF). 
2.2.7 	 Protein estimations using the BCA assay:  
The BCA assay is a colourimetric procedure for the estimation of protein concentrations 
which is related to the Lowry technique, in that it relies on the conversion of Cu2+ to 
Cu+. Under alkaline conditions, Cu2+ forms a complex with protein peptide bonds and 
is reduced to Cu+ which, in turn, is captured by bicinchoninic acid and forms an intense 
purple reaction product with an absorption maximum at 562nm. BCA assay reagents are 
commercially available (Pierce Chemical Company) and, using this procedure, protein 
concentrations can be estimated in a simple one-step process. In this current study, 
protein concentrations of normal and leukaemic cell extracts were estimated using the 
BCA procedure; cell extracts were diluted as required and assayed in parallel with a range 
of protein standards (Sigma Diagnostics). The absorbance at 562 (A562) was measured 
and the protein concentration of cell extracts estimated from a standard curve. 
2.2.8 	 Ontimisation of UV and Iltiorimetric esterase assays:  
2.2.8.1 UV spectrophotometric casco, of alpha-naphthyl acetate esterase (ANAE): A 
previously described assay for leucocyte alpha-naphthyl acetate esterase (ANAE) used an 
ultraviolet (UV) spectrophotometric procedure I Mastropaolo & Yourno, 19811 where the 
hydrolysis of the substrate (alpha-naphthyl acetate) to alpha-naphthol was monitored at 
235nm. Under standard conditions, the rate of hydrolysis is linear and directly 
proportional to the esterase concentration; where the enzymatic hydrolysis of inmol of 
alpha-naphthyl acetate results in an increase in A235 of 0.023 absorbance units. In order 
to validate this procedure and, if necessary, modify it for use in this study, a number of 
preliminary experiments were carried out to establish the effects of substrate 
concentration, assay time and enzyme concentration. 
Effect of substrate concentration: A leukaemic blast cell (AMML-M4) extract, containing 
all the major myeloid esterase isoenzyme forms, was tested for ANAE activity by UV 
spectrophotometric assay with a range (0.05mM to 0.75mM) of substrate concentrations, 
prepared by diluting a stock 50mM ANA solution (dissolved in 2-methoxyethanol; 
Sigma) in 10mM MES pH 6.3. 20111 of 1:2 and 1:4 dilutions of the cell extract were 
added to 1.0 ml of each working substrate solution (pre-warmed to 300C) in a semimicro 
quartz cuvette. The cuvette contents were then mixed and the rate of increase in 
absorption at 235nm (A235) measured over a period of 5 min (PU 8800 UV/V1S 
spectrophotometer; Pye Unicam). The observed rates of change for each substrate 
concentration were corrected for spontaneous substrate hydrolysis (control incubation of 
substrate in the absence of enzyme), thus giving the rate of increase in A235 due to 
specific enzymic hydrolysis. The effect of substrate concentration on reaction rate, 
additionally allowed a broad estimate of the Michaelis-Menten constant (Km) to be made 
for the hydrolysis of alpha-naphthyl acetate by unpurified esterases from this particular 
blast cell extract. 
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Reaction rate linearity: Esterases extracted from an AMML-M4 blast cell fraction, 
containing all the major myeloid esterase isoenzyme forms, were tested for ANAE activity 
by UV spectrophotometric assay over a period of 10.0 min. Preliminary studies were 
carried out at a substrate concentration of 0.2mM, as originally described (Mastropoalo & 
Yourno, 19811, but this was modified to 0.5mM as a result of the above substrate 
investigations. For these experiments, 20111 of neat, 1:2. 1:4 and 1:8 dilutions of the blast 
cell extract were added to 1.0m1 of working substrate solution in a semiquartz cuvette. 
The cuvette contents were mixed and the increase in absorbance at 235nm (A235) was 
measured at 0.5 min intervals over a period of 10.0 min. The rate of change in A235, 
over the 10 min period, was then analysed with respect to the leukaemic extract dilutions 
examined. 
Effect of enzyme (cellular extract) concentration: Serial dilutions of cell sonicate, ranging 
from neat (undiluted) to 1:8, were prepared for one case each of AMML-M4 and AMoL-
M5 (both of which contained all the major myeloid isoenzymes), and two cases of AML-
M I/M2 (which contained all myeloid isoenzyme forms with the exception of those 
specifically associated with monocytic differentiation). Cell extracts, at all the dilutions 
examined, were assayed by UV spectrophotometry for ANAE activity in order to 
determine the maximum rate of change which remained linear throughout a 5 min assay 
period. To achieve this, 20p.1 of each dilution of cell extract was added to Iml of working 
(0.5mM) alpha-naphthyl acetate substrate solution at 30°C in a semimicro quartz cuvette. 
The cuvette contents were mixed and the rate of increase in A235 was measured. After 
correcting the observed rates for spontaneous substrate hydrolysis. the maximum 
sustainable hydrolysis rate which remained linear through a 5 min assay period was 
determined. 
22.8.2 Fluorimetric assays for acetate and butyrate esterases:  As an alternative to UV 
spectrophotometry, it is possible to measure solubilised acetate and butyrate esterase 
activities by an end-point fluorimetric assay with the synthetic substrates 4- 
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methylumbelliferyl acetate (4MB-Ac) and 4-methyl umbelli fery I butyrate (4MB-But; 
Koch-Light). Fluorimetric assays, which are particularly suitable for the analysis of large 
sample numbers (e.g. chromatography fractions) are based on the principle that 
fluorogenic compounds, when excited at a particular wavelength, subsequently emit light 
energy in the form of fluorescence at a higher wavelength. This is due to the emission of 
energy when these compounds return to 'ground state' following excitation; excitation 
being a process causing the outermost electrons of such compounds to reach a higher 
energy state. 4MB-Ac and 4MB-But substrates show negligible fluorescence, compared 
to the enzyme hydrolysis product 4-methylumbelliferone (4MB), and by standardising the 
excitation and emission wavelengths for these particular compounds it is possible to 
quantitate the rate of formation of 4MB resulting from 4MB-Ac or 4MB-But hydrolysis. 
Effect of substrate concentration: An AMML-M4 leukaernic blast cell extract, containing 
all the major myeloid isoenzyme forms, was tested for acetate and butyrate esterase 
activities by fluorimetric assay with 4MB-Ac and 4MB-But substrate concentrations 
ranging from 0.05mM to 1.0mM. For this, 20111 of a 1:2 dilution of the blast cell extract 
was incubated at 37°C with 250p1 of 4MB-Ac or 4MB-But substrate solutions in 50mM 
MES pH 6.3 for 60 min, following which an additional 500111 of MES was added. As 
determined by preliminary studies of fluorescent spectra for 4-methylumbelliferone (data 
not shown), the fluorescence emission was measured at 460nm with an excitation 
wavelength of 400nm using a LS-2 Micro Filter Fluorimeter (Perkin-Elmer). The 
observed values were then corrected for non-specific hydrolysis, resulting from protein-
substrate interactions, by incubating a 100°C heat-inactivated cellular extract under 
identical assay conditions. 
Reaction rate linearity: The time course of esterase hydrolysis for both acetate and 
butyrate substrates, was established using esterases from an AMML-M4 blast cell extract 
containing all the major myeloid isoenzyme forms. Reaction rates were determined by 
adding 20111 of neat, 1:2 and 1:4 dilutions of the blast cell extract to replicate 250u1 
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volumes of 0.5mM substrate (4MB-Ac or 4MB-But) solution at 37°C. At 10 min 
intervals, ranging from 0 to 60 mins, the reaction mixtures were made to 750111 with 
50mM MES pH 6.4, and the fluorescence emission measured at 460nm with an excitation 
wavelength of 400nm. 
Effect of enzyme (cellular extract) concentration: Serial dilutions of blast cell extracts, 
ranging from neat to 1:8, were prepared for two cases of myelomonocytic leukaemia (one 
each of AMML-M4 and AMoL-M5) which contained all the major myeloid isoenzyme 
forms, and two cases of AML-Ml/M2 which contained all myeloid esterase isoenzyme 
forms with the exception of those specifically associated with monocytic differentiation. 
These leukaemic cell extracts were assayed for acetate or butyrate esterase activity using 
substrate concentrations of 0.5mM; 2041 of each extract dilution was added to 25041 of 
pre-warmed (37°C) substrate solution and the reaction mixture incubated at 37°C for 60 
min. At this time, the reaction mixtures were made to 750W with 50mM MES pH 6.3 
and the fluorescence emission at 460nm measured. Observed hydrolysis rates were 
corrected for non-specific hydrolysis, determined by assay of heat-inactivated samples, 
and the rate of reaction which remained constant throughout the assay period was 
determined. 
;.2.9 	 Correlations between UV and fluoritnetric esterase assays:  
2.2.9 I Effect of substrate concentration: A leukaemic AMML-M4 blast cell extract, 
containing all the major myeloid isoenzyme forms as defined by isoelectric focusing 
(IEF), was diluted 1:2 and 20p1 of this assayed for acetate esterase activity by both the 
UV (Section 2.2.8.1) and fluorimetric (Section 2.2.8.2) assay procedures at substrate 
(alpha-naphthyl acetate or 4-methylumbelliferyl acetate) concentrations ranging from 0.05 
to 0.5mM. The rate of substrate hydrolysis for both assay procedures at each substrate 
concentration was determined and compared. 
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2.2,9.2 Effect Qf enume concentration: Esterases extracted from AMML-M4 blasts, 
containing all the major myeloid isoenzyme forms, and a case of AML-M I/M2 containing 
all myeloid isoenzymes with the exception of those specifically associated with monocytic 
differentiation, were assayed for acetate esterase activity by both the optimised UV 
spectrophotometric and fluorimetric assays in order to determine the degree of correlation 
between the two procedures. To achieve this, the blast cell extracts were serially diluted 
from neat to 1:8 and 20g1 of each assayed for esterase activity using either alpha-naphthyl 
acetate (5 min UV assay) or 4MB-Ac (60 min fluorimetric assay) at 0.5mM substrate 
concentrations. Rates of substrate hydrolysis for both assays were determined and 
compared for each extract dilution studied. 
2.2.10 
	 Ouantitation of cell extract esterase activities:  
Acetate and butyrate esterase activities of leukaemic myeloid cell extracts were determined 
using the standardised UV spectrophotometric assay (Section 2.3.5.5). The extracts, 
which represented various ANAE-IEF isoenzyme pattern types, comprised 56 acute 
myeloid leukaemias (AML-Ml/M2, n=22; APL-M3, n=3; AMML-M4, n=19 and AMoL-
M5, n=12). In contrast, a series of normal granulocyte (n=11) and monocyte (n=9) cell 
extracts were analysed for their esterase activities using the standardised fluorimetric 
assay (Section 2.3.6.4). This particular assay was used for the normal myeloid cell 
extracts because their esterase concentrations were found to be too low for accurate 
quantitation by UV spectrophotometry. All normal and leukaemic samples showed, prior 
to sonication and detergent extraction (Section 2.2.5), >70% population homogeneity 
with high viabilities, and protein concentrations of these extracts were determined with 
the BCA assay procedure (Section 2.2.7). 
51 
2.3 RESULTS 
2.3.1 	 Prenaration and characterisation of myeloid cell fractions:  
2.3,1,1 Normal peripheral blood ranulocytes: Peripheral blood granulocytes 
(neutrophils) were fractionated from 11 different normal adult blood samples as detailed 
in Methods (Section 2.2.1.1). With this standardised procedure, the resulting 
granulocyte fractions in all cases exceeded 98% purity (Figure 2.1a), contained 
insignificant (<1.0%) monocytic components as adjudged by ANAE cytochemistry, and 
had viabilities in excess of 95%. Recovery of granulocytes from each blood examined 
was greater than 90% (range 91-98%) and, consequently, the loss of granulocytes at the 
interface of the Lymphoprep fractionation stage was minimal. Cytochemically, the 
normal granulocytes were unreactive for alpha-naphthyl acetate (ANAE) and butyrate 
(ANBE) esterase but were strongly positive for myeloperoxidase (MPO) and 
chloroacetate esterase (CAE). 
2.3.1.2 Normal peripheral blood monocytes: Normal peripheral blood monocytes were 
fractionated from nine individual normal blood samples using the three-step density 
sedimentation procedure described in Section 2.2.1.2. Analysis of the resulting cell 
suspensions by morphology (Figure 2.1b), ANAE cytochemistry (Figure 2.2b) and 
CD14 immunophenotyping revealed that this fractionation procedure provided monocyte 
purities ranging from 68-90% (mean 77%; Table 2.3) with viabilities in excess of 90%. 
The contaminating non-monocytic cells in these suspensions were predominantly of 
lymphoid lineage and were easily distinguishable from the monocytic components which 
showed ANAE cytochemical reactions of moderate-strong diffuse (M-type) strength. 
Furthermore, almost all (mean, 95%; range, 89-98%) of the platelets present in the 
original blood samples were removed as a result of including the 40% Percoll solution in 
the fractionation procedure, with no significant (<5%) loss of monocytes. In addition to 
determining the efficiency of monocyte purification by this fractionation method, these 
studies also analysed the yields (i.e. actual recovery/theoretical maximum). Although the 
incorporation of EDTA in the washing procedures and the use throughout of siliconised 
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glass vessels minimised monocyte loss, it was evident that the relatively low monocyte 
recoveries for the nine different blood samples studied (mean, 41%; Table 2.3) were 
primarily due to losses occurring within the gradients. Nevertheless, as the cytochemical 
staining of monocyte-enriched cell suspensions revealed that virtually all ANAE activity 
was associated with the monocytic components, and not with contaminating lymphoid 
elements, it was considered that these fractions were sufficiently pure for subsequent 
qualitative IEF analysis. 
2.3.1.3 Leukaemic blast cell fractions: Leukaemic blasts from 85 cases of acute myeloid 
leukaemia (AML-M1/M2), 11 cases of acute promyelocytic leukaemia (APL-M3), 63 
cases of acute myelomonocytic leukaemia (AMML-M4) and 45 cases of acute monocytic 
leukaemia (AMoL-M5) were fractionated by the density sedimentation technique 
described in Section 2.2.1.3. In all cases, the proportion of leukaemic blasts in the 
resulting cell suspensions exceeded 80% (defined morphologically) and, with the 
exception of the monocytic proliferations, contaminating mature monocytic components 
(defined by ANAE cytochemistry and CD14 immunophenotyping) were minimal (<2%). 
Viabilities of all cell fractions were in excess of 90%. 
2.3.14 Simultaneous demonstration of membrane CD14 and cytoplasmic ANAE: 
Enriched peripheral blood monocyte suspensions prepared by density sedimentation 
(Section 2.2.1.2) were examined by a combined analytical procedure designed to 
simultaneously assess membrane CD14 and cytoplasmic ANAE expression (Section 
2.2.4.4). These particular monocyte fractions, comprising 10-25% monocytes with the 
remainder being of lymphoid lineage (Figure 2.2a), of >90% viability were stained with a 
CD14 monoclonal antibody (LeuM3, 61D3 or My4), followed by incubation with goat 
anti-mouse immunoglobulin (GAM-1g) coated ox erythrocytes (oxE). Cytocentrifuge 
preparations of the oxE-labelled mononuclear cells were examined by morphology and 
ANAE cytochemistry. Cells exhibiting moderate/strong diffuse (M-type) ANAE 
reactions were considered positive whilst those showing granular or 'dot' type were 
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excluded, as were cells with non-monocytic morphology. Cell differentials (103  
leucocytes) of oxE rosettes and/or ANAE-positive cells were carried out to determine 
correlations between CD14 expression and ANAE staining. Three subgroups of normal 
monocytes were identified; (i) cells showing both CD14 expression and M-type ANAE 
(CD141-ANAE+; mean 92%); (ii) cells lacking CD14 expression but showing M-type 
ANAE staining ( 1-; mean 2.7%); and (iii) cells expressing CD14 but showing 
insignificant M-type ANAE staining (CD14+ANAE-; mean 4.9%). Monocytoid cells 
expressing neither CD14 nor ANAE were not seen. The relative distributions of these 
three normal monocyte sub-populations were remarkably similar for all three CD14 
monoclonal antibodies studied (Table 2.4). 
2.3.2 	 Leukaemic (AML) case classification;  
2.3.2.1 Diagnostic subtypes,' 
 A total of 309 cases of acute myeloid leukaemia were 
examined in this study. These were classified on the basis of morphological, 
cytochemical and immunophenotypic criteria as: (a) acute myeloblastic leukaemia (AML-
M1/M2, n=125), (b) acute promyelocytic leukaemia (APL-M3, n=44), (c) acute 
myelomonocytic leukaemia (AMML-M4, n=89), and (d) acute monocytic leukaemia 
(AMoL-M5, n=51). The acute monocytic leukaemias comprised 27 cases of AMoL-M5a 
and 24 cases of AMoL-M5b morphological subtypes, and diagnostic sub-categorisation 
of the acute promyelocytic leukaemias defined 30 cases of the hypergranular variant (M3-
Hyper) and 14 cases of the hypogranular form (M3-Hypo). 
2.3.2.2 ANAE cytochemistry: Blast cells from the 309 cases of acute myeloid 
leukaemia were cytochemically stained for alpha-naphthyl acetate esterase (ANAE), using 
hexazotised pararosaniline as coupler, and their reaction patterns analysed with respect to 
diagnostic subtype. Preliminary analysis of this data indicated wide variability in staining 
reactions and strengths and, consequently, it was decided to reduce the observations to a 
simpler form and categorise the ANAE cytochemical reactions as: 
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Negative or weak difilise: When the majority of blasts showed no significant 
reaction, or showed weak diffuse staining only (Figure 2.3), and where the 
proportion of blasts showing stronger ANAE staining (M-type) was <5%. 
Moderate to strong diffuse: When a minimum of 20% blasts showed moderate 
to strong diffuse staining (referred to as M-type) and the remaining blasts 
showed weaker diffuse reactions of variable strength (Figure 2.4). 
ANAE heterogeneity: When the majority of blasts showed weak diffuse 
staining with only 5% to 20% of the blasts showing typical M-type ANAE 
reactivity. 
Granular or focal: Where a significant proportion of blasts showed a localised 
focal reaction (Figure 2.5), or granular staining which was generally coarse 
with deposits unevenly distributed in the cytoplasm (Figure 2.6). 
Analysing the reaction patterns of the acute myeloid leukaemias in this way, it was found 
(Table 2.5) that blast cells in the majority (75%) of AML-Ml/M2 cases were negative or 
only stained weakly for ANAE. A further 22% of cases exhibited atypical granular or 
focal reaction products. Moderate to strong diffuse M-type reactions were only 
occasionally seen (4/125) in the AML-M1/M2 diagnostic subgroup. 
For the group of acute myelomonocytic leukaemias (AMML-M4), 47% of cases were 
either negative or weakly stained for ANAE; 15% exhibited ANAE staining heterogeneity 
with <20% of blasts showing M-type reactions; and the remaining 38% of cases were 
cytochemically characterised by the presence of >20% blasts with moderate to strong 
diffuse M-type ANAE staining, even though there was considerable inter-case variation in 
the reaction strengths of the blast cell population as a whole. When the blast cells in 39 of 
these AMML-M4 cases were additionally analysed for chloroacetate esterase (CAE) 
activity, four cytochemical subgroups became apparent; (i) those showing mixed 
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populations of CAE+ or ANAE+ (M-type reaction) blasts; (ii) those in which the blasts 
were uniformly ANAE negative but in which CAE+ blasts were seen; (iii) cases in which 
M-type ANAE+ blasts were noted in the absence of a CAE+ component; and (iv) cases in 
which the blasts were uniformly negative for both CAE and ANAE. The relative 
frequency of these four cytochemical subgroups of AMML-M4 were 20%, 20%, 23% 
and 37% respectively. 
Examination of ANAE cytochemical patterns for the acute monocytic leukaemias showed 
that the majority (65%) of cases had significant proportions (exceeding 60% in most 
cases) of blasts with moderate/strong diffuse M-type ANAE reactions. However, a 
further 12% of AMoL-M5 cases showed ANAE staining heterogeneity and, of particular 
importance, blast cells in the remaining 23% of morphologically and immunologically 
classified M5 cases were characterised by negative or weak diffuse ANAE reactions. 
When the data was analysed for AMoL-M5a and AMoL-M5b morphological subtypes 
separately, no significant correlations with ANAE cytochemical patterns were found. 
In contrast to the other acute myeloid leukaemia types, a significant proportion of acute 
promyelocytic leukaemias showed a distinctive ANAE reaction (Figure 2.7) pattern which 
was clearly different to that observed in the other diagnostic categories. Such cases, 
which were predominantly (20/30) associated with the hypergranular APL-M3 variant, 
showed a granular (occasionally seen as both granular and diffuse) type of staining which 
was evenly distributed throughout the cell cytoplasm. In such cases with significant. 
moderate to strong ANAE staining, the ANBE cytochemical reaction was present but was 
considerably weaker in strength. The type of granular reactivity in APL-M3 was in 
distinct contrast to the coarse granular reactivity found in some cases of AML-Ml/M2. A 
further notable difference was that most of the leukaemic promyelocytes with ANAE 
staining simultaneously showed chloroacetate esterase activity (double esterase 
positivity). 
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2.3.2,3 Inimunop_henoupic characteristics: All cases of acute myeloid leukaemia 
studied showed unequivocal evidence of myeloid differentiation, as adjudged by 
cytoplasmic myeloperoxidase (MPO) staining and/or expression of membrane CD13 
and/or CD33 determinants. Although the majority of myeloid leukaemias lacked 
detectable nuclear terminal deoxyribonucleotide transferase (TdT), which is a diagnostic 
marker for acute lymphoid proliferations, approximately 20% of cases were TdT-
positive. However, in these cases there was no evidence for the expression of membrane 
T- or B-cell associated determinants (all cases of myeloid leukaemia considered to show 
bilineal or biphenotypic characteristics were specifically excluded from the study). 
For the assessment of monocyte-associated membrane CD14 expression, a total of 89 
cases of acute myelomonocytic leukaemia (AMML-M4) and 45 cases of acute monocytic 
leukaemia (AMoL-M5) were stained with a minimum of two monocyte-associated 
membrane CD14 determinants from a panel comprising FMC17, FMC32, Mo2, My4, 
LeuM3, UCHM1 and 61D3. CD14 expression was arbitrarily considered 'positive' if 
>20% of the leukaemic blasts were stained and, using this criterion, 66% (59/89) of the 
AMML-M4 cases and 89% (40/45) of the AMoL-M5 cases studied were defined as 
CD14+ (Table 2.6). Although 20% CD14+ blasts was considered to represent the lower 
limit of significance for expression of this particular antigen, it is important to note that in 
most CD14+ AMoL-M5 cases, the proportions of positive blasts exceeded 60%. In 
addition, of the five AMoL-M5 cases that were adjudged to be CD14-, it is perhaps 
relevant that four were of the AMoL-M5a morphological subtype. 
As part of the investigation into nominal and leukaemic cell ANAE cytochemistry, the 
acute myelomonocytic and monocytic leukaemias were additionally examined for the 
comparative expression of membrane monocyte-associated CD14 determinants and 
cytoplasmic ANAE. For this analysis, AMML-M4 and AMoL-M5 cases were grouped 
according to whether they were CD14÷ or CD14-, as detailed above, and these groups 
were analysed with respect to their ANAE cytochemical staining patterns. The results 
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(Table 2.6) show that for the 89 cases of acute myelomonocytic leukaemia, 25% had a 
significant (>20%) monocytic component defined by both CD14 and ANAE expression 
(CD14+ANAE+); 13% of cases had a significant monocytic component defined by ANAE 
staining but not by CD14 expression ( +); 42% of cases had a significant monocytic 
component defined by CD14 expression but not by ANAE staining (CD14+ANAE
-) and 
the remaining 20% of cases did not show an increased monocytic component by either 
immunological or ANAE cytochemical criteria (the diagnosis of these AMML-M4 cases 
was effectively based on morphological impressions and/or increased serum lysozyme 
concentrations [Bennett et al., 1985; Stark et al., 19870. 
For comparison, the acute monocytic leukaemias could be subdivided into those which 
were + (5/45), CD14+ANAE- (16/45) or CD14+ANAE+ (24/45). Interestingly, 10/16 of 
the CD14+ANAE- cases were completely unreactive for ANAE even though the 
monocytic component in most of them, as defined by CD14 expression, exceeded 60% of 
the blast cell population. As a result of the criteria applied for leukaemia case 
classification, no cases within the AMoL-M5 category were found to be CD14-ANAE-. 
Although occasional CD14-ANAE- leukaemias with monocytoid features and increased 
serum lysozyme concentrations were noted during this investigation, their morphological 
features were not typically that of AMoL-M5 and, consequently, such cases were 
classified as AMML-M4. 
2.3.2.4 Relationships between ANAE. CAE and MPO cytoehenzistries of monocytic 
AML variants: In addition to investigating their ANAE cytochemical patterns, the blast 
cells from 89 cases of AMML-M4 and 51 cases of AMoL-M5 were also stained for 
myeloperoxidase (MPO) and chloroacetate esterase (CAE). For this comparative 
analysis, these leukaemias were further subdivided on the basis of MPO cytochemistry 
into those with either 0-5% or >5% blasts with detectable cytoplasmic MPO staining 
(defined as MPO-  and MPO+ respectively). Correlations between the MPO subgroups of 
both the AMML-M4 and AMoL-M5 groups with CAE and ANAE cytochemical staining 
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reactions are summarised in Table 2.7. The first observation of note is that the blast cells 
in all 16 MPO- AMML-M4 cases were CAE- (<5% positive blasts) and most (88%) of 
these were additionally ANAE- (<20% M-type positive blasts). In contrast, 47% (39/73) 
of the MPO+ AMML-M4 cases were CAE+ and 44% (32/73) had more than 20% M-type 
ANAE blasts. 
Of the AMoL-M5 cases studied, 33% (17/51) showed insignificant MPO and CAE 
staining but most (82%) of these had more than 20% M-type ANAE+ cells. Comparison 
of the ANAE and CAE reactions, in relation to MPO staining, did not however reveal any 
definitive correlations. 
2.3.3 extraction of cellular esterases:  
2.3.3.1 Optimisation of cellular esterase extraction procedure: Leucocyte esterases were 
extracted from a mixture of granulocytic and monocytic cells using six different extraction 
reagents: (a) 20mM MES buffer, (b) 0.25M potassium chloride (KC1), (c) 10mM 
CHAPS, (d) 10mg/mlIEGE, (e) 30mM n-octylglucoside, and (f) 10mg/m1 Triton X-100 
(Section 2.2.5.1). These extraction procedures provided an aqueous/detergent fraction, 
containing solubilised proteins, and a particulate suspension containing cellular debris and 
unsolubilised proteins. Quantitative analyses of solubilised cellular esterases, by 
measuring the relative concentrations of esterases in the extracted supernate and the 
resuspended cell pellet by fluorimetric assay with 4MB-Ac as substrate (Section 2.3.6.4), 
are shown in Table 2.8. From these results, it is seen that approximately 91% of 
leucocyte acetate esterase activity was extracted by aqueous MES buffer in the absence of 
any detergent. Increased acetate esterase extraction was obtained by the use of 
detergents, although the type of detergent appeared to be irrelevant, and the highest level 
(99.3%) of extraction was obtained with 0.25M potassium chloride. 
Qualitative studies of the sonicate supernates by IEF ANAE isoenzyme analysis, are also 
summarised in Table 2.8. The ANAE isoenzyme distribution profiles were identical for 
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all the extraction buffers examined however, there were minor quantitative differences in 
the staining intensities of individual isoenzyme groups. Thus, while all ANAE 
isoenzymes could be extracted by aqueous 20mM MES alone, or 20mM MES containing 
0.25M potassium chloride, better yields of isoenzymes within the pl range 5.5-6.2 were 
obtained when 20mM MES was supplemented with a detergent. As the type of detergent, 
zwitterionic or nonionic, did not appear to make any significant difference to the 
qualitative distribution of isoenzyme forms, it was decided to routinely incorporate the 
relatively inexpensive Triton X-100 in the initial extraction buffer. 
2.3.3.2 Effect of Afferent Triton X-I00 concentrations on the apparent molecular weight 
(Mr) species of raw sonicate esterases: In order to determine whether the concentration 
of Triton X-100 used in the extraction procedure was important with respect to the 
presence of different molecular weight species, cellular esterases were extracted from 
ultrasonicated leukaemic AMML-M4 blasts with various different Triton X-100 
concentrations, in 20mM MES (pH 6.4), ranging from 0% to 10.0%. This particular 
case of leukaemia was selected as it was known to contain all the major myeloid esterase 
isoenzyme forms as defined by IEF. 
Fractionation of leucocyte acetate/butyrate esterases (as assessed by hydrolysis of 
fluorimetric substrates) by Superose-12 FPLC gel filtration chromatography (Section 
2.2.5.2) resolved two major esterase forms which collectively represented >95% of the 
extractable cellular esterase activity (detailed analyses of myeloid esterase isoenzymes by 
gel filtration are given in Section 3.2). Furthermore, the relative concentrations of these 
two species, based on the hydrolysis of 4MB-Ac and 4MB-But in an equimolar 
(0.25mM) substrate mixture, indicated an approximate ratio of 1.75:1 for the lower and 
higher molecular weight forms. As this ratio was consistent throughout the range (0 -
10%) of Triton X-100 concentrations examined (Table 2.9 and Figure 2.8), the most 
important conclusions of these studies were therefore that; (i) the specific inclusion of 
Triton X-100 did not affect the relative distributions of the two esterase molecular weight 
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species; (ii) that the ratio of these two esterase forms was not affected by the actual 
detergent concentration; and (iii) that there was no evidence for the incorporation of 
esterases into detergent-micellar forms. 
2.3.4 Isockctric loci&ing s Ilit) of nis cloid cell esterases:  
2.3.4.1 Extract preparation and rationale: 
 Normal and leukaemic myeloid cases 
examined in this study were prepared and characterised as described in Sections 2.2.1 
and 2.2.2. Only cases showing greater than 80% cell population homogeneity with 
viabilities in excess of 90% were selected for isoenzyme analysis, and cell extracts were 
prepared by ultrasonication and detergent solubilisation as described in Section 2.2.51 
The solubilised esterases were subsequently examined by a combination of analytical IEF 
and alpha-naphthyl acetate esterase (ANAE) cytochemical staining in order to assess 
correlations between ANAE isoenzyme distributions, as defined by their isoelectric points 
(pI), cell-lineage and level of maturation. Studies of a large number of representative 
extracts also permitted a direct comparison of the ANAE isoenzyme expression with 
respect to normal and leukaemic myeloid differentiation, and additionally clarified the 
relationships between isoenzyme distributions, conventional ANAE cytochemistry and 
membrane CD14 expression. 
23.4.2 ANAE isoetrzyme patterns of normal myeloid cell fractions: ANAE isoenzyme 
analysis of normal granulocyte and monocyte extracts revealed three main isoenzyme 
pattern types which were designated GI, G2 and M (Figure 2.9). The G I and G2 
patterns were characterised by up to six ANAE isoenzyme forms within an approximate 
pI range of 6.7 - 7.9, with the G2 isoenzyme pattern differing only by the additional 
presence of a pair of weakly staining esterase isoenzymes with an approximate pI of 6.1; 
and the M esterase pattern showed high concentrations of four to six isoenzymes within a 
relatively narrow p1 range of 5.5 - 6.2 (subsequently referred to as the MonEst species) in 
addition to the GI myeloid ANAE isoenzyme forms. Of the 11 normal granulocyte 
extracts examined, four (36%) showed a GI isoenzyme pattern and seven a G2 pattern 
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(Table 2.10). In contrast, all nine normal monocytic extracts showed an M type ANAE 
isoenzyme pattern. As the higher pI (6.7-7.9) esterase isoenzymes were seen in virtually 
all cell extracts analysed, these will be subsequently referred to as ComEst (common to 
both granulocytic and monocytic differentiation) forms irrespective of whether or not 
MonEst isoenzymes were present. 
2.3.43 ANAE isoenzyme patterns of leukaernic myeloid c ell fractions - All myeloid 
leukaemias examined in this study were classified by morphological, cytochemical and 
immunophenotypic criteria. Comparative analysis of IEF esterase zymograms revealed 
that the isoelectric points of individual ANAE isoforms in leukaemic cell extracts were 
identical to those observed in normal myeloid cell zymograms. In addition, although 
there was a greater degree of inter-case variation with respect to individual isoenzyme 
expression, leukaemic myeloid cell IEF patterns could also be grouped as GI, G2 or M 
(Figure 2.10). When the ANAE isoenzyme pattern types were analysed with respect to 
myeloid leukaemia subtypes, it was found that the non-monocytic (AML-M1/M2 and 
APL-M3) variants predominantly showed either a GI or G2 pattern whereas M-type 
ANAE IEF patterns were invariably associated with monocytic (AMML-M4 and AMoL-
M5) variants (Table 2.10). Although the observed pI and the relative staining intensities 
of individual ComEst isoenzyme forms was remarkably similar for all the myeloid 
extracts with G1 and G2 patterns, there was more variability regarding those cases with 
M-type ANAE isoenzyme patterns. For example, the occurrence of multiple (ranging 
from five to more than ten) MonEst isoenzyme components in the pI range 5.5 - 6.2, or a 
decrease in the relative concentrations of ComEst ANAE isoenzymes (Figure 2.11), was 
observed in a proportion of monocytic leukaemic extracts. Of the 96 AML-Ml/M2 and 
APL-M3 fractions studied, 82% showed a 01 ANAE isoenzyme pattern, a further 17% 
showed a G2 pattern and only one case was found with significant concentrations of 
MonEst isoenzymes (Table 2.10). Of the monocytic myeloid leukaemia subtypes, 29/63 
and 30/45 of the AMML-M4 and AMoL-M5 subtypes respectively showed M-type 
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ANAE isoenzyme patterns with the remaining cases showing either GI or G2 type 
patterns. 
2.3.4.4 Relationships between ANAE coochemistry and isoenzyrne patterns: The 
esterase isoenzyme patterns from 39 cases of AML-M1/M2, 40 cases of AMML-M4 and 
45 cases of AMoL-M5 were additionally compared with respect to their ANAE 
cytochemistries (Table 2.11). Irrespective of diagnostic subtype, 66/69 cases with 
negative or weak diffuse ANAE cytochemistry showed 01 (n = 48) or G2 (n = 18) 
isoenzyme patterns, whilst MonEst isoenzymes were detected in only three cases (one 
AML-MI/M2 and two AMML-M4). Of the 16 cases with ANAE cytochemical 
heterogeneity, 13 showed significant levels of monocyte-associated ANAE isoenzymes 
(M-type pattern), as did 29/31 cases with moderate to strong blast cell ANAE staining. 
For comparison, none of the eight cases with granular or focal reaction products showed 
monocytic ANAE isoenzymes. 
With respect to acute promyelocytic leukaemia, all 11 cases examined showed ANAE-IEF 
patterns of 01 or G2 type (Table 2.12). None of the APL-M3 cases were found to 
express monocyte-associated esterase isoenzymes even though the ANAE cytochemical 
(granular) staining reactions in two of these cases were of moderate to strong intensity. 
2.3.4.5 Relationships between CD 14 expression and ANAE isoenzyme patterns: The 
ANAE-IEF pattern types of 32 AMML-M4 and 42 AMoL-M5 (M5a and M5b subtypes 
analysed separately) leukaemias were further compared with membrane CD 14 
expression. This was achieved by arbitrarily defining cases with >20% of leukaemic 
blasts with detectable CD14 expression as CD144-, and those with <20% as CD14-. For 
the AMML-M4 cases, there appeared to be no significant relationship between ANAE-
IEF pattern type and CD14 expression (Table 2.13). For comparison, the majority (71%) 
of AMoL-M5a cases showed M-type ANAE IEF patterns and there was again no apparent 
correlation between CD14 and ANAE isoenzyme expression; similar results were 
observed for AMoL-M5b cases which were all CD14+. 
63 
2.3.4.6 Subs_traie spec city of esterase isvenumes: Seven different myeloid leukaemia 
blast cell extracts, each of which expressed all the major myeloid esterase isoenzyme 
forms, were electrophoresed (IEF) in multiple lanes following which, individual tracks 
were immersed in staining solutions containing either alpha-naphthyl acetate, propionate 
or butyrate substrates (each at 5.0mM) with hexazotised pararosaniline as coupler at pH 
6.3 for 30 min. 
Consistent patterns of staining with the different substrates were observed for each extract 
studied, a representative analysis of which is shown in Figures 2.12 and 2.13. These 
studies clearly showed that the ComEst myeloid esterase isoenzyme forms preferentially 
hydrolysed substrates of low acyl-chain length (acetate), hydrolysed propionate with 
much lower efficiency, and showed no significant hydrolysis of the butyrate substrate. 
In contrast, the MonEst isoenzyme forms (pI 5.5 - 6.2), as well as the two weakly 
staining isoenzymes within the same pI range that characterised the G2 IEF pattern. 
hydrolysed all three substrates. 
2.3.4.7 Inhibirion studies of ANAE isoelinwies: A leukaemic (AMML-M4) blast cell 
extract, expressing both ComEst and MonEst isoenzymes, was electrophoresed (IEF) in 
multiple lanes. Following electrophoresis, individual tracks were stained in an alpha-
naphthyl acetate esterase substrate reaction mixture containing various inhibitors at pre-
determined concentrations. These procedures permitted direct and simultaneous 
assessments of the effect of these inhibitors on both the ComEst and MonEst isoenzyme 
forms, the results for which are summarised in Table 2.14. 
Only two, sodium fluoride (NaF) and phenylmethylsulphonyl fluoride (PMSF), of the 
five compounds tested showed any inhibition of myeloid esterases. At the concentrations 
examined (0.1mg/m1 NaF and 5.0mM PMSF), both these compounds significantly 
inhibited MonEst ANAE isoenzymes whilst showing only partial, or no inhibition of the 
ComEst species. However, when a range (up to 1.5 mg/ml) of NaF concentrations were 
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examined, it was evident that the inhibition of monocyte-associated isoenzyme forms by 
this compound was relative rather than absolute, as at higher NaF concentrations the 
ComEst isoenzyme components were also inhibited (Figure 2.14). A more detailed 
analysis of the relative staining intensities with respect to NaF concentration indicated an 
approximate 13 fold increased sensitivity of MonEst isoenzymes to NaF, when compared 
with the ComEst. In contrast, the inhibitory effects of PMSF (concentration ranging 
from 1.0 to 10.0mM) were found to be largely restricted to MonEst. 
2,3.5 Optimisation of UV spectronholornetric esterase assays:  
2.3.5.1 Effect of substrate concentration: A leukaemic AMML-M4 cell extract, 
containing all the major myeloid esterase isoenzyme forms, was diluted to 1:2 and 1:4, 
and examined for ANAE activity by UV spectrophotometric assay at 300C with a range of 
substrate concentrations from 0.05mM to 0.75mM. The aim of this analysis was to 
determine a saturating substrate concentration (where the concentration of free substrate 
remained essentially unchanged over the reaction period) which could be used for routine 
assay purposes in this study. Alpha-naphthyl acetate was found to be soluble in 10mM 
MES pH 6.3 up to 0.75mM, above which the absorption at 235nm was unacceptably 
high. At both dilutions of cell extract examined, the rate of substrate hydrolysis increased 
in proportion to the increasing substrate concentration up to approximately 0.4mM 
(Figure 2.15). At this concentration and above, the rate of substrate hydrolysis only 
increased minimally with increasing substrate concentration (i.e. substrate concentration 
exceeded enzymic hydrolysis). On the basis of these findings a working substrate 
concentration of 0.5mM was chosen as being saturating for subsequent assays with 
ANAE activities up to 5.3mU (Section 2.3.5.4), where 1.0mU was defined as that 
amount of enzyme causing an increase in A235 of 0.023 in 1.0 min at pH 6.25 and at a 
temperature of 30°C. 
2.3.5.2 Reaction rate linearity:  The time course of the UV spectrophotometric ANAE 
assay, and the period over which the rate of substrate hydrolysis remained constant, was 
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established by investigating a leukaemic AMML-M4 blast cell extract which contained all 
the major myeloid isoenzyme forms. This extract was serially diluted to 1:8, and 20p1 of 
each dilution was tested for ANAE activity at 300C. The increase in absorbance at 235nm 
(A235) was measured at 0.5 min intervals over a period of 10.0 min. At a substrate 
concentration of 0.5mM, hydrolysis was found to be linear with respect to time over the 
10 min period studied (Figure 2.16). However, as reaction rate linearity was more 
consistent in the first 5.0 min of the assay, this time period was chosen for subsequent 
determinations of ANAE activity by UV assay. 
2.3.5.3 Kinetic. characteristics of extract alpha-naphthyl acetate esterases: From the data 
obtained earlier (Figure 2.15), it was additionally possible to calculate the overall Km and 
Vmax values for the hydrolysis of alpha-naphthyl acetate by the mixture of myeloid 
esterase isoenzymes present in the leukaemic AMML-M4 blast cell extract. This was 
achieved by constructing a Lineweaver-Burk plot of 1/reaction velocity (1/v) against 
1/substrate concentration (1/s). Straight lines were observed for both dilutions of cell 
extract, the lines intersecting the x-axis (abscissa) at a point corresponding to -I/Km and 
the y-axis (ordinate) at points corresponding to 1/Vmax (Figure 2.17). The Vmax values 
were calculated to be 0.03 and 0.015 A235units/min for the 1:2 and 1:4 diluted samples 
respectively and the Km values were calculated to be 0.111mM for both dilutions of the 
extract. These results thus indicated that whilst the Vmax values varied with the amount 
of enzyme in the sample. the Km value was independent of enzyme concentration. 
2.3.5.4 Effect of enzyme concentration: Cell extracts from four different myeloid 
leukaemias (two containing all the major myeloid esterase isoenzymes and two containing 
all the myeloid isoenzymes with the exception of those associated with monocytic 
differentiation) were serially diluted to 1:8 and each examined for their rates of substrate 
hydrolysis at 300C with a standard 0.5mM solution of alpha-naphthyl acetate. The 
increase in A235 was monitored over a 5.0min period and the rate (per min) of substrate 
hydrolysis determined. Apparent ANAE activities of the four different undiluted 
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leukaemic cell extracts examined ranged from 2.0mU to 5.3mU with observed rates of 
change in A235 of 0.047 to 0.122/min. Subsequent analysis of dilutions of these cell 
extracts revealed (Figure 2.18) a linear correlation between the observed rate of ANA 
hydrolysis (increase in A235/min) and enzyme concentration (extract dilution). The 
minimum discernible linear rate of change in A235 in these experiments was found to be 
0.007, which corresponded to a defined ANAE enzyme activity of 0.3mU. 
2.3.5.5 Optimised UV spectrophotometric asst r for ANAE: As a result of the above 
investigations, an optimised method for the assay of ANAE in cellular extracts was 
devised. A stock 50mM substrate solution of alpha-naphthyl acetate in 2-methoxyethanol 
(stored at -20°C) was prepared and a working substrate solution made by diluting this in 
10mM MES pH 6.3 to a final concentration of 0.5mM. 20111 of test sample was added to 
1.0m1 of working substrate solution in a semiquartz cuvette and the rate of increase in 
A235 at 30°C measured (Pye Unicam 8800 UV/VIS Spectrophotometer) over a period of 
5.0 min. Samples were re-analysed, in diluted form, if the reaction rate was found to be 
either non-linear or exceeded 0.14 (corresponding to the upper limit of activity shown to 
be linear in the above studies) absorbance units/min. By calculating the rate of substrate 
hydrolysis, based on the formation of alpha-naphthol, it was possible to quantitate the 
level of ANAE. As in previous studies [Mastropaolo & Yourno, 19811, one unit of 
ANAE activity was defined as that amount of enzyme required to hydrolyse 1.0umol of 
substrate in 1.0 min at a pH 6.3 at 30°C. Relating this to an absolute change in A235, the 
hydrolysis of 1.0nmol of substrate (i.e. by 1.OmU of ANAE) results in an increase in 
A235 of 0.023. 
Similar evaluations were undertaken for alpha-naphthyl butyrate, and when using this 
substrate in a UV spectrophotometric assay, 1.0mU of enzyme (butyrate esterase) was 
defined as that which caused an increase in A235 of 0.024 under identical assay 
conditions to that outlined for alpha-naphthyl acetate esterase. 
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3.3.6 Optimisation of fluorimetric esterase assays:  
2.3,6.1 kftect of substrate concentration: A leukaemic AMML-M4 blast cell extract, 
containing all the major myeloid esterase isoenzyme forms, was diluted to 1:2 and 
examined for acetate and butyrate activity by fluorimetric assay at 37°C with substrate 
concentrations ranging from 0.05mM to 1.0mM. As for the optimisation of the UV 
assay, the aim of this analysis was to determine a saturating substrate concentration which 
could be used routinely for subsequent studies. 4-methylumbelliferyl acetate (4MB-Ac) 
was found to be soluble in 50mM MES p1-1 6.3 up to a concentration of 1.0mM, whereas 
traces of the 4-methylumbelliferyl butyrate (4MB-But) substrate precipitated out of 
solution at concentrations exceeding 0.3mM. Despite this, the rate of hydrolysis of both 
substrates increased proportionately with increasing substrate concentration, although at 
substrate concentrations of >0.4mM the rate of hydrolysis became less pronounced 
(Figure 2.19). On the basis of these findings, a substrate concentration of 0.5mM was 
chosen as being,saturating for routine use with fluorimetric assays. 
2.3.6.2 Reaction rate linearity; The time courses of the fluorimetric assays for cellular 
acetate and butyrate esterases were investigated with a leukaemic AMML-M4 blast cell 
extract, containing all the major myeloid esterase isoenzyme forms. The extract was 
serially diluted to 1:4, and 2041 of each dilution was incubated with 250111 of 0.5mM 
4MB-Ac or 4MB-But at 370C and the fluorescent emission at 460nm was measured at 
10, 20, 35, 45, 55 and 65 min_ The hydrolysis of both 4MB-Ac and 4MB-But was 
noted to be linear over the 65 min period examined (Figures 2.20a and 2.20b) and, on the 
basis of these findings, reaction periods up to a maximum of 60 min were chosen for 
subsequent fluorimetric assays. 
2.3.6.3 Erect cf enzyme concentration:  Serial dilutions to 1:8 of blast cell extracts were 
prepared for two cases of myeloid leukaemias with monocytic involvement (one each of 
AMML-M4 and AMoL-M5), which contained all the major myeloid esterase isoenzyme 
forms, and two cases of AML-M1/M2 which contained all myeloid esterase isoenzyme 
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forms with the exception of those associated with monocytic differentiation. 20w of each 
of the dilutions were assayed under standardised assay conditions of 37°C with 250[11 of 
working 0.5mM substrate in 50mM MES pH 6.3. At 60 min, the fluorescent emission at 
460nm was measured and corrected for inherent background fluorescence due to a small 
amount of autohydrolysis and (more importantly) from 'non-specific' interaction of 
proteins with the fiuorigenic substrates. Subsequent analysis of the results showed a 
linear relationship between observed substrate hydrolysis and sample dilution (Figure 
2.21). 
2.3.6.4 Optintisedfluarimetric assays for acetate and butyrate esterases: On the basis of 
the above findings, an optimised method for the measurement of solubilised esterases 
was devised. Stock 30mM substrate solutions of 4MB-Ac or 4MB-But (Koch-Light) 
were prepared in acetone and these solutions were stored at -200C until required, with no 
significant deterioration of substrate. The working substrate solutions were prepared by 
diluting stock substrates in 50mM MES pH 6.3 to give a final substrate concentration of 
0.5mM. A standard 20[11 of cell extract (or 50-100ttl of chromatography fraction) was 
added to 250111 of this working solution and the reaction mixture incubated at 370C for a 
fixed period not exceeding 60 min. Following incubation, the reaction mixture was 
made up to 7501.11 with 50mM MES pH 6.3 and the fluorescent emission at 460nm 
measured, with an excitation wavelength of 400nm. Standard curves for 4- 
methylumbelliferone standards were also determined (data not shown) but, as the primary 
application of these fluorimetric assays were for measuring the relative hydrolysis 
(enzyme activities) of sequential fractions in chromatographic separation procedures, 
formal conversion of observed values to unit values were not considered necessary. 
Consequently, for the purposes of this study, acetate and butyrate esterase activities were 
reported as arbitrary fluorescent units under the standardised conditions outlined above. 
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2.3.7 Correlations between UV sne_c_tronholoraetric and fluorimetric 
esterase assays:  
2.3.7.1 Effect (ff substrate concentration: 
 A leukaemic AMML-M4 blast cell extract was 
tested for acetate esterase activity by both optimised UV spectrophotometric (alpha-
naphthyl acetate) and fluorimetric (4-methylumbelliferyl acetate) assays (Section 2.2.9). 
A standard 20111 of 1:2 extract was used throughout and the results revealed a linear 
relationship between the activities defined by both assay procedures over the substrate 
concentration range of 0.05 to 0.5mM examined (Figure 2.22). 
2.3.7.2 Effect of enzyme concentration: Esterases extracted from leukaemic AMML-M4 
and AML-M1/M2 blasts were examined for acetate esterase activity by both UV 
spectrophotometric and fluorimetric assay procedures. The extracts were serially diluted 
to 1:8, and 201.11 of each dilution tested for acetate esterase activity by optimised UV 
spectrophotometric and fluorimetric assay procedures. A comparison of the rate of 
substrate hydrolysis by the two techniques revealed a linear relationship between the rate 
of hydrolysis of alpha-naphthyl acetate and 4MB-Ac for all the cell extract dilutions 
studied (Figure 2.23). 
On the basis of these results, it was considered that the optimised UV spectrophotometric 
and fluorimetric assay procedures were likely to be measuring the same enzymes and that 
esterase activities measured by either assay were directly comparable. 
2.3.8 Quantitation of cell extract esterase activities:  
Acetate and butyrate esterase activities for a total of 56 acute myeloid leukaemias (AML-
M1/M2, n=22; APL-M3, n=3; AMML-M4, n=19; and AMoL-M5, n=12) with G1 
(n=24), G2 (n=18) or M (n=14) esterase isoenzyme IEF patterns were determined by UV 
spectrophotometric assay. As detailed earlier (Section 2.3.5.5), 1.0mU of acetate or 
butyrate esterase activity was defined as that amount of enzyme required to hydrolyse 
1.0nmol of substrate in 1.0 min at a standardised pH (6.3) and temperature (30°C). 
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Relating this to an absolute change in absorption at 235nm, the hydrolysis of 1.0nmol of 
alpha-naphthyl acetate or butyrate substrate resulted in an increase in A235 of 0.023 and 
0.024 respectively. Using this assay system, the acetate and butyrate esterase activities 
were initially calculated as mU/m1 extract and this was converted, following measurement 
of the extract protein concentration, to mU/mg protein. When the acetate and butyrate 
esterase activities were examined in relation to the IEF pattern types (Figure 2.24), no 
obvious relationships were apparent even though cases with M-type patterns by IEF 
clearly had higher cellular esterase activities as assessed by conventional ANAE 
cytochemistry. Thus even though earlier cytochemical and electrophoretic analyses 
suggested that monocytic leukaemias with strong diffuse ANAE staining (and M-type IEF 
patterns) should have a higher ratio of butyrate to acetate esterase activity than 
myeloblastic leukaemias with insignificant or weak diffuse ANAE cytochemical staining 
(and 01 or G2 patterns), this was not reflected by their relative butyrate/acetate assays. 
These results therefore suggest that the esterase isoenzymes detected by IEF were not the 
only enzymes present in the myeloid cell extracts that could hydrolyse the substrates used 
in UV spectrophotometric and fluorimetric assays. Similarly, acetate and butyrate 
esterase activities (examined fluorimetrically as described in Section 2.3.6.4) of normal 
myeloid cell extracts (granulocyte, n=11 and monocyte, n=9) with GI (n=4), G2 (n=7) 
and M-type (n=9) esterase isoenzyme patterns, also showed no apparent relationships 
between the IEF pattern types and enzyme activities (Figure 2.25). Indeed, the majority 
(17/20) of normal myeloid cell extracts studied had apparently similar levels of esterase 
activity irrespective of the IEF pattern type or the substrate (acetate or butyrate esters of 4- 
methylumbelliferone) examined. The remaining three cases which showed higher relative 
rates of butyrate hydrolysis, compared to acetate, all showed M-type IEF patterns. 
2.4 DISCUSSION  
This section of the study has extensively evaluated the cytochemical and electrophoretic 
characteristics of normal and Ieukaemic myeloid cell alpha-naphthyl acetate (ANAE) and 
butyrate (ANBE) esterases, and assessed differences in esterase isoenzyme distribution 
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associated with granulocytic and monocytic differentiation. Normal peripheral blood 
granulocytes and monocytes were investigated as representative models of mature 
myeloid differentiation and acute leukaemias, in common with previous studies [Griffin et 
al., 1981: Glasser 1983; Ferraro et al., 1983; Ball & Fanger 19831, as models of myeloid 
precursor differentiation. Acute leukaemias offer unique opportunities for examining 
immature cells characterised by variable degrees of maturation arrest. While 
leukaemogenesis may result in aberrant or asynchronous phenotypic expression [Scott et 
al., 1983; Smith et al., 1983], the blast cells in many cases of leukaemia are considered to 
retain lineage fidelity [Reinherz el al., 1980; Habeshaw et al., 1983; Greaves 19861 and 
express developmental markers appropriate to their normal maturational counterparts. 
The first part of the investigation examined the ANAE cytochemical characteristics of 
normal and leukaemic myeloid cells. The acute leukaemias examined in this study were 
categorised by multiple morphological, cytochemical and immunophenotypic criteria 
(Section 2.3,2), into myeloblastic (AML-M 1/M2), promyelocytic (APL-M3), 
myelomonocytic (AMML-M4) and monocytic (AMoL-M5) variants. Using alpha-
naphthyl acetate as substrate at pH 6.0-6.3, ANAE activity has been reported as being 
very weak or negative in mature granulocytes, negative or weak granular in myeloblasts 
and moderate to strong diffuse in monocytic cells [Li et al., 1973; Kulenkampff et al., 
1977; Gordon & Hubbard 1978; Hayhoe & Quaglino 1980; Flandrin & Daniel 1973, 
1981; Scott et al., 19871. Consequently, ANAE cytochemical activity has proved to be of 
value in defining cells of monocytic-lineage [Scott et al., 19831 although relatively little 
has been reported on the ANAE activity of non-monocytic myeloid cells. 
This current study, where the ANAE cytochemical reactivities for a total of 309 acute 
myeloid leukaemias and 11 normal granulocyte and nine normal monocyte fractions were 
examined, confirms previous impressions that normal mature granulocytes and the 
immature blasts of AML-M1/M2 are essentially ANAE negative or show weak reactions 
only. For comparison, moderate to strong diffuse ANAE reactions were found to be 
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restricted to normal and leukaemic cells of monocytic-lineage. Although, the observation 
that blast cells in 22% (27/125) of the AML-Ml/M2 and 45% (20/44) of APL-M3 cases 
examined, showed distinct granular or focal ANAE reactions is of potential diagnostic 
relevance as, in such cases, there may be a tendency to interpret the presence of 
significant ANAE activity as an indicator of possible monocytic involvement. However, 
it appears from the results of this and previous studies [Hayhoe & Quaglino 1980; Scott 
et al., 1983, 1984a, b, cl that blast cell esterase cytochemistry alone may not adequately 
differentiate between monocytic and non-monocytic AML variants and that their 
diagnostic delineation may be better achieved by immunological or electrophoretic studies 
[ Scott et al., 1984a, b, c; Linch et al., 1984]. It is also apparent that the presence of 
significant ANAE cytochemical activity is not inconsistent with a diagnosis of AML, 
particularly when morphological and immunological impressions do not indicate 
monocytic involvement in the leukaemic process. For example, ANAE staining in APL-
M3 was noted to be predominantly associated with hypergranular cases (with only 1/14 
of the hypogranular cases showing weak ANAE activity) and confirms previously 
reported observations [Stavem et al.. 1981; McKenna et al., 1982; Tomonaga et al., 
1985]. This cytochemical reaction, which is atypical in that it is not seen in normal 
marrow promyelocytes [Scott et al., 1983; Tomonaga et al., 1985], has been interpreted 
to indicate 'bilineal' or 'mixed' monocytic-granulocytic differentiation [Tomonaga et al., 
1985; Lemez, 1988] based on the tenuous assumption that significant cytoplasmic ANAE 
staining is a restricted 'marker' for cells of the monocyte-macrophage lineage. None of 
the ANAE+ AML-Ml/M2 or APL-M3 cases examined in this study however, showed 
monocytic differentiation as defined by membrane CD14 expression. Furthermore, 
where equivocal ANAE activity was observed in these cases, a study of ANAE 
isoenzyme distribution helped to clarify the lineage-commitment of these cells. 
Acute myelomonocytic leukaemias (AMML-M4) are characterised by the presence of 
mixed populations of blasts showing monocytic and granulocytic differentiation, as 
adjudged by the presence of cytoplasmic ANAE and chloroacetate esterase (CAE) 
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activities [Gordon & Hubbard, 1978; Kass, 1979; Hayhoe & Quaglino, 1980; Flandrin & 
Daniel, 19811. Monocytic involvement in AMML-M4 cases was found in previous 
studies [Flandrin & Daniel, 1981; Huhn & Twardizik, 1983; Ball & Fanger, 1983; Linch 
et al., 1984] to be variable as reflected by the heterogeneous expression of cytoplasmic 
ANAE activity and membrane CD14 determinants. However, these studies suffered an 
inherent disadvantage in that the cases were usually classified according to morphological 
features only. The consequent limitations of this type of classification are thus, to a 
certain extent, reflected by their heterogeneous cytochemical and immunological features. 
Taking these factors into consideration, this present study only investigated cases in 
which myelomonocytic classification was unequivocal, using multiple discriminating 
criteria as described in Section 2.3.2. Of the 89 AMML-M4 cases examined, 38% 
showed monocytic involvement as characterised by moderate to strong ANAE staining in 
>20% of the blast cell population. However, when examined for membrane CD14 
expression, 66% (59/89) of the cases investigated showed apparent monocytic 
differentiation, as characterised by >20% antigen-positive blasts, with 63% of these 59 
CD144- cases showing negative or equivocal cytoplasmic ANAE reactivity. 
There are an increasing number of reports suggesting that apparent lineage commitment. 
characterised by the expression of granulocytic or monocyte-associated components, may 
not be irreversible and that there may be a transitional period in which changes in 
maturational direction can be affected by extracellular stimuli [Sachs, 1978; Rovera et al., 
1979; Kirschner & Goldberg, 1981; Tarella et al., 1982; Fibach et al., 1982]. The 
presence of chloroacetate esterase (CAE) positive blasts in 40% of the AMML-M4 cases 
studied, together with the ANAE heterogeneity observed in these cases, may be viewed 
as being consistent with the hypothesis that AMML-M4 blasts represent an early and 
transitional stage of monocytic differentiation. It is proposed therefore, that the 
cytochemical heterogeneity of blasts in AMML-M4 represents distinct maturational stages 
which comprise, to varying degrees, (a) blasts showing early and potentially reversible 
granulocytic differentiation which are myeloperoxidase (MPO) positive, CAE-positive (or 
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negative) and ANAE-negative; (b) blasts showing early monocytic differentiation which 
are MPO-positive (or negative), CAE-negative and ANAE-negative (or weakly positive). 
these may represent cells not irreversibly committed to monocytic differentiation; and (c) 
irreversibly committed blasts of monocytic-lineage characterised by variable MPO 
activity, negative CAE and positive cytoplasmic ANAE. The findings of this, and 
previous studies [Flandrin & Daniel, 1981; Huhn & Twardizik, 1983; Ball & Fanger, 
1983; Linch et al., 1984], that the blast cells of AMML are considerably more 
heterogeneous, perhaps because of their transitional nature, than the other variants of 
acute myeloid leukaemia is further reflected by their patterns of ANAE isoenzyme 
distribution (discussed below). 
Examination of the ANAE cytochemistry of morphologically and immunophenotypically 
classified acute monocytic leukaemias (AMoL-M5) revealed that whilst the majority of the 
cases showed M-type reactivity, high proportions (>80%) of blasts in a significant 
number (35%) of cases showed no apparent ANAE staining. Indeed when the AMoL-
M5 cases were further examined for the comparative expression of membrane monocyte-
associated CD14 expression and cytoplasmic ANAE, it was found that 53% of cases 
showed expression of both CD14 and ANAE components (ANAE+ CD14+). A further 
11% of cases showed typical M-type ANAE staining in the absence of CD14 expression 
(ANAE+ CD14-) whilst the remaining cases expressed membrane CD14 despite the 
absence of significant cytoplasmic ANAE (ANAE- CD14+). It would appear therefore 
that, as with the AMML-M4 cases, a greater proportion of cases expressed membrane 
CD14, compared to cytoplasmic ANAE, and this is consistent (in the absence of 
leukaemia-associated defects in protein transcription and synthesis) with the view 
[Ferraro et al., 1983; Scott et , 1984c, 1985] that expression of membrane CD14 
precedes cytoplasmic ANAE synthesis. 
Electron microscopy studies have shown that the intense diffuse esterase reactivity of 
monocytes is associated with a plasmalamella ectoenzyme [Bozdech & Bainton, 1977, 
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1981; Monahan el al., 19811. Similarly, the granular or focal esterase reactivity of 
myeloblasts (conventional microscopy) and T-lymphocytes (electron microscopy) has 
been reported to be associated with clusters of smooth membrane vesicles in the 
cytoplasm found close to the Golgi apparatus [Bozdech & Bainton, 1981; Monahan et al., 
1981; Marec et .41., 1981; Zicca et al., 19811. Indeed, the ANAE cytochemical pattern 
types, observed in cells of myeloid lineages, correlate well with the subcellular location of 
these enzymes as determined by ultrastructural studies. 
The esterase polymorphism of haemopoietic cells, in view of their different cytochemical 
staining patterns and subcellular localisations, were further examined by zymogram 
studies, as advocated by Hunter and Burstone [19601. The aims of these studies were 
primarily to clarify whether the above observations reflected differential subcellular 
distribution of the same isoenzymes or the existence of different esterase isoenzyme 
groups. In earlier studies, electrophoretic separation of esterase components was 
achieved using conventional polyacrylarnide gel electrophoresis (PAGE) [Li et al., 1973; 
Kass & Peters 1978; Yourno & Mastropaolo, 19811. For example, separation of myeloid 
esterase isoenzymes by PAGE at pH 4.0 [Li et al., 19731 defined nine main esterase 
components (designated 1 to 9). Four of these components (2, 4, 5 and 6), representing 
nonspecific esterases, were noted to hydrolyse acetate and/or butyrate esters of alpha-
naphthol, while the remainder hydrolysed naphthol-AS-D chloroacetate and corresponded 
to chloroacetate esterases. Three nonspecific esterase components (2, 5 and 6) were 
additionally shown to be common to both granulocytes and monocytes, whereas 
component 4 was shown to be unique to cells of monocytic lineage. Moreover, inhibitor 
studies with 0.04M sodium fluoride (NaF) further indicated that isoenzymes 4 and 5 were 
NaF sensitive. Similarly, PAGE separation of leucocyte esterases at pH 9.5 [Yourno & 
Mastropaolo, 1981], resolved a total of 12 different isoenzyme components but again 
only four of these (designated Al, A2, AB I and AB2) were noted to be expressed by 
cells of granulocytic and monocytic lineages. Two of these isoenzymes (Al and A2) 
preferentially hydrolysed alpha-naphthyl acetate and were relatively NaF-resistant 
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whereas the other two species (AB1 and AB2) showed similar reactivity with both acetate 
and butyrate esters and were highly NaF-sensitive. However, despite differences in 
substrate and inhibitor properties all four esterase components were noted to be common 
to both granulocytes and monocytes. 
While PAGE techniques have revealed differences between esterases from various types 
of haemopoietic cell, with the advent of isoelectric focusing (JEF) it became possible to 
demonstrate additional isoenzyme components [Kass & Munster, 1979a, 1979b] which 
were previously unresolved by PAGE. Separation of myeloid esterases by IEF [Kass & 
Munster, 1979a, 1979b; Radzun et al., 1980: Parwaresch et al., 1981; Scott et l., 1984a; 
Drexler et al., 1985; Cohn et al., 1987] resolved up to 18 esterase isoenzymes displaying 
different isoelectric points (pis), and granulocyte preparations showed up to 11 esterase 
isoenzyme components within the pI range 6.3 to 7.9 [Radzun et al., 1980; Scott et it, 
1984a; 1984b; Cohn et al., 1987]. In contrast, the strong diffuse cytochemical staining 
of normal and leukaemic monocytes was found to result from the presence of high 
cellular concentrations of 5-6 acidic isoenzymes within a narrow pl range of 
approximately 5.5 to 6.2 [Radzun et al., 1980: Scott et al., 1984a; 1984b; Drexler et al., 
1985; Cohn et al., 19871. These initial findings were considered to be sufficient to 
warrant the use of IEF, rather than conventional PAGE, for the characterisation of 
myeloid esterases in this study. 
In this present study, esterase isoenzymes were extracted from purified myeloid cells by 
ultrasonication followed by membrane solubilisation using the nonionic detergent Triton 
X-100. Preliminary investigations showed that the solubilisation of cellular myeloid 
ANAE was partially facilitated by the incorporation of detergent in the extraction buffers 
and that the type of detergent used, nonionic or zwitterionic, made no significant 
qualitative or quantitative difference to the resulting esterase isoenzyme patterns. 
Consequently, the nonionic detergent Triton X-I00, in agreement with previous studies 
[Yourno & Mastropaolo, 1981; Scott ell., 1983; Oertel & Kastner, 1984; Oertel 111., 
77 
1985; Cohn et al., 1987], was chosen for the routine extraction of cellular ANAE. In 
addition, the use of this nonionic detergent permitted analyses of the extracted enzymes 
by means of biological activity and also allowed fractionation by ion-exchange and 
electrophoretic techniques. In this context, supplementary investigations showed that 
increasing Triton X-100 concentration (up to 10%) had no effect on the relative 
distribution of ANAE molecular forms when compared with ANAE extracted in absence 
of detergent. Therefore, the findings of this study indicate no evidence for the 
incorporation of ANAE into detergent-micellar forms which could lead to differences in 
molecular weight profiles of extracted proteins. However, the observations suggest that 
myeloid ANAE isoenzymes may be membrane-associated although, this and previous 
studies were unable to definitively elucidate the nature, intrinsic or extrinsic, of the 
enzyme-membrane association. 
Composite IEF zymograms of esterase isoenzyme components for most normal blood 
myeloid elements have been investigated by independent groups [Radzun et al., 1980; 
Parwaresch et a., 1981; Cohn et al., 1987; Scott et al., 19891. This present study, 
detailing the ANAE isoenzyme distributions of normal granulocytic and monocytic 
preparations, in addition to 204 acute myeloid leukaemias (representing different levels of 
maturation and lineage-commitment), extends these previous observations. Esterase 
zymograms of normal myeloid subtypes showed three main isoenzyme pattern types, 
designated Gl, G2 and M (Figure 2.9). Normal granulocyte extracts expressed up to six 
ANAE isoenzyme components within a broad pl range of 6.3-7.9 (0 1) and the 
monocytic extracts were characterised by the additional presence of a group of strongly 
staining isoenzymes within a narrow p1 range of 5.5-6.2 (M). The third isoenzyme 
pattern type, seen with a significant proportion of the granulocyte extracts and designated 
G2, was identical to the 01 pattern with the exception that two weakly staining ANAE 
isoenzymes with pls of 6.1-6.2 were seen in addition to the consistently observed 
isoforms with higher pls. 
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Some variations in these composite pattern types have been reported in a small proportion 
of monocytic leukaemias [reviewed in Drexler et al., 1991a]. These include an over 
expression of monocyte-associated isoenzymes and/or reduced expression of isoenzymes 
within the pl range of 6.2-7.9. However, comparative analyses of IEF esterase 
zymograms in this current study indicate that the pI of individual ANAE isoenzymes and 
the distribution of the two main esterase isoenzyme groups (pI 6.3-7.9 and 5.5-6.2) in 
myeloid leukaemias were virtually identical with those seen in their normal counterparts. 
For example, the AML-M 1/M2 and APL-M3 cases, representing early granulocytic 
differentiation, predominantly expressed ANAE isoenzymes within the p1 range of 6.3 to 
7.9 (i.e. G1 pattern), with a minor proportion of cases expressing the two additional 
isoenzymes characteristic of the G2 pattern. With regards to expression of monocyte-
associated ANAE isoenzymes, only one of the 96 acute myeloblastic/promyelocytic cases 
studied showed the additional presence of these components; in retrospect, it is likely that 
this case was in fact a CD14- AMML-M4 which was incorrectly classified as AML-M2. 
The simultaneous expression of ANAE isoenzymes of pi range 6.3 to 7.9 and pI range 
5.5 to 6.2 was closely associated with monocytic variants in which moderate to strong 
diffuse ANAE staining was seen. In acute myelomonocytic leukaemia (AMML-M4), IEF 
patterns appeared to reflect cytochemical heterogeneity in that 46% of cases showed the 
presence of significant monocyte-associated ANAE components, whilst the remainder 
only expressed ANAE isoforms with higher pls. Of the 45 AMoL-M5 cases examined 
by IEF it was found, irrespective of morphological subtype (M5a and M5b) or membrane 
CD14 expression, that the majority (67%) of the cases expressed both groups of ANAE 
isoenzymes. 
The true value of ANAE isoenzyme studies became apparent when the isoenzyme patterns 
were compared with the ANAE cytochemistry and CD14 expression. In addition to 
conclusively excluding monocytic involvement in leukaemias with atypical ANAE 
reaction products, these analyses were able to clarify the nature of myeloid leukaemias in 
which membrane CD14 expression was aberrant or where conventional ANAE 
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cytochemistry was equivocal and difficult to interpret. With respect to acute 
promyelocytic leukaemia, all cases examined showed a GI or G2 ANAE-IEF pattern-type 
with no detectable monocyte-associated isoenzyme forms. The cases studied included 
five M3-hypergranular subtypes in which high proportions of the promyelocytes showed 
significant (weak to moderate/strong) ANAE staining, and indicates that the 'atypical' 
ANAE cytochemical staining patterns of hypergranular M3 cases are not due to the 
presence of monocytic esterase isoenzymes. It appears that the 'atypical' cytochemical 
patterns observed in these cases can be attributed to an over-expression of esterase 
components with pI 6.3 to 7.9, possibly as a result of leukaemogenesis, rather than the 
de novo synthesis of monocyte-associated isoenzymes. Therefore, the earlier 
interpretations of 'mixed' or 'bilineal' granulocytic/monocytic differentiation [Tomonaga 
et al., 1985; Lemez, 1988] in leukaemic promyelocytes are not confirmed by this current 
study of ANAE isoenzymes. 
To broadly summarise these particular investigations, this current study has in common 
with previous reports [Scott et al., 1983, 1984a; Cohn et a.. 1987] demonstrated by 1EF 
two main groups of esterase isoenzymes in normal and leukaemic myeloid cells. The first 
group, with a pI range of 5.5 to 6.2, was found to be expressed exclusively by 
monocytoid cells and the second group (pI range 6.3 to 7.9) showed weaker staining 
intensities and was found to be expressed by both monocytic and granulocytic cells. The 
individual isoenzyme components comprising each of these esterase isoenzyme groups 
were found consistently to have the same pls in all the normal and leukaemic myeloid cell 
extracts analysed. This suggested that the artefactual creation of secondary isoenzymes, 
subsequent to sonication/protein extraction, was not a significant factor. The differences 
in pI between the two isoenzyme groups clearly reflect differences in overall charge, 
which may be of genetic origin, making them true isoenzymes, or may result from post-
translational modifications (i.e. secondary isoenzymes). Alternatively, differences in 
charge may well reflect the existence of distinct enzymes, which display different 
physiological roles in vivo but share the ability to hydrolyse the same non-physiological 
80 
substrate (alpha-naphthyl acetate) in vitro. For ease of discussion, the monocyte-
associated ANAE isoenzymes of pI 5.5 to 6.2 will be hereafter referred to as 'MonEst' 
and the ANAE isoenzymes of pI 6.3 to 7.9 as 'ComEst' because of their common 
expression by both monocytic and granulocytic cells. Using standard biochemical 
nomenclature, MonEst are generally considered as being 'carboxylesterases' (EC 
3.1.1.1) and are most commonly demonstrated cytochemically by a substrate-diazonium 
dye reaction using alpha-naphthyl acetate (ANA) as substrate and diazotised 
pararosaniline as coupler. Although, ComEst may also be demonstrated by a similar 
substrate-diazonium dye reaction, the nature of these esterases has (to date) not been 
described in terms of biochemical nomenclature. 
Current concepts of myeloid differentiation are consistent with a common precursor for 
granulocytes and monocytes. With respect to esterase synthesis, this current study has 
shown that ComEst isoenzymes are synthesised by both normal and leukaemic myeloid 
elements, irrespective of lineage (granulocytic or monocytic) commitment and stage of 
maturation, and that myeloid cells committed to monocytic differentiation are 
characterised by the additional expression of MonEst isoenzymes, which are not observed 
in granulocytic differentiation. Thus the transition from precursor to committed myeloid 
cells is accompanied by the differentiation-linked expression of monocyte-specific 
esterases. Investigations to determine the level of myeloid maturation at which 
commitment to specific granulocyte or monocyte differentiation occurs have largely been 
based on the in vitro characterisation of cell lines such as HL60 (originally obtained from 
a patient with acute myeloblastic leukaemia [Collins e al., 1977]). HL60 cells have been 
demonstrated in vitro to differentiate either to mature granulocytes or monocytes 
following treatment with various chemical inducers. Granulocytic differentiation may be 
induced by treatment with dimethylsulphoxide (DMSO) or retinoic acid, and monocytic 
differentiation by 12-0-tetradecanoylphorbol-13-acetate (TPA). These cells therefore 
represent a possible model for studying alterations in biochemical characteristics 
associated with specific granulocytic or monocytic differentiation [Chia() et al., 1981; 
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Fibach et a., 1982; Ball & Fanger, 1983; Ferraro el al., 1983; Yourno et a., 1984]. The 
main conclusions drawn from these studies appear to indicate that commitment to 
granulocytic or monocytic differentiation occurs at the promyelocyte stage and that this 
process may not be irreversible as there appears to be a transitional period in which 
changes in maturational direction may be effected by alterations in extracellular stimuli 
[Rovera et a., 1979; Tarella et al., 1982; Fibach et al., 1982; Ball & Fanger, 1983]. 
Again, with respect to esterase synthesis, the expression of MonEst components appears 
to be restricted to HL60 cells induced to monocytic differentiation using TPA 1Youmo et 
al., 19841, while non-induced and DMSO or retinoic acid induced cells are characterised 
by the expression of chloroacetate esterase (CAE). This hypothesis requires that both 
ANAE and CAE expression by committed myeloid cells is subject to differential gene 
activation, a possibility first suggested by Marken & Hunter 11959] and more recently by 
Yourno and Mastropaolo [1981]. 
Having established the lineage association of the two main myeloid esterase isoenzyme 
species, this study additionally undertook preliminary analyses of substrate specificities 
and inhibitor sensitivities in order to assess possible physicochemical differences between 
these two main esterase groups. Qualitative histochemical studies of the individual 
isoenzyme groups (following IEF fractionation), using substrates of increasing acyl chain 
length provided a definitive insight into the relative substrate affinities of the MonEst and 
ComEst species. These analyses revealed that whereas MonEst components were capable 
of hydrolysing equimolar acetate, propionate and butyrate esters, the ComEst components 
showed a markedly decreased staining with increasing acyl chain length and showed no 
significant hydrolysis of alpha-naphthyl butyrate. Esterase substrate specificities studies, 
following IEF fractionation of individual isoforms, have not previously been carried out 
and can be applied to explain earlier cytochemical observations where, for example, the 
finding that promyelocytes in APL-M3 with abnormally increased ANAE activity, which 
were unreactive with the butyrate substrate [Scott et al., 1989; Scott & Drexler, 1989], is 
entirely consistent with the absence of MonEst isoenzymes in these cells. 
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In order to further substantiate these observations, two different quantitative esterase 
enzyme assays were optimised. Using these procedures, the acetate and butyrate esterase 
activities of crude normal and leukaemic myeloid cell fractions were determined and 
related to esterase isoenzyme pattern types as defined by IEF. These studies however, 
showed no apparent correlations between the type of isoenzymes expressed and the rates 
of acetate or butyrate ester hydrolysis. Indeed, it was found that extracts with ComEst 
isoenzyme components only, hydrolysed butyrate esters at similar rates to those extracts 
containing both ComEst and MonEst isoenzyme components. These observations are not 
in accord with the above substrate studies, where the separated ComEst components 
consistently showed no significant hydrolysis of alpha-naphthyl butyrate. 
The diversity of esterases from various tissues and the lack of specific differentiating 
characteristics has led to some confusion regarding the biochemical classification of 
myeloid esterase isoenzymes. Classification of enzymes with esterolytic activities have 
traditionally been based, in the absence of knowledge of physiological substrate, on 
criteria such as substrate specificity and inhibitor sensitivity. Histochemically and 
cytochemically important esterases, belonging to the carboxylic ester hydrolase (EC 
3.1.1) group, include carboxylesterases (EC 3.1.1.1), arylesterases (EC 3.1.1.2), 
acetylesterases (EC 3.1.1.6), acetylcholinesterases (EC 3.1.1.7) and cholinesterases (EC 
3.1.1.8). Carboxylesterases represent esterolytic enzymes which hydrolyse carboxylic 
esters and are inhibited by organophosphates (i.e. di-isopropyl fluorophosphate; DFP) 
but not eserine [Holmes & Masters, 1967; Krisch. 19711. Arylesterases are classified on 
the basis of their restricted reactivity with aromatic esters, and their relative sensitivity to 
sulphydryl reagents (i.e. p-hydroxymercuribenzoic acid; HMBA) and resistance to 
organophosphates [Holmes & Masters, 19671. Acetylesterases show restricted reactivity 
with aromatic esters of acetic acid and are not inhibited by organophosphates, sulphydryl 
reagents or eserine [Holmes & Masters, 19671. Finally acetylcholinesterases and 
cholinesterases, as the nomenclature suggests, hydrolyse esters of acetylcholine and 
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choline respectively and are inhibited by organophosphates, neostigmine and/or eserine 
[Holmes & Masters, 19671. 
Preliminary examination, undertaken in this current study, of inhibition characteristics of 
MonEst and ComEst isoenzymes revealed that sodium fluoride (NaF) and 
plienylmethylsulphonyl fluoride (PMSF) exerted inhibitory effects predominantly on the 
MonEst isoenzyme components. In agreement with previous studies [Scott et al., 1984a; 
Drexler et al.. 1991a], the inhibition of MonEst by NaF was shown to be relative rather 
than specific, as inhibitor concentrations exceeding 1.5mg/m1 (36mM) also inhibited 
ComEst components. Cohn al., [19871 report, in their inhibition studies of myeloid 
esterases, that PMSF inhibits both groups of esterase isoenzymes and that the inhibition 
of MonEst is irreversible whilst that of ComEst is reversible. However, this is not 
substantiated in the current study, which demonstrated that PMSF specifically inhibits the 
MonEst species and shows no inhibitory activity against the ComEst components. PMSF 
and organophosphates irreversibly inactivate enzymes by covalently binding to a serine 
residue present in the active site of the enzyme, PMSF through sulphonylation and 
organophosphates through phosphorylation [Choudhury, 1971; 1972; Cohn et al., 
19871. Inhibition of the two isoenzyme groups by organophosphates (DFP or bis-(4- 
nitropheny1)-phosphate; BNPP) have been reported by various authors [reviewed in 
Drexler et al., 1991aj and the findings consistently indicate that both esterase isoenzyme 
groups are inhibited by organophosphorous compounds, suggesting the presence of a 
serine residue at the active site of both isoenzyme groups [Choudhury, 1971; 1972; 
Drexler et al., 19914 Due to their highly toxic nature, organophosphorous compounds 
were not investigated in this present study although, a closer examination of recent 
publications reporting esterase inhibition with these compounds [Owe! & Kastner 1984; 
reviewed in Drexler et al., 1991a1 reveals that where authors describe the inhibition of 
granulocyte-associated esterases these isoenzymes have been quoted as displaying pls 
values of 4.5 to 5.0. Consequently, these isoenzyme components, in light of the findings 
of this and previous studies [Scott et al., 1983, 1984a; Cohn et al., 19871, almost 
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certainly do not represent the ComEst isoforrns (pI 6.3-7.9) associated with cells of 
granulocytic and monocytic differentiation. Taking these points into account, it is 
proposed therefore, that MonEst isoenzymes probably have a serine active site whilst this 
is less likely for the ComEst species. Neostigmine, eserine and the sulphydryl reagent 
HMBA showed no observable inhibition of enzymatic activity of either enzyme group, 
thereby ruling out the possibility of either group being arylesterases (I-MBA-sensitive), 
acetylcholinesterases or cholinesterases (neostigmine and/or eserine-sensitive). 
In conclusion, the present study has demonstrated two distinct myeloid enzyme forms. 
showing esterolytic activity, with differing cytochemical, electrophoretic and catalytic 
characteristics. The MonEst components have been shown to be expressed in a lineage-
restricted manner by cells of monocytic-lineage, whilst ComEst components have been 
demonstrated to be expressed by both monocytic and granulocytic cells. These 
observations, in conjunction with previous ultrastructural investigations [Bozdech & 
Bainton, 1977, 1981; Monahan et al., 1981; Marec et al., 1981; Zicca et al., 19811, 
which indicate differences in subcellular locations of the granulocytic and monocytic 
esterases, suggest that the ComEst and MonEst species could represent two distinct 
esterolytic enzymes which may be encoded by separate structural genes [Moss, 1986]. 
Indeed, it appears that the preliminary substrate specificity and inhibitor sensitivity studies 
undertaken here substantiate the general view that MonEst isoenzymes fulfil the rather 
loose criteria for categorisation as carboxylesterase (EC 3.1.1.1) and that the ComEst 
components, contrary to previous findings [Oertel & Kastner, 1984; Cohn et al., 1987], 
represent a separate and, as yet, uncharacterised esterase group. These initial observations 
and interpretations are further investigated in Chapters Three and Four. 
CHAPTER 2 
Figures 2.1a to 2.25 and Tables 2.1 to 2.14 
Figure 2.1a: May-Grunwald Giemsa (Rornanowsky) stained cytocentrifuge 
preparation of enriched peripheral blood neutrophifs. Neutrophils were isolated 
from peripheral bloods of healthy donors by density sedimentation. techniques 
(Section 2.2.1.1) with resulting purities of >98%, and viabilities in excess of 95%. 
Figure 2.1b: May-Grunwald Giemsa stained cytocentrifuge preparation of 
enriched peripheral bfood monocytes isolated from the peripheral brood of healthy 
adult donors by a three-stage fractionation procedure (Section 2.2.1.2) to a mean 
purity of 77%, with viabilities in excess of 90%. 
Figure 2.2a: Alpha-riaphthyl acetate esterase (AVE) stained cytocentrifuge 
preparation of peripheral brood lymphocytes- and monocytes fractionated by a 
single-step density sedimentation with Lymphoprep (Section 2.2.1.2). The 
monocytes show typical strong diffuse (94-type) reactivity whereas the 
lymphocytes show either negative or 'dot' type AN:AE cytochemistries. 
Figure 2.2b: ?alpha-naphtliyf acetate esterase stained cytocentrifuge 
preparation of enriched peripheral blood monocytes isolated from the peripheral 
blood of healthy adult donors by a three-stage fractionation procedure (Section 
2.2.1.2) to a mean purity of 77% with viabilities in excess of 90%. Note the strong 
diffuse staining (NI-type) of virtually all ceffs in this particular fraction. 
Figure 2.3: Negative alpha-naphthyl acetate esterase (AVE) blast cell 
cytochernistry in a case of acute myetodlastic leukaemia (91.91L•311/M2). The 
majority of leukaemic blasts are unreactive for ANTE in contrast to the strong 
diffuse (911-type) reactivity of coexisting normal monocytes. 
Figure 2.4: Alpha-naphthyl acetate esterase (AVM) blast cell cytochemistry 
in a typical case of acute monocytic leukaemia (ALVOL•9115). The majority of 
leukaemic blasts show moderate to strong diffuse cytoplasmic (Nitype) staining 
whereas the mature granulocyte forms are unreactive. 
Figure 2.5: Atypical alpha-naphthyt acetate esterase (A E) blast cell 
clitochemistry in a case of acute myelobrastic leukaemia (AM.L-gif1/914-2). 
majority of leukaemia blasts shozo a moderate to strong localised (focal) 91_NAE 
staining pattern. 
Figure 2.6: Atypical alpha-naphthyr acetate esterase (ANAE) blast cell 
cytochemistry in a case of acute myeroblastic leukaemia (AML-94f1/%12). The 
majority of feukaernic blasts show a localised coarse „al./('AE reaction which differs 
from the 'atypical granular reaction (A jam' associated with granulocytes in some 
cases of WIDS and hypergranufar promyerocytic leukaemia (see Figure 2.7). 
Figure 2.7: Alpha-naphthyf acetate esterase p-tV.E) cytochemicaf reaction in 
a case of myerodysplastic syndrome (MDS)• Ark ;RE-positive cells are 
predominantly of atypical granular (Acigt) type and the reaction product is evenly 
distributed throughout the cytoplasm of both mature and immature granulocytes. 
This type of A.N.AE reactivity is also commonly seen in the hypergranular variant 
of acute promyefocytic leukaemia (ATL: M3-hyper) and is in distinct contrast to 
typical M-type staining (arrows) and the coarse localised granular reaction 
occasionally seen in AML blasts (see Figure 2.6). 
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Figure 2.8: Effect of incorporating different Triton X-100 detergent concentrations in tie extraction 
buffer on the relative concentrations of esterase molecular weight species defined by Superose-12 FTLC 
gelfiftration. Extraction procedures were carried out as detailed in Section 233.1. Column flow rates 
were 0.35m1/min, and esterase activities were determined byfruoritnetric assay with an equimoiar 411B-
Ac and -IMB-But substrate mixture (results expressed as fluorescent units/100ml fraction/hr at .37C). 
The fourdiagrams compare esterase molecular weight profiles obtained in the presence of 0%, 1.0%, 5.0% 
and 10.0% Triton X-100. Note that the relative proportions of the two esterase species are apparently 
unaffected by the different detergent concentrations used 
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Figure 2.9: Schematic representation of j1, G2 and 91,l alpha-naphthyr acetate esterase (ANRE) 
isoenzyme patterns of nonnaf and kukaernic myeloid cells, as defined fly analytical IEF. Individual 
isoenzyme components are shown according to their isodectric point 0, and relative staining intensities 
are shown as — weak., — moderate, and — strong. Note that the M pattern is characteris-
tically defined by Me presence of High concentrations of isoenzyme components within the narrow pI 
range 5.5. 6.2. 
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Figure 2.11: Alpha-naphthyl acetate esterase (A.NRE) isoenzyme pattern 
variations in acute nwnocytir leukaemia (A_MoL-115). 'Three representative cases 
are presented; (a) shows h0 concentrations of monocyte-associated (MonEst) 
isoenzymes (p1 range 5.5-6.2) with relatively little evression of ComEst myeloid 
forms (p1 range 6.3-7.9). In contrast, (b) and (c) both show 'common' isoenzyme 
forms in addition to those which are specifically nwnocyte-associated; note minor 
variations in the relative distributions of various isoetizyme components in these 
two cases. 
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Figure 2.12: Schematic representation indicating the relative hydrolysis of 
acetate (A_N.A), propionate (ANT) and butyrate (A_NB) esters of alpha-naphthol 
by feukaemic cell esterase isoenz.ymes. Esterases extracted from feukaemic blasts 
were efectrophoresed (IEF) and subsequently stained with staining solutions 
containing 5.0 mgvf ANA, ANP or ANB substrate concentrations and hexazotised 
pararosanifine as coupler. This Figure represents a summary of the results observed 
for a total of seven different feukaernias with 94 esterase IEF patterns (AM/IL-
9114, n = 5; and .A9bfoL.M5 n = 2). 
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Figure 2.13: Original electrophoretk gel comparing substrate specificities of 
esterase isoerzzyme forms. A leukaemic blast cell extract containing all the major 
myeloid isoenz.yme forms was efectrophoresed (PEF) in three separate lanes, each of 
which was alternatively stained with butyrate (a), propionate (b), or acetate (c) 
substrates (Section 2.2.6.2). Noe that the lower p1 (monocyte-associated) esterase 
isoenzymes appear to be stained with all three substrates, although the reaction is 
weaker with alpha•naphthyl butyrate. For comparison, the higher pl (common) 
isoenzymes preferentially stain with the alpha-naphthyl acetate substrate. 
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Figure 2.15: Relationships between alpha-naphthyf acetate substrate 
concentration. and observed reaction rates. A feukaemic 21fgfrf_L-14 blast cell 
extract with an approximate AVE activity of 110mq.1/mf was diluted 1:2 and 
1:4, and the rate of substrate hydrolysis over 5.0 min determined for each of the 
substrate concentrations indicated. Pie reaction rates at each substrate 
concentration are shown as increases in absorbance at 235nm per min, with each 
data point representing a mean of duplicate determinations. 
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Figure 2.16: Time course of the UV spectrophotometric assay for alpha-
naphthyf acetate esterase oNgE). .A standard 0.5mM alpha-rzaphthyt acetate 
substrate concentration was used throughout and a single leukaemic AMML-944 
blast cell extract, containing all the major myeloid esterase isoenzyme forms, was 
tested at dilutions ranging from Neat to 1:8. The change in absorbance at 235nm 
0235), for each extract dilution examined, was measured. at 1.0 min intervals over 
a period of 10.0 min. 'The results are shown as the observed .R235 values as a 
function of time. 
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Figure 2.17: Lineweaver-Burk plot for the estimation of Michaelis-nfenten 
constant (K) and maximum velocities (Vina) for a mixture of alpha-naphthyf 
acetate esterases (VE) extracted from feukaemic AMML-M4 blasts, The data 
from. Figure 2.15 was converted to inverse readings and the 1/velocity values plotted 
against 1/substrate (nal) concentration. The Km value remained constant at 
0.111101 for both dilutions of extract tested and the Nmax values were calculated 
to be 0.03 and 0.015 A235/min for the 1:2 and 1:4 dilutions respectively. 
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Figure 2.18: Wefationship between alpha-naphthyr acetate esterase (AN  :AE) 
concentration and reaction velocity. Serial dilutions, ranging from neat (1.0) to 1:8 
(0.125), of two myelomonocytic leukaemia (.494ML/A9lioL-91(4/M5) blast cell 
extracts (containing all the major myeloid isoenzyme forms) and two myelobfastic 
leukaemia (glalL-9$11/M2) blast cell extracts (containing all the major myeloid 
isoenzyme forms with the exception of those associated with monocytic 
differentiation) were analysed. The increase in the rate of substrate hydrolysis 
(standard 0.5mM alpha-naphthyr acetate concentration) for each extract dilution 
was determined over a period of 5.0 min at 30°C. Note the linear relationship 
between extract dilution and reaction rate within the range (0,25n21 to 5.3m21) of 
ANAE activity studied (each data point representing a mean of duplicate 
determinations). 
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Figure 2.19: tVationships between 4-methyfumbeffiferyf acetate (49b1B-Ac) 
and butyrate (On-But) substrate concentration and rates of hydrolysis in the 
ffuorimetric assay. An AthIML-9114 Ieukaemic blast cell extract was diluted to 1:2 
anti the rate of On-Ac and Ofb-But hydrolysis over 60 min (expressed as 
fluorescent units at 460nm/20ut/60 min) determined for each of the substrate 
concentrations studied (0.05 to 1.0m9► f). Each data point represents a mean of 
duplicate determinations. 
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Figure 2.20: 'Time course of the fluorimetric assay for acetate (a) and butyrate 
(b) esterases using standard 4-methyfumbeiliferyl acetate (4MB-9c) and butyrate 
(4MB-But) substrate concentrations of 0.5mM. 	 AMML-M4 feukaemic blast 
cell extract, containing a mixture of all the major myeloid isoenzyme forms, was 
assayed for acetate esterase activity by fluorimetric procedures over a period of 65.0 
min. 'Tim increase in fluorescent emission at 460nm resulting from enzymic 
hydrolysis of the 4MB-ester was determined in duplicate for undiluted, 1:2 and 1:4 
dilutions of the leukaemic cell extract. 
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Figure 2.21: Relationships between acetate esterase concentration and reaction 
velocity in a standardised fluorimetric assay system with a 4-methyfurndeihjeryl 
acetate (4MB-Ac) substrate concentration of 0.5tri9tf. Serial blast eel! extract 
dilutions, ranging from neat (1.0) to 1:8 (0.125), of two myetotnonocytic leukaemia 
(ANNE/' MOL-fA14/M5) blast cell extracts (containing all the major myeloid 
isoenzyme forms) and two myelobiastic leukaemia (AML-91/11/N12) blast cell 
extracts (containing all the major myeloid isoenzyme forms with the exception of 
those associated with monocytic differentiation) were analysed 'The rate of 49dB-
Ac substrate hydrolysis for each extract dilution was determined over a period of 60 
min at .37°C (each data point representing a mean of duplicate determinations) and 
it is clearly seen that the reaction rate is linear throughout the range (20 to 240 
units/20uf extract dilution/60 min) of acetate esterase activities studied. 
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Figure 2.22: Correlation between WV spectrophotometric (alpha-naphthyt 
acetate) and fluorimetric (4-methyiumbeffiferyf acetate) assays for the estimation 
of cellular extract esterase activities. A teukaemic AMML-M4 blast cell extract 
was diluted to 1:2 and assayed for acetate esterase activity by both assay procedures 
with a range (0.05 to 0.50m.11) of substrate concentrations. A comparison of the 
rates (fluorescent or absorption units) of substrate hydrolysis reveals a linear 
relationship between the two assay procedures which is maintained throughout the 
range of substrate concentrations examined (each data point representing a mean of 
duplicate determinations). 
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Figure 2.23: Correlation between WV and ffuorimetric acetate esterase assays. 
Serial dilutions from neat (1:1) to 1:8 of cell extracts from a case of acute 
mye(omonocytic leukaemia (A9iIgvf.C-M4), containing all the major myeloid 
esterase isoenzyme forms, and neat to 1:4 from a case of acute myelobfastic 
leukaemia (A.ML-941/9112), containing all the major myeloid esterase isoenzyme 
forms with the exception of those associated with Inonocytic difftrentiaion, were 
assayed for acetate esterase activity by both UV spectrophotometric and 
fluorimetric assay procedures. A comparison of the rate (absorption or fluorescent 
units/min) of alpha-naphthyl acetate (UV assay) and 4-methylumbeffiferyf 
acetate (ffuorimetric assay) substrate hydrolysis reveals a linear relationship 
between the two assay procedures throughout the range of extract dilutions 
examined (each data point representing a mean of duplicate determinations). 
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Figure 2.24: Alpha-napiithyl acetate (ANTE) and butyrate (AN BE) esterase 
activities of 56 feukaentic myeloid cell extracts as determined by UV 
spectrophotometric assay. v(esuits for individual feukaemic extracts, grouped 
according to alpha-napfithyl acetate esterase isoenzyme pattern types (5i, ("7 2 or 
M), are given as mU acetate (or butyrate) activity per mg extract protein. 
E
st
er
as
e
 
 
A
ct
iv
ity
 
 
200 
150 - 
100 - 
50 - 
Es
te
ra
se
 
 
A
ct
iv
ity
 
 
- 
40 
30 - 
20 - 
10 - 
0 INif3A, • 411E-113111 
0 
o • 
	
8 
o 
0  
0 	 g 	 i 	 1 	 i 
0 	 G1 	 G2 	 M 	 4 
lEF Pattern Type 
Figure 2.25: acetate (acE) and butyrate (ButE) esterase activities of 20 
normal. granulocytic (n=11) and monocytic (n=9) cell extracts, as determined by 
fluorimetric assay. Tvsults for individual extracts, grouped according to alpha-
. 
naphtliyl acetate esterase isoenzyme pattern types (g1, G2 or Al), are given as 
acetate (or butyrate) activity per mg extract protein. 
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11111 Table 2.1 Cytochemical reactions of blast cells in acute myeloid leukaemia a 
Cytochemical AML AML AML APL AMML AMoL 
stain 	 (MO) 	 (M ) b 	 (M2) b 	 (M3) b 	 (M4) 	 (M5) 
MPO 	 - or + 	 + 	 + 	 + 	 - or + 
SBB 	 - or + 	 + 	 + 	 + 	 + 
CAE 	 + 	 + 	 - or + 
ANAE c 	 - 	 - or + 	 + 
11 Reactions indicate presence (+) or absence (-) of cytochemically positive blasts for 
MPO (myeloperoxidase). SBB (Sudan Black B), CAE (chloroacetate esterase) and 
ANAE (alpha-naphthyl acetate esterase). 
b MPG. SBB and CAE reaction strengths increase with increasing maturity. 
ANAE positive blasts are occasionally observed in cases of Ml. M2 and M3. 
However, the staining patterns in these are atypical as compared to the diffuse ANAE 
reactions seen in cells of monocytic lineage (discussed in Section 2.3.2.2). 
Table 2.2 	 Monoclonal reagents used for the immunophenotypic classification of 
myeloid leukaemias by flow cytometry a 
CD group Clone Primary specificity Source 
3 T3 T Dako 
7 Leul9 T Becton Dickinson 
10 CALLA Restricted B Becton Dickinson 
11c C KB90 M. and Restricted B Dako 
13 My7 G, M Coulter Electronics 
14 Tuk4 M Dako 
19 HD37 B Dako 
33. My9 G. M Coulter Electronics 
- HLA-Dr d G. M, B Becton Dickinson 
a Leukaemic blast cell analyses carried out using FITC/PE two-colour combinations: 
CD3 with CD19: CD7 with CD13; CD10 with CD33; CD14 with HLA-Dr and: 
CD11c with CD19. 
b Primary specificities: G, blasts of granulocytic lineage: M. blasts showing monocytic 
differentiation; B. blasts of immature B-lineage (i.e. ALL): T. blasts of immature T-
lineage (i.e. T-ALL); Restricted B, reacts with B-cells at certain levels of B-
differentiation only. 
Primarily employed for the differentiation of acute myeloid leukaemias of monocytic 
and non-monocytic type [Master et al.. 1989]. 
d Primarily employed as a marker to assess relative levels of granulocytic 
differentiatiOn. 
Table 23 	 Purity and yield (recovery) of normal peripheral blood monocyte fractions 
prepared for esterase isoenzyme studies a 
Pre-fractionation b 
Total 
Post-fractionation b 
Total 
Yield e 
6.5 17.6 68 6.1 35 
13.0 25.9 75 7.9 30 
7.0 12.1 70 4.9 40 
7.0 14.3 69 8.9 62 
5.5 11.2 79 4.5 40 
7.5 20.1 81 5.3 26 
7.0 15.6 90 7.8 50 
3.0 13.6 83 4.5 33 
4.0 13.3 76 6.6 50 
Mean 	 6.7 16.0 77 6.3 41 
a Monocyte fractions prepared by a three-stage procedure as detailed in Materials and 
Methods (Section 2.2.1.2). 
Results expressed as percentages and total counts where the percentage indicates the 
proportion of each blood sample (pre-fractionation) or monocyte-enriched cell 
suspension (post-fractionation) defined as being of monocytic lineage (morphology, 
cytochemistry and/or membrane CD14 expression). The total represents the absolute 
number (x 09/1) of monocytes for the pre-fractionation blood sample (i.e. volume x 
leucocyte count x monocyte percentage) or for the post-fractionation monocyte-
enriched cell suspension. 
e Yield, expressed as a percentage, indicating the total number of monocytes in the 
post-fractionation suspension compared with the (starting) pre-fractionation monocyte 
number. 
Table 2.4 Simultaneous analysis of monocyte-associated membrane CD14 
determinants and cytoplasmic ANAE expression by normal peripheral 
blood monocytes a 
CD14/ANAE-defined monocyte subgroups b 
CD14 
Antibody CD14+ANAE+ CD14-ANAE+ CD144-ANAE- 
LeuM3 (n=19) 91.5 (1.6) 3.8 (0.4) 4.7 (1.6) 
61D3 (n=19) 91.9 (1.5) 3.0 (0.4) 5.1 (1.3) 
My4 (n= 7) 93.4 (0.3) 2.2 (0.3) 4.4 ( 1.0) 
a Peripheral blood monocytes were fractionated from EDTA-anticoagulated blood by 
density sedimentation on Lymphoprep to a purity of 10-25%. the contaminating cells 
being lymphocytes. Membrane CD14 expression was determined by an indirect 
immuno-rosetting technique (McKarill 	 1987). Monocytes defined as CD14 
positive were morphologically classified by the binding of at least three ox 
erythrocytes (oxE). ANAE cytochemistry was subsequently carried out on 
cytocenuifuged rosette preparations. ANAE positive cells with typical M-type 
reactions were defined as those with moderate-strong diffuse activity. 
b Results are shown as the mean percentages (standard errors in parentheses). for all 
those cases examined, of each defined CD14/ANAE subpopulation. 
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Table 2.6 Alpha-naphthyl acetate esterase (ANAE) cytochemistry and CD14 
expression in acute myelomonocytic and monocytic leukaemias 
ANAE reaction pattern a 
	 CD14 expression b 
Negative Positive 
Acute imelomonocvtic leukaemia 
Negative or Weak diffuse 
	 (n = 42) 13/42 29/42 
ANAE heterogeneity 
	 (n = 13) 5/13 8/13 
Moderate to strong diffuse 	 (n = 34) 12/34 22/34 
Acute monocvlic leukaemia 
Negative or weak diffuse 	 (n = 10) 0/10 10/10 
ANAE heterogeneity 
	 (n = 6) 0/6 6/6 
Moderate to strong diffuse 	 (n = 29) 5/29 24/29 
a Reaction patterns: Negative or weak diffuse - indicates that majority of blasts were 
unreactive or showed weak diffuse staining reaction with only a minor proportion 
(<5%) of the remaining cells showing stronger staining: ANAE heterogeneity -
indicates that whilst the majority of blasts showed weak diffuse staining, a proportion 
(5-20%) showed stronger M-type ANAE reactions: Moderate to strong diffuse -
indicates that a minimum of 20% blasts were stained with good reaction intensity (i.e. 
M-type reaction) with the remaining blasts showing variable negative to moderate 
diffuse activity. 
h CD14 expression was tested for with a minimum of two monocyte-associated 
antibodies (Section 2.2.2,2). Cases were defined as negative (<20% blasts positive) 
or positive (>20% blasts positive). 
Table 2.7 Relationships between myeloperoxidase (MPO). chioroacetate esterase 
(CAE) and alpha-naphthyl acetate esterase (ANAE) cytochemistry in acute 
myelomonocytic leukaemia (M4) and acute monocytic leukaemia (M5) a 
MPO CAE ANAE 
<5% >5% <20% >20% 
AMML-M4 cases 
MPO- (n = 16) 16/16 0/16 14/16 2/16 
MPO+ (n = 73) 34/73 39/73 41/73 32/73 
AMoL-M5 cases 
MPO- (it = 17) 17/17 (1/17 3/17 14/17 
MPO+ (n = 34) 30/34 4/34 h 15/34 19/34 
a Cases within each diagnostic group (AMML-M4 or AMoL-M5) were arbitrarily 
subdivided into those with 0 to 5% (MPO-) and >5% MPO positive blasts (MPO+). 
CAE cytochemistry indicates the proportions of MPO- or MPO+ cases that showed 
<5% or >5% CAE-positive blasts; ANAE cytochemistry indicates the proportions of 
MPO- or MPO+ cases with <20% or >20% blasts showing moderate to strong diffuse 
(M-type) reaction. 
CAE-positive blast cells in these four cases did not exceed 10% and these all showed 
>60% M-type ANAE or CD14 positive cells. 
Table 2.8 	 Comparative solubilisation of myeloid leucocyte esterases with aqueous 
and detergent extraction reagents following ultrasonic cell disruption 
Extraction Reagent a 	 % Esterase h 
	 Isoenzymes groups c 
pI 5.5-6.2 
(MonEst) 
pI 6.3-7.9 
(ComEst) 
20mM MES 90.7 ++ ++ 
0.25M KC1 99.3 ++ ++/+++ 
10mM CHAPS 97.1 ++/+++ ++/+++ 
10mg/m1 IEGE 97.3 ++/+++ ++/+++ 
30mM n-octylglucoside 97.4 ++/+++ ++/+++ 
10mg/m1 Triton X-100 95.8 ++/+++ ++/+++ 
a The extraction reagents. (a) potassium chloride (KCI); (b) zwitterionic detergent, 3- 
R3-cholamidopropyl)dimethyl-ammonio1-1-propanesulphonate (CHAPS): (c) 
nonionic detergent isotridecylpoly (ethylene glycol ether) (1EGE): (d) nonionic 
detergent n-octylglucoside: and (e) nonionic detergent Triton X-100 were all dissolved 
in 20mM aqueous morpholino-ethane sulphonic acid (MES). 
Acetate esterase (ANAE) activity was determined by fluorimetric assay and the 
percentage enzyme extracted calculated. 
Esterase isoenzymes were fractionated by isoelectric focusing (IEF) and visualised by 
alpha-naphthyl acetate esterase (ANAE) cytochemical staining. The relative staining 
intensities of each defined pI (isoelecuic point) group were graded as moderate (++) 
or moderate to strong (++/+++). 
Table 2.9 	 Effect of different Triton X-100 concentrations on the relative distribution 
of esterase molecular weight (Mr) species a 
Triton X-100 	 Acetate/butyrate esterase b 	 Ratio 
(%) HMW Species LMW Species LMW:HMW 
0.0 960 1560 1.6 
0.25 800 1646 2.() 
0.5 800 1390 1.7 
1.0 970 1480 1.5 
5.0 840 1330 1.6 
10.0 820 1360 1.6 
a Two molecular weight esterase species were defined by Superose-12 FPLC gel 
filtration (results detailed in Chapter 3 Section 3.2.2). For the purpose of this 
preliminary analysis, HMW represented a high molecular weight esterase form 
and LMW a low molecular weight form. 
Total acetate/butyrate esterase activities were measured by a tluorimetric assay using 
an equimolar (0.25mM) mixture of acetate and butyrate esters of 4- 
methylumbelliferone as substrates. The activities shown represent the observed modal 
values for each of the two molecular weight species. 
LMW:HMW ratios indicate the relative proportions of the low and high molecular 
weight acetate/butyrate esterases solubilised with increasing Triton X-100 
concentrations. 
Table 2.10 IEF pattern types of ANAE isoenzymes in normal and leukaemic myeloid 
cells 
Myeloid cell type a 
ANAE pattern type 
G1 G/ M 
Normal neutrophils 4/11 7/11 0/11 
Normal rnonocytes 0/9 0/9 9/9 
Acute myeloblastic leukaemia (AML-M1/2) 76/85 8/85 1/85 
Acute promyelocytic leukaemia (APL-M3) 3/11 8/11 0/11 
Acute myelomonocytic leukaemia (AMML-M4) 12/63 22/63 29/63 
Acute monocytic leukaemia 	 (AMoL-M5) 13/45 2/45 30/45 
a Myeloid leukaemic subtypes were defined by morphological. cytochemical and 
irnmunophenotvpic criteria as outlined in Section 2.3.2. 
b ANAE isoenzyme pattern types G 1. G2 and M as defined by isoelectric focusing 
(Figure 2.9). 
Table 2.11 Comparison of ANAE cytochemistry and isoenzyme patterns (IEF) in 
acute myeloid leukaemia. Cases are grouped according to ANAE 
cytochemical reaction independently of myeloid leukaemia subtype 
ANAE cytochemistry a IEF pattern b 
GI G",  
Negative or weak diffuse 
(AML. n = 33; AMML, n = 24; AMoL. n = 12) 48/69 18/69 3/69 
ANAE heterogeneity 
(AMML. n = 7; AMoL. n = 9) 0/16 3/16 13/16 
Moderate to strong diffuse 
(AMML. n = 7; AMoL. n = 24) 0/31 2/3 I G 29/31 
Granular or focal 
(AML. n = 6; AMML, n = 2) 7/8 1/8 0/8 
a Reaction patterns: Negative or weak diffuse - indicates that the majority of blasts were 
unreactive or showed a weak diffuse staining reaction with only a minor proportion 
(<5%) of the remaining cells showing M-type activity: ANAE heterogeneity - indicates 
that whilst the majority of blasts showed weak diffuse staining. a minor proportion 
(5-20%) showed stronger M-type ANAE reactions: Moderate to strong diffuse -
indicates that a minimum of 20% blasts were stained with good reaction intensity (i.e. 
M-type reaction) with the remaining blasts showing variable negative to moderate 
diffuse activity: Granular or focal - where a significant proportion of blasts showed a 
localised (focal) reaction or a granular staining deposit which was generally coarse 
and unevenly distributed in the cytoplasm. 
b ANAE isoenzyme patterns 01. G2 and M (Figure 2.9) as defined by analytical 
isoelectric focusing (IEF). 
Both these cases were AMML-M4. 
Table 2.12 Comparison of ANAE cytochemistry. CD14 expression and IEF 
isoenzyme patterns in acute promyelocytic (APL-M3) leukaemia a 
ANAE cytochemical reaction CD 14 b IEF pattern 
GI G2 
Negative 
(M3-Hyper. n = 4; M3-Hypo. n = 2) 0/6 1/6 5/6 0/6 
Weak diffuse/granular 
(M3-Hyper. n = 	 M3-Hypo. n = 0) 0/3 2/3 1/3 0/3 
Moderate diffuse/granular 
(M3-Hyper, n = 2; M3-Hypo. n = 0) 0/2 0/2 2/2 0/2 
a Acute promyelocytic leukaemia cases were further subdivided for this analysis into 
Hypergranular (M3-Hyper) and Hypogranular (M3-Hypo) variants B en nett et al.. 
1980. 1985: Golomb et ;11_ 19801. 
b CD14 expression assessed using monoclonal antibodies LeuM3. My4, Mot, 
UCHLM1 and FMC32. 
C GI, G2 and M pattern types as defined by isoelectric focusing (Figure 2.9). 
Table 2.13 Comparison of CD14 expression and ANAE isoenzyme patterns in acute 
myelomonocytic (AMML-M4) and monocytic leukaemias (AMoL-M5) a 
CD14 expression h IEF pattern 
G1 G2 
AMML-M4 cases 
CD14+ (n = 15) 5/15 5/15 5/15 
CD14- (n = 17) 6/17 5/17 6/17 
AMoL-MSa cases 
CD14+ (n = 16) 4/16 1/16 11/16 
CD14- (n = 5) 1/5 0/5 4/5 
A MoL-M5b cases 
CD14+ (n = 21) 7/21 1/21 13/21 
CD14- (n = 0) na na na 
a Acute monocytic leukaemia subtypes defined in accordance with the French-
American-British (FAB) classification [Bennett et al.. 19761. 
h CD14 expression was examined with a minimum of two rnonocyte-associated 
antibodies (Sections 2.2.2.2 and 2.2.4). Cases were graded as negative (<20% blasts 
positive) or positive (>20% blasts positive). 
ANAE isoenzyme patterns GI, G2 and M us defined by analytical isoelectric focusing 
(IEF) (Figure 2.9). 
Table 2.14 Inhibition studies of myeloid alpha-naphthyl acetate esterase (ANAE) 
isoenzymes 
Inhibitor 	 Concentration 	 Isoenzyme Group b 
mM 	 MonEst 	 ComEst 
Phenylmethylsulphonyl fluoride (PMSF) 5.0 
Sodium fluoride (NaF) 2.4 
Neostigmine 10.0 
Eserine 0,1 
P-hydroxymercuribenzoic acid (HMBA) 1.0 
a Leukaemic cell (AMML-M4) IEF zymograrns were stained for ANAE in the presence 
of the above inhibitors as described in Section 2.2.6.3. The relative inhibition of the 
two main groups of myeloid cell ANAE isoenzymes with these inhibitors is shown as: 
(+1 ANAE isoenzymes sensitive to inhibitor or (-1 no significant inhibition with the 
inhibitor concentration tested. 
LI Two groups of myeloid esterases, as defined by isoelectric focusing. comprise 
isoenzymes with isoelectric point ranges of 5.5-6.2 (MonEst) and 6.3-7.9 (ComEst). 
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CHAPTER 3 
EVALUATION OF ESTERASE PURIFICATION  
PROCEDURES  
86 
3A INTRODUCTION  
Chromatography is the most widely accepted procedure for protein separation in modern 
biochemistry, and each methodological type exploits different physical and/or biological 
properties of the protein molecule as a basis for separation. Molecular characteristics that 
are frequently used for protein purification include size, hydrophobicity, solubility. 
charge, or specific binding affinity. In order to purify any given protein, some or all of 
these properties can be utilised, depending on the nature of the protein itself and the 
characteristics of coexisting contaminating solutes. Although the physical characteristics 
of a protein are important for the selection of chromatographic procedures, the 
preservation of biological activity also requires consideration, particularly for the 
purification of enzymes, where biological activity is invariably required for monitoring 
progress during the purification, and subsequently for the characterisation of the purified 
enzyme. 
As a prelude to full-scale MonEst and ComEst purification, it was necessary to determine 
their chromatographic characteristics (i.e. their binding and elution profiles). Many of 
these studies were designed to evaluate buffer and pH parameters, and these data will not 
be shown. However, where an experimental procedure was found to be of direct 
importance to the understanding of the molecular characteristics of either species, these 
observations will be presented. With the exception of gel filtration and Benzamidine-
Sepharose chromatography. where a representative number of different myeloid cell 
extracts were additionally analysed, all the methodological procedures were evaluated 
with a single cell extract (SA1) which was obtained from the leucophoresis of a patient 
with acute myelomonocytic leukaemia (AMML-M4). Analysis of ANAE isoenzyme 
components by IEF [Scott et al., 1984; Scott & Drexler. 19891 of this cell extract 
revealed the presence of moderate concentrations of MonEst isoenzymes together with 
significant staining of esterase isoenzyme components (ComEst) with a higher pl (>6.3) 
common to all myeloid cells 'Scott et al., 1985, 1987, 19891. Preparation of the protein 
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extract was achieved by ultrasonication (MSE Soniprep 150) of the cell-rich fluid at an 
amplitude of 181.1 for one minute; 10% Triton X-100 was added to give a final detergent 
concentration of 1% and, after mixing at 40C for 10 mins and subsequent high speed 
centrifugation, the solubilised protein supernate was removed from pelletted cell debris. 
3.2 GEL FILTRATION CHROMATOGRAPHY  
3.2.1 Introduction: Gel filtration or size exclusion chromatography provides a mild 
chromatographic method for the separation of bioactive molecules according to 
differences in their molecular size. The technique utilises the principle of molecular 
sieving, whereby different solutes are passed through a sponge-like matrix containing 
pores of uniform dimensions, and are eluted in order of decreasing molecular size. The 
matrices are generated by cross-linking dextran (e.g. Pharmacia Sephadex), 
polyacrylamide (Bio-Rad Bioge]s) or agarose (Pharmacia Sepharose) which are all 
hydrophilic compounds and swell to form insoluble porous gels. 
Gel filtration columns are formed under conditions which permit uniform packing of the 
particles, thus forming the bed. The sample, containing a mixture of protein species 
differing in molecular sizes, is applied to the bed surface and subsequently passaged 
through the bed by eluent flow. As elution proceeds, molecules which are too large to 
enter the pores of the gel pass rapidly through the bed in the space surrounding the gel 
particles, and are eluted in a single void zone. Molecules which are capable of diffusing 
into the pores of the matrix are retarded in their migration through the bed, and the extent 
of retardation is inversely correlated to molecular size (i.e. the smallest molecules are 
retarded to the greatest extent and are thus the last to be eluted). The rate of passage of 
proteins through the bed is dependent on both the flow rate of the mobile phase and the 
partition coefficient between the porous stationary phase and the mobile phase. The 
molecular sieve processes may be viewed as a type of column liquid-liquid partition 
chromatography, where the liquid contained within the pores of the matrix forms the 
'stationary' phase and the liquid surrounding the gel particles is the 'mobile' phase. The 
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partition coefficient of a solute is then determined by its ability to penetrate the pores of 
the matrix. 
Gel filtration chromatography may be used analytically to determine molecular weights of 
unknown protein species. The elution profiles of known proteins (molecular weight 
standards) are determined and a standard curve constructed, from which the molecular 
weights of unknown proteins may be estimated. However, as migration through the gel 
matrix is also largely dependent on protein configuration, molecular weight 
determinations using gel filtration chromatography may only be regarded as estimates 
(i.e. relative molecular weights, Mr) rather than true values, which may be attained by 
more definitive electrophoretic techniques (described in Chapter Four). 
3.2.2 	 Superose-12 FPLC gel filtration 
3.2.2,1 Experimental procedures: The molecular weight distribution of esterase species 
of a representative number of 'crude' normal and leukaemic cell extracts was assessed 
using a 30 x 1.0cm Superose-12 high-resolution Fast Protein Liquid Chromatography 
(FPLC) column (MW range 103 to 3 x 105 kDa; Pharmacia). These extracts comprised 
normal blood granulocytes (n=6), normal blood monocytes (n=7), and blast cell fractions 
from 15 cases of acute myeloid leukaemia (AML-M1/M2, n=5; APL-M3, n=1; AMML-
M4, n=4; and AMoL-M5, n=5). Enriched cell fractions were prepared as detailed in 
Section 2.2.1, and the extracts prepared by ultrasonication and detergent solubilisation 
(Section 2.2.5). The normal granulocyte extracts showed either GI (n=3) or G2-type 
(n=3) ANAE-IEF isoenzyme patterns (Section 2.3.4.2); the normal blood monocyte-
enriched fractions all showed an M-type ANAE isoenzyme pattern (Section 2.3.4.2); and 
the leukaemic myeloid blast cell extracts showed G1 (6/15), G2 (3/15) or M-type (6/15) 
ANAE isoenzyme patterns (Section 2.3.4.3). 
Chromatographic separation was achieved by passage of 5041 of each extract through the 
Superose-12 column, pre-equilibrated with 50mM phosphate buffer pH 6.8 containing 
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0.15M NaCI, at an optimised flow rate of 0.35m1/min. The eluate was collected in 60 x 
1.0min (0.35m1) sequential fractions and 50p.1 of each fraction was assayed for acetate 
and butyrate esterase activity by the standardised fluorimetric esterase (acetate and 
butyrate) assay procedures (Section 2.3.6.4). The relative molecular weights (Mr) of the 
observed esterase species for each 'crude' cell extract were estimated by comparison with 
a standard curve constructed from Ve/Vo (elution volume/void volume) versus the log 
molecular weights of protein standards. 
3.2.2.2 Results: Fractionation of normal and leukaemic cell extracts by FPLC gel 
filtration chromatography revealed a diverse distribution of enzyme forms with esterolytic 
activity. Virtually all of the normal and leukaemic extracts examined showed two or three 
distinct peaks of esterase activity (Figures 3.1 and 3.2) which were designated PI, P2 
and P3 in order of elution. The elution volume (Ve) of P1 was similar to the void volume 
(Vo) for the column and therefore esterase species eluted in P1 were considered to 
represent either high molecular weight enzyme-membrane complexes, enzyme-protein 
aggregates, or multimeric enzyme forms. Consequently, the analysis of esterase 
molecular weight distributions only considered the P2 and P3 components. 
Representative gel filtration profiles of normal blood granulocyte and monocyte esterase 
forms are shown in Figure 3.1. The apparent molecular weights for the granulocyte and 
monocyte P2 species were 284-342 kDa (mean 313) and 135-236 kDa (mean 201) 
respectively (Table 3.1), and analysis of the relative rates of acetate and butyrate substrate 
hydrolysis showed that the P2 form preferentially hydrolysed acetate substrate in 4/6 of 
the granulocyte extracts and 2/7 of the monocyte extracts. For comparison, the 
granulocyte and monocyte P3 species showed apparent molecular weights of 53-77 kDa 
(mean 64) and 37-77 kDa (mean 63) respectively with a preferential rate of acetate 
substrate hydrolysis by 5/6 of the granulocyte cell extracts and 3/7 of the monocyte cell 
extracts. Additional analyses of the relative concentrations of the P2 and P3 molecular 
weight species with respect to cell type (i.e. granulocytic versus monocytic lineage) and 
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ANAE isoenzyme profile (GI and G2 combined, versus M) revealed no apparent 
relationships. 
Similarly, a total of 15 leukaemic blast cell extracts with Gl/G2 (n=9) or M (n=6) type 
ANAE-IEF isoenzyme patterns were analysed by gel filtration chromatography. Esterase 
components analogous to normal granulocyte/monocyte peaks P1, P2 and P3 were also 
observed with the leukaemic samples (Figure 3.2) although species P2 was undetectable 
in two cases with 01/02 IEF patterns (Table 3.2). The observed range of molecular 
weights for the P2 components were 100-333 kDa (mean 210) and 143-216 kDa (mean 
173), for Gl/G2 and M-type ANAE isoenzyme patterns respectively, with an apparent 
acetate substrate preference for most G1/02 IEF extracts and a butyrate preference for 
most extracts with M-type IEF patterns. For comparison, the observed molecular 
weights of the P3 species were 24-38 kDa (mean 30) and 26-64 kDa (mean 43), for 
extracts with G 1/G2 and M-type isoenzyme patterns, with no consistent pattern of 
substrate preference by individual extracts. 
C011C114S1011S: Superose-12 gel filtration of myeloid extracts resulted in the 
fractionation of two or three different molecular weight (Mr) enzyme species with 
esterolytic activity. Irrespective of cell-lineage commitment or type of esterase isoenzymes 
(ComEst or MonEst) expressed, these molecular weight species were present in virtually 
all of the normal and leukaemic myeloid cell extracts studied. The highest Mr form 
(designated P1) was eluted in the void volume of the gel filtration column, and was 
considered to represent either active enzyme aggregate or enzyme-membrane associated 
components, whereas the Mr of enzyme species P2 suggested that these components 
represented multiple subunit-associated forms of the P3 monomer. However, when 
molecular weights of the various P2 species (form normal and/or leukaemic myeloid 
extracts) were considered with respect to Mr of P3, apparent dimer, trimer, tetramer, 
pentamer and hexamer associations were implied for P2. It would therefore appear that 
the P2 species were unlikely to simply represent subunit-associated forms of P3, the 
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more likely explanation being that the various P2 and P3 species represented distinct 
enzymes with esterolytic activity. 
The findings of this study suggest, that while gel filtration is able to fractionate esterolytic 
enzymes with different molecular weights, the accurate assessment of Mr (particularly of 
the high molecular weight form) or the subunit configuration of individual esterase forms 
may not be achieved when processing crude extracts. Gel filtration however, provides a 
means of separating proteins on the basis of molecular size and therefore its inclusion in 
the final protocol for the purification of esterase isoenzyme components. would allow the 
fractionation of esterase components from other contaminating proteins of differing Mr. 
;.3 ION-EXCHANGE CHROMATOGRAPHY  
.3.3.1 Introduction: 
 Proteins are amphoteric molecules which possess either a net 
positive or negative charge and are isoelectric (no net charge) at a pH referred to as the 
isoelectric point (pi) (Sluyterman & Wijdenes, 1977; 1978; Sluyterman & Elgersma, 
1978]. The net molecular charge of a protein reflects the balance, at any given pH, of the 
ionisable amino (-NH2) and carboxyl (-COOH) groups found on the side chains of basic 
and acidic amino acids. Principally, the amino groups of lysine (and its hydroxylated 
form) and arginine, and the carboxyl groups of aspartic and glutamic acids govern the 
differential charge characteristics of proteins. Other amino acid side chain groups (e.g. 
the hydroxyl groups of serine, threonine and tyrosine, the sulphydryl group of cysteine, 
and the imidazole ring of histidine) also contribute towards the net charge of proteins, but 
to a much lesser extent. At a pH above the pI of a protein, -COOH groups become 
ionised (-COOH ---> -COO-) resulting in a net negatively charged protein. Conversely, 
at a pH below the pI, -NH2 groups become ionised (-NH2 ---> -NH3+) and the protein is 
thus positively charged. Electrophoretic titration curves are often used to predict the pH 
at which charge differences between contaminating proteins and the protein of interest are 
maximal, thus giving optimal separation by ion-exchange chromatography. 
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Protein retention on an ion-exchange column results from electrostatic interactions 
between the charged groups of the protein and oppositely charged groups of the matrix; 
the degree of retention being proportional to the charge density on both the ion-exchange 
matrix and the protein. In addition, the nature of the charged groups of the ion-exchanger 
and the distribution of charged amino acid groups on the protein also influence retention. 
Charged groups on ion-exchangers can be positive (anion exchange) or negative (cation 
exchange) and are covalently immobilised on insoluble cellulose, dextran or synthetic 
polymer-based matrices. Ion-exchangers may be broadly subdivided into; (a) strong, 
such as quaternary aminoethyl (QAE, anion) or sulphopropyl (SP, cation); or (b) weak, 
such as diethylaminoethyl (DEAE, anion) or carboxymethyl (CM, cation). In 
comparative terms, strong exchangers are completely ionised over a wide pH range and 
show little or no variation in ionic characteristics with changes in pH whereas, weak 
exchangers show marked variations in ionic state (and sample retention) with changes in 
pH. In practice, the charge distribution on the surface of protein molecules determines 
the number of charged groups available for interaction with the ion-exchanger, and thus 
govern their binding characteristics to ion-exchange media 1Regnier, 1984]. 
For the successful separation of enzymes by ion-exchange chromatography, the technique 
can be viewed in two stages. Firstly, the enzyme of interest (and similarly charged 
proteins) is bound to the appropriate ion-exchanger using a low ionic strength buffer at a 
pre-determined pH. The appropriately charged proteins and buffer counterions (e.g. Cl-
for anion exchangers or Na+ for cation exchangers) compete for binding sites on the 
exchanger whilst uncharged and oppositely charged proteins flow through the column in 
the void fraction. As the heterogeneous binding affinities exhibited by proteins are 
dependent on the ionic strength and pH of starting (binding) buffers, a gradually varying 
gradient based on either of these parameters may be used to differentially elute bound 
proteins. Ionic strength gradients at fixed pH are by far the most commonly used and the 
easiest to generate. 
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Desorption, and thereby elution, of proteins with ionic strength gradients is achieved by 
increasing the ionic strength (by continuous or step gradients) of the mobile phase. 
Counterions compete with bound proteins for the charged binding sites on the exchanger, 
resulting in desorption and elution of bound proteins which are generally displaced from 
the column in order of increasing charge (i.e. weakly charged proteins being eluted first). 
In addition, the pH of buffers used in ion-exchange separations should be at least 0.5 pH 
unit above (anion exchange) or below (cation exchange) the pI(s) of the component(s) of 
interest, and appropriate buffers should be selected to ensure that their pKa is within 0.3-
0.5 units of the chosen pH. When separating bioactive molecules, this chosen pH also 
needs to be compatible with preservation of biological activity. 
3.3.2 	 Anion-exchange chromatography:  
33,2.1 Experimental procedures: In order to determine the binding and elution 
characteristics of MonEst and ComEst esterase isoenzyme species, anion-exchange 
chromatography was carried out using a quaternary aminoethyl-Sepharose (Q-Sepharose) 
exchanger (Pharmacia). For this preliminary evaluation, 5m1 of the AMML leukaemic 
cell extract was dialysed against 25mM tris-HC1 buffer pH 8.4 and then diluted to 25m1 
with the same. This was centrifuged at 104g for 20 min to remove particulate material 
and the resulting supernatant applied to a 15.0m1 Q-Sepharose column, pre-equilibrated 
with tris buffer, at a flow rate of 1.0m1/min. Unbound proteins were collected, reduced 
in volume using an Amicon Ultrafiltration (10 kDa) cell, and the esterase activities (acetate 
and butyrate), protein concentration, and isoenzyme profile determined. Proteins binding 
to the column were eluted sequentially using the following 25mM buffers at 0.5 pH unit 
intervals; pH 7.0 tris-HCI, pH 6.5 bis-tris-HCI, pH 6.0 bis-tris-HCI, pH 5.5 piperazine-
HCI. and pH 5.0 piperazine-HCI. Elutions were monitored using an in-line 280nm UV 
monitor and proteins desorbed at each pH interval were collected until baseline A280 
readings were re-attained. Following the pH 5.0 elution, remaining bound proteins were 
eluted with 1.5M NaCI. The unbound fraction and all eluates were concentrated and 
analysed for protein, esterase activities and IEF esterase isoenzymes patterns. 
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332.2 Results: 
 Analysis of the Q-Sepharose unbound and step pH eluates revealed that 
approximately 30% of starting protein did not bind to the column, and that this fraction 
contained most of the higher pI (7.3-7.9) ComEst isoenzymes (Table 3.3 and Figure 
3.3). Further minor amounts of protein and ComEst esterase isoenzymes were eluted 
with the pH 7.0, 6.5 and 6.0 buffers, but the pH 5.5 piperazine eluate contained virtually 
all of the MonEst isoenzymes. A high proportion of the bound protein was subsequently 
eluted with the pH 5.0 and 1.0M NaCI buffers although these fractions did not contain 
any significant amounts of ColnEst or MonEst isoenzymes. In addition, esterase 
activities determined by fluorimetric assays of the eluates did not show any apparent 
relationship with the relative staining intensities of myeloid esterase isoenzymes. 
3.3.2.3 Conclusions: Quaternary aminoethyl (Q-Sepharose) anion-exchange 
chromatography using pH step elution, resulted in the complete separation of the two 
major myeloid esterase species. Q-Sepharose anion-exchange gel was chosen in 
preference to DEAE as it is capable of maintaining charge characteristics over a wide pH 
range. At a starting pH of 8.4, both the ComEst (pl range >6.3-7.9) and MonEst (p1 
range 5.5-6.2) esterase species should, in theory, be sufficiently negatively charged and 
bind to the anion-exchanger. However, the finding that the major ComEst components 
(pI 7.3-7.9) did not bind at this pH suggests that the negatively charged groups of these 
components were inaccessible (e.g. internal). In contrast, the MonEst species (together 
with a minor proportion of the lower pl ComEst isoenzymes) were sequentially eluted 
from the column at a pH lower than their pl. In summary, the use of a discontinuous 
step-pH elution enabled approximately 60% of the non-esterase extract proteins to be 
discarded, thus making this column procedure extremely useful as a preliminary step in 
the fractionation protocol. 
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3.3.3 	 Cation-exchange chromatography:  
,3.3.3.1 Experimental procedures: The unbound pH 8.4 Q-Sepharose fraction, 
containing enriched ComEst esterase species (pI range 7.3 to 7.9), was further examined 
by cation-exchange chromatography using a sulphopropyl-Sepharose gel (S-Sepharose, 
Pharmacia). A 5m1 aliquot of this material was dialysed against 25mM morpholino-
ethane sulphonic acid (MES) pH 6.0, diluted to 25m1 with the same and passaged at a 
flow rate of 2.0m1/min through a 15m1 pre-equilibrated S-Sepharose column. Unbound 
proteins were collected, reduced in volume by ultrafiltration and stored at 40C. Proteins 
that bound to the column were eluted using a linear (0.0 to 0.5M) NaCI gradient in a total 
volume of 90m1. The eluate was collected as 2.0m1 fractions, and 50ttl of each was 
assayed for acetate and butyrate esterase activity by fluorimetric procedures. The NaC1 
concentration of each fraction was measured with a chloride meter (EEL-920 Corning), 
and fractions with significant enzyme activity were pooled as individual peaks, 
concentrated and analysed for protein, esterase activities and IEF isoenzyme patterns. 
3.3.3.2 Results: The S-Sepharose elution profile of enriched ComEst species revealed 
two main peaks of esterolytic activity (Figure 3.4); peak (i) was eluted through a 40- 
140mM NaC1 concentration range and found to show a marked preference for butyrate 
substrate hydrolysis; peak (ii) was eluted at a higher (120-220mM) NaCI concentration 
and appeared to preferentially hydrolyse the acetate substrate. Determination of specific 
enzyme activities showed that peak (i) had acetate and butyrate esterase concentrations 
respectively of 285 and 963 fluorescent units/ml/min/mg of extract protein compared to 
446 and 169 for peak (ii). When these two fractions were further analysed by IEF. peak 
(i) showed relatively weak concentrations of ComEst isoenzymes within the pl range 6.1 
to 7.2 whereas peak (ii) comprised high concentrations of the four major ComEst 
isoenzymes with a p1 range of 7.3-7.9. 
3.3.3.3 Conclusions:  The cation-exchange bindingJelution characteristics of MonEst 
isoenzymes were not investigated in this current study as the theoretical pH required to 
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promote their binding to a cation-exchange column (pH <5.0) was considered to be too 
low to maintain the structural integrity of this protein. The elution profile of ComEst 
components revealed two peaks of esterase activity, suggesting the presence of two 
distinct ionic forms. Elution of Peak (i) was achieved at a lower sodium chloride (NaC1) 
concentration than the elution of Peak (ii) and lEF analysis showed that the first of these 
fractions contained two to four weakly staining ComEst isoenzymes of lower pI (range 
6.1-7.2) whereas the major ComEst components of higher pI (range 7.3-7.9) were 
associated with Peak (ii). Measurements of protein concentrations further indicated that 
the fractions which did not contain significant concentrations of ComEst (i.e. the 
unbound material and the fractions corresponding to Peak i) together represented 
approximately 40% of the starting protein. Consequently, the use of S-Sepharose 
chromatography for the purification of ComEst would allow the removal of a large 
proportion of contaminating non-esterase proteins whilst simultaneously providing a high 
binding capacity for the ComEst. Additionally, as S-Sepharose is able to withstand 
relatively high flow rates (up to 7m1/min), its inclusion in the early stages of ComEst 
fractionation would facilitate the processing of large starting extract volumes. 
3.4 LECTIN AFFINITY CHROMATOGRAPHY  
Introduction: Lectin affinity chromatography is a form of adsorption 
chromatography which is frequently used for fractionating glycoproteins. The proteins of 
interest specifically and reversibly interact with complementary lectin ligands immobilised 
on an insoluble matrix. Since the introduction of cyanogen bromide coupling of ligands 
to polysaccharide matrices [Axen et al., 1967], many novel procedures have been 
developed for the isolation of specific proteins from complex mixtures [reviewed in 
Wilchek et al., 1984J. Lectins are proteins which interact reversibly with specific sugar 
residues which, in effect, enables them to distinguish between polysaccharides. 
glycolipids and glycoproteins that display differences in their glycosidic contents. For 
glycoproteins, this binding is dependent on the type and extent of glycosylation of the 
polypeptide chains although. with respect to individual lectins, this affinity may also be 
97 
influenced by differences in the accessibility of sugar residues within the glycoprotein 
structure. Primary isoenzymes of a particular enzyme are not generally distinguishable 
using lectin chromatography however, secondary (post-translational) isoenzymes, which 
differ in their glycan constituents, are often resolved by employing lectin-affinity 
techniques [Swallow, 1977]. 
A potentially important means of fractionating leucocyte esterase enzymes in this current 
study was by the use of lectins immobilised on inert Sepharose or agarose matrices. An 
increasingly wide range of plant and animal lectins are available for protein separation 
although, Concanavalin-A (Con-A) is by far the most commonly used for enzyme 
purifications. The various types of lectin evaluated in this present study, together with 
their sugar affinities, are detailed in Table 3.6. Most lectins can be grouped into one of 
the following six categories, based on their carbohydrate-binding specificity (lectins used 
in this current study are shown in parentheses); mannose/glucose-binding lectins (Con-A, 
PSA, LCA); N-acetylgalactosamine/galactose-binding lectins (VVA B4, HPA, PNA, 
RCA I); N-acetylglucosamine-binding lectins (GSA II, WGA); L-fucose-binding lectins 
(UEA I); sialic acid-binding lectins and those with 'complex' specificities [Goldstein & 
Poretz, 1986]. 
3.4.2 Concarw Ain A (Con-Al affinity cnromatogravii“  
3.4.2.1 Experimental procedures: Glycoproteins and glycolipids containing alpha-D-
mannopyranosyl, alpha-D-glucopyranosyl or sterically related residues interact with 
Con-A in a reversible manner. The desorption of bound glycoproteins form Con-A is 
normally achieved with methyl alpha-D-mannopyranoside or methyl alpha-D-
glucopyranoside, although desorption of proteins interacting through nonspecific ionic or 
hydrophobic associations may be achieved by sodium chloride or detergent. For 
glycoproteins binding through specific interactions the strength of binding, and 
consequently the ease of desorption, is generally proportional to the number of accessible 
sugar residues within the native structure. Binding of glycoproteins to Con-A is 
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additionally facilitated by the presence of low (0.5mM) concentrations of Mg2+, Mn2+ 
and Ca2+ ions. 
To analyse the binding characteristics of myeloid cell esterases, 1ml of the leukaemic 
AMML blast cell extract was dialysed overnight against 12.5mM succinic acid pH 6.8 
containing 0.5mM each of magnesium, manganese and calcium chlorides. Following 
dialysis, the cell extract was further diluted to a final volume of 5m1 in the same buffer 
and any particulate material, such as precipitated proteins and nucleic acids, were 
removed by centrifugation at 104g for 20 min. The resulting supernatant was applied to a 
pre-equilibrated 1.0 x 2.0cm Con-A Sepharose column (Pharmacia) at a flow rate of 
1.0m1/min. Non-binding proteins were collected and concentrated by ultrafiltration (10 
kDa membrane, Amicon) to the original starting volume, and proteins binding to the 
column through nonspecific-ionic interactions were eluted with a 30 minute linear (0.0 to 
1.0M) NaCI gradient at a flow rate of 1.0m1/min; two minute (2m1) fractions were 
collected and 501.11 of each assayed for acetate and butyrate esterase activity by 
fluorimetric procedures. Proteins remaining bound to the column were then eluted with 
0.5M methyl alpha-D-mannopyranoside in 10mM phosphate buffer pH 7.0 and 
concentrated to 5m1. 
The above elution procedure was repeated twice more with alternative linear (0.0 to 
0.5M) gradients of alpha-D-glucopyranoside or alpha-D-mannopyranoside (total elution 
volumes of 30m1 at a flow rate of 1.0m1/min). Fractions with significant esterase 
activities from each of the three gradients were individually pooled and concentrated prior 
to quantitative esterase assays and IEF-ANAE isoenzyme analysis. Electrophoresis of 
these fractions, as well as the unbound material from each experiment, was carried out as 
described in Section 2.2.6.1 and the gel was stained in a cytochemical reaction mixture 
containing 5.0mM alpha-naphthyl acetate and hexazotised pararosaniline (Section 
2.2.3.4). 
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3.4.2.2 Results: 
 The Con-A Sepharose binding characteristics of ComEst and MonEst 
were investigated using an AMML leukaemic cell extract expressing both isoenzyme 
forms. Acetate and butyrate esterase activities, for both the unbound fractions and 
column eluates, and IEF analyses are summarised in Table 3.4. Although the unbound 
fraction did not contain any significant amounts of ComEst or MonEst as determined by 
IEF, examination of the fluorimetric assay data for these, and other fractions lacking 
detectable ComEst or MonEst species, clearly indicated in all three experiments the 
presence of other enzymes/proteins capable of hydrolysing the fluorimetric esterase 
substrates. 
Sodium chloride (NaCI) elution: Following the binding of leukaemic myeloid cell 
esterases to Con-A, a gradient (to 1.OM) of NaCI failed to elute either bound ComEst or 
MonEst. These esterases were however desorbed by the subsequent single-step elution 
with 0.5M alpha-D-mannopyranoside. 
Methyl alpha-D-glucopyranoside elution: A minor proportion of the MonEst species was 
eluted by methyl alpha-D glucopyranoside concentrations of 0.1-0.18M and 0.19-0.28M. 
In contrast, majority of the ComEst was eluted with 0.19-0.28M glucopyranoside. No 
further ComEst or MonEst staining was seen in the higher (0.29-0.5M) glucopyranoside 
gradient fractions although residual bound ComEst and most of the bound MonEst was 
eluted with the subsequent 0.5M mannopyranoside wash. 
Methyl alpha-D-mannopyranoside elution: Both ComEst and MonEst myeloid esterase 
species were completely eluted from the Con-A column at alpha-D-mannopyranoside 
concentrations of 0.1 to 0.38M. Again, although esterase activities were detectable by 
fluorimetric assay at higher mannopyranoside concentrations, no further ComEst or 
MonEst isoenzyme forms were detected by IEF. 
3.4.2.3 Conclusions:  Both ComEst and MonEst isoenzyme components bound to Con-
A and were not eluted by increasing ionic strength (to 1.OM NaCI). Investigation of two 
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different sugar eluants showed that the main ComEst components were eluted by both 
alpha-D-glucopyranoside and alpha-D-rnannopyranoside. In contrast, most of the bound 
MonEst, which was not desorbed by alpha-D-glucopyranoside, was eluted by alpha-D-
mannopyranoside. Con-A exhibits a higher affinity for alpha-D-mannopyranoside than 
alpha-D-glucopyranoside [Goldstein & Poretz. 1986] thereby suggesting that ComEst 
binds to Con-A either through a specific interaction with alpha-D-glucopyranoside 
residues or through a weaker interaction with alpha-D-mannopyranoside residues. 
Conversely, MonEst isoenzymes are likely to predominantly bind to Con-A through 
specific interactions with alpha-D-mannopyranoside residues. These findings indicate 
that there are possible differences in the type and/or extent of glycosylation between the 
ComEst and MonEst isoenzyme components, and that the incorporation of this column in 
esterase fractionation procedures would be of potential value. 
3.4.3 Supplementary Lectin affinity columns:  
3.4.3.1 Experimental procedures: In addition to Con-A, nine further lectin affinity 
columns were evaluated in this study to determine the binding characteristics of leukaemic 
myeloid cell ComEst and MonEst esterase isoenzyme forms. The commercial sources for 
these gels and the types of matrices to which each lectin had been immobilised are shown 
in Table 3.5, their sugar specificities in Table 3.6, and the gel volumes and sugar eluants 
used for protein desorption in Table 3.7. For each lectin affinity gel studied, the 
chromatographic procedures followed were identical with respect to flow rates and 
column cross-sectional areas (10mm diameter, K10/10 column: Pharmacia). 
The practical procedures for sample preparation, column loading and protein elution for 
each column were as follows: 1.0m1 aliquots of the AMML cell extract were thawed and 
diluted to 15m1 with lectin binding buffer (12.5mM succinic acid pH 6.9 containing 
0.5mM each of calcium chloride, magnesium chloride and manganese chloride: and 
0.15M sodium chloride). Large aggregates and cell debris were pelleted by centrifugation 
and the solubilised protein supernate was dialysed overnight against lectin binding buffer 
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at 4°C. Following dialysis and further centrifugation, the sample was passaged through 
the lectin column at 0.5mlimin. The absorbance at 280nm of unbound proteins was 
constantly monitored and after completion of sample loading, further buffer was passaged 
until the 280nm baseline was re-attained. The unbound protein fraction was then 
concentrated (Amicon Ultrafiltration Cell with a 10 kDa limiting membrane) to a final 
volume of 3-5m1 and stored at 4°C. Proteins bound to the lectin were eluted with an 
appropriate group-specific desorption agent (Table 3.7) dissolved in the lectin binding 
buffer at a flow rate of 1.0m1/min. Eluted proteins were monitored at 280nm, collected 
on ice and then concentrated to approximately I ml. The protein concentrations of bound 
and unbound fractions were determined with the bicinchoninic assay procedure (Section 
2.2.7), and the esterase isoenzyme components of the bound fraction were analysed by 
IEF and histochemical staining of the gels in a reaction mixture comprising 5.0mM alpha-
naphthyl acetate and hexazotised pararosaniline. 
3.4,3.2 Remits;  
Enzyme and protein assays: By taking into account the volumes of the bound (eluted) 
and unbound fractions, it was possible from the enzyme and protein assays to determine 
the proportion (%) of extract acetate esterase, butyrate esterase and protein bound to each 
lectin column. Only minor (<2.0%) proportions of sonicate protein were bound to UEA 
HPA, and PNA lectins (Table 3.8 and Figure 3.5). Between 2.0% and 10.0% of 
extract protein bound to and was eluted from PSA, LCA, GSA II, VVA B4 and RCA I, 
whereas only WGA bound in excess of 10% extract protein. With respect to the relative 
amounts of bound esterase enzyme activity, the highest and lowest bound acetate esterase 
activities were obtained with the LCA (6.6%) and VVA B4 (0.1%) columns respectively, 
whereas the highest and lowest butyrate esterase activities were found with the LCA 
(14.2%) and HPA/PNA (both 0.3%) columns. In addition, although there was 
considerable variation in the actual amounts of bound enzyme, it was a consistent finding 
that the level of eluted butyrate esterase activity was always higher than acetate esterase 
activity. 
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Esterase isoenzyme analysis: Qualitative analyses of esterase isoenzymes was achieved 
by IEF. The esterase zymogram of the pre-column cell extract comprised both ComEst 
and MonEst myeloid isoenzyme species. Analysis of the binding characteristics of these 
isoenzyme groups to the lectin columns showed (Table 3.8) that the MonEst isoenzyme 
forms did not bind to any of the columns studied. In contrast, a minor proportion of 
ComEst isoenzyme forms were found to bind to LCA and PSA (Figure 3.6). 
Interestingly, even though the WGA and RCA I columns bound a significant proportion 
of cell extract esterase activity, as defined by the hydrolysis of 4-methylumbelliferyl 
butyrate, no ComEst or MonEst esterase isoenzymes were detected by IEF with either 
alpha-naphthyl acetate or butyrate substrates. 
3.4.3.3 Conclusions: Of the nine supplementary lectin columns examined, only two 
(LCA and PSA) showed any significant binding of myeloid esterases. Both LCA and 
PSA, like Con-A, are categorised as mannose/glucose-binding lectins (Table 3.6) 
however, while Con-A showed strong binding of both ComEst and MonEst, LCA and 
PSA bound only a proportion of the ComEst species. Although collectively the lectin 
columns examined here appear to contribute only marginally, in terms of removing 
contaminating proteins from raw cell extracts, it is suggested that with repeated 
processing of the unbound material, their incorporation in a fractionation procedure 
would allow the removal of significant quantities of contaminating, non-ComEst/MonEst 
glycoproteins with esterolytic activity. 
3.4.3.4 Glycon structures rtf ComEst and MonEst as determined by their lectin affinities: 
The lectin binding studies (Sections 3.4.2 and 3.4.3) showed that all MonEst bound to 
Con-A with no apparent affinity for any of the other lectins examined. In contrast, the 
ComEst species showed some affinity for PSA and LCA in addition to strong binding to 
Con-A. Carbohydrate structures of glycoproteins or proteoglycans are formed by the 
glycosidic linkage to an amino acid side-chain which may be N-glycosidic (through the 
amide nitrogen of an asparagine residue) or 0-glycosidic (through the hydroxyl group of 
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serine, threonine, hydroxylysine or hydroxyproline). When interpreted in the context of 
the differential sugar specificities of these lectins, these observations reveal significant 
differences in the carbohydrate structure of these two myeloid esterase types. For 
example, the pattern of lectin binding for MonEst is compatible with the presence of 
oligomannosidic-type glycan(s) N-glycosidically linked to the protein (Figure 3.7a) 
whilst ComEst appears to contain approximately 80-90% biantennary N-
acetyllactosamine-type (complex-type) asparagine-linked glycan(s) (Figure 3.7b) together 
with a-1,6-fucosylated biantennary N-acetyllactosamine-type glycan(s) (Figure 3.7c). 
The results of these lectin binding studies were partly interpreted by Dr H. Debray 
(Laboratoire de Chimie Biologique, Universite des Sciences et Techniques de Lille 
Flandres-Artois, France) who, in collaborative work, also assisted in proposal of the 
possible glycan structures for ComEst and MonEst enzymes denoted in Figure 3.7. 
These studies of 'crude' cell extracts for esterase-lectin affinities are further extended in 
Chapter 4, where analyses of purified MonEst and partially purified ComEst provide 
further confirmation of the proposed glycan structures for these myeloid esterase species. 
3.5 	 NON-LECTIN AFFINITY CHROMATOGRAPHY  
3.5.1 Introduction: Three non-lectin affinity columns were evaluated in this current 
study for the potential isolation of myeloid esterase species. Benzamidine-Sepharose 
(Pharmacia) is an affinity chromatography gel to which the synthetic trypsin inhibitor p-
aminobenzamidine (PAB) is covalently coupled to an inert matrix. This allows the gel to 
specifically bind trypsin and other related proteins such as thrombin, urokinase and 
collagenase. 
Arginine-Sepharose (Pharmacia) affinity chromatography has been used to isolate or 
remove various serine proteases from a wide range of materials. L-arginine residues are 
covalently coupled to a Sepharose matrix, predominantly through their alpha-amino 
groups, and affinity has been demonstrated in particular for enzymes which contain serine 
at their active sites and cleave proteins at the carboxyl group of arginine residues. 
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Arginine-Sepharose affinity chromatography may also be utilised to specifically adsorb 
molecules with biospecific or charge dependent affinity for L-arginine. 
Blue-Sepharose (Pharmacia) is produced by the covalent attachment of Cibacron Blue 
F3G-A dye to a cross-linked agarose (Sepharose CL-6B). The dye itself is capable of 
binding many enzymes including Icinases, dehydrogenases and most enzymes requiring 
adenyl-containing substances (e.g. NAD+). A number of non-enzyme proteins such as 
albumin, lipoproteins, blood coagulation factors and interferon also bind this dye, thus 
making Blue-Sepharose chromatography particularly versatile with many potential 
applications. 
3.5.2 	 Benzamidine-Sepharose chromatography:  
3.5.2,1 Experimental procedures: In preliminary studies, it was found that optimal 
binding could be achieved by use of low ionic strength buffers, such as 25mM sodium 
phosphate pH 6.5 or 12.5mM succinic acid pH 6.8, and that elution of bound proteins 
could be facilitated by increasing the ionic strength (e.g. 0.3M sodium phosphate or 
molar sodium chloride). The following evaluations detail individual experimental aspects 
that are directly applicable to the design of a purification system for myeloid ComEst and 
MonEst species. 
Experiment (a): A 5.0m1 aliquot of the leukaemic AMML cell extract, containing both 
ComEst and MonEst myeloid esterase isoenzymes, was dialysed overnight against 25mM 
sodium phosphate buffer pH 6.5 containing 1% Triton X-100. Following dialysis, the 
sample was passaged through a 5m1 Bennunidine-Sepharose column at 0.5rnl/min and 
the unbound proteins collected. Proteins binding to the column were eluted with a linear 
sodium phosphate gradient to 0.3M at 1.0m1/min; one minute fractions were collected and 
assayed for butyrate esterase activity by fluorimetry. Fractions corresponding to distinct 
peaks of butyrate esterase activity were pooled, concentrated and analysed by IEF for the 
presence of ComEst and MonEst species. 
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Experiment (b): 0.5ml aliquots of nine different leukaemic cell extracts, variously 
expressing 01, G2 or M-type ANAE-IEF patterns, were dialysed overnight into 25mM 
sodium phosphate buffer pH 6.5 containing 1% Triton X-100. These dialysed samples 
were individually passaged at 0.5m1/min through a 5m1 Benzamidine-Sepharose column 
and, in each case, bound proteins were single-step eluted with 0.3M sodium phosphate 
buffer. Unbound and eluted proteins (after concentrating to approximately 0.5m1) were 
assayed for acetate and butyrate esterase activity by fluorimetry using standard 
procedures, and analysed by IEF for the presence of ComEst and MonEst species. The 
relative proportions of total acetate and butyrate esterase activity in the unbound and 
bound fractions were then calculated. 
Experiment (c): A 5.0m1 aliquot of the leukaemic AMML cell extract, expressing both 
ComEst and MonEst myeloid esterase isoenzymes, was dialysed overnight against 25mM 
sodium phosphate buffer pH 6.5 containing 1% Triton X-100. Following dialysis, the 
sample was passaged through a 5m1 Benzamidine-Sepharose column at 0.5m1/min and 
the unbound proteins collected; proteins binding to the column were single-step eluted 
with 0.3M sodium phosphate buffer and concentrated to 5.0m1. The pre-column sample, 
as well as the unbound and bound (eluted) fractions were then investigated by IEF for the 
presence of ComEst and MonEst species and additionally analysed by Superose-12 FPLC 
gel filtration chromatography for esterase molecular weight species (Section 3.2.2). 
3.5.2.2 Results:  
Experiment (a): Gradient elution (to 0.3M sodium phosphate) of proteins binding to the 
Benzamidine-Sepharose column resolved (Figure 3.8) two distinct peaks of butyrate 
esterase activity which eluted at approximate phosphate concentrations of 55mM (peak i) 
and 145mM (peak ii). The relative rates of acetate and butyrate hydrolysis (Ac:But ratio) 
for these two peaks were both 0.4, although the highest total activity was associated with 
peak ii. However, IEF studies showed that neither peak contained demonstrable ComEst 
or MonEst myeloid esterase isoenzyme species and, furthermore, analysis of the unbound 
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fraction confirmed that there had been no apparent binding of these particular myeloid 
esterase isoenzymes to the column. This lack of binding was unequivocal, despite 
evidence that significant amounts of proteins with esterolytic activity were eluted from the 
column. Interestingly, even though there was apparent differential binding, the Ac:But 
ratios of the pre- and post-column fractions remained essentially unchanged at 1.04:1. 
Experiment (b): The results for this particular investigation showed that, irrespective of 
the ANAE-IEF pattern type (i.e. Gl, G2 or M), means of 39% (range 24-60%) and 25% 
(17-35%) of the total leukaemic cell extract acetate and butyrate esterase activities were 
bound to the Benzamidine column (Table 3.9). Esterolytic activities of these bound 
protein fractions were not however associated with the presence of detectable ComEst or 
MonEst isoenzymes when analysed by IEF. 
Experiment (c): In this part of the study, comparative studies of the ANAE-IEF 
isoenzyme pattern types and the Superose-12 gel filtration profiles of enzymes with 
esterolytic activities were undertaken for (1) the pre-Benzamidine column cell extract, (ii) 
the post-Benzamidine (unbound) column fraction, and (iii) the protein fraction eluted 
from the Benzamidine column with 0.3M sodium phosphate pH 6.5. In this way it was 
found that the pre-column extract, which contained both ComEst and MonEst isoenzyme 
components, showed two distinct molecular weight species (with approximate elution 
times of 36 and 43 mins), and that both of these showed higher relative rates of butyrate 
substrate hydrolysis (Figure 3.9). Following passage of this sample through the 
Benzamidine column, a high proportion of the high molecular weight species (Ve, 36) 
was removed but the ANAE-IEF pattern of this unbound fraction did not appear to have 
been affected. Moreover, proteins eluted from the Benzamidine column contained 
significant concentrations of the high molecular weight species (with marked preference 
for butyrate substrate hydrolysis) but no ComEst or MonEst isoenzymes were 
demonstrable by IEF. 
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3.5.2.3 Conclusions: 
 The results for the three experiments showed that neither ComEst 
nor MonEst isoenzymes bound to Benzamidine-Sepharose even though significant 
concentrations of esterolytic enzymes were clearly present in the eluate. As Benzamidine-
Sepharose binds trypsin and closely related serine proteases, these observations suggest 
that the contaminating enzymes with esterolytic activity are likely to be trypsin-like 
proteases. However, as many proteolytic enzymes are known to catalyse the hydrolysis 
of ester substrates (due to the similarities between ester and peptide bonds), these 
findings are perhaps not unexpected and illustrate the requirement of more than one 
analytical approach to monitor ComEst and MonEst activities during fractionation. 
Furthermore, gel filtration studies of the pre- and post-Benzamidine-Sepharose fractions 
suggest that the proteolytic enzymes with esterolytic activity, which bound to the column, 
have a similar Mr to the high molecular weight esterase species (P2) present in many cell 
extracts (Section 3.2.2). 
It is concluded that Benzamidine-Sepharose affinity chromatography is an important step 
in the purification of esterase isoenzyme components, as it provides a means of removing 
a large proportion of non-MonEstiComEst esterolytic activity whilst simultaneously 
removing potentially harmful digestive proteases from the extract. 
3.5.3 	 A rginine-Sepharose chromatography:  
3.53.1 Ekperimenta/ procedures:  To evaluate the application of this affinity column to 
esterase fractionation, 5.0m1 of leukaemic AMML cell extract was dialysed overnight 
against 12.5mM succinic acid buffer pH 6.8 containing 0.5mM each of magnesium, 
manganese and calcium chlorides. Following dialysis, the sample was diluted to 25m1 in 
the same buffer and passaged through a pre-equilibrated 10.0 x 1.1cm Arginine-
Sepharose (Pharmacia) column at 1.0m1/min. The unbound material was collected and 
following re-attainment of baseline A280, bound proteins were eluted with a single-step 
passage of molar sodium chloride in succinie acid (pH 6.8). The unbound and eluate 
fractions were then dialysed into 50mM morpholino-ethane sulphonic acid (MES) pH 6.4 
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and concentrated by ultrafiltration to approximately 5.0m1. These concentrated fractions 
were then analysed by IEF, for the presence of ComEst and MonEst esterase isoenzymes, 
and assayed for protein concentrations and (fluorimetric) acetate/butyrate esterase 
activities. 
3.5.3.2 Results: 
 The column performance characteristics for Arginine-Sepharose are 
shown in Table 3.10. These show that 32% of the total extract protein and approximately 
40% of the acetate/butyrate esterase activities were associated with the proteins elated 
from the column. Interestingly, IEF analysis clearly revealed that despite the relatively 
high esterase activities of the eluate, neither ComEst nor MonEst species bound to the 
column. 
3.5.3.3 Conclusions: Arginine-Sepharose is known to bind serine proteases, particularly 
those cleaving proteins at the carboxyl group of arginine residues. As with Benzamidine-
Sepharose chromatography, significant esterolytic activity was demonstrated, in the 
absence of demonstrable ComEst or MonEst isoenzyme components, in the Arginine-
Sepharose eluate. The conclusions drawn for this column are therefore similar to those 
for Benzamidine-Sepharose in that Arginine-Sepharose chromatography provides an 
additional means of removing potentially harmful contaminating proteases with esterolytic 
activity. 
3.5.4 Blue-Sepharose chromatography:  
3.5.4.1 Experimental procedures:  To evaluate this affinity column for esterase 
fractionation, 5.0m1 of leukaemic AMML cell extract was dialysed overnight against 
12.5mM succinic acid buffer pH 6.8 containing 0.5mM each of magnesium, manganese 
and calcium chlorides. Following dialysis, the sample was diluted to 25ml in the same 
buffer and passaged through a pre-equilibrated 10.0 x 1.1cm Blue-Sepharose 
(Pharmacia) column at 1.0m1/min. The unbound material was collected and following re-
attainment of baseline A280, bound proteins were eluted with a single-step passage of 
109 
molar sodium chloride in succinic acid (pH 6.8). The unbound and eluate fractions were 
then dialysed into 50mM MES pH 6.4 and concentrated by ultrafiltration to approximately 
5.0m1. These concentrated fractions were subsequently analysed by IEF, for the 
presence of ComEst and MonEst esterase isoenzymes, and assayed for protein 
concentrations and (fluorimetric) acetate/butyrate esterase activities. 
3.5.4.2 Results: The column performance characteristics for Blue-Sepharose are 
summarised in Table 3.10. These show that 35% of the total extract protein, including 
34% and 52% of the acetate and butyrate esterase activities respectively, were associated 
with proteins eluted from the column. IEF analysis again revealed that there was no 
significant binding of the MonEst species to Blue-Sepharose and that, apart from a minor 
proportion of ComEst within the pl range 6.3 - 7.2, most of the ComEst isoenzymes 
(particularly within the pl range 7.3-7.9) failed to show significant binding. 
3.5.4.3 Conclusions: Blue-Sepharose binds a large number of proteins including 
kinases, dehydrogenases, albumin, lipoproteins, blood coagulation factors, interferon 
and most enzymes requiring adenyl-containing compounds. The results for these 
preliminary evaluations indicate that although esterolytic activity could be demonstrated in 
the eluate, very little of the ComEst and none of the MonEst isoenzyme components 
bound to this gel. Therefore, as with the Benzamidine- and Arginine-Sepharose 
columns, Blue-Sepharose chromatography provides yet another method for removing 
potentially harmful proteases displaying esterolytic activity. Additionally, when the 
starting material is contaminated with serum proteins, the use of Blue-Sepharose would 
facilitate the specific removal of albumin and blood coagulation factors which are present 
in relatively high concentrations in human serum. 
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HYDROPHOBIC' INTERACTION CHROMATOGRAPHY (HIC)  
,3.6.1 Introd uctionz Hydrophobic interaction chromatography separates biomolecules 
on the basis of varying degrees of hydrophobicity. Most proteins contain amino acid 
residues with hydrophobic side chains and many of these groups are sufficiently exposed 
in their native state to allow interaction with an HIC gel. Two commercially available 
HIC gels in general use are octyl- and phenyl-Sepharose. However, as strongly 
hydrophobic proteins are not easily eluted from octyl-Sepharose, and because the 
hydrophobicities of ComEst and MonEst components were unknown, phenyl-Sepharose 
was used in this current study. HIC gels are equilibrated using high ionic strength 
buffers (i.e. under conditions favouring hydrophobic binding) and, following sample 
application, elution is usually achieved by means of a decreasing ionic strength gradient. 
3.6,2 Phenvl-Sepharose III C:  
3.6.2.1 Experimental procedures: The binding and elution characteristics of MonEst and 
ComEst species were evaluated by two different procedures. For both, 5.0m1 of the 
leukaemic AMML cell extract was dialysed overnight against 50mM phosphate buffer pH 
7.0 containing 1.0M ammonium sulphate. The sample was then diluted to 25m1 with the 
same buffer and passaged through a 5.0 x 1.6cm phenyl-Sepharose column at a flow rate 
of 1.0m1/min. For the first experimental procedure, unbound proteins were collected and 
proteins binding to the column were eluted using a linear descending (1.0 to 0.0M) 
ammonium sulphate gradient over a period of 60mins at a flow rate of 1.0m1/min. 
Fractions were collected at 4min intervals and each dialysed against 50mM MES pH 6.4 
prior to fluorimetric assay for acetate and butyrate esterase activities. 
For the second experiment, unbound proteins were again collected and proteins binding 
to the colunm were step-eluted using 50mM phosphate buffers pH 7.0 containing 
decreasing ammonium sulphate concentrations of 0.8. 0.6, 0.4, 0.2 and 0.0M. Protein 
desorption was monitored with an in-line 280nm UV monitor and proteins eluted at each 
ammonium sulphate concentration were collected until baseline A280 readings were re- 
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attained. Following passage of the final phosphate buffer eluant (0.0M ammonium 
sulphate), the remaining strongly-binding proteins were eluted with 6.0M urea. 
Unbound and eluate fractions were then dialysed against 50mM MES pH 6.4 and 
concentrated (Amicon Ultrafiltration cell with a 10 kDa limiting membrane) to 
approximately 5.0m1 prior to ANAE-IEF isoenzyme analysis, determination of protein 
concentrations, and fluorimetric acetate and butyrate esterase assays. 
In addition to these studies, a pH 5.5 piperazine eluate from the Q-Sepharose anion 
exchanger (Section 3.3.2.2), which contained relatively high concentrations of MonEst 
isoenzymes but no detectable ComEst, was processed instead of the raw leukaemic cell 
extract. For this experiment, 25m1 of the piperazine Q-Sepharose eluate was dialysed 
overnight into 50mM phosphate buffer pH 7.0 containing 1.0M ammonium sulphate, and 
passaged through a pre-equilibrated 5.0 x 1.6cm phenyl-Sepharose column at a flow rate 
of 2.0m1/min. Ammonium sulphate/urea step-elutions were carried out in exactly the 
same way as for the whole leukaemic cell extract and, following the final 6M urea elution 
of strongly-bound proteins, unbound and eluate fractions were dialysed into 50mM MES 
pH 6.4, and concentrated prior to esterase isoenzyme analysis, protein and esterase 
assays. 
3.6,2.2 Results:  Following passage of the leukaemic cell extract through the HIC 
column, desorption of bound proteins was initially evaluated using a linear (1.0 to 0.0M) 
descending ammonium sulphate gradient. The results for this experiment (Figure 3.10) 
revealed that acetate and butyrate esterase activity was eluted over a wide ammonium 
sulphate concentration range with no evidence for differences in the elution of individual 
esterase HIC species. 
For the step-gradient elution of bound proteins from the passaged whole Ieukaemic cell 
extract, the acetate/butyrate esterase activities, protein concentrations and myeloid esterase 
isoenzyme (ComEst and MonEst) profiles of the unbound and eluate fractions (decreasing 
0.2M ammonium sulphate intervals) are summarised in Table 3.11. These analyses 
112 
revealed that a total of 56% of the original extract protein, as well as 44% of the acetate 
esterase and 17% of the butyrate esterase activities, were associated with the 1.0M 
(unbound), 0.8, 0.6 and 0.4M ammonium sulphate eluates combined even though 
ComEst or MonEst myeloid esterase isoenzymes were not detectable by IEF. Although 
some staining of these isoenzymes was observed in the 0.2M ammonium sulphate eluate, 
the highest concentrations of ComEst and MonEst isoenzymes were associated with the 
0.0M ammonium sulphate and 6M urea eluates. Together, these two fractions 
represented approximately 30% of the original protein, and 47% and 75% of the original 
acetate and butyrate esterase activities respectively. 
Examining the step elution characteristics of the partially-processed MonEst-enriched 
sample (Q-Sepharose pH 5.5 piperazine eluate) in the same way, it was again found 
(Table 3.12 and Figure 3.11) that the presence of demonstrable MonEst isoenzymes was 
associated with the 0.4-0.0M ammonium sulphate and 6.0M urea eluates. Protein and 
esterase assays further revealed that 55% of the protein processed did not bind to the 
column, whereas the eluates containing MonEst together represented 32% of the protein 
and approximately 70% of the acetate/butyrate esterase activities. 
3.6,2.3 Conclusions: Hydrophobic interaction chromatography (HIC) was investigated 
by both linear and step descending gradients of ammonium sulphate. The results show 
that, whereas the linear elution of proteins bound to the phenyl-Sepharose column did not 
result in any great degree of resolution, with respect to ComEst and MonEst components, 
stepped elution clearly showed that these myeloid esterases were only successfully 
desorbed in the latter part of the gradient. This suggests that both these esterase species 
are very hydrophobic, and that the procedure provides a means of removing a high 
proportion of relatively lower hydrophobic contaminating proteins. Furthermore, as 
phenyl-Sepharose is an intermediate-capacity column, which is able to withstand 
relatively high flow rates (up to 7m1/min), its inclusion in the early stages of fractionation 
would facilitate the processing of large starting extract volumes. 
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3.7 DISCUSSION  
A primary consideration for the purification of any enzyme is the maintenance of 
biological activity throughout the fractionation procedure. Consequently, the 
chromatographic techniques proposed for the full-scale purification of myeloid esterases 
utilise both mild buffer conditions and, where possible, a pH close to that of 
physiological fluids. The preliminary analyses detailed in this Chapter, of the binding 
affinities of esterolytic enzymes in crude cellular extracts, showed that a high proportion 
of the total esterase activity, defined by assays with esters of alpha-naphthol and 4- 
methylumbelliferone, could not be demonstrated by standard azo-dye histochemical 
zymogram procedures. This suggested that these particular enzymes (including trypsin 
and chymotrypsin-like enzymes), which were present in addition to the histochemically 
demonstrable ComEst and MonEst isoenzyme species, hydrolysed the substrates in such 
a way as to make subsequent and spontaneous coupling with the diazonium salt 
impossible. Although further studies of these particular enzymes were not undertaken, as 
they were not the subject of these present studies, the recognition of their presence 
effectively meant that (a) the column procedure designed for the final chromatographic 
purification of MonEst and ComEst had to ensure their removal, (b) that the monitoring 
of column efficiencies and their ability to successfully resolve these myeloid esterase 
species could only be reliably achieved by histochemical zymogram analysis, and (c) that 
the conventional expression of enzyme purification and column yields (i.e. reporting 
enzyme activities relative to protein concentration) would be meaningless. It was also 
concluded from these initial studies that because of the diverse chromatographic 
characteristics of co-existing esterolytic enzymes, and because the deteriorated nature of 
the starting material precluded the technically less demanding processing of a cell 
membrane extract, that an extensive series of columns would be required to achieve an 
acceptable degree of resolution for the myeloid esterases. Consequently, a wide range of 
chromatographic columns were required for fractionating the ComEst and MonEst and, 
where possible, these columns were specifically arranged to minimise the requirement of 
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time-consuming buffer changes and loss of enzymatic activity through prolonged 
exposure to non-optimal conditions. 
For the first stage of both MonEst and ComEst fractionation, Q-Sepharose anion-
exchange chromatography would be used because of its high protein binding capacity and 
ability to withstand relatively high (up to 7.0m1/min) flow rates. Furthermore, 
preliminary column binding studies indicated that both MonEst and ComEst could be 
separated at a starting pH of 8.4 and, as the use of NaC1 gradients from 0.0 to 1.0M did 
not appear to offer significant advantages (preliminary analyses, data not shown) in terms 
of specific ComEst/MonEst resolution, a series of pH step elutions would be used. The 
major ComEst components (pI 7.3-7.9) were found in the unbound fraction and using 
pH step elutions, the MonEst components were subsequently eluted by pH 5.5 
(piperazine) elution. These studies also indicated that in addition to the separation of 
MonEst and ComEst, Q-Sepharose also significantly reduced the total starting volume 
and protein concentration and allowed the removal of a large proportion of contaminating 
lipid and nucleic acid (DNA and RNA) components. 
MonEst Fractionation:  
Following anion-exchange chromatography, phenyl-Sepharose hydrophobic interaction 
chromatography (HIC) was considered the most suitable for the next stage of MonEst 
fractionation. This particular column was considered to be more appropriate than the S-
Sepharose cation-exchanger, as the pH required (< or = 5.0) to bind MonEst to this latter 
column could potentially affect its native structure and biological activity. Furthermore, 
the preliminary studies detailed in this Chapter indicated that the use of HIC could 
considerably reduce the sample volume and total protein. As with Q-Sepharose, the use 
of a linear descending ammonium sulphate gradient from 1.0 to 0.0M for HIC desorption 
did not appear to increase MonEst resolution and, therefore, a series of step elutions 
would be used. MonEst was found to avidly bind to phenyl-Sepharose, as evidenced by 
its presence in the low ammonium sulphate and 6M Urea eluates, and could thus be 
separated from other less hydrophobic proteins. Indeed, in view of the hydrophobic 
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nature of MonEst, which can induce irreversible protein aggregation when concentrated, a 
principle of negative enrichment was employed for subsequent chromatographic 
procedures. Consequently, the next stages of chromatographic fractionation were 
specifically designed to take account of this and to allow the MonEst components to pass 
through in the unbound fraction. 
The Benzamidine-, Arginine- and Blue-Sepharose non-lectin affinity columns, which 
predominantly bind trypsin, chymotrypsin and other related proteolytic enzymes, were 
chosen to precede the lectin columns because of their ability to remove potentially 
degradative proteases. Furthermore, these particular columns were shown in the 
preliminary evaluations to bind significant amounts of proteins with esterolytic activity, 
with no apparent affinity for MonEst. Consequently, these three columns were connected 
in series and incorporated into the purification scheme. It was also considered necessary 
to introduce two additional non-lectin affinity columns (Protein-A and Protein-G) at this 
stage of MonEst purification to remove any residual contaminating serum IgG present in 
the starting material. 
A series of lectin columns were selected to follow Protein-A/Protein-G. These were 
ordered according to the proportions of starting protein they bound; i.e. lectins which 
bound the least amount of protein preceded those binding higher proportions of the 
starting protein. However, in practice the actual order of the lectin series was not an 
important factor as unbound proteins would be re-passaged through the series until no 
further binding was detected. These lectin columns provided an important means of 
removing various contaminating glycoproteins that might not otherwise be resolved by 
conventional chromatographic procedures. 
Con-A lectin chromatography was then chosen to precede the final Superose-12 gel 
filtration stage, as preliminary analyses indicated that all MonEst components bound to 
Con-A and would therefore be concentrated prior to use of the low-capacity Superose-12 
gel filtration column. Con-A binds glycolipids and glycoproteins containing alpha-D- 
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mannopyranosyl, alpha-D-glucopyranosyl or sterically related residues as part of their 
glycan structure and consequently provides a means of separating MonEst components 
from non-glycoproteins or other glycoproteins with different glycan structures. Again, as 
the use of linear (glucopyranoside or mannopyranoside) elution gradients did not appear 
to offer significant advantages in terms of specific MonEst resolution, a single step 
elution with mannopyranoside would be used to desorb bound components. The final 
stage of the proposed purification procedure would then utilise Superose-12 gel filtration 
to separate MonEst from residual contaminating proteins with differing relative molecular 
weights (Mr). 
ComEst Fractionation; 
The rationale followed for the purification of ComEst was essentially the same as that for 
the MonEst in that, the columns were specifically organised to allow a rapid fractionation 
with the least number of buffer exchanges required. The primary consideration was to 
reduce the rather large starting sample volume using high- and intermediate capacity 
columns thus leaving manageable volumes for the low capacity column procedures. 
S-Sepharose cation-exchange column was chosen to further process the Q-Sepharose 
unbound fraction containing the major ComEst components. Its high protein binding 
capacity and ability to withstand relatively high flow through rates would permit the 
processing of large volumes of starting material. For this, a starting pH of 6.35 was 
chosen, which allowed the binding of ComEst components and their separation from 
many of the contaminating proteins by a single-step elution with 0.25M NaCI. 
Benzamidine- and Arginine-Sepharose non-lectin affinity columns would subsequently be 
employed to further remove a high proportion of potentially degradative proteases from 
the ComEst-enriched post S-Sepharose fraction followed by the lectin affinity columns 
(with the exception of Lens culinaris agglutinin and Pisum satirum agglutinin), which 
would be arranged as described for the MonEst fractionation. As for MonEst, Con-A and 
Superose-12 chromatography procedures were chosen for the final purification stages of 
ComEst. 
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In summary, the investigations detailed in this Chapter provide a basis for constructing 
fractionation schemes for the independent purification of MonEst and ComEst myeloid 
esterase species. In the next Chapter, these proposed procedures will be applied to the 
full-scale purification of these enzymes, and the resulting fractionated esterases will be 
extensively investigated to compare their molecular and biochemical characteristics. 
CHAPTER 3 
Figures 3.1 to 3.11 and Tables 3.1 to 3.12 
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Figure 3.1: flZepresentative Superose-12 FPLC gel. 
 filtration profiles of esterase 
molecular weight species of normal mature myeloid cells (grartufoeytes/monocytes). 
Diagrams (a), (6) and (c) illustrate the observed esterase molecular weight species 
for cell extracts with Ci, g2 and 911-type 1E1' isoenzynte patterns respectively 
(detailed in Section 2.3.4.2); the continuous lines indicate acetate esterase activities 
of the gel filtration fractions, and the broken fines butyrate esterase activities. 
Note that the Pl species was eluted at No, suggesting that this represented high 
molecular weight aggregates or enzyme-protein complexes. 
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Figure 3.2: 14' presentative Superose-12 FPLC ger filtration profiles of esterase 
molecular weight species of feukaemic myeloid blasts. Diagrams (a), (b) and (c) 
illustrate the observed esterase molecular weight species for feakaemic cell extracts 
with Gl, G2 and M.-type 	 isoenzyme patterns respectively (detailed in Section 
2.3.4.3); the continuous lines indicate acetate esterase activities of the gel filtration 
fractions, and the broken lines butyrate esterase activities. Noe that the P1 species 
was eluted at No, suggesting that this represented high molecular weight 
aggregates or enzyme-protein complexes. 
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Figure 3.3: Alpha-naphthyf acetate esterase (Ni)A.A isoenzyme profiles, as 
defined by IEF, of Q:Sepharose (anion exchanger) unbound (pH 8.4) and e(uate 
(p5f 7.0, 6.0, 5.5, 5.0 and molar NaCO fractions. The ANAE-1E7 isoenzyme 
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Figure 3.4: Elution profile of ComEst isoenzyme components binding to .5- 
Sepharose cation exchanger at pH 6.0. B014 rid proteins were desorbed with a 0.0 to 
0.5M linear sodium chloride (Nati) gradient, and fractions were assayed for 
acetate (continuous line) and butyrate esterase (broken line) activities. 'The upper 
diagram reveals that two distinct peaks of esterase activity were fluted under these 
conditions; the first of these (i) shows a marked preference for butyrate substrate 
hydrolysis, but when analysed by LEY" (lower diagram), shows low levels of 
ComEst (pl range 6.2-7.2) isoenzyme staining; peak., (ii) in contrast shows an 
acetate substrate preference with high levels of ComEst isoenzyme (pl range 7.3 - 
7.9) staining. 
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protein that were bound to the Pectin columns evaluated in this study; results 
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total amount processed, for each characteristic measured. PSA., Pisum sativum 
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communis agglutinin I. 
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Figure 3.6: Isoefectric focusing (IEF) of myeloid cell alpha-naphthyl acetate 
esterase (A.NAE) isoenzyrnes eluted from Concanavalin A (Con-A; track_ a), Lens 
culinaris agglutinin (LCA; track b) and Pisum sativum agglutinin (PSA; track.c). 
Note that Con-A binds both the MonT.st and ComEst species white PSA and LCA 
bind minor proportions of ComEst only. 
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Figure 3.8: Elation profile of esterases bound to Benzantirfine-Sepharose. ghe 
sodium phosphate gradient to 0.3M (100%) resolved two distinct peaks of butyrate 
esterase activity. ghe relative rates of acetate and butyrate substrate hydrolysis 
(Ac.d.gat ratio) for these two peaks were both 0.4 although, the highest total 
activity was associated with peak,(ii). Subsequent IEF isoenzynte analysis revealed 
that neither peak, contained demonstrable ComEst or MoniEst myeloid esterase 
isoenzytne species. 
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Figure 3.9: Superose-12 FITC gel filtration profiles of esterase molecular 
weight species; (a) pre-Benzamidine column teukaemic cell extract S.A.1; (b) post-
column (unbound) protein fraction; (c) protein eluate from Benzamidine-
Sepharose. Nate that a great proportion of the high molecular weight species (51), 
is removed from the feukaemic cell extract by passage through this column and 
that this constitutes the majority of esterases in the eluate fraction. 
300 
• pC 
2511 	 • 
• 
• U 
 
< c 200 
• 
0 
7,-; 0 150 
13.3 
e.) 
`? 
e.) 	 100 U 
< 0  
50 
I ) 13 17 
00 
08 
06 
I  A
m
m
on
iu
m
 
 
Su
lp
ha
te
]  (
M
l  
02 
00 
E 3 (b) 
= 
• c 	
.. 	
, 
.... .c 
... 	
250 
• • 	 0 —0 
	
i .4. 	 • 	 • --a' ... - • 
I 
 
, 	 • 	 I Q .L.: 
	
= 	
% 
• / 
1 	 1 1 	 0,8 "El,
a) 0 2(X) 	 n 	 i 	 i 
	
TO, • mai 	 5. 	 /  
	
L111 I: 
	 N 	 i 	 1 ril 
t.) 
	
E 150 	
\ 
r 
	
I 	 a 0 
tn 
. 	
% %. 	 1 	 s 	
.6 
	
I-0 4) 	 \ , 	 I 
	
C.) a 	 'Sr1., 	 I I 
	
c.) 	 OA 
	
tt C.) 	 100 	 i \ N. 	
t 
	
!A 	 r 	 I I... 
= 	
. 8 	 1 	
▪ 
 . 
. 	
. 
	
crl ...9 	 50 	 / 	 5. 	 1 	 0.2 
	
1.1.. 	 •
.. 	
i 
• — 
,.. 
0.0 
S 	 0 	 1 
	 15 	 17 
Fraction Number 
Figure 3.10: Phenyl-Sepharose hydrophobic interaction chromatography 
(-(IC) profile of esterases eluted with a descending (1.0 to 0.0M) linear gradient of 
ammonium sulphate. Diagrams (a) and (b) show acetate and butyrate esterase 
activities respectively of fractions assayed at •7nin intervals. Note that there 
appears to be a continuous elution of esterases from. approximately 0.5M 
ammonium sulphate, with no suggestion of distinct peak, and that elution of 
proteins with esterolytic activity continues for a considerable time at 0.0M 
ammonium sulphate, suggesting their relatively high hydrophobicity. 
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Table 3.1 	 Analysis of normal myeloid cell (granulocyte/monocyte) esterase molecular 
weight species by Superose-12 FPLC gel filtration a 
Cell type IEF 
Pattern 
Peak P2 
Mr 	 Ac:But 
Peak P3 
Mr 	 Ac:But 
Granulocytes GI 342 1.6 64 2.3 
Granulocytes G1 342 1.6 64 2.7 
Granulocytes GI 284 1.2 64 4.0 
Granulocytes G2 284 1.0 64 2.4 
Granulocytes G2 284 0.9 77 1.9 
Granulocytes G2 342 0.7 53 0.7 
Mean ((;1 (;2): 313 1.2 64 2.3 
Monocytes M 236 0.5 64 0.6 
Monocytes M 236 0.9 53 0.9 
Monocytes M 236 0.4 77 0.2 
Monocytes M 236 0.6 77 1.6 
Monocytes M 135 1.4 77 1.7 
Monocytes M 196 1.6 53 2.3 
Monocytes M 135 0.7 37 0.7 
Mean (M): 201 0.8 63 L1 
a Apparent molecular weights (Mr) were determined by comparison of Ve/Vo (elution 
volume/void volume) values obtained using protein standards of known molecular 
weight. The relative hydrolysis of acetate and butyrate substrates (Ac:But ratios) were 
determined using standard fluorimetric assay conditions (Section 2.3.6.4). and IEF 
pattern types Gl. G2 and M are as defined in Section 2.3.4.2. 
Table 3.2 Analysis of leukaeinic myeloid cell esterase molecular weight species by 
Superose-12 FPLC gel filtration a 
Diagnostic 
Category 
IEF 
Pattern 
Peak P2 
Mr 	 Ac:But 
Peak P3 
Ac:But 
MI/M2 GI 38 0.1 
M1/M2 G1 100 0.2 26 1.6 
M 1/M2 G1 262 6.9 30 0.7 
M3 GI 143 3.7 34 0.3 
M4 G I 333 2.4 30 0.3 
M4 G I 206 5.5 30 0.6 
M4 G2 162 1.1 24 1.6 
MI/M2 G2 262 1.1 26 0.3 
M 1/M2 G2 - 34 0.6 
Mean (G1 & G2): 210 2.9 30 0 . 7 
M4 	 M 196 0.3 64 1.4 
M5 M 216 0.3 64 1.1 
M5 M 162 0.1 26 0.5 
M5 M 143 0.5 38 1.5 
M5 M 162 2.9 34 1.2 
M5 M 162 2.1 34 0.5 
Mean (M): 173 0.8 43 1.0 
a Cases grouped according to JEF pattern type. Apparent molecular weights (Mr) 
were determined by comparison of Ve/Vo (elution volume/void volume) values 
obtained using protein standards of known molecular weight. The relative hydrolysis 
of acetate and butyrate substrates (Ac:But ratios) were determined using standard 
tluoritnetric assay conditions (Section 2.3.6.4), and IEF pattern types Gl. G2 and M 
are as defined in Section 2.3.4.2. 
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Table 3.4 Fractionation of myeloid esterase isoenzymes by Conan/am/in-A (Con-A) lectin affinity 
chromatography. Comparison of elusions using sodium chloride (NaCI). alpha-D-
glucopyranoside and alpha-D-matmopyranoside a 
Esterase activity ( 
	 b 	 TEF patterns c 
Acetate Butyrate ComEst MonEst 
fa) 	 N'aCI eluant 
89 
4 
7 
73 
10 
17 +/++ ++/+++ 
Unbound 
NaCI: 0 - 1.0M 
0.5M Mannopyranoside wash 
(b) 	 Gluconyranoside eluant 
Unbound 86 65 
Eluant: 	 0.10 - 0.18M 2 5 +/++ 
0.19 - 0.28M 3 5 +/++ +/++ 
0.29 - 0.38M 3 7 
0.39 - 0.48lvt 3 7 
0,49 - 0.50M 2 ", 5 
().5M Mannopyranoside wash 1 3 + ++/+++ 
(Cl Mannopyranoside eluant 
Unbound 79 56 
Eluam: 	 0.10 - 0.18M 5 14 +/++ +++ 
0.19 - 0.28M 5 10 +/++ ++/+++ 
0.29 - 0.38M 3 6 + +/++ 
0.39 - 0.48M 4 7 
0.49 - 0.50M 4 7 
a  A leukaemic blast cell extract. conatining both the major myeloid esterase isoenzyme components, 
was passaged through a Con-A column (Section 3.4.2.1) and dined using linear gradients of: (a) 0.0 to 
1.0M NaCI: (b) 0.0 to 0.5M methyl alpha-D-glucopyranosidc. and (Cl 0.0 to 0.5M methyl alpha-D-
mannopyranoside. 
13  Acetate and butyrate esterase activities were detetinined by standardised fluorinietric assay (Section 
2.3.6.4). Results are expressed as the percentage (%) of total acetate or butyrate esterase activity 
within each defined fraction of the chromatographic procedure, 
c Esterase ComEst and MonEst isoenzyme components as defined in Section 2.3.4.2. Reaction 
strengths graded from negative (-) to strong (+++). 
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Table 3.6 Sugar specificities of immobilised lectins evaluated in this current study 
Lectin 	 Sugar Specificity a 
.PiS11171 SatiV171 agglutinin (PSA) 
Lents eulinaris agghitinin (LCA) 
Coneanavalin A (Con-A) 
Ulex europaeus agglutinin I (UEA 1) 
Griffonia simplifocia agglutinin 11 (GSA II) 
Wheat germ agglutinin (WGA) 
Vida vilk)sa agglutinin B4 (VVA B4) 
Helix pomatia agglutinin (HPA) 
Arachis hypogaea (Peanut) agglutinin (PNA) 
Ricinus C01711771111iS agglutinin 1 (RCA I) 
a-D-man > a-D-glc = GIcNAc 
a-D-man > a-D-glc > GIcNAc 
a-D-man > a-D-gle > GIcNAc 
a-L-Fuc 
13-D-GIcNAc = a-D-GIcNAc 
p-D-G1cNAc 
a-D-GaINAc 
a-D-GalNAc 
P-D-ga1(1-3)-D-GaINAc > a-D-
Gal = P-D-Gal 
> a-D-Gal 
a Indicates primary sugar specificity. spatial relationships with other sugar groups may 
be important: D-man, D-mannose; D-Gal, D-galactose: D-glc, D-glucose; D-
GalNAc, D-N-acetyl galactosamine; D-GIcNAc. D-N-acetyl glucosamine: L-Fuc, L-
fucose. 
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Table 3.8 Protein concentrations, enzyme assays and isocnzymatic characteristics of sonicate extract 
proteins with lectin affinities " 
Esterase Activity 
Protein 
Esterase Isoenz.ymft b 
Lectin Acetate But ► rate MonEst ComEst 
t ,1. enropaeus agglutinin I (UEA I) 
Bound 0.7 ().6 1.2 
Unbound 99.3 99.4 98.8 +++ +++ 
Araehis hypo,E,aea agglutinin (PNA) 
Bound 0.2 0.3 1.3 - 
Unbound 99.8 99.7 98.7 +++ -H-+ 
Helix pontatia agglutinin (HPA) 
Bound 0.1 0.3 1.8 
Unbound 99.9 99.7 98.2 +-F+ +-H- 
Pisum satirum agglutinin (PS A) 
Bound 3.3 10.1 2.2 + 
Unbound 96.7 89,1 97.8 +++ ++ 
Vida villosa agglutinin B4 (VVA B41 
Bound 0.1 0.6 3.2 
Unbound 99.9 99.4 96.8 +++ +++ 
Lens culinaris agglutinin (LCA) 
Bound 6.6 14.2 4.5 + 
Unbound 93..1 85.8 95.5 +++ ++ 
'Grimes cammunis agglutinin I (RCA 1) 
Bound 2.7 8.0 6.7 - 
Unbound 973 92.0 93.3 +-1-1- +++ 
Grifiania simpliforia agglutinin II (GSA Ili 
Bound 1.1 2.4 7.1 
Unbound 98.9 97.6 92.1 +++ +++ 
Wheal germ agglutinin (WGA) 
Bound 2.5 8.9 I1.6 
Unbound 97.5 91.1 88.4 +++ +++ 
Unbound and eluted sonicate fractions were concentrated to approximate volumes of 41m1 and I ml 
respectively. These were assayed for acetate esterase activity. butyrate esterase activity, and protein 
concentrations as described in Section 3.4.3. Results arc shown as the proportions ((Yr) of 
the total extract esterase or protein that does not hind (unbound) or binds to (cluate) each column. 
These data arc graphically presented in Figure 3.5. 
b IEF patterns were determined for both the unbound and bound fractions. Results are shown as the 
relative staining intensities of monocyte-associated (MonEst: pI range 5.6 - 6.1) and 'common 
(ComEst: p1 >6.2) myeloid esterase isoenzymes: - indicates no isoenzymes detected in the (bound or 
unbound) fraction: +++ indicates high isoenzyme concentrations: and + or ++ indicates intermediate 
levels. 
Table 3.9 Analysis of Benzamidine-Sepharose for the binding of ComEst and 
MonEst myeloid esterase species 
Sample 
Pre-Column 
IEF 
Benzamidine Eluate 
Acetate 	 Butyrate 	 IEF 
Benzamidine Unbound 
Acetate 	 Butyrate 	 IEF 
1 GI 60% 26% 	 - 40% 74% 0 1 
2 GI 40% 31% 60% 69% Cl 
3 G1 40% 22% 60% 78% G I 
4 01 49% 27% 51% 73% G I 
5 G2 36% 19% 	 - 64% 81% 02 
6 G2 38% 21% 62% 79% 02 
7 02 30% 27% 70% 73% G2 
8 M 24% 35% 	 - 76% 65% M 
9 M 30% 17% 70% 83% M 
Results indicate the proportions of the total acetate and butyrate activities that are 
associated with the unbound and eluate fractions, together with their ANAE-IEF 
patterns (G1. G2 or M as defined in Section 2.3.4.2: - indicates complete absence of 
demonstrable ComEst and MonEst species). 
Table 3.10 	 Evaluation of Arginine-Sepharose and Blue-Sepharose columns for the 
fractionation of myeloid esterase isoenzyme species a 
Column Protein N 
Esterase Activity N 
Acetate 	 Butyrate 
Esterase isoenzymes 
MonEst 
	
ComEst 
A rginine-Seuha rose 
Unbound 68% 58% 51% ++4- ++ 
Molar NaCI eluate 31%. 42% 49% 
Blue-Sepharose 
Unbound 65% 66% 48% +++ ++ d 
Molar NaCI eluate 35% 34% 52% +d 
a Leukaemic AMoL-M5 blast cell extract SA I was passaged through Arginine-
Sepharose or Blue-Sepharose columns: unbound proteins were collected. bound 
proteins were single step-eluted with molar sodium chloride (NaCI). 
Protein concentrations and esterase activities (acetate and butyrate) of unbound and 
eluate fractions were determined by standard procedures (Sections 2.2.7 and 2.3.6.4) 
and each expressed as proportions of the total processed. 
Analysis of esterase isoenzyme components by isoelectric focusing (IEF): the relative 
staining intensities of MonEst and ComEst myeloid isoenzyme species are shown as -
(negative) to +++ (strong). 
d ComEst isoenzymes which did not bind to the Blue-Sepharose column (i.e. unbound 
fraction) were characteristically of higher pl (range 7.3 - 7.9); ComEst components 
binding to and being eluted from this column were restricted to a lower pl range (6.3 -
7.2) and of weaker staining intensity. 
Table 3.11 Evaluation of hydrophobic interaction chromatography (HIC) for the 
fractionation of esterase isoenzymes: The binding and elution 
characteristics of MonEst and ComEst myeloid esterase isoenzyme species 
to phenyl-Sepharose 
Fraction Protein h 
Esterase Activity h 
Acetate 	 Butyrate 
Esterase Isoenzymes 
MonEst 	 ComEst 
LOM ammonium sulphate 3 4 2 - 
0.8M ammonium sulphate 15 14 5 - 
0.6M ammonium sulphate 18 11 4 - - 
0.4M ammonium sulphate 20 15 6 - 
0.2M ammonium sulphate 12 9 8 + + 
0.0M ammonium sulphate 10 20 39 +++ +++ 
6M urea eluate 22 27 36 +/++ +/++ 
a Leukaemic AMoL-M5 blast cell extract SA1 was passaged through the phenyl-
Sepharose column in the presence of 1.0M ammonium sulphate. Unbound proteins 
were collected: bound proteins were step-eluted with decreasing (0.8 to 0.0M) 
ammonium sulphate concentrations at intervals of 0.2M. followed by elution with 6M 
urea. 
Protein concentrations and esterase activities (acetate and butyrate) of unbound and 
eluate fractions were determined by standard procedures (Sections 2.2.7 and 2.3.6.4) 
and each expressed as proportions of the total processed. 
c Analysis of esterase isoenzyme components by isoelectric focusing (IEF): the relative 
staining intensities of MonEst and ComEst myeloid isoenzyme species are shown as -
(negative) to +++ (strong). 
Table 3.12 	 Evaluation of Phenyl-Sepharose hydrophobic interaction chromatography 
(HIC) for the fractionation of MonEst isoenzymes a 
Fraction Protein h 
Esterase Activity h 
Acetate 	 Butyrate MonEst 
1.0M ammonium sulphate 55 29 19 
0.8M ammonium sulphate 6 2 2 
0.6M ammonium sulphate 7 2 6 
0.4M ammonium sulphate 9 8 15 +/++ 
0.2M ammonium sulphate 8 16 16 +++ 
0.0M ammonium sulphate 7 20 20 +++ 
6M urea eluate 8 23 22 +++ 
a Partially-purified Q-Sepharose pH 5.5 piperazine eluate conatining high concentrations 
of MonEst, but not ComEst (Section 3.3.2.2), was passaged through the phenyl-
Sepharose column in the presence of 1.0M ammonium sulphate. Unbound proteins 
were collected: bound proteins were step-eluted with decreasing (0.8 to 0.0M) 
ammonium sulphate concentrations at intervals of 0.2M, followed by elution with 6M 
urea. 
b Protein concentrations and esterase activities (acetate and butyrate) of unbound and 
eluate fractions were determined by standard procedures (Sections 2.2.7 and 2.3.6.4) 
and each expressed as proportions of the total processed. 
c Analysis of esterase isoenzyme components by isoelectric focusing (IEF): the relative 
staining intensities of the MonEst myeloid isoenzyme species are shown as -
(negative) to +++ (strong). 
CHAPTER 4 
MYELOID CELL ESTERASE ISOENZYMES:  
PURIFICATION, MOLECULAR AND BIOCHEMICAL 
CHARACTERISATION  
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4.1 INTR,oDucTIoN 
This Chapter describes the purification, and subsequent molecular and biochemical 
characterisation of the two major myeloid esterase enzyme forms (MonEst and ComEst). 
The earlier findings of this study (Chapter 2) showed that MonEst is expressed in a 
lineage-restricted manner, by cells of the monocytic lineage, whilst ComEst components 
are commonly expressed by both monocytic and granulocytic cells. These observations, 
together with previous ultrastructural studies [Bozdech & Bainton, 1977, 1981; Monahan 
et al., 1981; Marec et al., 1981; Zicca et al., 1981] which indicated differences in the 
subcellular localisation of esterases in granulocytes and monocytes, suggest that the 
ComEst and MonEst species may represent distinct esterolytic enzymes. In order to 
further clarify their relationships, it was considered necessary to purify both enzyme 
forms and compare their molecular and biochemical characteristics. 
Individual isoenzymes of any given enzyme often display differences in catalytic and 
physicochemical properties. Differing isoenzyme forms can originate at the genetic level 
(i.e. representing different gene products and corresponding to primary or true 
isoenzymes) or as a consequence of post-translational modification (secondary 
isoenzymes). Primary isoenzymes can additionally differ in that they may be encoded by 
either multiple genetic loci, common to all members of the species, or they may result 
from the existence of allelic variation at the enzyme-determining structural locus 
(allozymes). Some generalisations can be made, with greater or lesser degrees of 
certainty, about isoenzymes determined by multiple gene loci. They usually show 
differences in catalytic properties, such as substrate affinity or sensitivity to inhibitors, 
they can be expected to be antigenically distinct, (reflecting differences in the amino acid 
sequences encoded by distinct structural genes), and they are likely to differ in stability. 
By comparison, the nature of 'allozymes' is much less predictable as they are derived 
from individual random mutations, although monoclonal antibodies are generally capable 
of distinguishing between different allozymic forms of an enzyme molecule. In contrast, 
the catalytic properties of post-translational variants are often similar, there may be only 
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minor changes in stability, and the modified form may be antigenically identical even 
though differences in size and net molecular charge may be seen 'reviewed in Moss, 
1986]. 
Based on their gel binding characteristics, individual procedures were devised for the 
fractionation and purification of ComEst and MonEst myeloid esterase species (Section 
3.7). In view of the large amount of serum/cellular extract protein used for these 
fractionations, and taking into account the fact that many different types of columns were 
included as part of these chromatographic sequences, it was considered that wherever 
possible a single buffer system should be employed (to obviate the need for time-
consuming buffer changes) and that the columns should be primarily employed to remove 
contaminating proteins (i.e. negative enrichment of ComEst and MonEst). This latter 
point is particularly important as the high hydrophobicity of esterases (clearly evidenced 
by the results from the phenyl-Sepharose evaluation; Section 3.6.2.2) tends to lead to 
significant aggregation when these enzymes are concentrated, and because 
chromatographic procedures which utilise the principles of negative enrichment permit the 
sequential linkage of different columns in series. Furthermore, the preliminary column 
evaluations indicated that a high proportion of the total esterase activity defined by assays 
with esters of alpha-naphthol and 4-methylumbelliferone could not be demonstrated by 
standard azo-dye histochemical zymogram procedures. This suggested that these 
particular enzymes (including trypsin and chymotrypsin-like enzymes), which were 
present in addition to the histochemically demonstrable ComEst and MonEst isoenzyme 
species, hydrolysed the substrates in such as way as to make subsequent and 
spontaneous coupling with the diazonium salt impossible. Although further studies of 
these particular enzymes were not undertaken, as they were not the subject of these 
present studies, the recognition of their existence effectively meant that (a) the column 
procedure designed for the final chromatographic purifications of ComEst and MonEst 
had to ensure their complete removal, (b) that the monitoring of column efficiencies and 
their ability to successfully resolve individual esterase species could only be reliably 
121 
achieved by histochemical zymogram analysis, and (c) that the conventional expression of 
enzyme purification and column yields (i.e. reporting enzyme activities relative to protein 
concentration) would be meaningless. It was also concluded from these initial studies 
that because of the diverse chromatographic characteristics of these co-existing esterolytic 
enzymes, and because the nature of the starting material for MonEst in particular 
precluded the technically less demanding processing of a cell membrane extract, that an 
extensive series of columns would be required to achieve acceptable enzyme resolution. 
Thus, all the columns used in the final purification procedure (detailed in Table 4.1) were 
found to positively contribute towards this aim, with the final sequence being designed to 
maximise the removal of unwanted proteins and esterolytic enzymes and to minimise the 
loss of the myeloid esterase species. 
4.2 MATERIALS AND METHODS  
4.2.1 Purification of myeloid cell esterases:  
4.2.1.1 Purification of numocrte-vecific esterase (MonEst) isoenzymes: The raw 
material used for the full-scale fractionation of MonEst was obtained, at post-mortem, 
from the chest cavity of a patient who died with untreated acute monocytic leukaemia 
(AMoL-M5). Because there was evidence of significant cellular deterioration, with 
relatively high concentrations of MonEst in the extracellular fluid, it was decided to 
process all of the post-mortem material, rather then the cells alone. The intact cellular 
components were disrupted by ultrasonication (MSE Soniprep 150) at an amplitude of 
1811 for one minute and Triton X-100 was added to give a final detergent concentration of 
1%. After mixing at 25°C for 10 mins and subsequent high speed centrifugation, the 
solubilised protein supernate was recovered from pelletted cell debris. 
Individual 150-200 nil aliquots (total volume, 950m1) of the solubilised protein extract 
were dialysed overnight against 25mM tris-HCI buffer pH 8.4 containing 5% betaine 
(TBB), diluted to 400m1 in the same, centrifuged and then filtered using 1.0p.m 
nitrocellulose membranes (Millipore). This material was then passaged at a flow rate of 
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4.0m1/min through a 26.0 x 2.5cm Fast Flow Q-Sepharose anion exchange column 
which had been pre-equilibrated with TBB. Sample loading was monitored at 280nm and 
the unbound protein fraction, which was confirmed by IEF analysis to lack detectable 
MonEst, was discarded. After re-attainment of the A280 baseline, desorption of bound 
proteins with approximate pis of >6.5 was achieved by passaging 25mM bis-tris-1-1C1 
(containing 5% betaine) pH 6.3 at a flow rate of 4.0m1/min. MonEst isoenzymes were 
then eluted with 25mM piperazine-HC1 (containing 5% betaine) pH 5.5, and this was 
followed by elution from the column of remaining bound proteins with molar NaCl. A 
substantial proportion (approximately 35%) of the processed serum/cell extract protein 
remained tightly bound to the column and this could only be eluted by 2M NaOH. 
Although this particular eluate could not be analysed for the presence of active esterase 
isoenzymes there was no suggestion, from comparing the IEF profiles of pre-column 
sample with that of the p1-1 5.5 piperazine (MonEst) eluate, that there had been any 
significant loss of MonEst components. 
Individual Q-Sepharose piperazine (pH 5.5) eluates were pooled and dialysed overnight 
at 4°C against 1.0M ammonium sulphate in 50mM phosphate buffer pH 7.0 and, 
following centrifugation to remove protein aggregates, passaged through a 17.5 x 2.5cm 
phenyl-Sepharose column at a flow rate of 4.0m1/min. The unbound protein material, 
which did not contain any esterase isoenzyme forms as defined by IEF, was discarded. 
Following re-attainment of the A280 baseline, desorption of bound proteins was achieved 
by sequential passage of decreasing 0.2M ammonium sulphate steps (i.e. 0.8, 0.6, 0.4, 
0.2 and 0.0M) in 12.5mM succinic acid pH 6.8 containing 0.5mM each of magnesium, 
manganese and calcium chlorides (Affinity Buffer A) at a flow rate of 4.0m1/min. A 
further desorption from phenyl-Sepharose of tightly-bound proteins was then carried out 
with 6M urea in Affinity Buffer A. The eluates from phenyl-Sepharose were then 
dialysed against Affinity buffer A and analysed by IEF for the presence of esterase 
isoenzymes; eluates (see Results Section 4.3.1.1) containing significant concentrations of 
MonEst were then pooled prior to further chromatographic processing. 
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The dialysed MonEst enriched eluate from phenyl-Sepharose was passaged through 20.0 
x 1.6cm Benzamidine-Sepharose 6B, 6.0 x 2.5cm Arginine-Sepharose 4B and 23.0 x 
2.5cm Blue-Sepharose CL-6B columns connected in series at a flow rate of 3.0m1/min. 
The unbound material, containing majority of the MonEst was collected at 40C; proteins 
(including a minor proportion of the total MonEst) binding to this column series were 
eluted with molar NaCI and discarded. Following re-equilibration of these affinity 
columns, the procedure was repeated until no further binding (as adjudged by elution 
profiles monitored by A280) was seen. The unbound material was then dialysed against 
fresh Affinity Buffer A for 4hrs at 250C prior to further processing. 
The dialysed unbound proteins from the Benzamidine/Arginine/Blue-Sepharose column 
series were passaged at a flow rate of 3.0m1/min through 10m1 Protein-A Sepharose CL-
4B and 6m1 Protein-G Sepharose CL-4B columns connected in series. Bound proteins 
were eluted with molar acetic acid and the unbound material was, following re-
equilibration of the columns with Affinity Buffer A, re-passaged until no further binding 
was seen. At this stage, the unbound material was dialysed overnight at 40C against 
Affinity Buffer A containing 0.15M NaC1 (Affinity Buffer B). 
The dialysed unbound proteins from Protein-A/Protein-G were then passaged at a flow 
rate of 1.0m1/min through a sequential series of previously evaluated lectin columns 
comprising Ulex europaeus agglutinin (UEA I), Arachis hypogaea agglutinin (PNA), 
Helix pornatia agglutinin (HPA), Pisum sativton agglutinin (PSA), Vicia tiillosa 
agglutinin lsolectin B4 (VVA B4), Lens culinaris agglutinin (LCA, Pharmacia), Ricinus 
communis agglutinin I (RCA-1), Griffonia sirnplifocia agglutinin II (GSA II) and 
Wheatgerni agglutinin (WGA, Pharmacia). Bound proteins were eluted from this column 
series with a sugar solution comprising a mixture of 200mM methyl a- D 
mannopyranoside, 50mM a-L-fucose, 100mM N-acetyl-D-glucosamine. 20mM N-
acetyl-D-galactosamine and 50mM D-galactose, and the columns were re-equilibrated 
with Affinity Buffer B. The unbound material, containing MonEst, was then re-passaged 
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and the process repeated until no further protein binding was seen. The unbound proteins 
were then passaged through a Concanaralin-A Sepharose column (Con-A) at a flow rate 
of 2.0m1/min. Bound proteins, including virtually all detectable MonEst, were eluted 
with Affinity Buffer B containing 200mM methyl cx-D mannopyranoside. The MonEst-
enriched eluate was then mixed with glycerol to a concentration of 20% (final 
approximate volume 40m1). The unbound material, representing 69% of the total protein 
passaged through Con-A, was discarded. 
The final stage of MonEst purification was achieved by Superose-12 FPLC gel filtration 
chromatography; ten 500111 aliquots of the Con-A eluate were separately chromatographed 
at a flow rate of 0.35m1/min in 50mM phosphate buffer pH 7.0 containing 0.15M NaCl 
and 20% glycerol. Fractions were collected at one minute intervals and assayed for 
acetate and butyrate esterase activity by fluorimetry. Those fractions containing esterase 
activity, from all ten runs, were pooled and concentrated to approximately 0.7m1 with 
Centricon 10 microconcentrators (Amicon) and glycerol added to 50% v/v prior to storage 
at -20°C. 
4.2.1.2 Purification of common myeloid esterase (ComEst) isoenzymes: The starting 
material used for ComEst fractionation was obtained from the leucophoresis of a patient 
with acute myelomonocytic leukaemia (AMML-M4). Cells obtained from this patient, 
which were used for the preliminary evaluations of chromatographic procedures (Chapter 
3) and were shown by IEF analysis to express both ComEst and MonEst esterase 
isoenzymes, were pelletted and stored at -20°C prior to processing. Individual 100 ml 
aliquots (total volume, 400m1) of the cell pellets were disrupted by ultrasonication (MSE 
Soniprep 150) at an amplitude of 181i for one minute; Triton X-100 was added to give a 
final detergent concentration of 1% and, after mixing at 250C for 10 mins and subsequent 
high speed centrifugation, the solubilised protein supernate was recovered from pelletted 
cell debris. The solubilised proteins were then dialysed overnight against 25mM tris-HCI 
buffer pH 8.4 containing 5% betaine (TBB), diluted to 400m1 in the same and centrifuged 
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to remove protein aggregate. The supernatant was then filtered using 1.01.1m 
nitrocellulose membranes (Millipore). This material was then passaged at a flow rate of 
4.0m1/min through a 26.0 x 2.5cm Fast Flow Q-Sepharose anion exchange column 
which had been pre-equilibrated with TBB. Sample loading was monitored at 280nm and 
the unbound protein fraction, containing the main group of non-specific or 'common' 
myeloid (ComEst) esterase isoenzymes (pI range 7.3-7.9), was concentrated by 
ultrafiltration (Amicon) to 500m1. Proteins remaining bound to the gel were desorbed 
with 1M NaC1 and an absence of additional ComEst species confirmed by IEF. The pH 
8.4 Q-Sepharose unbound (ComEst-rich) proteins, from all four original 100m1 aliquots, 
were pooled and extensively dialysed against 25mM morpholino-ethane suiphonic acid 
(MES) pH 6.2. This was then passaged as four individual 500m1 aliquots (total protein, 
2100mg) through a pre-equilibrated Fast Flow S-Sepharose cation exchange column at a 
flow rate of 4.0m1/min. Unbound proteins were collected, concentrated and discarded 
after confirming an absence of ComEst isoenzymes. Preliminary experiments had shown 
that esterase isoenzymes which bound to S-Sepharose could be eluted at relatively low 
NaC1 concentrations. A single-step elution with 0.25M NaC1 was therefore carried out 
and following re-attainment of the A280 baseline, the remaining bound proteins were 
eluted with 1.0M NaCl. Both eluates were concentrated, and IEF isoenzyme analyses 
undertaken to confirm that all the ComEst isoenzymes were confined to the 0.25M NaCI 
fraction. The 0.25M NaCI eluates from the four original 500m1 aliquots were then 
pooled, concentrated to approximately 300m1 and dialysed overnight at 4°C against 
Affinity Buffer A. 
The dialysed material eluted from S-Sepharose was passaged through Benzamidine-
Sepharose and Arginine-Sepharose columns connected in series at a flow rate of 
2.0m1/min. Bound proteins were eluted with molar NaCI and discarded; unbound 
proteins were collected and re-passaged following column re-equilibration. After 
repeating this process until no further protein binding occurred, the unbound material was 
dialysed overnight at 4°C against Affinity Buffer B. 
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The unbound material from the Benzamidine/Arginine-Sepharose columns was then 
passaged at a flow rate of 1.0m1/min through a sequential series of lectin columns 
comprising UEA 1, PNA, HPA, VVA B4, RCA-1, GSA-II, and WGA. The columns 
were re-equilibrated after eluting bound proteins with a sugar solution, as detailed above 
for MonEst purification, and the process repeated until no further binding was seen. The 
unbound material was then passaged through a pre-equilibrated Con-A column at a flow 
rate of 1.0m1/min. The bound material, containing all detectable ComEst isoenzyme 
activity, was desorbed with an eluent comprising 200mM methyl a-D mannopyranoside 
in Affinity Buffer B, and concentrated to 2.0m1. The unbound material was discarded 
after confirming by [EF an absence of ComEst isoenzymes. 
As for MonEst, the final stage of ComEst purification was achieved by Superose-12 
FPLC gel filtration (four 500111 aliquots) of the concentrated Con-A eluate at a flow rate 
of 0.35m1/min. One minute fractions were collected and esterase activities determined by 
fluorimetric assays using 4MB-Ac and 4MB-But as substrates. Fractions showing 
acetate esterase activity were pooled and concentrated to approximately 0.3m1 with 
Centricon 10 microconcentrators. Glycerol was then added to a final concentration of 
50% and this was stored at -20°C prior to further analysis. 
4,2.2 Protein and enzyme activities of purified MonEst and ComEst: 
Protein concentrations of chromatography fractions and purified esterase species were 
determined by the bicinchoninic acid method (Pierce Chemicals), and esterase enzyme 
assays were performed either by UV spectrophotometric (alpha-naphthyl acetate or 
butyrate) or fluorimetric (4-methylumbelliferyl acetate or butyrate; 4MB-Ac, 4MB-But) 
procedures as previously described (Sections 2.3.5.5 and 2.3.6.4). For the UV 
spectrophotometric method, one unit of acetate or butyrate esterase activity was defined as 
the amount of enzyme required to hydrolyse 11.1mo1 of substrate in one minute at 30°C, 
where in a total assay volume of 1.0m1, the enzymatic hydrolysis of 1.0nmol of alpha- 
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naphthyl ester results in an increase in A235 of 0.023 and 0.024 absorbance units 
respectively for alpha-naphthyl acetate and butyrate [Mastropaolo & Yourno, 1981]. 
Purified, post gel filtration, MonEst was also examined with an extensive range of 
peptidase substrates by standard fluorimetric, spectrophotometric, radiometric or 1-1PLC 
techniques (this work was carried out by Professor AJ Turner; Department of 
Biochemistry, University of Leeds). 
4.2.3 Electronhorelic and chromatographic studies:  
42,31 Electrophoretic analyses Of MonEst and ComEst;  
Introduction: 
 Gel electrophoresis in polyacrylamide gels provide rapid and reproducible 
methods for studying the molecular characteristics of proteins. Although the detailed 
theory of gel electrophoresis is complicated, the fundamental concepts are easily 
understood. During electrophoretic separation, charged particles (proteins) migrate under 
the influence of an externally applied electric field toward the electrode of opposite 
polarity, with the degree of mobility (electrophoretic migration) being largely dependent 
on the charge density of the molecule being examined. Electrophoretic migration is 
however, also influenced by interactions between the charged protein and the surrounding 
gel matrix, which acts as a molecular sieve (gradient-PAGE) [reviewed in Garfin, 19901. 
Consequently. proteins are separated during gel electrophoresis on the basis of their net 
charge and additionally their size and conformation. Many electrophoretic systems have 
been developed which variously involve the use of continuous or discontinuous buffer 
systems, but no attempt will be made to summarise these here. This brief introductory 
review will however summarise the essential features of the most important 
electrophoretic techniques in relation to this present study. 
Of the various electrophoretic methods that are available, Native-PAGE is of particular 
value for the characterisation of biologically active molecules as it allows the molecule of 
interest to be demonstrated by its specific activity. Systems designed to separate proteins 
under non-denaturing conditions are unable to distinguish between the differential effects 
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of size, shape, and charge on electrophoretic migration. Consequently, proteins with 
differing molecular size may often be seen to have identical electrophoretic mobilities. 
Thus, while PAGE methods for native proteins are valuable for fractionating protein 
mixtures and for the visualisation of enzymes using specific enzyme stains, they are of 
little value in assessing purity of preparation or the molecular weight of unknown 
proteins. 
In contrast, SDS-PAGE is frequently used for the estimation of molecular weights of 
unknown proteins. This technique additionally provides an excellent means of 
monitoring protein purification and is particularly useful for the assessment of protein 
homogeneity. SDS-PAGE overcomes the limitations of native-PAGE by imposing 
uniform charge characteristics on all proteins in a sample mixture. This anionic detergent 
(SDS) binds to most proteins at an approximate ratio of 1.4:1 and results in negatively 
charged protein-detergent complexes. Furthermore, the interaction with SDS disrupts 
non-covalent protein associations and generally causes proteins to assume uniform 
tertiary configurations. Concomitant treatment with disulphide-reducing agents, such as 
2-mercaptoethanol or dithiothreitol (DTI"), results in the denaturation of covalent bonds 
and consequently the proteins are reduced to their constituent subunits. Migration of SDS 
derivatives is toward the anode at rates inversely proportional to the logarithms of their 
molecular weights. This allows the molecular weight of an SDS-treated protein to be 
estimated from its relative mobility in a calibrated SDS-PAGE gel, and a single band in 
such a gel is often regarded as a useful indication of protein homogeneity. A major 
disadvantage of this technique is that SDS treatment generally results in the denaturation 
of native protein conformation and consequently, proteins often lose biological activity. 
Gradient gels for Native- and SDS-PAGE enhance resolution, sharpen the protein bands 
and allow complex mixtures of proteins, with wide variations in molecular weights, to be 
separated on a single gel. Electrophoresis, using gradient gels, utilises the sieving 
properties of a gel which results from a three-dimensional network of fibres and pores 
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formed by the cross-linking of bisactylamide with adjacent polyacrylamide chains. The 
pore size, as a rule, decreases with increasing acrylamide concentration and the effective 
pore size of the gel governs its sieving properties. 
Native-PAGE analysis: 
 Conventional polyacrylamide gel electrophoresis was carried out 
at pH 8.8 on 8-25% polyacrylamide gradient PHASTgeIs (molecular weight range for 
native proteins of 50 to 750 kDa), using a PHAST electrophoresis system (Pharmacia). 
One microlit•e aliquots of the purified MonEst and ComEst esterase fractions were 
electrophoresed for 268 volt hours (Vhrs) at a constant current of lOmA and the gels were 
subsequently stained for ANAE activity. In addition, the effects of four different 
glycosidases on the relative distribution of MonEst and ComEst charged species was also 
examined. This was achieved by incubating the purified esterase forms, for 20hrs at 
370C, with neuraminidase (Sigma), alpha-mannosidase (Sigma), alpha-L-fucosidase 
(Boehringer) or endoglycosidase-H (Genzyme) at final supplier-recommended 
concentrations of 0.8mU/ml, 66U/ml, 4U/ml and 0.2U/ml respectively, prior to Native-
PAGE analysis. 
SDS-PAGE analysis: SDS-PAGE was canied out at pH 8.6 on 8-25% polyacrylamide 
gradient PHASTgels (molecular weight range for SDS-treated proteins of 6 to 300 kDa). 
10111 aliquots of purified MonEst and ComEst were each incubated with equal volumes of 
20mM tris-HC1 pH 8.6 containing 1.0mM EDTA, 0.01% bromophenol blue and 2.0% 
SDS at 25°C for 5 mins. One tnicrolitre of these SDS-treated samples were 
electrophoresed for 75 Vhrs at a constant current of 10mA, using the PHAST 
electrophoresis system, and the gels were subsequently silver stained for proteins or for 
alpha-naphthyl acetate esterase by standard azo-dye histochernistry. Purified MonEst was 
additionally analysed by reduced SDS-PAGE, following treatment with 5% 2- 
mercaptoethanol, 1% dithiothreitol (DTT), and also subsequent to endoglycosidase-H 
treatment (as described above for Native-PAGE). 
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Isoelectric focusing (1EF): 
 The principles of IEF are fully described in Section 2.1.2. 
Methodologically, the IEF analysis was carried out by fractionation of purified ComEst 
and MonEst on 5% polyacrylamide gels containing 2.4% ampholine (Pharmacia/LKB) 
for 1500 Vhrs (LKB Multiphor 2103) as previously described (Section 2.2.6.1). Plates 
were stained for alpha-naphthyl acetate esterase (ANAE) activity following 
electrophoresis, by standard histochemical procedures (Section 2.2.3.4), and the 
isoelectric points (pl) of individual isoenzyme components determined by reference to the 
pH gradient measured using a surface pH electrode. The effect of neuraminidase 
treatment on the relative distribution of MonEst and ComEst charge species was also 
examined by IEF. In order to achieve this, 200;11 of the purified esterase species were 
incubated for 20hrs at 37°C with 0.8mU/m1 of Vibrio cholera neuraminidase (Sigma). 
Following this, the samples were re-analysed by IEF to determine whether or not 
neuraminidase treatment induced any changes in the observed pI of the individual esterase 
isoenzyme species. 
4.2.32 Chromatographic analyses of MonEst and ComEst:  
Gel filtration chromatography: The relative molecular weights (Mr) of purified MonEst 
and ComEst species were assessed with a 30 x 1.0cm Superose-12 high-resolution FPLC 
analytical gel filtration column. Chromatographic separation was achieved by the passage 
of 501.1I aliquots of each species, at an optimised flow rate of 0.35m1/min, through the gel 
filtration column, pre-equilibrated with 50mM phosphate buffer pH 6.8 containing 0.15M 
NaC1 and 20% glycerol. Apparent molecular weights of the esterase species were 
estimated by comparison with a standard curve constructed from the Ve/Vo (elution 
volume/column void volume) versus the log molecular weights of protein standards. 
Further investigations of MonEst were also undertaken to determine the possible 
existence of subunits and, if present, to assess the nature (electrostatic or hydrophobic) of 
this subunit association. In order to achieve this, purified MonEst was pre-incubated (30 
mins at 25°C) and chromatographed in the presence of four different reagents (5M urea, 
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4M guanidine hydrochloride, 1% Triton X-100 and 1% SDS), all of which promote 
subunit dissociation. Chromatography was carried out under identical column 
conditions, one minute (0.35m1) fractions were collected and esterase activities 
determined by fluorimetric assays using 4MB-Ac and 4MB-But as substrates. 
Concanavajin A (Con-A) affinity chromatography: 
 As described previously (Section 
3.4), the lectin binding of MonEst isoenzymes was restricted to Con-A, in contrast to 
ComEst which additionally showed some affinity for LCA and PSA. Further clarification 
of the mechanisms of lectin binding was obtained by analysing the purified (post Con-A 
eluates; Section 4.3.1) MonEst and ComEst enzymes. This was carried out by dialysing 
40411 of MonEst or ComEst (stored at -20°C in 20% glycerol) for three hours against 
lectin binding buffer (12mM succinic acid pH 6.9, containing 0.15M sodium chloride and 
0.5mM each of calcium, magnesium and manganese chlorides). Following dialysis. 
2001.11 aliquots of each esterase species were taken into glass vials with 25111 of 
endoglycosidase H (endo H, Genzyme; 400U/ml) or 2411 of buffer (control). These 
vials were then sealed and incubated at 37°C for 20hrs. Following incubation the 
samples were diluted to 1.5ml with the lectin binding buffer and in turn, the endo H 
treated and untreated (control) esterase samples were passaged through a 2m1 pre- 
equilibrated Con-A column at 1.0m1/min. For each sample, the unbound fraction was 
collected and the bound protein eluted with 200mM methyl alpha-D mannopyranoside. 
The volumes of both unbound and bound fractions were measured and their acetate 
and/or butyrate esterase activities determined by fluorimetric assay (Section 2.3.6.4). 
Following this, the remaining samples were reduced in volume to 100111 with Centricon 
10 microconcentrators (Amicon) and then analysed by IEF. 
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4.2.4 	 Kinetic studies:  
4.2.4,1 Influence of pH on MonEst and ComEst activities:  As part of the assay 
standardisation, preliminary analyses were undertaken to determine the relationships 
between pH and reaction rates. This was carried out by standardised UV 
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spectrophotometric assays (Section 2.3.5.5) in 10mM buffers at 0.5 pH unit intervals 
through the range 4.0-9.0 (lactic acid, pH 4.0 and 4.5; piperazine, pH 5.0; MES, pH 
5.5-6.5; phosphate, pH 7.0 and 7.5; and tris, pH 8.0 and 9.0). The initial rates of 
hydrolysis of alpha-naphthyl acetate or butyrate, were determined at a constant substrate 
concentration of 0.3mM, over the pH range examined. Immediately prior to assay, the 
concentrations of purified MonEst and ComEst esterase preparations were adjusted to a 
level which ensured linear rates of enzyme hydrolysis with 0.3mM substrates over a two 
minute period; in practice, this was equivalent to an approximate maximum mean rate of 
change in absorbance at 235nm (A235)  of 0.40/min. 1041 of esterase fraction was then 
added to 1.0m1 of pre-warmed (300C) substrate solution in a semimicro quartz cuvette, 
the contents were mixed and the rate of increase in A235 measured at 12 second intervals 
over a period of 2.0 min (Pye Unicam 8800 UV/VIS spectrophotometer). 
4.2.4.2 MonEst and ComEst enzyme kinetics: Relationships between rates of hydrolysis 
and substrate concentrations were determined for both the MonEst and ComEst myeloid 
isoenzyme species by standardised UV spectrophotometric assays (Section 2.3.5.5). The 
initial rates of hydrolysis of each ester of alpha-naphthol studied (acetate, propionate and 
butyrate; Sigma) were determined at various substrate concentrations within the range 
0.0125mM to 0.60mM. These were prepared by diluting stock 25mM substrate solutions 
(in 2-methoxyethanol; Sigma) with 10mM MES pH 6.3. Immediately prior to assay, the 
concentrations of purified MonEst and ComEst were adjusted as described above (Section 
4.2.4.1) and 10111 of each fraction was then added to 1.0m1 of pre-warmed (300C) 
substrate solution in a semimicro quartz cuvette; the contents were rapidly mixed and the 
rate of increase in A235 measured at 12 second intervals over a period of 2.0 min. The 
specific enzymatic turnover rates, at each substrate concentration studied, were corrected 
for the observed rates of change from spontaneous substrate hydrolysis (in the absence of 
enzyme). Lineweaver-Burk plots of 1/initial reaction velocity (1/v) against I/substrate 
concentration (1/[s[) and Eadie-Hofstee plots of v against v/[s] were constructed and used 
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to estimate Vmax  and Km 
 values for the hydrolysis of acetate, propionate and butyrate 
substrates individually by both MonEst and ComEst species. 
4.2.4.3 MonEst and ComEst inhibitor studies. 
 The nature of enzyme-substrate 
interactions, and the possibility that ComEst and MonEst esterase species differed in their 
reaction mechanisms, was initially evaluated by incorporating a range of enzyme 
inhibitors in the standardised alpha-naphthyl acetate UV spectrophotometric assay 
(Section 2.3.5.5). 14.1 aliquots of chromatographically purified ComEst and MonEst 
fractions (adjusted as described in Section 4.2.4.1) were pre-incubated for 5 mins at 
300C, in semimicro glass cuvettes, with 1.0m1 of 10mM morpholino-ethane sulphonic 
acid (MES) pH 6,3 containing pre-defined concentrations of various inhibitors (detailed 
in Results Section 4.3.4.4). At this time, the enzyme reactions were initiated by the 
addition of (10g1) 50mM stock alpha-naphthyl acetate substrate (in 2-methoxyethanol), to 
give final working concentration of 0.5mM. After mixing, the rate of increase in 
absorption at 235nm (A235) was measured at 12 second intervals over a period of 2.0 
min_ Enzyme reaction rates, both in the presence and absence of inhibitor, were corrected 
for spontaneous substrate hydrolysis and the results expressed as: 
Reaction rate (A235/min) in the presence of inhibitor 
Reaction rate (A235/min) in the absence of inhibitor 
The type of inhibitory action (reversible or irreversible) exerted was further investigated 
by gel filtration and/or isoelectric focusing (IEF) for those compounds causing significant 
decrease in ComEst and/or MonEst activity. This involved pre-incubation of MonEst and 
ComEst with inhibitor followed by (a) passage through an FPLC Superose-12 gel 
filtration column (Pharmacia) and fluorimetric esterase assay of eluted components, or (b) 
IEF electrophoresis and subsequent histochemical (alpha-naphthyl acetate esterase) 
staining of gels. Reversible inhibition was indicated by regeneration of enzymatic activity 
following chromatographic or electrophoretic separation and irreversible inhibition by 
irrecoverable loss of enzymatic activity. 
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42.44 MonEst and ComEst inhibition kinetics: 
 Sodium fluoride (NaF) is commonly 
incorporated in histochemical staining procedures for the delineation of monocytic 
esterases. However, the inhibition of monocyte-associated esterase (MonEst) by this 
compound appears to be, compared to ComEst, relative rather than specific [Drexler et 
al., 1991a; Chapter 2 of this study]. Additionally, although the inhibition of esterases by 
NaF is extensively documented, the mechanisms of esterase inactivation remain 
unknown. In order to further investigate this, the effect of NaF (as well as 
phenylmethylsulphonyl fluoride, PMSF; and diethyl pyrocarbonate, DEPC) on enzyme 
reaction rates was analysed; studies which were primarily designed to compare their 
inhibitory actions (competitive, non-competitive, uncompetitive, irreversible etc) on the 
ComEst and MonEst species. In practical terms, the inhibition constants (KO for both 
myeloid esterase species could be determined by measuring the effect of increasing the 
inhibitor concentration on substrate hydrolysis, at different substrate concentrations. 
Experimentally this was achieved by pre-incubating 1041 of ComEst (or MonEst) fraction 
(adjusted as described in Section 4.2.4.1) with 1.0m1 of 10mM MES pH 6.3 containing 
differing concentrations of NaF, PMSF or DEPC in a semimicro quartz cuvette for 5 
mins at 300C. At this time 4, 8, 12 or 161.11 of stock 25mM alpha-naphthyl acetate 
solution (in 2-methoxyethanol) were added to the cuvette contents (final substrate 
concentrations, 0.1 to 0.4mM) and the rate of increase in absorption at 235nm (A235) 
measured at 12 second intervals over a two minute period. At each inhibitor 
concentration studied, a Lineweaver-Burk plot of 1/initial reaction velocity (1/v) against 
1/substrate concentration (Ws]) was constructed and the maximum velocity in the 
presence of inhibitor (Vmax') estimated. Secondary plots of the reciprocal Vmax' values 
(1/Vmax'), at the different inhibitor concentrations examined, against inhibitor 
concentration were constructed for each inhibitor and the inhibition constant Ki 
determined. In this present study, the NaF inhibitor concentrations examined ranged 
from 0.0 to 1.0mM; PMSF concentrations (prepared immediately prior to assay from 
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stock PMSF solutions in 2-isopropanol) ranged from 0.0 to 0.2mM: and DEPC 
concentrations from 0.0 to 0.1mM. 
4.23 N-terminal amino add sequencing: A 100p1 sample (at a concentration of 
0.5ing/m1) of purified MonEst was diluted 1:2 with 0.2M 4-methylmorpholine/0.1% SDS 
and dried in 50p.I aliquots onto a Sequelon-diisothiocyanate membrane disc at 56°C. The 
disc was washed in 1ml water. redried and the diisothiocyanate-coupled polypeptide then 
subjected to automated solid-phase Edman degradation on a MilliGen/Biosearch 6600 
ProSequencer (this work was carried out by Dr J. Keen, Department of Biochemistry, 
University of Leeds). 
4.3 RESULTS  
4.3.1 Column performance characteristics:  
4.3.1.1 MonEst fractionation: The first part of this fractionation involved the use of a 
Q-Sepharose anion exchanger at pH 8.4 and was designed to remove the maximum 
amount of non-esterase protein with the minimum loss of MonEst. As the use of NaC1 
gradients from 0.0 to 1.0M did not appear to offer significant advantages in terms of 
specific MonEst resolution, a series of pH step elutions were used. Protein estimations 
and IEF analyses of esterase isoenzyme components for the different eluates showed that 
the Q-Sepharose unbound, bis-tris (pH 6.3), piperazine (pH 5.5) and molar NaC1 
fractions represented 22.3%. 8.7%, 17.2% and 17.0% of the total applied (26125mg) 
protein respectively (Figure 4.1 and Table 4.2a): esterase isoenzyme (IEF) studies of 
these same fractions confirmed that all detectable MonEst was restricted to the piperazine 
eluate. Subsequent fractionation of this eluate by phenyl-Sepharose hydrophobic 
interaction chromatography showed that most of the MonEst activity was associated with 
the 0.2M/0.0M ammonium sulphate and 6M urea eluates and that together, these 
comprised 2.8% of the starting protein and 20.1% of the original acetate esterase activity. 
Subsequent processing of the pooled MonEst-rich phenyl-Sepharose eluates through the 
series of Benzamidine, Arginine and Blue-Sepharose columns similarly showed that 
136 
virtually all of the MonEst remained unbound, and passage of this through Protein-A and 
Protein-G columns removed a further 59% of protein (predominantly lgG). The 
following series of nine lectin columns removed an additional 25% of the remaining 
protein, with no significant loss of MonEst activity, and the Con-A column used to 
concentrate the MonEst component prior to gel filtration chromatography resulted in the 
removal of a further 69% of contaminating protein and 44% of acetate esterase activity 
that was not associated with MonEst as adjudged by IEF analysis. Prior to the final stage 
of FPLC gel filtration, the Con-A eluate containing high concentrations of MonEst 
represented 0.2% of the starting solubilised extract protein and 2.1% of the original 
acetate esterase activity. With this final chromatographic procedure, a single peak of 
esterase activity was identified which was collected and stored at -200C in 50% glycerol 
prior to further analysis (elution characteristics of FPLC gel filtration are further detailed 
in Section 4.3.3.2). 
4.3.1.2 ComEst fractionation: The starting material for ComEst fractionation consisted 
of an ultrasonicated detergent extract of leukaemic blasts from a patient with 
myelomonocytic leukaemia (AMML-M4), known to express high concentrations of both 
ComEst and MonEst enzyme forms. Following centrifugation and dialysis, the total 
amount of starting protein passaged (as four separate aliquots) through the Q-Sepharose 
anion exchanger at pH 8.4 was 8107mg. The unbound material from the pH 8.4 Q-
Sepharose anion exchanger, which constituted 26% of the starting protein (Figure 4.2 
and Table 4.2b) and contained majority of the extract ComEst, was pooled from all four 
original aliquots and extensively dialysed against 25mM morpholino-ethane sulphonic 
acid (MES) pH 6.2. A further 44% of the starting protein was desorbed from the anion 
exchanger with 1M NaCI and shown by IEF analysis to lack ComEst isoenzymes (but did 
contain the MonEst species), with the remaining tightly bound proteins being eluted with 
2M NaOH (the observed concentration of ComEst isoenzymes obtained in the unbound 
fraction tended to exclude the possibility that this latter fraction contained significant 
amounts of this species). The dialysed unbound material was then passaged in MES 
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through a S-Sepharose cation exchange column at pH 6.2. Step elutions of bound 
proteins and IEF analysis showed that all detectable ComEst was associated with the 
0.25M NaCI eluate whereas the 1.0M NaC1 and unbound S-Sepharose fractions, 
representing 1.5% and 20% of starting protein respectively, had no ComEst activity and 
were discarded. Subsequent passage of this 0.25M NaCI eluate through 
Benzamidine/Arginine columns removed a further 8.4% of protein with little loss of 
acetate esterase activity. The protein concentration of the unbound material from the 
Benzamidine/Arginine columns was reduced by a further 52% by passage through a 
series of seven lectin columns, and the final pre-gel filtration binding of ComEst to Con-
A reduced the level of contaminating proteins by a further 91%. Prior to the final stage of 
FPLC gel filtration, the Con-A eluate protein represented 0.11% of the original raw 
extract protein and 4.1% of the starting acetate esterase activity. With this final 
chromatographic procedure, a single peak of esterase activity was identified which was 
collected and stored at -200C in 50% glycerol prior to further analysis (elution 
characteristics of FPLC gel filtration are further detailed in Section 4.3.3.2). 
4.3.2 Protein and enzyme activities of _purified MonEst and ComEst:  
Further purification and characterisation of ComEst and MonEst species (eluted from 
Con-A Sepharose) by Superose-12 FPLC gel filtration revealed significant differences in 
their apparent molecular weights (Mr). The purified MonEst eluted from the gel filtration 
column as a single species with a higher Mr than the ComEst which also eluted as a single 
Mr form (the Mr values and further differences in molecular characteristics between these 
two species are examined in Section 4.3.3.2). With respect to the MonEst eluted from 
Con-A, the additional gel filtration step did not, because of its relative homogeneity, 
result in any further significant purification apart from the removal of a minor proportion 
of low Mr contaminants. However, the 9mg of Con-A enriched ComEst, when passaged 
through the Superose-12 gel filtration column, was further purified by the removal of 
approximately 85% of contaminating proteins. The protein concentrations of the final 
CornEst and MonEst fractions were 1.29mg/rn1 and 1.04mg/m1 respectively, and UV 
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spectrophotometric esterase assays revealed distinct differences in substrate affinities 
between the two esterase forms. The ComEst species showed a marked preference 
(>40:1) for alpha-naphthyl acetate substrate hydrolysis (1.21U/ml, see Section 4.2.2 for 
enzyme Unit definitions), compared to alpha-naphthyl butyrate (0.03U/m1). In contrast. 
MonEst showed similar rates of butyrate (2.46U/ml) and acetate (2.74U/m1) hydrolysis 
although, at the substrate concentration (0.5mM) used in the assay, there is evidence that 
apparent butyrate esterase activities may be underestimates (Section 4.3.4.2). i.e. alpha-
naphthyl butyrate appears to inhibit esterase activity at concentrations exceeding 0.4mM. 
Additional studies demonstrated that purified MonEst did not show peptidase activity and 
was incapable of hydrolysing a series of aminopeptidase, angiotensin converting enzyme, 
carboxypeptidase, dipeptidylpeptidase, endopeptidase, microsomal dipeptidase, or 
glutamyltransferase substrates (Table 4.3). 
4.3.3 Electrophorelic and chromatouraohie studies 
4.33.1 Electrophoretic analyses of MonEst and ComEst:  
Native-PAGE electrophoresis: Native-PAGE analyses revealed four different charge 
forms for both MonEst and ComEst: MonEst comprised one major charge species and 
three additional minor species with greater anodic migration, and ComEst comprised four 
main individual charge species with a pattern of migration distinct from that of MonEst 
(Figures 4.3a & 4.3b). As FPLC gel filtration (Section 4.3.2) revealed only one Mr form 
for each species. it is concluded that under the electrophoretic conditions used in this 
particular study (0.88M L-alanine and 0.25M tris at pH of 8.8) that MonEst and ComEst 
components both migrated as charge species rather than Mr forms. Indeed, because of 
their relative pis, it was predicted and confirmed that anodic migration of the MonEst 
species would be greater than the ComEst forms. 
Additional studies, undertaken to assess whether the various charge isoforms of the 
MonEst resulted from differential post-translational glycosylation, revealed that the 
treatment of MonEst with a-mannosidase, a-L-fucosidase or endoglycosidase-H had no 
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effect on either the apparent enzymatic activity or the relative distribution of the individual 
charge isoforms (Figure 4.4). These studies were not possible for the ComEst because 
of presence of protein contaminants in this preparation and also due to limited sample 
availability. 
SDS-PAGE electrophoresis: 
 SDS-PAGE followed by silver (protein) staining, 
confirmed that MonEst had been purified to homogeneity and migrated as a single protein 
band with an apparent molecular weight of 63 kDa, under both reducing and non- 
= 	
reducing conditions (Figures 4.5a and 4.5b). Attempts to histochemical stain this band 
for alpha-naphthyl acetate/butyrate esterase failed. This observation indicates that SDS 
has a denaturing effect on MonEst activity, either because of the protein-SDS association 
or possibly as a result of subunit dissociation. Additional studies also showed that the 
treatment of purified MonEst with endoglycosidase-H resulted in its deglycosylation and 
the generation of a protein band with a lower Mr of 60.1 kDa (Figure 4.5b). 
For comparison, silver staining of the purified ComEst species revealed a small number 
of contaminating proteins and, consequently, it was not possible to directly determine its 
molecular weight by this method. However in contrast to MonEst, SDS had no apparent 
effect on ComEst enzymatic activity and, because this myeloid esterase species also 
migrated in the presence of SDS as a single band (Figure 4.5a), it was possible to 
estimate its apparent molecular weight (68 kDa) following ANAE staining. 
An additional finding of interest (discussed in Section 4.3.4.4) was that treatment of 
ComEst with SDS (i.e. generating SDS-ComEst complexes) could be reversed by gel 
filtration, as adjudged by the regeneration of the four active charge isoforms (Native-
PAGE), whereas this could not be demonstrated for SDS-treated MonEst, which 
remained enzymatically inactive following gel filtration. 
isoelectric focusing (IEF):  Analysis of ComEst and MonEst species by IEF 
demonstrated that the chromatographic purification procedures employed in this study had 
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successfully resolved the two enzyme groups and that the pl distribution of individual 
isoforms had not been affected by the fractionation techniques (Figure 4.6). Alpha-
naphthyl acetate esterase (ANAE) histochemical staining of IEF plates revealed no 
significant cross-contamination of the two esterase groups, and MonEst was confirmed as 
representing a series of isoenzymes within a narrow p1 range of 5.5-6.2, compared to the 
ComEst species which comprised four main isoenzymes within the pl range 7.3-7.9. 
Staining of IEF plates with alpha-naphthyl butyrate showed that MonEst, but not 
ComEst, hydrolysed this substrate, although its staining intensity was significantly less 
than that seen with alpha-naphthyl acetate. Further studies were also undertaken to 
ascertain whether the individual isoenzymes of ComEst and MonEst resulted from post-
translational differences in glycosidic structures of these species. However, these 
experiments revealed no effect on the observed pis of ComEst isoforms following 
neurarninidase treatment (Figure 4.7). or on the distribution of MonEst isoenzymes 
following a-mannosidase, a-L-fucosidase or endoglycosidase-H treatment (Figure 4.4). 
433.2 Chromatographic analyses MonEst and ComEst:  
Gel filtration chromatoyraphy: The relative molecular weights (Mr) of the native MonEst 
and ComEst enzyme species were examined using an analytical gel filtration (Superose-
12) column. Chromatographic separation was achieved by the repassage of 5041 aliquots 
of each purified species, at an optimised flow rate of 0.35m1/min, through the gel 
filtration column pre-equilibrated with 50mM phosphate buffer pH 6.8 containing 0.15M 
NaCI and 20% glycerol. Estimation of the Mr was achieved by comparison of elution 
volumes (Ve/Vo) of esterase species with a molecular weight curve obtained by 
chromatography of standard proteins under identical conditions. ComEst myeloid 
esterase isoforms eluted as a single molecular weight species with an approximate Mr of 
53.2 kDa (Figure 4.8 a); fluorimetric assays further indicating that substrate hydrolysis of 
4MB-Ac by ComEst esterases was considerably in excess of 4MB-But. For comparison, 
MonEst eluted with a higher Mr of 157.0 kDa (Figure 4.8 b) and hydrolysed 4MB-But at 
approximately 1.9 times the rate of 4MB-Ac. Further studies. undertaken to assess the 
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nature of subunit association of the MonEst enzyme, revealed that gel filtration in the 
presence of 5M urea and 1% Triton X-100 had no effect on the Ve of MonEst or on its 
enzymic activity, and that MonEst activity was completely absent when gel filtration was 
carried out in the presence of 4M guanidine hydrochloride (Figure 4.8 c) or 1% SDS 
(Section 4.3.4.4). 
Concanavalin A (Con-A) affinity chromatograpkv: As described previously (Chapter 3, 
Section 3.4), the lectin binding of monocyte-specific MonEst isoenzymes was restricted 
to Con-A whereas the ComEst species showed some affinity for LCA and PSA in 
addition to Con-A. The mechanisms of Con-A binding were investigated for purified 
MonEst and partially purified ComEst subsequent to endoglycosidase H (endo H) 
treatment. Fluorimetric (acetate and butyrate) esterase assays of untreated (control) 
MonEst and ComEst species showed that >90% of the total activity was bound to and 
eluted from Con-A. However, following endo H treatment, the proportion of total 
MonEst activity binding to Con-A was significantly reduced to 25% whereas. in marked 
contrast, the binding of ComEst to Con-A was not affected by endo H treatment. A more 
definitive and specific analysis for the presence of MonEst and ComEst in the endo H 
treated and untreated fractions was obtained by IEF which conclusively demonstrated 
(Figure 4.9) that the treatment of MonEst with endo H abolished its binding to Con-A, 
but had no influence on ComEst binding. These particular observations substantiate the 
earlier interpretation (Chapter 3, Section 3.4.3.4) of lectin-binding studies of 
unfractionated myeloid esterases, with respect to their glycan structures, and indicate the 
presence of N-glycosidically linked oligomannosidic-type glycan(s) for MonEst and a 
mixture of (80-90%) biantennary N-acetyllactosamine-type (complex-type) asparagine-
linked glycan(s) and ot-1,6-fucosylated biantennary N-acetyllactosamine-type glycan(s) 
for the ComEst species. 
1 42 
4.3.4 Kinetic studiesz 
4 3.4.1 ',Whence of pH on MonEst and ComEst activities: 
 Preliminary studies to 
examine relationships between pH and substrate hydrolysis rates by purified ComEst and 
MonEst showed (Figure 4.10) that both esterase species hydrolysed alpha-naphthyl 
acetate with only marginal differences through a pH range of 5.5-7.5 and that the 
observed increases in reaction rates above this pH were insignificant. Hydrolysis of 
alpha-naphthyl butyrate by the MonEst species (ComEst caused no detectable hydrolysis 
of this substrate) showed marginal differences in the reaction rates within the pH range 
6.0-7.0 but, because of a marked increase in spontaneous substrate breakdown above pH 
7.0, further analysis at higher pH was not possible. The UV spectrophotometric esterase 
assay used in this study, which measures the generation of alpha-naphthol at 235nm, was 
originally standardised in morpholino-ethane sulphonic acid (MES) at pH 6.3. As the 
histochemical demonstration of ComEst and MonEst are also typically carried out at an 
acidic pH. and in order to standardise the pH for both acetate and butyrate substrates, a 
pH of 6.3 was used for all the kinetic analyses in this present study. 
4.3.4.2 Enume Icirwtic studies: Initial IEF studies of unfractionated myeloid esterases, 
and subsequent histochemical staining with alpha-naphthyl acetate, propionate or butyrate 
(Chapter 2, Section 2.3.4.6) indicated that the ComEst species were primarily acetate 
specific, in contrast to MonEst isoenzymes which could hydrolyse all three substrates, 
albeit with apparent decreasing staining intensities with increasing acyl chain length 
(Figure 4.11). In order to further substantiate these observations, the hydrolysis of 
acetate, propionate and butyrate esters of alpha-naphthol was determined by quantitative 
UV spectrophotometric assays, for both purified MonEst and ComEst myeloid isoenzyme 
species. The initial reaction rates were determined for all three substrates at differing 
concentrations (Figure 4.12) and Vmax and Km values were calculated by constructing 
Lineweaver-Burk (1/v against 1/1s1) and Eadie-Hofstee (v against v/Isl) plots. These 
analyses clearly demonstrate that the ComEst species preferentially hydrolysed alpha-
naphthyl acetate. showed minimal hydrolysis of the propionate ester and no significant 
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hydrolysis of the butyrate ester (Figures 4.12 and 4.13). In contrast, the kinetic results 
for the MonEst isoenzyme species differed considerably in that esters of higher acyl chain 
lengths (butyrate > propionate > acetate) were preferentially hydrolysed (Figures 4.12 
and 4.14). An additional observation of some relevance to histochemical practice was 
that the kinetic characterisation of MonEst provides some evidence that the butyrate 
substrate caused reaction inhibition at concentrations exceeding 0.4mM (Figure 4.15). 
Examination of the Vmax and Km values for each group of esterase isoenzymes (Table 
4.4) suggest that although ComEst have similar affinities for acetate and propionate 
substrates, the turnover rate for the propionate substrate is considerably lower. In 
addition, as the turnover rate of ComEst for alpha-naphthyl butyrate was below the limit 
of accurate detection, these results are completely in accord with the preliminary 
observations for histochemical staining of esterases fractionated by IEF (Section 
2.3.4.6). For comparison, examination of the data for the MonEst species revealed 
decreasing Km values with increasing acyl chain length, suggesting a considerably higher 
binding affinity of these isoenzymes for the butyrate substrate. Furthermore, the Vmax 
values for the hydrolysis of these substrate esters by MonEst indicated an increasing rate 
of catalysis with increasing acyl chain length. These observations therefore indicate that 
(a) the binding site of MonEst enzyme recognises butyrate and propionate acyl groups 
more readily than the acetate group, and (b) that the catalytic mechanism of MonEst 
hydrolyses the butyrate substrate with greater efficiency than propionate and acetate 
esters. 
4.3.4.3 En:yrne kinetics of degIvcosylated MonEst:  Studies to determine the effect of 
endo H treatment on the hydrolysis of alpha-naphthyl acetate (ANA) by MonEst, showed 
(Figure 4.16) that the deglycosylated form of this esterase species had a higher affinity 
for ANA (Km = 0.08mM) than the untreated control (Km = 0.16mM) and that the 
substrate turnover rates did not appear to be significantly different (Vmax deglycosylated, 
0.17A135/rnin; control, 0.22A235/min). These findings suggest that the glycan structure 
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of MonEst may be closely associated, in the native tertiary/quaternary conformation, with 
the substrate binding site. However, it is noted that this observation may only be 
validated by detailed conformational studies, which were not undertaken in this current 
study. 
4.3.4.4 nzy.nie inhibitor studies: 
 This study additionally examined the effects of a 
wide range of enzyme inhibitors on the purified ComEst and MonEst esterases. To allow 
a direct comparison of the effects of the various inhibitors on these two esterase species, 
the substrate used throughout these analyses was alpha-naphthyl acetate. The inhibitors 
examined, their concentrations and effects are summarised in Table 4_5 and, based upon 
arbitrary definitions of significant and partial inhibition as <50% and 50-80% of control 
(no inhibitor) activity respectively, only two compounds (1% SDS; and 1.0mM diethyl 
pyrocarbonate; DEPC) exerted significant inhibitory effects on both ComEst and MonEst. 
Phenylmethylsulphonyl fluoride (PMSF, 0.2mM), 3-4, dichloroisocoumarin (DCIC, 5.0 
x 10-3mM), and N-tosyl-L-phenylalanine chloromethyl ketone (TPCK, 0.1mM) inhibited 
MonEst but not ComEst; sodium fluoride (NaF, 1.0mM) was shown to significantly 
inhibit MonEst while partially inhibiting ComEst; and iodoacetamide (2.0mM) induced 
partial inhibition of ComEst but not MonEst. All the other inhibitors examined failed to 
cause any significant inhibitory effects on either of the esterase isoenzyme species. 
Chromatographic and electrophoretic (IEF) studies, which were undertaken to investigate 
the mechanisms of inhibition, revealed that higher concentrations of PMSF (5.0mM) and 
DCIC (0.05mM) irreversibly inhibited MonEst isoenzyme activity whilst showing no 
significant inhibition of ComEst forms (Table 4.6). For comparison, 20mM NaF 
inhibited both esterase species in a reversible manner, in that ComEst and MonEst 
activities were restored following electrophoretic or chromatographic separation. A 
further finding of note was that 1% SDS, which inhibited both ComEst and MonEst 
isoenzyme activities in the UV spectrophotometric assay. was shown to inhibit ComEst in 
a reversible fashion whereas, in distinct contrast, SDS treatment of MonEst isoenzymes 
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resulted in irreversible inhibition. Finally, DEPC was shown to reversibly inhibit both 
ComEst and MonEst species, compared to TPCK which inhibited MonEst irreversibly 
with little significant effect on ComEst activity. 
4.3.4.5 Inhibition kinetics: 
 A series of kinetic studies were undertaken in order to 
further characterise the mechanisms involved in the inhibition of ComEst and MonEst 
isoenzyme species by NaF, PMSF and DEPC. The type of inhibition (competitive, 
uncompetitive, noncompetitive, or mixed) exerted by these three compounds was 
assessed by investigating the effects of varying the inhibitor concentration on Km and/or 
Vmax values for substrate hydrolysis, and their inhibition constants were determined by 
constructing secondary plots of altered Vmax values against the inhibitor concentration. 
Lineweaver-Burk plots of 1/v against 1/[s] for the inhibition of ComEst and MonEst 
isoenzymes by NaF clearly showed that both esterase species were inhibited in a 
noncompetitive manner (Figures 4.17 and 4.18). Furthermore, the K1 values calculated 
for NaF inhibition of purified myeloid esterases, indicated that the MonEst isoenzymes 
were approximately 130 times more sensitive to NaF inhibition than the ComEst (Table 
4.7). Similarly, the reversible inhibition of esterase species by DEPC was shown to be 
noncompetitive for ComEst and MonEst (Figures 4.19 and 4.20) although, in contrast to 
NaF, the K1 values for both species were found to be similar (Table 4.7). For 
comparison, PMSF which was shown by electrophoretic analyses to irreversibly inhibit 
MonEst isoenzymes at high concentration (5.0mM), appeared to show 'mixed 
competitive-noncompetitive' inhibition at lower concentrations (Figure 4.21). 
Determination of the inhibition constants for the mixed competitive/noncompetitive 
revealed that the value of competitive inhibition constant (Ki = 0.11mM) was identical to 
the observed affinity (Km) of MonEst species for alpha-naphthyl propionate (Table 4.4) 
and that the Ki (noncompetitive inhibition) value of 0.01mM was identical to that found 
for NaF inhibition of MonEst (Table 4.7). Consequently, it is concluded that the binding 
site of MonEst 'recognises' alpha-naphthyl propionate and PMSF with similar affinities 
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and that the reversible noncompetitive inhibition, which is apparent at lower PMSF 
concentrations, is likely to result from interactions between the MonEst active site and the 
fluoride ion of PMSF. 
4.3,5 N-tcrininal amino acid sequencing:  
The N-terminal amino acid sequence of purified MonEst is shown in Table 4.8. 
Approximately one half of the protein was found to start with histidine (residue 2 in 
sequence), giving rise to an overlapping sequence of residues. This did not however 
present any difficulties in elucidating the sequence, and this heterogeneity would have had 
no effect on pl or other characteristics employed in the purification of the protein in this 
study. Although it is not possible to comment on whether the missing glycine residue is 
an artefact of isolation, or due to variable processing of the signal sequence, but it is 
interesting to note that rat and rabbit liver esterases also start at the histidine residue. 
The average repetitive sequencing yield was 93% and the theoretical initial sequencing 
yield was calculated to be approximately 150pmol. This value for the amount of protein 
sequencing at the start of the run confirmed that the major component of the sample was 
being sequenced rather than a minor contaminant. The amount of protein used for 
attachment to the sequencing disc (501.11, 800pmol) would more than saturate the binding 
capacity of the membrane (200-300pmol), thus the 150pmol sequencing represents about 
one half of the material attached to the disc, a figure normally encountered in sequence 
analysis. 
The observed amino acid sequence shows a high degree of sequence identity to the 
recently described human alveolar macrophage esterase [Munger et 	 19911 and differs 
only in a Val 	 Thr substitution at position 12. It is of some interest that rat liver 
esterase shows the same substitution whereas rabbit liver tnicrosomal esterase shows the 
same Thr as human MonEst. Furthermore, when compared to the two non-human 
esterase N-terminal sequences, human MonEst and alveolar macrophage esterase both 
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show His substituting for Lys at position 13; and Ile instead of Val at positions 32 and 
36. 
4.4 DISCUSSION  
The diversity of esterases from various tissues and the lack of specific differentiating 
characteristics has led to considerable confusion regarding their biochemical 
classification. Categorisation of enzymes with esterolytic activity have traditionally been 
based, in the absence of knowledge of physiological substrate, on criteria such as 
substrate specificities and inhibitor sensitivities. Histochemically and cytochemically 
important esterases. belonging to the carboxylic ester hydrolyse (EC 3.1.1) group, 
include carboxylesterases (EC 3.1.1.1), arylesterases (EC 3.1.1_2), acetylesterases (EC 
3.1.1.6). acetylcholinesterases (EC 3.1.1.7) and cholinesterases (EC 3.1.1.8). 
Carboxylesterases represent esterolytic enzymes which hydrolyse carboxylic esters and 
are inhibited by organophosphates (e.g. di-isopropyl fluorophosphate; DFP) but not 
eserine [Holmes & Masters, 1967; Krisch, 1971]. Arylesterases are defined on the basis 
of their primary reactivity with aromatic esters, their relative sensitivity to sulphydryl 
reagents (e.g. p-hydroxymercuribenzoic acid; HMBA), and their resistance to 
organophosphates [Holmes & Masters, 1967]. Acetylesterases show restricted reactivity 
with esters of acetic acid and are not inhibited by organophosphates, sulphydryl reagents 
or eserine [Holmes & Masters, 19671. Finally, acetylcholinesterases and cholinesterases 
hydrolyse esters of acetylcholine and choline respectively and are inhibited by 
organophosphates, neostigmine and/or eserine [Holmes & Masters, 1967]. 
Leucocyte-associated carboxylesterases in their strictest sense catalyse the hydrolysis of 
uncharged carboxylic esters [Krisch, 1971] but may also act upon esters of fatty acids or 
glycerol Nachlas & Seligmann, 19491, a property usually associated with lipases. 
Despite these overlaps in substrate specificity, carboxylesterases may be regarded in 
general terms as enzymes which act on esters of short-chain glyceryl and simple 
monoesters (acyl chain-lengths of C2-C4) whereas lipases act on longer chain (fatty acid) 
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esters (C8 or more) [Khoo & Steinberg, 19751. The most widely used substrates for the 
cytochemical demonstration of leucocyte esterases are alpha-naphthyl acetate, propionate 
and butyrate which show progressive increases in acyl chain length of C2, (CO.CH3), 
C3, (CO.C2F1s) and C4, (CO.C3H7) respectively. 
Normal and leukaemic myeloid cells express two main groups of alpha-naphthyl acetate 
esterase (ANAE) isoenzymes, as defined by isoelectric focusing (IEF). The first of these 
(ComEst), expressed by cells of both granulocytic and monocytic lineage, comprise a 
series of isoenzymes with isoelectric points ranging from 6.3 to 7.9. In contrast, 
expression of the second myeloid esterase group, which comprises a series of 
isoenzymes (MonEst) within a narrow pI range of 5.5-6.2, is restricted to cells of 
monocytic lineage. 
It is crucial to the study of any enzyme that molecular and biochemical analyses are 
undertaken in the absence of contaminating proteins. This is particularly true when 
contaminants have molecular and/or biochemical characteristics that are similar to those of 
the enzyme of interest. Preliminary chromatographic studies (Chapter 3) indicated that 
there were many proteins in the starting cellular extracts which displayed esterolytic 
activity and showed similarities in molecular features (such as charge, hydrophobicity, 
lectin affinity and relative molecular weight) to the MonEst and ComEst myeloid esterase 
species. Also, because the MonEst starting material contained contaminating serum 
protein, in addition to extracted cellular proteins (discussed in Section 4.2.1.1), an 
extensive range of chromatographic procedures were utilised for the final purification 
protocols. Whilst these chromatographic procedures are far more complex than the 
relatively simple fractionation steps previously described (detailed later in this Discussion) 
for the purification of monocyte-associated esterases [Lam gig, 1978; Youmo, 1986; 
Saboori & Newcombe, 19901, the nature of the starting material necessitated their use. 
Indeed, despite the extremely complex nature of the raw materials, the success of the 
purification schemes was evidenced by the isolation of approximately 40mg of 
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homogeneous MonEst and 1.3mg of enriched ComEst. Isoelectric focusing of the 
purified MonEst and partially purified ComEst revealed that the isoenzyme distributions 
and pl values were identical to those of the unprocessed serum/cell extracts, thus 
confirming that modifications in the charge characteristics of these two myeloid esterase 
species had not occurred as a result of the purification procedures. Furthermore, in terms 
of esterolytic activity and accepting the difficulty of estimating non-specific losses, the 
results of this current study also suggested that when related to the original total esterase 
activities of the serum/cell extract used for the purification of MonEst, only 2.1% of the 
starting acetate esterase and 2.2% of the butyrate esterase activities corresponded to the 
recovered purified MonEst enzyme. For comparison, the resulting partially-purified 
ComEst fraction constituted 4.1% of the total original cell extract acetate esterase activity. 
While there is little doubt that the extensive purification schemes used in this study led to 
a non-specific loss of the enzymes of interest, the results nevertheless indicate that a high 
proportion of the esterolytic activity present in the starting materials was not of ComEst or 
MonEst type. This conclusion is entirely consistent with the observations detailed in 
Chapter 3. 
Early comparisons of carboxylesterases (EC 3.1.1.1) from diverse sources revealed a 
number of common structural and chemical features [reviewed in Heymann, 19801. 
Many of these esterases were reported to be trimeric proteins in their native state, 
possessing three identical subunits each capable of enzymatic activity. Molecular weights 
in the region of 162-168 kDa were recorded for mammalian (including human) liver 
carboxylesterases [reviewed in Krisch, 19711, with some evidence of reversible 
dissociation to active subunits in presence of dilute acid or salt concentrations exceeding 
0.5 molar [Barker & Jencks, 19691. More recent reports [Heymann et al., 1971; Harano 
et al., 1988; Ozols, 1987; 19891 however, suggest that the true molecular weight of 
hepatic carboxylesterases is considerably lower (50-60 kDa) and that an apparent higher 
Mr species results from in vitro generation of polymeric enzyme forms during extraction 
and purification. Although these observations may provide broad insights into the 
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general nature of esterases, it is nevertheless important not to assume that these 
characteristics are a common feature of all esterases, including the ComEst and MonEst 
species which are the subject of this study. 
The results of this current study have considerably clarified the molecular weight 
characteristics of myeloid esterase enzyme forms. The purified MonEst enzyme eluted 
from an analytical gel filtration column as a single enzymatically active peak with an 
approximate Mr of 157 kDa. When examined by SDS-PAGE (reduced and non-reduced) 
this esterase species migrated as a single enzymatically inactive protein band with an 
apparent molecular weight of 63 kDa. For comparison, partially purified ComEst eluted 
from an analytical gel filtration column as a single lower (53 kDa) Mr form, which 
migrated as a single enzymatically active band, with a Mr of 68 kDa, following SDS-
PAGE. These findings therefore suggest that the enzymatic activity of MonEst enzyme is 
predominantly associated with a trimeric protein and that, contrary to previous reports 
[Lam et al., 1978; Yourno, 1986; Yourno et al., 1986; Cohn et al., 1987; Saboori & 
Newcombe, 19901. no significant enzymatic activity is associated with its monomeric 
constituents. In contrast to MonEst, the ComEst species showed no apparent subunit 
association as adjudged by reduced and non-reduced SDS-PAGE. 
With regards to subunit association of the MonEst enzyme, repeated gel filtration of the 
157 kDa species following treatment with 5M urea or 4M guanidine hydrochloride 
(reagents which cause dissociation of polymeric proteins) revealed that. whilst 
degradation of enzymatic activity was observed with guanidine hydrochloride, neither 
compound induced the generation of active monomeric enzyme forms. Furthermore, 
because native MonEst could be fully dissociated to its monomeric constituents by an 
anionic (SDS) rather than nonionic detergents (Triton X-100 and CHAPS), it was 
considered that MonEst subunit associations are ionic rather than hydrophobic in nature, a 
view shared by Yourno [1986]. The possibility of covalent (disulphide) associations 
were ruled out because the trimeric protein was fully dissociated by SDS under non- 
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reducing conditions and showed no further alteration in monomer Mr following reduction 
with 13-mercaptoethanol or dithiothreito] (DTT). Furthermore, and in distinct contrast to 
MonEst, the inhibition of ComEst activity by SDS could be reversed following its 
removal by gel filtration. These findings are particularly relevant because they clearly 
indicate fundamental differences between the molecular characteristics of the two enzyme 
forms. In this respect, it is suggested that SDS binding to MonEst results in the 
disruption of its quaternary structure (i.e. dissociation of subunits) which is essential for 
enzymatic activity. By comparison, it is postulated that the association of SDS with 
ComEst protein disrupts the tertiary structure, inducing a change in the active site and 
resulting in a loss of enzymatic activity in the presence of SDS however, because 
quaternary structure in not involved, SDS inactivation may be reversed by its removal 
(i.e. ComEst protein is able to re-establish its tertiary conformation following SDS 
removal). 
As little is known of the carbohydrate side-chain expression by the MonEst and ComEst 
species, this study also analysed their binding characteristics to a range of immobilised 
lectins. Preliminary studies were undertaken in Chapter 3 (Section 3.4) using an 
unprocessed solubilised cell extract from a case of myeloid leukaemia, which was known 
to express high concentrations of both esterase species. These investigations showed that 
all detectable MonEst bound to Corsa/nava/in A (Con-A) and that this esterase species had 
no apparent affinity for any of the other lectins examined. In contrast, the ComEst 
species showed partial affinity for Pisum sativum agglutinin (PSA) and Lens culinaris 
agglutinin (LCA) in addition to strong binding to Con-A. Carbohydrate structures of 
glycoproteins or proteoglycans are formed by the glycosidic linkage to an amino acid 
side-chain which may be N-glycosidic (through the amide nitrogen of an asparagine 
residue) or 0-glycosidic (through the hydroxyl group of serine, threonine, hydroxylysine 
or hydroxyproline). When interpreted in the context of the differential sugar specificities 
of these lectins, these observations indicate significant differences in the carbohydrate 
structure of these two myeloid esterase types. Thus, the pattern of lectin binding for 
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MonEst is compatible with the presence of oligomannosidic-type glycan(s), N-
glycosidically linked to the protein, whilst ComEst appears to contain approximately 80- 
90% biantennary N-acetyllactosamine-type (complex-type) asparagine-linked glycan(s) 
together with an cc-1,6-fucosylated biantennary N-acetyllactosamine-type glycan(s). 
Further confirmation of the interpretation for the MonEst species was obtained in this part 
of the study by treatment of purified enzyme with endo H, which acts on oligosaccharide 
units of the high-mannose or hybrid type, which completely abrogated its binding to Con-
A. In addition. deglycosylation of MonEst with endoglycosidase H (endo H) increased its 
affinity for alpha-naphthyl acetate (discussed in detail below) but had little effect on either 
the rate of substrate turnover or the isoelectric points (pI) of the various molecular 
isoforms which constitute this enzyme species. This latter observation is important in that 
it not only excludes the possibility that the carbohydrate components of this enzyme 
contribute to the pI, but confirms previous studies (Scott et al., 19840 that treatment of 
MonEst with neuraminidase also has no discernible effect on pI (Le. consistent with the 
lack of terminal N-acetyl neuraminic acid groups). In distinct contrast, endo H treatment 
of partially purified ComEst did not affect its binding to Con-A, further supporting the 
interpretation for the presence of biantennary N-acetyllactosamine-type glycan(s). One 
difficulty with this interpretation however is that attempts to increase the binding of 
ComEst to an immobilised Ricinus communis agglutinin I (RCA I) column, or to modify 
the pI of individual ComEst components [Scott et al., 1984c], by clostridium perfringens 
neuraminidase treatment failed. RCA I column specificity was checked and confirmed 
with neuraminidase-treated and untreated purified human serotransferrin. 
In this context, it is also important to note that glycoproteins which bind to any given 
lectin share only that property; a common factor which itself does not necessarily imply 
the identical nature of their oligosaccharide structures. Furthermore, although it has been 
suggested that molecular variants of individual glycoproteins display glycan uniformity, 
there is some evidence that this may not always be the case [Lis & Sharon, 19861. Such 
interpretations of lectin binding studies may also be limited by oligosaccharide side-chain 
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Flamodifications induced by contaminating glycosidases in complex (unfractionated) 
biological mixtures and the occasional cross-reactivity between lectins and the amino acid 
constituents of a protein. However, providing these factors are taken into account, it is 
nevertheless possible to ascertain the basic oligosaccharide structure for any glycoprotein 
based on its lectin binding profile; analyses that are particularly relevant to the functional 
analysis of cloned esterase proteins where variations in glycosylation may have a 
considerable influence on biological properties. 
Having excluded a possible contribution of the glycan structures to the variable pis of the 
different MonEst and ComEst isoforms, it is concluded that these are likely to result from 
either other post-translational modifications, such as deamidation (glutamine and 
asparagine), sulphydryl oxidation or acetylation of the terminal amino groups of lysine or 
arginine, or may originate at the genetic level (i.e. true isoenzymes) through differences in 
constituent amino acid sequences. Primary modifications of this nature could adequately 
explain charge differences in that substitution of basic amino acid residues with acidic 
residues could lead to differences in charge in the absence of alteration in Mr, and could 
also explain the apparent ionic association of the MonEst monomeric subunits to form the 
active trimeric protein. 
Examination of charge species by pH 8.8 Native-PAGE electrophoresis in this study 
revealed that both MonEst and ComEst each comprised four different Native-PAGE 
isoforms. MonEst consisted of one major species, with three minor charge components, 
while the four ComEst Native-PAGE isoforms appeared to directly correspond to the four 
pl forms resolved by IEF. For comparison, two previous independent investigations 
reported the existence of nine different haemopoietic cell (myeloid, lymphoid and platelet) 
esterase isoforms as defined by Native-PAGE at pH 4.0 [Li e.t 	 19731, and 12 
different isoforms at pH 9.5 [Yourno & Mastropaolo, 19811. At pH 4.0, two main 
esterase components (designated isoforms 4 and 5) were found to be associated with both 
monocytes and platelets. PAGE isoform 5 was seen to preferentially hydrolyse alpha- 
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naphthyl acetate (ANA) whereas PAGE isoform 4 showed a high affinity for alpha-
naphthyl butyrate (ANB); the first of these (isoform 5) was however not considered 
lineage-specific, due to its high concentration in platelets. In contrast, normal and 
leukaemic granulocytes only expressed small amounts of PAGE isoforms 5 and 6. The 
second study of PAGE isoforms at pH 9.5 described two granulocytic esterase 
components, designated Al and A2. which preferentially hydrolysed acetate esters and 
were relatively fluoride-resistant. For comparison, the monocytic esterase components 
(designated AB1 and AB2) hydrolysed both acetate and butyrate esters and were fluoride-
sensitive. Comparison of these findings with those of this current study indicate that 
PAGE isoforms 5/6, AI and A2 correspond to the ComEst species whereas isoforms 4, 
AB1 and AB2 almost certainly represent the MonEst species. 
As it was not possible to fractionate sufficient amounts of each ComEst/MonEst isoform, 
many of which differed only by a minor charge or pl differences, the kinetic analyses 
were carried out, in this current study, under the assumption that individual isoforms of 
each species would not show major variations in substrate affinities or inhibitor 
characteristics. This assumption was substantiated to some extent by the observed linear 
reaction kinetics for both ComEst and MonEst, which allowed the calculation of Km and 
K1 values and would not have been possible had the individual isoforms shown 
significant differences in substrate and inhibitor reactivities. 
The enzymatic catalysis of a given single substrate reaction, generally speaking, takes 
place via a two stage process: (a) Enzyme + Substrate <=> Enzyme/substrate complex; 
and (h) Enzyme!substrate complex <=> Enzyme + P•oduct(s). Under equilibrium 
conditions, the Michaelis-Menten constant (Km) derived from the Michaelis-Menten 
equation: v = Vmax[s///s/ + Km, (where v = initial reaction velocity, [s] = initial substrate 
concentration and Vmax  = maximal initial velocity at the enzyme concentration being 
examined) represents the enzyme/substrate dissociation constant and can therefore be 
interpreted as being a reciprocal measure of the affinity of the enzyme for its substrate. 
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Conversely, the Vmax 
 value is a direct measure of the rate of breakdown of the 
enzyme/substrate complex and for single substrate reactions, indicates the capacity of the 
enzyme to catalyse the hydrolysis of its substrate. Consequently, the lower the Km value 
the greater the affinity of the enzyme for its substrate, and the higher the Vmax value the 
higher the capacity of the enzyme to catalyse the hydrolysis of that substrate. Numerous 
methods have been described for the calculation of Km and Vmax values although the 
most frequently reported interpretations are those derived from Lineweaver-Burk or 
Eadie-Hofstee plots [Dixon & Webb, 1979a; Palmer, 19851. As the Lineweaver-Burk 
method has been criticised for placing greater emphasis on enzymatic activity at low 
substrate concentrations, this current study calculated Km and Vmax values by both the 
Lineweaver-Burk and Eadie-Hofstee linear regression methods. Computerised data 
processing, based on the 'least-squares' approach to curve fitting, have also been used 
more recently for the determination of Km and Vmax values, although values calculated by 
such procedures are not entirely reliable because they fail to discriminate between true 
linear graphs and those which deviate slightly from linearity [Palmer, 19851. 
As the pH can significantly influence substrate hydrolysis by any given enzyme, 
preliminary studies were carried out to determine the reaction rates of both myeloid 
esterase species over a wide pH range. These results showed that the assay of MonEst 
species for butyrate esterase activity was not possible above pH 7.0, because of high 
rates of spontaneous substrate hydrolysis, and that in the pH range 6.0-7.0 there 
appeared to be little significant difference in the reaction rate. Although acetate esterase 
activities could be measured at a higher pH. the reaction rates were generally similar 
throughout the pH range of 6.0-9.0. The UV spectrophotometric esterase assay used in 
this study, which measures the generation of alpha-naphthol at 235nm, was originally 
standardised in morpholino-ethane sulphonic acid (MES) at pH 6.3. As the histochemical 
demonstration of ComEst and MonEst are also typically carried out at an acidic pH, and 
in order to standardise the pH for both acetate and butyrate substrates, a pH of 6.3 was 
used for all the kinetic analyses in this present study. 
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It was evident from the kinetic studies, which examined the ability of purified myeloid 
esterases to hydrolyse alpha-naphthol esters of increasing acyl chain length, that ComEst 
and MonEst showed distinctly different substrate reactivities. The K,,, and Vmax values 
conclusively showed that the ComEst species had higher affinities and turnover rates for 
the shorter acyl chain esters (acetate > propionate), with negligible turnover of the 
butyrate ester. Furthermore, although the ComEst species had similar binding affinities 
for both the acetate and propionate substrates, the turnover rate for the acetate substrate 
was four-fold higher than that of propionate. These quantitative findings confirm earlier 
qualitative analyses obtained by IEF zymogram studies (Section 2.3.4.6), and strongly 
suggest that the ComEst species should be biochemically classified as an acetylesterase 
(EC 3.1.1.6) rather than a carboxylesterase (3.1.1.1). In marked contrast, the MonEst 
Species showed considerably higher affinities and turnover rates for the longer acyl chain 
esters (butyrate > propionate > acetate) even though preliminary qualitative studies 
(Section 2.3.4.6) also showed that the staining intensity of MonEst with this substrate 
was considerably weaker than with ANA. Additional studies, undertaken to clarify this 
discrepancy, revealed that MonEst was inhibited by ANB concentrations exceeding 
0.4mM and, as the ANB concentration routinely used for histochemical techniques often 
exceeds 5 mM, it was concluded that the apparent lower reactivity with ANB in the two-
stage histochemical procedure used for staining IEF gels was due to reaction inhibition by 
high substrate concentrations. 
Inhibition reactivities and substrate specificities are particularly informative in discerning 
the mechanism of enzyme action and ultimately the physiological role of the enzyme. 
Inhibitors in biological systems serve as control mechanisms and many xenobiotic drugs 
and toxic agents are effective through their ability to act as enzyme inhibitors. Enzyme 
inhibition can either be a reversible or irreversible process; reversible inhibition results 
from a loose, usually electrostatic, association between an inhibitor and enzyme whereas 
with irreversible inhibition, the inhibitor usually becomes covalently linked to the 
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enzyme. In this study, purified MonEst and ComEst preparations were extensively 
investigated to determine their inhibitor sensitivities with respect to types of inhibition 
(competitive, uncompetitive, non-competitive, reversible or irreversible). For this, 
representative carboxyl ester hydrolase (EC 3.1.1) and protease inhibitors (Table 4.5) 
were used, firstly to elucidate differences between the MonEst and ComEst enzymes, and 
secondly to provide further insights into the nature of their active sites. Of the 17 
inhibitors examined, only two (sodium dodecyl sulphate, SDS; and diethyl 
pyrocarbonate, DEPC) showed significant (>50%) inhibition of the ComEst species, and 
a further two (sodium fluoride, NaF; and iodoacetamide) exerted partial (20-50%) 
inhibition. For comparison, a total of six compounds (NaF; phenylmethylsulphonyl 
fluoride, PMSF; 3-4 dichloroisocoumarin, DC1C; N-tosyl-L-phenylalanine chloromethyl 
ketone, TPCK; DEPC and SDS) caused significant (>50%) inhibition of the monocyte-
restricted MonEst species. NaF, SDS and DEPC were therefore the only compounds to 
show common inhibition of both esterase species. 
NaF is traditionally incorporated in cytochemical procedures to differentiate monocyte-
associated esterases from other myeloid esterases [Wachstein & Wolf, 1958; Braunstein, 
1959; Yam et al., 1971; Li et al., 1973; Dulac & Yang, 19911. More recent analysis of 
esterase isoenzymes [Scott et al., 1984c; Drexler et al., 1991a] have indicated that the 
inhibition of MonEst species by NaF is a relative rather than specific phenomenon, in that 
the ComEst species is also inhibited at higher NaF concentrations (exceeding 1.0mg/rn1). 
Although much work has been carried out to assess the inhibition of esterases by NaF, 
the mechanisms of its inhibitory action are unknown (Drexler et al., 1991a1. This current 
study reveals for the first time that the NaF inhibition of both MonEst and ComEst 
species is reversible and further shows that this inhibition is noncompetitive for both 
enzymes. The most commonly observed mode of NaF inhibition is through fluoride ion 
binding to essential metal ions (e.g. Ca2+, Mg2+, Mn2+ etc.) although examination of the 
effects of metal chelating agents (described below) suggest that neither myeloid esterase 
contain metal prosthetic groups and are therefore unlikely to be inhibited by this means. 
rig  Furthermore, as NaC1 does not exert any inhibitory effects on either MonEst or ComEst, 
inhibition of enzymatic activity must result through a specific fluoride ion interaction 
rather than through monovalent Na+ ion. These observations therefore suggest that the 
fluoride ion interacts with the enzyme at a position which is distinct from the substrate 
binding site (i.e. Km 
 values remain unaltered and therefore substrate affinity is not 
affected by increasing NaF concentration), and that inhibition is achieved through 
decreasing the turnover rate of the enzyme rather than by diminishing the proportion of 
enzyme molecules (i.e. the Vmax 
 decreases with increasing NaF concentration). 
Although the type of inhibition exerted by NaF was similar for both esterase species, the 
magnitude of inhibition was quite different, in that MonEst showed a 128-fold increased 
sensitivity to NaF compared to ComEst (Ki values of 0.01mM and 1.28mM 
respectively). In a previous study [Scott et d., 1984c1, a thirteen-fold increased 
sensitivity to NaF inhibition was reported for MonEst when compared to ComEst, 
although these findings were obtained from analysis of raw cell extracts with only semi-
quantitative comparisons of cytochemically stained IEF plates. In an earlier study [Lam et 
al., 19781, NaF inhibition of monocytic esterases was reported as being competitive 
rather than noncompetitive although the study did not document how this conclusion was 
reached. 
The presence of essential serine residues, in the active site of an enzyme, is commonly 
assessed by investigating the inhibitory effects of di-isopropyl fluorophosphate (DFP) 
and other related organophosphates. Although organophosphate inhibition of esterases 
has been widely interpreted as evidence for the presence of an active serine residue, 
alternative studies [Choudhury, 1972; Li et al., 1973] have suggested that these inhibitors 
may react with a group (possibly imidazole) near the active centre and that the actual 
inhibition results from steric hindrance rather than through a specific inactivation of the 
active serine. However, in subsequent studies [reviewed in Dixon & Webb, 1979b1 
organophosphates have been shown to react with a single unique serine residue in the 
enzyme active site. Furthermore, peptide sequence analyses, of the active sites of a 
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number of mammalian enzymes (Table 4.9), have shown a high degree of conservation 
around an active serine residue. Although these enzymes differ considerably with respect 
to their physiological roles, they all share a common ability to catalyse the hydrolysis of 
esters. DFP and related organophosphates are thought to act as active-site-directed 
inhibitors; i.e. they gain access to the enzyme active site by mimicking the substrate and 
subsequently covalently modify, through phosphorylation, the essential serine residue 
causing irreversible inhibition. 
A recent study [Saboori et al., 1991) which investigated the effects of several different 
organophosphorous compounds on human monocyte carboxylesterase activity found that 
the molecular bulk and charge of these particular inhibitors plays a significant role in 
determining their effectiveness on esterase activity. These authors further demonstrated 
that charged organophosphates, such as diphenyl phosphate, are far less effective 
inhibitors of esterase activity than uncharged (diphenyl methyl phosphate) compounds. 
and that increasing the molecular bulk of phosphorous compounds results in decreased 
esterase inhibition. These findings are particularly relevant to the physiological role(s) of 
esterases which are discussed in more detail in Chapter 5. 
Two compounds used in this current study (PMSF and DCIC) are known to show similar 
inhibitor characteristics to DFP. Both these compounds. which are are considerably less 
toxic than organophosphates, were shown to specifically inactivate the MonEst 
isoenzymes whilst causing no significant inhibition of ComEst. PMSF and DCIC 
irreversibly inactivate enzymes containing active serine residues by sulphonylation and 
acylation respectively. These observations therefore clearly indicate a significant 
difference between the two myeloid esterases in that the presence of a serine residue in the 
active site is strongly indicated for MonEst but not for ComEst. These findings are in 
accord with earlier observations [reviewed in Drexler gi1., 1991al postulating the 
existence of a serine active site for monocytic esterases. Further characterisation of the 
effects of lower (0.05-0.20mM) PMSF concentrations on MonEst, revealed that PMSF 
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inhibits MonEst activity through mixed competitive-noncompetitive inhibition. The 
competitive inhibition provides significant evidence that this compound mimics the 
substrate to gain access to MonEst active site. It is therefore proposed that at higher 
PMSF concentrations (>0.2mM), when the equilibrium is shifted to the right (i.e. 
Enzyme + PMSF >> Enzvme-PMSF), PMSF sulphonylates an essential serine residue 
and causes irreversible inhibition. In contrast, the noncompetitive inhibition of MonEst is 
almost certainly fluoride-induced and this conclusion is supported by the finding that the 
Ki values for the noncompetitive inhibition of MonEst by both PMSF and NaF are 
identical. 
Assessing the presence of essential histidine residues within the enzyme active site is 
generally achieved by examining the inhibitory effects of diethyl pyrocarbonate (DEPC), 
N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), or N-alpha-p-tosyl-L-lysine 
chloromethyl ketone (TLCK) [Palmer, 19851. All three compounds mimic the enzyme 
substrate to gain access to the active site and subsequently alkylate an essential histidine 
residue causing irreversible inactivation. Any differences in the sensitivity of individual 
enzymes to these compounds therefore reflect the ability of their binding sites to recognise 
these particular inhibitors as potential substrates. 
DEPC reversibly inhibited both ComEst and MonEst species in a noncompetitive manner; 
the mechanism of inhibition for both enzymes being similar to that exhibited by NaF. In 
this situation, DEPC reversibly binds to an amino acid residue close to the active site 
which, although not preventing substrate binding, does cause sufficient conformational 
change to the catalytic machinery to result in diminished substrate hydrolysis. Although 
DEPC inhibits both esterase forms, the presence of an essential histidine residue is not 
(because of its reversible action) suggested for either ComEst or MonEst. In contrast, 
TPCK irreversibly inhibits MonEst activity and shows no inhibitory effect against 
ComEst. As TPCK also irreversibly inactivates chymotrypsin, the results suggest a 
degree of similarity between the active site configuration of this proteolytic enzyme and 
11FMonEst. More fundamentally, the findings indicate additional differences between 
ComEst and MonEst, with regards to requirement of histidine residues for enzymatic 
activity. The finding that MonEst isoenzymes are specifically and irreversibly inactivated 
by TPCK suggest the possible involvement of histidine residues in the active site of these 
esterase forms. Although, as mentioned above, inhibition could also result from steric 
hindrance, where the binding of TPCK to a histidine residue close to, but not part of the 
active centre. may physically prevent access of a substrate to the active site and therefore 
X-ray crystallography or further studies involving specific amino acid modifications 
would be required in order to confirm the role of histidine in the catalytic mechanism of 
MonEst. The inability of TLCK to exert significant inhibition of either esterase species 
further suggests that the active sites of both ComEst and MonEst differ from that of 
trypsin. 
lodoacetamide inactivates enzymes containing essential cysteine residues by alkylation 
[Palmer, 19851. Consequently, the lack of significant inhibition of either esterase 
isoenzyme species by this compound tends to rule out the involvement of cysteine 
residues within their active centres. This interpretation is further substantiated by the 
failure of p-hydroxymercuribenzoic acid (HMBA), which inactivates enzymes containing 
-SH groups in a non-specific manner, to show any significant effect. This is in accord 
with previous conclusions [Kirsch, 19711 that sulphydryl groups are not essential for 
acetylesterase and carboxylesterase activity. 
Analysis of two metal-chelating reagents (1-10, phenanthroline and EDTA) further 
confirmed that MonEst and ComEst are not metalloproteins, and this substantiates earlier 
conclusions that the NaF inhibition of myeloid esterases does not occur through 
conventional inactivation of metal prosthetic groups. Neostigmine, a potent 
cholinesterase inhibitor and the chymotrypsin inhibitor 2-nitro-4-carboxyphenyl N,N-
diphenyl-carbamate (NCDC) also failed to significantly inhibit MonEst or ComEst 
activities. 
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This study also analysed the N-terminal amino acid sequence of purified MonEst. The 
derivation of this sequence not only confirmed homogeneity of the preparation but also 
revealed a high degree of homology with carboxylesterases from at least two other non-
human sources (Table 4.8) and with carboxylesterases from human alveolar macrophages 
[Munger et al., 1991]. Only one difference, an apparent Val --- Thr substitution at 
position 12, was noted when the first 39 N-terminal amino acid residues of MonEst were 
compared with that of human alveolar macrophage esterase. As the MonEst purified in 
this study was obtained from a single individual, the possibility that this difference is due 
to sequence polymorphism cannot be excluded. Further investigation of this possibility 
presents many practical difficulties, not least in obtaining sufficient cellular material from 
a representative number of different subjects. Longer term amino acid sequencing studies 
of proteolytic fragments of MonEst, generated by chemical and enzymatic cleavage of the 
protein, should provide sequence information from various parts of the molecule and 
should clarify whether or not there are more significant differences between human 
MonEst and macrophage carboxylesterase. 
The complete amino acid sequence of monocyte/macrophage-associated carboxylesterase 
species has recently been reported by two separate groups [Munger et al., 1991; 
Zschunke et al., 19911. As there is virtual identity between the N-terminal sequence of 
MonEst and the cDNA-derived sequence of Munger and colleagues 119911, together with 
distinct similarities in their esterase cytochemistries and undoubted ontogenic 
relationships, this suggests that MonEst is very similar if not identical (not withstanding 
possible minor amino acid substitutions) to alveolar macrophage carboxylesterase. 
Similarly, excluding the first 47 amino acid residues, which were not sequenced by 
Zschunke and colleagues [1991], an overlay of the remaining sequence indicates almost 
absolute identity between normal macrophage carboxylesterase and that expressed by the 
myelomonocytic U937 cell line. 
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Amino acid sequencing is frequently useful in determining the targeting of newly 
synthesised proteins. This is particularly the case when assessing whether the 
synthesised protein is retained within the cell, transported to specific subcellular 
organelles (e.g. mitochondria, endoplasmic reticulum, Golgi apparatus, lysosomes, 
plasma membrane or other cellular membranes ), or secreted from the cell. For example. 
the COOH-terminal tetrapeptide sequence of His-Ile-Gly-Leu (HIEL) found for 
monocyte/macrophage esterases 'Munger et al., 1991; Zschunke et al., 1991] is very 
important. This sequence is analogous to the Lys-Asp-Glu-Leu (KDEL) retention 
sequence, which is now widely accepted as being expressed by proteins retained in the 
endoplasmic reticulum of cells [Andres et al., 1990; Munger et al., 1991; Haugejorden et 
al., 1991]. In a separate study Rabbi and Beaufay [1991], who reviewed the COOH 
terminal sequences of several wild-type and mutant liver carboxylesterase species, found 
that KDEL and related tetrapeptide carboxyl terminal sequences (including HIEL) play an 
important role in determining whether liver esterase is retained or secreted. They 
conclude that the presence of KDEL-like carboxyl terminal sequence is strongly indicative 
of retention of protein in the ER. However, Zschunke and colleagues [1991] postulate 
from hydropathy calculations of their amino acid sequence, that monocyte esterase is an 
integral membrane protein with a membrane-spanning hydrophobic portion comprising 
amino acid residues 352 to 367. Munger and colleagues [19911 also reported that 
macrophage carboxylesterase was insoluble in the absence of solubilising reagents, a 
view not shared by either this current study or that of Zschunke et al., [1991]. 
Furthermore, these same investigators suggest that macrophage carboxylesterase may 
also be a secretory protein. Both these observations would appear to contradict what is 
currently understood about proteins expressing KDEL-like carboxyl terminal 
tetrapeptides, in that these proteins are generally soluble and rarely secreted [Andres et 
al., 1990: Haugejorden et al., 1991: Robbi & Beaufay, 1991]. However, it is pertinent 
to point out that the degree of retention of protein in the endoplasmic reticulum, whilst 
requiring the presence of a retention signal, is also influenced by the remaining sequence. 
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As such, it may well be that although MonEst expresses the retention tetrapeptide, the 
remaining sequence may not be conducive to its retention in the endoplasmic reticulum. 
Furthermore, analysis of the N-terminal amino acid sequence of MonEst reveals 
insufficient consecutive hydrophobic amino acids to suggest that the enzyme is anchored 
to the membrane in this region. Although not conclusive, it is generally accepted that 
most integral membrane ectoenzymes express hydrophobic portions at either the NH2- or 
COOH-terminal (i.e. the bulk of the enzyme, including active site, is invariably on either 
the external or the internal face of the membrane and not equally distributed between both 
[Kenney & Turner 1987]). Consequently, the interpretation by Zschunke et al., [1991] 
that monocyte esterase is associated with the plasma membrane through hydrophobic 
amino acids (residues 352-367) in the sequence could only be explained if MonEst had an 
unconventional membrane-association. 
In conclusion, this study has successfully purified MonEst to homogeneity and ComEst 
to a highly enriched state. The availability of these myeloid esterase species in purified 
form further provided an opportunity to compare their molecular and biochemical 
characteristics. Before summarising the similarities and differences between the MonEst 
and ComEst species, it is perhaps pertinent to consider the findings of other investigators 
who have claimed the apparent purification of human MonEst (there are no reports to date 
of ComEst purification). For example, Saboori & Newcombe [1990] recently described 
a four column procedure which provided a single 60 kDa protein that, under non-
denaturing conditions, formed a trimer with a relative Mr of 200 kDa. However, the 
apparent pis of this purified protein ranged from 7.5-7.8 and are clearly more in keeping 
with the ComEst species rather than the widely accepted pI range of 5.5-6.2 for MonEst 
1Radzun et al., 1980; Cohn et al., 1987; Scott & Drexler, 19891. Furthermore, 
examination of the kinetic results reveal discrepancies in the Km (ANA, 0.16mM; ANB, 
0.33mM) and Vmax  (ANA, 7.5 U/mg protein; ANB. 14.0 U/mg protein) values of their 
purified esterase in that these data indicate a two-fold higher binding affinity for ANA 
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even though the butyrate ester was hydrolysed at twice the rate of ANA. Although it is 
conceivable that the acetate substrate inhibits purified MonEst, thereby giving a low Km 
value accompanied by an unexpectedly low Vmax, the results of this current study clearly 
indicate the converse to be the case (i.e. ANB causes MonEst inhibition and not ANA). 
In an earlier study [Lam et al., 1978], a carboxylic ester hydrolase isolated from 
myelomonocytic leukaemia blasts was shown to have a molecular weight of 
approximately 70 kDa but its substrate specificities suggested that this was an 
acetylhydrolase and kinetically inconsistent with MonEst. In a separate study of the 
myelomonocytic cell line ML-1 [Yourno, 1986], monocyte-associated esterase 
isoenzymes fractionated by sequential DEAE-52 anion exchange, Sephadex G-200 gel 
filtration and hydroxyapatite adsorption chromatography were shown to exist as 68 kDa 
monomers and 205 kDa [rimers. In addition. IEF analysis of these species demonstrated 
that their pis were similar (monomer, range 6.2-6.3; trimer, range 5.8-6A) and that 
electrophoresis of dissociated forms in the presence of SDS indicated the esterase 
molecule to be a single chain structure with an apparent molecular weight of 62 kDa. 
However, whereas this fractionated enzyme appeared to be a single protein with the 
molecular and pi characteristics of MonEst. enzyme homogeneity was not confirmed by 
more precise techniques such as amino acid sequencing. Furthermore, although the two 
molecular weight forms were shown in the same report to correspond to previously 
defined pH Native-PAGE isoforms AB1 (monomer) and AB2 (trimer), the MonEst 
purified to homogeneity in this present study revealed only one major Mr form (157 kDa) 
with no evidence for the existence of an active monomer. One immediate explanation 
reconciling the presence of an active monomer in this earlier study, and the failure to 
convincingly demonstrate it in this, is that the active monomeric AB I esterase described 
by Yourno (1986] is in fact not monocyte-specific and corresponds to the pair of higher 
pl (monomeric) ComEst isoenzymes which are characteristically found in both rnonocytic 
and granulocytic cells (associated with the G2-type IEF pattern: detailed in Chapter 2) and 
share many of the chromatographic features of MonEst. 
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Although the genetic mechanisms which control the synthesis and expression of MonEst 
and ComEst myeloid esterases are unknown, it has been suggested [Yourno et al., 1984] 
that monocyte-specific esterase isoenzymes (MonEst) may be derived from pre-formed 
(ComEst) esterases with a higher pl, with 'conversion' resulting from commitment to 
trionocytic differentiation. This concept is clearly based on the assumption that the 
ComEst and MonEst species are subject to related genetic mechanisms. However, the 
results presented in this part of the study provide strong evidence that these are in fact 
distinct enzymes which share a common ability to hydrolyse simple non-physiological 
esters. In this context, it is considered that MonEst should be biochemically classified as 
a carboxylesterase (EC 3.1.1.1) whereas ComEst has characteristics that are more in 
keeping with acetylesterases (EC 3.1.1.6). 
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Figure 4.1: Schematic representation of the chromatographic purification sequence for 911insEst from a leukaernic 
cell extract. This shows the different fractions obtainedjor each column procedure (detailed in Ifateriafs and 
Methods) together with the results for 1E5 analysts of ContEst and fAlonEst isoenzymes, and the proportions of 
protein (Trot) and acetate esterase (AcE) activity expressed in relation to the original raw cell extract 
concentrations, The arrows indicate the fractions which were sequentially passaged al indicates that the 
0.011 and Of urea eluates were pooled prior to benzamidine/arginine/Bfue-Sepharose chromatography; h !indicates 
that these columns were usedfor the removal of immunogtobulins (predominantly IgG)from the crude cell extract; el 
refers to the series of rutin columns comprising Illexeuropaeus agglutinin, AracJiis hypogaea agglutinin, 
villosa agglutinin Isdectin B4, 56(k pornatia agglutinin, 94cittus entrununis agglutinin, tin/Pala simplijOcia 
agglutinin II, (Wheatgerm agglutinin, Piston sativum agglutinin and Lens culinaris agglutinin, and the use of a 
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Figure 4.2: Schematic representation of the chrmnatographic punfication sequence for ConeEst 
from a teuknetnic cell extract. ?his shows the different fractions obtained for each column 
procedure (detailed in Materials and Methods) together with the results for lEF analysis of 
ComEst isoenzymes, and the proportions of protein (Trot) and acetate esterase (AcE) activity 
eApressed in relation to the original raw cell extract concentrations. ?he arrows indicate the 
fractions which were sequentially passaged; a)indicates preliminaryfractionation of the MonEst 
and CornTst species by Q.5epharose chnnnatogrcrphy b) the unbound protein from Q-Sepharose 
was precipitated with 80% ammonium sulphate prior to further fractionation by S-Sepitarose; c) 
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Figure 4.3a: Native-PAGE (p91 8.8) electrophoresis of purified CornEst (track, 
a) and MonEst (track b) myeloid esterases. Separation was performed as detailed 
in Materials and Methods, and gels were stained for alpha-naphthyl acetate 
esterase (ANAE). Note that the majority of the purified MonEst is associated 
with a single charge species, with three minor charge components, whereas 
ComEst comprises three/four charge species that appear to correspond to the 
individual ComEst p1 forms defined by l'EF. 
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Figure 4.4: Native-PAC-1'E (pH 8.8) electrophoresis of purified MonEst 
following treatment with alpha-mannosidase (track_ 6), alpha-L-fueosidase (track 
c) and endogfycosidase 9-1- (track. d) as detailed in Materials and Methods. 'The gels 
were stained for alpha-naphthyl acetate esterase (ANAE). Note that the 
distribution. of the various charge species remains identical to the untreated 
Mon'Est (track_ a). 'The minor retardations noted in track c resulted from presence 
of high glycerol concentrations in the alpha-Llucosidase solution. 
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Figure 4.5a: _,;(DS-PAGE electrophoresis (p91 8.6) of chromatographically 
purified MonEst and ComEst myeloid esterase fractions; tracks (a) and (b) show 
the partially purified ComEst fraction stained for alpha-naphthyl acetate esterase 
(AVE); (c) - (e) show Neat, 1:2 and 1:4 dilutions of the original serum/cell 
extract used for the MonEst purification (silver stain); (f) and (g) show purified 
MonEst and partially purified ComEst respectively (silver stain); and track (h) 
shows molecular weight standards (silver stain). 1 t is evident from these 
observations that (1) the fractionated MonEst is homogeneous and migrates with 
an apparent molecular weight of approximately 630a, and (ii) that the ComEst 
fraction is contaminated with a number of other proteins (predominantly 
aggregate) but is homogeneous (68kDa) with respect to AVE staining. 
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Figure 4.5b: SIDS-PAGE electrophoresis (PH 8.6) of the chromatographically 
purified MonEst myeloid esterase fraction; tracks (a) and (I) show molecular 
weight standards (silver stain); (d) and (e) show non-reduced and redueed MonEst 
(Mr of OA) purified to homogeneity as described in Section 4.2.1.1; (b) and (c) 
show non-reduced and reduced MonEst subsequent to digestion by endoglycositfase- 
91 (Mr of 60.1kEra). 
Figure 4.6: IEF profiles of purified Cortast (a) and MonEst (b) esterase 
isoenzyme species confirming that the isoeketric point characteristics of individual 
isoenzyme components were unaffected by the chromatographic fractionation 
procedures. 
a 	 b 
Figure 4.7: IEF profiles of purified CornEst esterase isoenzyme species, 
untreated (a) and following dOcestion with neurarninadase (b), gi,(ote that there is 
no alteration in the apparent charge distribution of individual ComEst isoenzyrnes 
as a result of desialyation. 
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Figure 4.8: Superose•12 TPLC gel filtration profiles of purified myeloid cell esterase species. 
Diagrams (a) and (b) show the elution volumes (fraction number) and enzymatic activities (acetate 
esterase, unbroken fines; butyrate esterase, broken lines) of ComEst and MortEst respectively. 'The 
main points of note are that ComEst has an apparent molecular weight WO of  530a ant shows a 
marked preference for acetate substrate Hydrolysis, in contrast to MotrEst which has a predominant 
Mr of 153eDa (with only a minor proportion of activity being associated with the 53kpa species) and 
preferentially hydrolyses the butyrate substrate. }figure (c.1 shows the effect of 5M urea (n) and 
411- guanidine hydrochloride ('n) on the Mr and enzymatic {acetate/butyrate combined esterase) of 
purified AforrEst. Note: 'Urea displays no apparent effect on either the Mr or enzymatic activity 
whereas guanidine hydrochloride completely abrogates fli, forEst activity. 
B 
1 	 2 	 3 	 4 
Figure 4.9: Isoelectric focusing (IEF) zymogrants of Con-A unbound and 
eluted fractions of partially purified ComEst (gel A) and purified MonEst (gel B) 
species prior to and* following endogrycosidase 51 treatment. Tracks I and 2 show 
Con-.A binding characteristics, where track 1 indicates the Con-A unbound fraction 
and track. 2 the Con-A eluted fraction; tracks 3 and 4 show the Con-A binding 
characteristics of endo 9-1.  treated CorirEst and NfonEst, where track .3 indicates the 
Con-A unbound fraction and track 4 the Con-A elated fraction. Note that 
untreated ComEst and 9frfonEst species both show complete binding to Con-A but, 
following exposure to endo 56 MonE.st fails to bind Con-A whereas ComEst 
binding is unaffected 
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Figure 4.10: Effect of p5f on ComEst and NtonEst reaction. rates. Enzyme 
activities at 30°C of ComEst and MonEst with 0.3mni alplia-naphthyt acetate 
(.91.V) and alpha-naphthyt butyrate (iott,B) substrates were determined at 0.5 
p5f intervals between the range of 4.0 and 9.0. Noe that ComEst did not cause 
significant hydrolysis of BNB and that because of a high degree of spontaneous 
A.NB hydrolysis above pH 7.0, the reaction rates for Mot:Est with this substrate 
were not evaluabte. p5f at which inhibition kinetics were carried out is shown 
by the vertical dotted fine. 
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Figure 4.11: 5-Ctstochemicar staining of MonEst and ComEst myeloid esterase 
species using alpha-naphthy1 acetate (AV, track a), propionate (AiNP, track, b) 
and butyrate (ANB, track. c) as substrates. fA1pte that the ComEst esterase 
isoenzymes only appear to hydrolyse ANA, with little or no staining in the 
presence of ANJP or ANB. In contrast, the lower pI Nfon'Est species hydrolyse all 
three substrates but the histocheinicat staining with AFB is considerably weaker 
than that seen with :ANA and A.V. 
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Figure 4.12: Relationships between afpha•napfithyr acetate (ANA), 
propionate (ANP) and butyrate (ANB) substrate concentrations and observed 
reaction rates of purified ComEst (diagram a) and Monist (diagram 6) species. 
The rate of hydrolysis of acetate, propionate and butyrate esters was determined by 
UV spectrophotometry IMastropaoto & Yourno, 1981] at each substrate 
concentration as detailed in Materials and Methods. Weaction rates are shown as 
increases in absorbance at 235nm/min, with each data point representing a mean 
of duplicate determinations. 
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Figure 4.13: Lineweaver-Burk (upper diagram) and Sadie-Hofstee (lower 
diagram) plots for the determination of Michaelis-Menten constants (Km) and 
maximum velocities (Vmax) for the purified ComE.st species with alpha-naphthyr 
acetate (ANA) and propionate (AV) substrates. ComEst did not cause any 
significant hydrolysis of alpha•naphthyf butyrate. `The data from figure 4.12 was 
converted to inverse readings and the 1/velocity values plotted against 1/substrate 
concentration. 
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Figure 4.14: Lineweaver-Burk. (upper diagram) and Eadie-g-fofstee (lower 
diagram) plots for the determination of Michaelis-Menten constants (Kin) and 
maximum velocities (Vmax) for the purified MonEst species with alpha-naphthyr 
acetate (A_NA), propionate (Af.keP) and butyrate (A_NB) substrates. The data 
from Figure 4.12 was converted to inverse readings and the 1/velocity values plotted 
against 1/substrate concentration. 
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Figure 4.15: Relationships between alpha-naphthyr acetate (.M), 
propionate (INT) and butyrate (ANB) substrate concentrations and observed 
reaction rates of purified gtfonEst species. 'The rate of hydrolysis of acetate, 
propionate and butyrate esters was determined by UV spectrophotometry 
Olastropaoro & Yourn.o, 19811. Rraction rates arc shown as increases in 
absorbance. at 235nm/min, with each data point representing a mean of duplicate 
determinations. Note the apparent reaction inhibition at butyrate concentrations 
above 0.4mM which is not observed for the acetate or propionate substrates. 
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Figure 4.16: Lineweaver-Burk kinetic plot (1/v against 144) for the analysis 
of Mchealis-Ifenten constant (flk-m) and nra4mum velocity (VmaA) of Enda 5f 
treated and untreated purified giforrEst. Note that deglycasylation of MonEst 
appears to significantly increase its affinity for alpha-naphthyl acetate (i.e. kin 
value of 0.08tef as compared to 0.16m7i for the untreated form), whilst showing 
only a marginal decrease in the Nmax value. 
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Figure 4.17: Effect of sodium. fluoride (9aJ) on the observed rate of alpha-
naphthyr acetate (ANA) hydrolysis by the purified ComEst species. 'fie rate of 
ANA hydrolysis was determined by UV spectrophotornetry Wastropaolo c 
7ourno, 19811 at each inhibitor concentration as detailed in Materials and 
Methods; reaction. rates are shown as increases in 91235/min with each data point 
representing a mean of duplicate determinations. The upper diagram shows the 
ComEst rates of ANA hydrolysis with a range (0.1 to 0.6ingt,1) of substrate 
concentrations in the presence of increasing NO- (0.0 to 1.0m.M). 'The 
Lineweaver-'Burk.plot (centre diagram) indicates that NaF exerts noncompetitive 
inhibition on ComEst; a secondary plot of altered 1/Nmax (1/Nmax) values 
versus inhibitor concentration (Cower diagram) was used to determine the 
inhibition constant (f.i(i) for inhibition of CoinEst by - 615. 
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Figure 4.18: Effect of sodium fluoride ( W) on the observed rate of alpha-
naphthyf acetate (AV) hydrolysis by the purified MonEst species. The rate of 
AI hydrolysis was determined by WV spectrophotometry (Mastropacdo 6 
Yourno, 1981] at each inhibitor concentration as detailed in Materials and 
Methods; reaction rates are shown as increases in .4235/min with each data point 
representing a mean of duplicate determinations. The upper diagram shows the 
MonEst rates of ANA hydrolysis with a range (0.1 to 0.4mM) of substrate 
concentrations in the presence of increasing ,MaF (0.0 to 0.02na1). 'The 
Lin.eweaver'Burk plot (centre diagram) indicates that NaF exerts noncompetitive 
inhibition on Mon'Est; a secondary plot of altered 1/ilmax (1/Nmax) values 
versus inhibitor concentration (lower diagram) was used to determine the 
inhibition constant (2(j) for inhibition of MonEst by NaF 
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Figure 4.19: Effect of diethyl polyearbonate (DEPC) on the observed rate of 
alpha-naphthyt acetate (ANA) hydrolysis by the purified ComEst species. 'The 
rate of ANA hydrolysis was determined by WV spectrophotometry Wastropaoto 
& Yourno, 19811 at each inhibitor concentration as detailed in. Materials and 
Methods; reaction rates are shown as increases in A235/min with each data point 
representing a mean of duplicate determinations. 'The upper diagram shows the 
ComEst rates of ANA hydrolysis with a range (0.1 to 0.5m9q) of substrate 
concentrations in the presence of increasing DERC (0.0 to 0.05mM). The 
Lineweaver-Burk,plot (centre diagram) indicates that DEPC exerts noncompetitive 
inhibition on ComEst; a secondary plot of altered 1/Vmax (1/4Vmax) values 
versus inhibitor concentration (lower diagram) was used to determine the 
inhibition constant (Ki) for inhibition of ComEst by DEPC. 
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Figure 4.20: Effect of diethyl* potycarbonate (VEX) on the observed rate of 
alpha-naph thy( acetate (AV) hydrolysis by the purified MorrEst species. 'File 
rate of A_NA hydrolysis was determined by UV spectrophotometry (Mastropaofo 
6 Yourno, 19811 at each inhibitor concentration as detailed in Materials and 
Methods; reaction rates are shown as increases in 91235/min with each data point 
representing a mean of duplicate determinations. The upper diagram shows the 
ComEst rates of A.N.A hydrolysis with a range (0.05 to 0.3mM) of substrate 
concentrations in the presence of increasing DEPC (0.0 to 0.05m 1). 'The 
Lineweaver-Burpp49t (centre diagram) indicates that DEPC exerts noncompetitive 
inhibition on MonEst; a secondary plot of altered 1/Vittax (i/Vmax) values 
versus inhibitor concentration (lower diagram) was used to determine the 
inhibition constant (K) for inhibition of MonEst by DEPC. 
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Fri  Table 4.2a: Summary of column performance for MonEst fractionation 41  
Column/Fraction Protein 
(mg) 
Acetate Esterase 
(U/min x 10-3 ) 
Butyrate Esterase 
(U/min x 10-3 ) 
Pre-Q Sepharose b 
(Serum/cell extract): 26125 (100% ) 3262 (100%) 3338 (100%) 
Q-Scpharose 
Unbound: 5820 (22.3%) 118 (3.6%) 376 (11.3%) 
pH6.3 eluatc: 2274 (8.7%) 72 (2.2%) 75 (2.2%) 
pH5.5 eluate: 4506 (17.2%) 1473 (45.2%) 1639 (49.0%) 
1.0M NaCl eluate: 4437 (17.0%) 931 (28.5%) 614 (18.4%) 
Phenvl-Swharose 
Unbound: 1705 (6.5%) 410 (12.6%) 238 (7.1%) 
0.8/0.6M eluates: 365 (1.4%) 28 (0.9%) 83 (2.5%) 
0.4M eluate: 286(1.1%) 108 (3.3%) 450 (13.5%) 
0.2/0.0M eluates: 465 (1.8%) 303 (9.3%) 295 (8.8%) 
Urea eluate: 254 (1.0%) 355 (10.8%) 325 (9.7%) 
Be ft:1,41.01(re Series 
Unbound: 437 (1.7%) 440 (13.5%) 426 (12.8%) 
NaCl eluate: 204 (0.8%) 47 (1.4%) 156 (4.7%) 
Urea eluate: 49 (0.2%) 10 (0.3%) 54 (0.3%) 
Prowin AIG 
Unbound: 180 (0.7%) at nt 
Eluate: 145 (0.6%) at nt 
Lectin Series 
Unbound: 135 (0.5%) 119 (3.6%) 109 (3.3%) 
Eluate: 18 (0.1%) 4 (0.2%) 4 (0.1%) 
Con-A 
Unbound: 77 (0.3%) 24 (0.7% ) 154 (4.6%) 
Eluate: 42 (0.2% ) 67 (2.1%) 75('2%) 
a Protein and fluorimetric enzyme assays performed as described in Materials and Methods. 
Fluorescent units/min were calculated using the equation: 
Fluorescent unitslml x volume (ml). 
Assay time (mins) 
Indicates data for the total amount of extract protein and esterase activity processed (following 
ultrasonication. detergent extraction, dialysis and centrifugation of the original serum/cellular 
material) 
Table 4.2b: Summary of column performance for ComEst fractionation a 
Column/Fraction Protein (mg) Acetate Esterase 
(U/min x10-3 ) 
pre-O Sepharose 
(Cell extract) 8107 (100%) 5106 (100%) 
9-Sepircirose 
Unbound: 2100 (25.9%) 2000 (39.2%) 
1.0M NaCI Eluate: 3583 (44.2%) 1969 (38.6%) 
S-Sepharose 
Unbound: 1610 (19.9%) 200 (3.92%) 
0.25M NaCl Eluate: 239 (2.95%) 1000 (19.6%) 
1.0M NaC1 Eluate: 120 (1.48%) 40 (0.78%) 
Sen:amidinelAqinine Scriei 
Unbound: 219 (2.70%) 610 (11.9%) 
Eluate: 93 (1.15%) 20 (0.39%) 
Lenin Series 
Unbound: 104 (1.3%) 680 (13.3%) 
Eluate: 54 (0.67%) 5 (0.10% ) 
Con-A 
Unbound: 136 (1.68%) 110 (2.15%) 
Eluate: 9 (Oil%) 210 (4.11%) 
a Protein and fluorimetric enzyme assays performed as described in Materials and Methods. 
Fluorescent units/min were calculated using the equation: 
Fluorescent units/nu x volume (ml)  
Assay time (mins) 
h Indicates data for the total amount of extract protein and esterase activity processed (following 
ultrasonication. detergent extraction. dialysis and centrifugation of the original serum/cellular 
material) 
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Table 4.4 Kinetic studies to determine Vmax and Km values for myeloid esterase 
isoenzyme species a 
ComEst 
	 MonEst  
Substrate . 	 Vmax 	 Km 	 Vmax 	 &111 
(n niohniori ) 	 ( 77M) 
	
(11 moldnitri ) 	 (Hill?) 
Alpha-naphthyl acetate 5.6 0.20 5.2 0.19 
Alpha-naphthyl propionate 1.3 0.24 7.2 0.11 
Alpha-naphthyl butyrate :4.: * 10.0 0.05 
a Kinetic studies of the two esterase isoenzyme species with each substrate were carried 
out as detailed in Materials and Methods. Maximum rates of substrate hydrolysis 
(Vmax) and Michaelis-Menten constants (Kin) were calculated using Lineweaver-
Burk and Eadie-Hofstee plots: the results are shown as the mean of these two plots 
and are expressed as n 	 I and mM respectively for Vmax and Km. 
* indicates. no significant substrate hydrolysis 
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Table 4.6 Mechanisms of esterase inhibition 
Inhibitor b ComEst 
Species 
MonEst 
Species 
Analytical 
Methods 
1% SDS reversible irreversible Gel filtration 
20mM NaF reversible reversible Gel filtration 
and IEF 
5.0mM PMSF resistant irreversible IEF 
0.05mM DCIC resistant irreversible IEF 
5.0mM DEPC reversible reversible IEF 
5.0mM TPCK resistant irreversible IEF 
a Purified monocyte-specific (MonEst) and 'common' myeloid (ComEst) esterase 
isoenzyme fractions incubated with various inhibitors and then analysed following gel 
filtration chromatography or isoelectric focusing (IEF) to assess whether inhibition 
was reversible or irreversible. 
h Inhibitors: SDS, sodium dodecyl sulphate; NaF, sodium fluoride: PMSF. 
phenylmethylsulphonyl fluoride: DCIC, 3-4 dichloroisocoumarin: DEPC, diethyl 
pyrocarbonate: TPCK, N-tosyl-L-phenylalanine chloromethyl ketone. 
Table 4.7 	 NaF. PMSF and DEPC inhibitor kinetic studies of 'common' myeloid (ComEst) and monocyte- 
spec ific (MonEst) esterase isoenzyme species a 
Inhibitor 
CornEst Species MonEst Speeiel 
Inhibition type Ki (rnM) Inhibition type 
	 KJ/Kt (mM) 
NaF: (0.() to 1.0mM) 
PMSF: (0,0 to 0.2mM) 
DEPC: (0.0 to 0.1mM) 
noncompetitive 
no inhibition 
noncompetitive 
1.28 
0.05 
noncompetitive 
mixed-inhibition h 
(noncompetitive 
(competitive 
noncompetitive 
0.01 
0.01) 
0. 1 1 ) 
0.1)5 
a Alpha-rraphthyl acetate esterase activities were determined in the presence of varying concentrations of 
sodium fluoride (NaF). phenylmethylsulphanyl fluoride (PMSF) or diethyl pyrocarbonate (DEPC) by UV 
spectrophotometric assay. The type of inhibition was determined by Lineweaver-Burk plots and the K.; (or 
K1 for competitive inhibition) was estimated using secondary plots of 1/Vmax' against inhibitor 
concentration. 
b At concentrations exceeding 0.5mM. PMSF was shown to cause irreversible inhibition of MonEst: K1 and 
K1 values for the noncompetitive and competitive components respectively are given separately. 
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Table 4.9 Active site amino acid sequence of an ox liver carboxylesterase and 
comparison with sequences from a number of other mammalian esterase and proteinase 
enzymes a 
Enzyme 	 Amino acid sequence of the active site 
Chymotrypsin A (EC 3.4.21.1) 	 Cys.Met.Gly.Asp.Ser.Gly.Gly.Pro.Leu.Val 
Trypsin (EC 3.4.21.4) 	 Cys.G1n.Gly.Asp.Ser.Gly.Gly.Pro.Va1. Val 
Elastase (EC 3.4.21.11) 	 Cys.G1n.Gly.Asp.Ser.Gly.Gly.Pro.Leu.His 
Thrombin (EC 3.4.21.5) 	 Cys.Gln .G ly.Asp.Ser.G I y.Gly.Pro.Phe. Val 
Acetylcholinesterase (EC 3. 1. 1 .7 	 Glu. 	 Ser.Ala 
Cholinesterase (EC 3.1.1.8) 
	
Phe.Gly.Glu. 	 Ser.Ala.Gly.A la. Al a.Ser 
Carboxylesterase (ox liver; EC 3.1.1.1) Gly.G1u. 	 Ser.Ala.Gly.Ala.Glu.Ser 
a Sequences quoted from Dayhoff et al.. [19721. 
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Cytochemical studies are routinely used to supplement traditional morphological 
evaluations for the accurate identification and classification of leukaemic cells. In this 
context, the application of alpha-naphthyl acetate esterase (ANAE) cytochemistry is 
regarded as being particularly valuable for the delineation of monocytic/histiocytic cells 
and the subtyping of acute myeloid leukaemias (AML) [Scott, 1989; Li et al., 1989; 
Drexler et al., 1991a]. However, whilst the interpretation of ANAE staining patterns of 
normal haemopoietic elements is usually straightforward, atypical cytochemical reactivity 
of leukaemic cells is often difficult to interpret and may conflict with morphological 
and/or immunophenotypic impressions. Consequently, conventional ANAE 
cytochemistry in such cases is of limited value and a requirement for further 
discriminative analysis of ANAE isoenzymes is necessary. Early zymogram (PAGE and 
IEF) studies have shown that haemopoietic cells synthesise and express several ANAE 
isoenzyme components. With particular reference to myeloid cells, two distinct groups 
of ANAE isoenzymes have been documented; one which is commonly expressed by all 
myeloid cells (ComEst) and the other which is restricted to haemopoietic cells of 
monocytic lineage (MonEst) [reviewed in Scott & Drexler, 1989 and Drexler et al., 
1991a, b]. The aims of this current study were initially to confirm and substantiate the 
previously reported relationships between normal and leukaemic myeloid cell 
cytochemical ANAE reactivity and the distribution of ANAE isoenzymes as defined by 
IEF with the second part of these investigations being designed to extend these 'baseline' 
studies by preparing purified ComEst and MonEst isoenzyme fractions in order to 
compare their molecular and biochemical characteristics. These latter studies were 
specifically undertaken to establish whether the two main myeloid esterase species 
represented variant forms of the same parent enzyme or, alternatively, were unrelated 
enzymes with a shared ability to hydrolyse simple non-physiological ester substrates. 
To achieve the initial aims, esterase cytochemistries of a representative number of normal 
and leukaemic myeloid cells were examined and these were correlated with the qualitative 
expression of ANAE isoenzymes. For this, ANAE cytochemical reactions for a total of 
Pr  309 acute myeloid leukaemias and 20 normal granulocyte/monocyte fractions were assessed. These investigations confirmed previous impressions [Flandrin & Daniel 
1973; Li et al., 1973; Kulenkam pff et al., 1977; Gordon & Hubbard 1978; Hayhoe & 
ID 
Quaglino 1980; Flandrin & Daniel 1981; Scott et al., 19871 that normal mature 
granulocytes and the blast cells of non-monocytic AML subtypes are typically ANAE 
negative (or show weak diffuse/granular staining) and that moderate to strong diffuse 
(M-type) ANAE reactions are restricted to normal and leukaemic cells developing along 
the monocyte/macrophage differentiation axis. Furthermore. zymogram (IEF) analyses 
of normal granulocyte and leukaemic AML-M I/M2 cell extracts consistently revealed the 
presence of ANAE isoforms (ComEst) within the pl range of 6.3 to 7.9. As the cellular 
concentration of ComEst components in these particular cell extracts was generally weak, 
it was apparent that the absence of detectable ANAE cytochemical staining of these cell 
types was a quantitative rather than qualitative phenomenon. This distinction is of some 
importance as a minor, but significant, proportion of acute myeloid leukaemias (AML-
M1/2), as well as the abnormal promyelocytes of most hypergranular promyelocytic 
leukaemias, show relatively intense granular or focal ANAE reaction products. Although 
the presence of ANAE staining in these cases has been interpreted as being suggestive of 
'mixed' or 'bilinear granulocytic/monocytic differentiation [Tomonaga et al., 1985; 
Lemez, 19881. an analysis of ANAE isoenzyme distributions unequivocally showed that 
all such cases expressed ComEst isoforms only. Consequently, these findings indicate 
that the atypical cytochemical patterns of these particular leukaemias is due to a 
leukaemia-associated 'over-expression' of ComEst isoforms rather than resulting from 
the additional presence of MonEst or other ANAE isoenzyme species. 
In contrast, normal monocyte fractions consistently showed moderate to strong diffuse 
cytochemical staining which correlated with the presence of high concentrations of 
MonEst ANAE isoforms within a narrow pI range of 5.5 to 6.2, in addition to the 
occurrence of myeloid cell ComEst components. However, additional analyses revealed 
that up to 5% of morphologically and immunophenotypically (CD14+) defined normal 
169 
Pr 
 monocytes lacked significant esterase activity. For comparison, high proportions of 
blasts in 62% of the acute myelomonocytic (AMML-M4) and 35% of the acute monocytic 
(AMoL-M5) leukaemias examined also showed no apparent ANAE staining. When these 
cytochemical impressions were related to IEF zymograms, it was found that all 
cytochemically unreactive AMML-M4 and AMoL-M5 cases were characterised by a 
complete absence of MonEst components even though expression of ComEst isoforms in 
these cases was still observed. 
Having confirmed the lineage association of the two main myeloid esterase isoenzyme 
species, and prior to the analysis of purified ComEst/MonEst forms, this study also 
undertook preliminary analyses (using representative unfractionated cell extracts) of their 
substrate specificities and inhibitor sensitivities. Histochemical staining of esterase 
isoenzymes following IEF separation, using substrates of increasing acyl chain length, 
provided further definitive insights into the relative substrate affinities of the two myeloid 
cell esterase species. These investigations showed that MonEst isoforms were capable of 
hydrolysing acetate, propionate and butyrate esters whereas ComEst components showed 
a decreasing substrate affinity with increasing acyl chain length (with no significant 
hydrolysis of alpha-naphthyl butyrate). These qualitative substrate studies therefore, 
confirmed the above interpellation that atypical ANAE cytochemistry of hypergranular 
APL-M3 cases resulted as a consequence of ComEst over-expression, in that the 
leukaemic promyelocytes of such cases were unreactive or only weakly reactive with 
butyrate esters. 
Further analyses of unfractionated cell extracts for the inhibitory effects of various 
inorganic and organic compounds on MonEst and ComEst activities revealed that two 
compounds, sodium fluoride (NaF) and phenylmethylsulphonyl fluoride (PMSF), 
significantly inhibited MonEst but not ComEst. In agreement with previous studies 
[Scott gt g, 1984a; Drexler gl al., 1991a], it was additionally found that the inhibition of 
MonEst by NaF was a relative rather than specific phenomenon, as higher (>1.0mg/m1) 
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NaF concentrations also inhibited CornEst. However in contrast to previous observations 
(Cohn et al., 19871, PMSF at various concentrations specifically inactivated MonEst but 
had little effect on ComEst activity. Three other inhibitors examined (Neostigmine, 
eserine and p-hydroxymercuribenzoic acid: HMBA) showed no significant inhibition of 
either MonEst or ComEst, suggesting that these myeloid cell esterases were not 
arylesterases (HMBA-sensitive), acetylcholinesterases or cholinesterases (neostigmine 
and/or eserine-sensitive). From these preliminary substrate and inhibitor studies, it was 
concluded that MonEst and ComEst were likely to be unrelated esterolytic enzymes: an 
interpretation which provided sufficient impetus for their purification and further 
characterisation. 
Using representative leukaemic cell extracts, the next part of the study evaluated the 
chromatographic characteristics of ComEst and MonEst components with a wide range of 
gel types in order to establish practical schemes for a scaled-up purification of ComEst 
and MonEst components. One of the most important observations from these initial 
analyses was that the cellular extracts contained, in addition to the histochemically 
demonstrable CoinEst and MonEst species. a large number of esterolytic enzymes 
(including trypsin and chymotrypsin-like enzymes). which were capable of hydrolysing 
simple fluorimetric and naphtholic esters. Although further studies of these particular 
enzymes were not undertaken, as they were not the subject of these present studies, the 
recognition of their presence effectively meant that (a) the column procedures designed 
for the final chromatographic purification of the ComEst and MonEst species had to 
ensure their complete removal, (b) that the monitoring of column efficiencies and their 
ability to successfully resolve ComEst and MonEst could only be reliably achieved by 
histochemical zymogram analysis, and (c) that the conventional expression of enzyme 
purification and column yields (i.e. reporting enzyme activities relative to protein 
concentration) would be meaningless. This latter point is emphasised in particular by the 
investigations which examined correlations between total cell extract esterase activities (as 
defined by standardised fluorimetric assays) and esterase isoenzyme patterns. These 
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studies clearly indicated that there was no relationship between the quantitative level of 
esterase activity and the concentrations of ComEst/MonEst isoenzymes defined 
histochemically, therefore strongly suggesting the existence of additional esterolytic 
species. 
Chromatographic evaluations additionally provided evidence of qualitative differences in 
the molecular characteristics of the ComEst and MonEst species. For example, the major 
ComEst components did not bind to anion exchangers with quaternary amino-ethyl 
groups whereas MonEst did, suggesting a possible conformational difference between 
the native structures of these two myeloid esterase types. In addition, preliminary lectin 
binding studies showed that whereas MonEst bound to Concanavalin A (Con-A), with 
no apparent affinity for any of the other lectins examined, ComEst showed partial 
affinities for Piston sativum agglutinin (PSA) and Lens culinaris agglutinin (LCA) in 
addition to strong Con-A binding. When interpreted in the context of the differential 
sugar specificities of these lectins, these observations indicate significant differences in 
the carbohydrate structure of the two myeloid esterases. The pattern of lectin binding for 
MonEst was considered compatible with the presence of N-glycosidically linked 
oligomannosidic-type glycan(s) whereas, in contrast, ComEst showed a lectin binding 
pattern that was interpreted as being consistent with a mixture of (80-90%) biantennary 
N-acetyllactosamine-type (complex-) asparagine-linked glycan(s) and (10-20%) a-1,6- 
fucosylated biantennary N-acetyllactosamine-type glycan(s). In addition to revealing 
significant molecular differences between ComEst and MonEst, these investigations also 
provided a basis for constructing schemes for their chromatographic purification. 
Indeed, it was further apparent that because of the diversity of co-existing esterolytic 
enzymes in cell extracts, a wide range of chromatographic procedures would be required. 
Accordingly, the final chromatographic sequence was designed to maximise the removal 
of unwanted proteins and esterolytic enzymes and to minimise the loss of either the 
ComEst or MonEst species. 
173 
The final part of the study successfully achieved the purification of MonEst to 
homogeneity and ComEst to a highly enriched state using chromatographic procedures 
devised on the basis of results obtained in the preliminary evaluations. Although these 
procedures were extensive (due to the highly complex nature of the cell extracts used), 
compared to the relatively simple fractionation steps previously described for the 
purification of monocyte-associated esterases [Lam et al., 1978; Yourno, 1986; Saboori 
& Newcombe, 19901, the success of the purification schemes was, to some extent, 
evidenced by the isolation of approximately 40mg of homogeneous MonEst and 1.5mg 
of enriched ComEst. Isoelectric focusing of purified MonEst and partially purified 
ComEst revealed that both enzymes had been successfully resolved and showed no 
cross-contamination. Furthermore, the isoenzyme distributions and pI values of these 
purified esterases were identical to those of the unprocessed material, thus confirming 
that modifications in their charge characteristics had not occurred as a result of the 
purification procedures. Accepting the difficulty of estimating non-specific losses, the 
results of these studies also suggested that, when related to the original total esterase 
activities of the serum/cell extract used for the purification of MonEst, only 2.1% of the 
initial total acetate esterase and 2.2% of the butyrate esterase activities corresponded to 
the recovered purified MonEst enzyme. For comparison, the purified ComEst fraction 
constituted 4.1% of the total original cell extract acetate esterase activity. While there is 
little doubt that the extensive purification schemes used in this study led to some non-
specific loss of the enzymes of interest, the results nevertheless indicate that a high 
proportion of the original esterolytic activity present in the starting materials was not of 
ComEst or MonEst type. 
The subsequent investigations of purified material considerably clarified the molecular 
and biochemical characteristics of the two myeloid esterase species. Molecular weight 
estimations of purified MonEst indicated a relative molecular weight (Mr) in its native 
state of 157 lcDa which, following SDS treatment, dissociated to an enzymatically 
inactive 63 kDa molecule. In contrast, ComEst comprised an active monomeric species 
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which had an apparent molecular weight of 53 kDa when determined by gel filtration 
chromatography and an Mr of 68 kDa by SDS-PAGE. Accepting the limitations of gel 
filtration chromatography for the accurate assessment of Mr, these findings suggest a 
possible monomeric and trimeric configuration for MonEst, an interpretation which is in 
accordance with previously reported observations [Lam et al., 1978; Yourno, 1986; 
Yourno et al., 1986; Cohn et al., 1987; Saboori & Newcombe, 1990], while the ComEst 
species showed no apparent subunit association as adjudged by reduced SDS-PAGE. In 
this context, it is important to emphasise that a trimeric configuration for MonEst is now 
widely accepted [reviewed in Drexler et al., 1991a] even though a recent communication 
IZschunke et al., 1992] concluded from computer modelling studies that native MonEst 
is a dimeric membrane bound ectoenzyme. These authors essentially based their 
contention on the observation that the amino acid sequence of MonEst protein contains 
five cysteine residues, four of which are proposed to form internal stabilising disulphide 
bonds and the other forming an intramolecular disulphide bond (i.e. constituting the 
dimeric configuration). However, the probable existence of disulphide interactions is not 
supported by this current study, which consistently showed that MonEst is completely 
dissociated by SDS under non-reducing conditions and that under reducing conditions, 
there is no further change in Mr. Furthermore, investigations to ascertain the nature of 
MonEst subunit association, strongly suggested that individual subunits are associated 
through electrostatic interactions rather than covalent linkages. 
Studies of chromatographically purified esterase species further confirmed the 
preliminary conclusions that the pattern of lectin binding for MonEst was compatible with 
the presence of N-glycosidically linked oligomannosidic-type glycan(s), whilst ComEst 
contained fucosylated and non-fucosylated biantennary N-acetyllactosamine-type 
(complex-type) asparagine-linked glycan(s). This was achieved by treating purified 
MonEst with endoglycosidase H, which acts on oligosaccharide units of the high-
mannose type, and abrogating its binding to Con-A. Furthermore, although 
deglycosylation of MonEst decreased the Mr from 63 kDa to 60.1 kDa, this treatment had 
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no significant effect on the isoelectric points (pI) of its constituent isoenzymes. This 
latter observation is particularly important as it excludes the possibility that the 
carbohydrate components of this enzyme contribute to the p1 and confirms previous 
studies [Scott et al.. 1984c1 that treatment of MonEst with neuraminidase also has no 
discernible effect on pI (i.e. consistent with the lack of terminal N-acetyl neuraminic acid 
groups). In a similar way, the predicted bianttenary glycan stricture of ComEst was 
further substantiated when treatment with endo H failed to affect its binding to Con-A. 
In addition to their molecular differences, kinetic studies revealed distinct substrate 
reactivity patterns for ComEst and MonEst. Km and Vmax estimations showed that the 
ComEst species had higher affinities and turnover rates for the shorter acyl chain esters 
(acetate > propionate), with negligible turnover of the butyrate ester. In contrast, the 
MonEst species showed considerably higher affinities and turnover rates for the longer 
acyl chain esters (butyrate > propionate > acetate). Purified MonEst and ComEst 
preparations were also extensively investigated to determine their inhibitor sensitivities 
with respect to types of inhibition (competitive, uncompetitive, non-competitive, 
reversible or irreversible). For this, representative carboxyl ester hydrolase and protease 
inhibitors were used, firstly to elucidate differences between the MonEst and ComEst 
enzymes, and secondly to provide further insights into the nature of their active sites. Of 
the 17 inhibitors examined, only two (SD& and diethyl pyrocarbonate, DEPC) induced 
significant (>50%) inhibition of the ComEst species, with a further two compounds 
(NaF; and iodoacetamide) exerting partial (20-50%) inhibition. For comparison, a total 
of six inhibitors (NaF; PMSF; DEPC; SDS; 3-4 dichloroisocoumarin, DCIC; and N-
tosyl-L-phenylalanine chloromethyl ketone, TPCK) caused significant (>50%) inhibition 
of the monocyte-specific MonEst species. NaF, SDS and DEPC were therefore the only 
compounds to induce inhibition of both esterase species. Inhibition of both species by 
NaF was shown (for the first time) to be noncompetitive, with MonEst having a 130 fold 
increased sensitivity to this compound compared to ComEst. Another significant 
difference between ComEst and MonEst revealed by these studies, was that MonEst was 
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irreversibly inhibited by SDS whilst the inhibition of ComEst activity was found to be 
reversible. Additionally, whereas the requirement of serine and histidine residues was 
implicated for MonEst activity (i.e. because of irreversible inhibition by PMSF/DCIC and 
TPCK), their requirement was not evident for ComEst. Together, the substrate and 
inhibitor studies provide sufficient evidence to conclude that MonEst shows 
characteristics consistent with its classification as a carboxylesterase (EC 3.1.1.1) while 
ComEst displays characteristics more in keeping with its classification as an 
acetylesterase (EC 311.6). The molecular and biochemical characteristics of MonEst 
and ComEst are summarised in Table 5.1. Collectively, these observations indicate that 
these two myeloid esterase species are unrelated enzymes which share a common ability 
to hydrolyse simple non-physiological ester substrates. 
Because the MonEst species had been purified to homogeneity, this study was also able 
to ascertain its N-terminal amino acid sequence. As the complete amino acid sequences 
of monocyte/macrophage-associated carboxylesterase species have recently been reported 
by two independent groups, it was possible to make comparisons with the results 
obtained for purified MonEst. The first of these (in which the initial 47 amino acids at 
the N-terminus were not determined [Zschunke et al., 1991]) was obtained by analysing 
a cDNA sequence of purified carboxylesterases from the U937 cell line; the second was 
obtained from limited amino acid sequencing of alveolar macrophage esterase and 
subsequent screening of the corresponding cDNA library [Munger et al., 199l]. These 
comparisons revealed a high degree of homology between MonEst and carboxylesterase 
from human alveolar macrophages 'Munger et al., 1991] and the U937 cell line 
[Zschunke et al., 19911. Furthermore, extensive literature and data base searches also 
indicated significant sequence homology with human liver esterase [Ozols, 1989; Riddles 
gal, 1991; Long g al., 1991], and carboxylesterases from at least two other non-human 
sources I Korza & Ozols, 1988: Long et al., 1988; Takagi et al., 1988; Robbi et al., 
1990). Consequently, the similarities in esterase cytochemistries and their undoubted 
ontogenetic relationships, suggest that the purified MonEst analysed in this current study 
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is very similar if not identical (not withstanding possible minor amino acid substitutions, 
which may reflect molecular polymorphism) to alveolar macrophage and U937 
carboxylesterases. 
Amino acid sequence data is frequently valuable in determining the targeting of newly 
synthesised proteins. This is a particularly useful strategy when assessing whether 
synthesised protein is retained within the cytoplasm, transported to specific subcellular 
organelles (e.g. mitochondria, endoplasmic reticulum, Golgi apparatus, lysosomes, 
plasma membrane or other cellular membranes), or secreted from the cell. In this 
respect, the sequence data presented by Munger and colleagues [1991] is informative in 
that it represents the complete gene product sequence prior to co- or post-translational 
protein modification, whereas the N-terminus sequence derived in this current study 
effectively represents that of the post-translationally modified and functionally active 
protein. The presence of a transient 16-17 residue N-terminus signal peptide [Munger et 
g., 1991j, together with the observation that MonEst is N-glycosylated, strongly 
suggests that its biosynthesis occurs within the endoplasmic reticulum (ER). 
Furthermore, the presence of His-Ile-Glu-Leu (HIEL) COOH-terminal tetrapeptide 
[Munger et al, 1991; Zschunke et Al., 19911 on MonEst protein, which is now widely 
accepted as being analogous to the Lys-Asp-Glu-Leu (KDEL) ER retention sequence 
[Andres et al., 1990; Munger et al.. 1991; Haugejorden et al., 1991; Robbi & Beaufay, 
1991j and, to a lesser extent, the observation that its glycosidic structure remains as a 
high mannose type and is not further modified, indicates that. MonEst could indeed be 
retained in the ER. This view is further supported by the findings of Rabbi and Beaufay 
[1991], who reviewed the COOH terminal sequences of several wild-type and mutant 
liver carboxylesterase species and concluded that the presence of a KDEL-like carboxyl 
terminal sequence (including HIEL) is strongly indicative of protein retention in the ER. 
However, Zschunke and colleagues [1991, 1992] postulate from hydropathy calculations 
and computer modelling of their amino acid sequence that monocyte esterase is an 
integral membrane protein. This observation is partially substantiated by Munger and 
lir 
colleagues [ 1991], who report that macrophage carboxylesterase is insoluble in the 
absence of solubilising agents (a view not shared by either this current study or that of 
Zschunke el al, [1991]). However, these authors also suggest that macrophage 
carboxylesterase may be a secretory protein, but these conclusions appear to contradict 
what is currently understood about proteins expressing KDEL-like carboxyl terminal 
tetrapeptides, which are generally soluble and rarely secreted [Andres et al., 1990; 
Haugejorden et al., 1991; Robbi & Beaufay, 1991]. It is however important to note that 
the degree of protein retention within the ER, whilst requiring the presence of a retention 
signal, is also influenced by the remaining sequence. Consequently, although considered 
unlikely it is nevertheless feasible that despite expressing the retention tetrapeptide, the 
remaining sequence of MonEst may not be conducive to its retention in the ER. 
Alternatively, as suggested in a recent report [Zschunke et al., 1992]. MonEst may be 
localised within the ER in resting monocytes/macrophages but, following activation, it 
may be translocated to the plasma membrane. In this context, it is pertinent to note that 
these present studies found that both the ComEst and MonEst esterase species remained 
soluble in the absence of detergent throughout their purification, and that virtually all 
detectable ComEst and MonEst activity could be extracted from cell fractions without the 
inclusion of detergents in the extraction buffers. These observations, in conjunction with 
the information obtained from amino acid sequence analysis, indicate that MonEst is 
essentially soluble and not a peripheral or intrinsic membrane protein, thus contradicting 
the widely held belief that MonEst is a plasma membrane ectoenzyme [Bozdech & 
Bainton, 1977, 1981; Monahan et al., 1981; Zschunke et al., 1991, 1992]. However, 
although this matter remains unresolved, it is nevertheless clear that determination of the 
subcellular localisation of MonEst will have fundamental implications with regards to 
elucidating its physiological function(s). 
With regards to origin (genetic or post-translational) of esterase polymorphism, Peters 
[1982] described a total of 17 different structural genes which control the expression of 
murine esterase enzymes. Each locus was reported to contain a minimum of two 
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111 7  different alleles, and clusters of esterases encoded by these multiple gene loci were noted 
to display differences in tissue distribution and subcellular locations. In a further study, 
Coates & Cortner [1986] described an alpha-naphthyl butyrate esterase (designated 
isoform B3) of human mononuclear leucocytes which was expressed as two allelic 
variants with differing molecular and catalytic properties. These authors concluded that 
whilst the B3 isoform exists as an active trimer of identical subunits, its allelic variant 
(designated isoform B32) existed as an active monomer; therefore the primary phenotypic 
difference between the two forms appears to result from an inability of the B32 subunits 
to form trimers. Although the genetic mechanisms which regulate the synthesis and 
expression of the two myeloid esterase enzymes are unknown, one suggestion [Yourno 
et al., 1984] has been that monocyte-specific MonEst isoenzymes may be derived from 
pre-formed esterases with a higher pl (ComEst). This concept is based on the 
assumption that the ComEst and MonEst species are related at the genetic level and that 
the synthesis of MonEst results from post-translational processing of the ComEst 
protein, following specific commitment to monocytic differentiation. However, there has 
been no convincing scientific evidence to support this view and, indeed immunological 
studies, using rabbit polyclonal antisera with apparent specificity against MonEst, clearly 
indicate antigenic differences between MonEst and ComEst isoenzyme forms Madzun et 
al., 1981; Cohn et al., 1987]. An alternative view [Yourno & Mastropaolo. 1981] is that 
there are distinct gene systems encoding ComEst and MonEst proteins. In this respect, it 
is considered that the expression of ComEst and MonEst may be dependant on the 
differential activation and suppression of distinct esterase encoding-genes (i.e. gene(s) 
coding for ComEst protein are activated during both granulocytic and monocytic 
differentiation whilst MonEst gene(s) are activated following specific monocytic 
commitment or, alternatively, are suppressed during granulocytic differentiation). 
When considering the origin of the individual charge (pl) isoforms of ComEst and 
MonEst enzymes, evidence of a multiple gene origin of MonEst isoforms comes 
inadvertently from a recent report [Zschunke g_t :41., 19911, which suggested that 
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hybridisation of digested genomic DNA with a 151-bp 5'-terminus cDNA fragment of 
monocyte-associated esterase resulted in a pattern of several bands on Northern blots. 
The significance of these data, which was surprisingly not considered by the authors, 
indicate that if MonEst isoforms were indeed encoded by a single gene, then the DNA 
sequence of the transcribed gene would comprise several periodic repeating bases with 
>80% homology for the 151-bp 5'-terminus fragment. As this is not readily apparent 
from examination of the cDNA sequence provided by these authors, an alternative view 
is that the observed hybridisation pattern represents recognition of several related genes 
from a multigene family. These findings therefore suggest that MonEst polymorphism 
may originate at a genetic level (i.e. true isoenzymes) through differences in constituent 
amino acid residues or their sequence. Primary modifications (e.g. substitution of basic 
amino acids with acidic residues) of this nature could also account for their minor charge 
differences, with no discernible effect on molecular size, and could also explain the 
apparent charge association of MonEst monomeric subunits to form active trimers (e.g. 
electrostatic attraction between amino acid residues with opposite polarities). 
As would be expected from the diversity of esterase species, there appears to be a large 
degree of confusion regarding the physiological role of esterases. Some evidence has 
been presented [Junge & Krisch, 1975] suggesting that carboxylesterases may be 
associated with the hydrolysis and detoxification of xenobiotic substrates. In this 
context, it is perhaps relevant that the MonEst purified in this current study showed some 
N-terminus sequence homology with human cytochrome P450 and furthermore, as the 
cytochrome P450 cascade of enzymes is essentially localised in the smooth ER of 
hepatocytes, this lends some support to the possible ER localisation of MonEst in 
monocytes/macrophages. The biological role of esterases has also been associated with 
the hydrolysis of arylamine carcinogens [Lund-Pero et al., 19891, steroid esters 
(including sex steroid hormones) and glucocorticoids [Schottler & Krisch, 19741, 
although a recent report [Saboori & Newcombe, 19901 has shown that purified monocyte 
esterase itself does not hydrolyse these compounds. Other investigators have reported 
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hydrolysis of the xenobiotic compound triphenyl phosphate Waxman et al., 1988] by 
monocyte-associated esterase. However, as these studies used whole cell preparations to 
investigate esterase function, it is quite possible that enzymes other than esterases could 
have catalysed the hydrolysis of these compounds, a view substantiated by Saboori & 
Newcombe (1990]. The results of this present study did however, additionally indicate 
that MonEst was incapable of hydrolysing aminopeptidase, angiotensin converting 
enzyme, carboxypeptidase, dipeptidylpeptidase, endopeptidase, microsomal dipeptidase, 
or glutamyltransferase substrates and therefore this particular enzyme is unlikely to be 
involved in primary protein modification processes. As with MonEst, little is known of 
the function of ComEst. This current study has shown that this esterase species is likely 
to be an acetylesterase, and ultrastructura] cytochemistry [Monahan et al., 1981] further 
indicates that it is primarily localised within cytoplasmic lysosomes/granules. This 
conclusion is supported by conventional cytochemical observations that the increased 
ComEst activity of APL-M3 hypergranular promyelocytes parallels increased granulation 
in these cells, and the finding that focal staining in some AML blasts is associated with 
the presence of Auer rods which are known to be formed from neutrophlic azurophil 
granules. Primary functions associated with lysosomal enzymes include degradation of 
nucleic acids (acid RNase; acid DNase), carbohydrates ((3-galactosidase; a-glucosidase; 
lysozyme), mucopolysaccharides (13-glucuronidase; lysozyme; hyaluronidase), and 
proteins (cathepsins; collagenase). Additional lysosomal enzymes include phosphatases, 
esterases and sulphatases. It is therefore considered quite likely that the function of 
ComEst is associated with the degradation of internalised (phagocytosed) esterified 
molecules or molecular structures of particle membranes (e.g. bacteria) following fusion 
of the lysosome with phagocytic vesicles. However, in the absence of known 
physiological substrate(s) the biological significance of ComEst remains elusive. 
Compared to ComEst, there have been more intensive studies, largely because of its 
highly lineage-restricted nature, to investigate the functional role(s) of MonEst. Indeed, 
it has been speculated that MonEst protein may be involved in a diverse range of 
182 
physiological functions including pinocytosis [Cohn et al., 1987j, facilitation of 
diapedesis and migration through tissues [Monahan et al., 1981], inflammation and 
growth regulation 1Youmo et al., 1986], and detoxification and metabolic processing of 
drugs [Li el al., 1973; Oertel & Kastner 1984; Yourno 1986]. Involvement of MonEst in 
monocyte associated cytotoxicity has also been speculated jOertel et al., 19851, although 
this contention was based on the rather tenuous assumption that reduced cytotoxicity 
results from specific inhibition of MonEst activity by bis-(4-nitrophenyl)-phosphate in an 
in vitro assay system measuring cytotoxic lysis of tumour target cells. However, this 
inhibitor is likely to have simultaneously inhibited other cellular enzymes, and therefore 
the direct effect of MonEst on tumour cell cytotoxicity remains unproven. Nevertheless, 
some circumstantial evidence that MonEst may play a role in tumour cell killing has been 
provided by a report [Markey et al., 1990] of a statistically significant correlation 
between hereditary MonEst deficiency and the occurrence of malignant neoplasia. These 
investigators have hypothesised that severe diminution in MonEst activity may, to some 
extent, predispose to certain malignancies or be associated with such a predisposition 
[Markey et al., 19871. The major limitations to this conclusion however are (a) that the 
great majority of patients with haemopoietic and non-haemopoietic malignancies appear 
to have normal monocyte esterase activities; (b) there have been no subsequent reports of 
hereditary MonEst deficiency to confirm these impressions; and (c) monocyte esterase 
deficiency often occurs as a secondary (acquired) event in a wide range of haematological 
and non-haematological disorders (e.g. rheumatoid arthritis [Bell et al., 1992]). An 
alternative approach to this was recently provided by Newcombe 119921, who 
hypothesised that an absence or inhibition of MonEst (and perhaps esterases of other 
immune surveillance cells such as natural killer cells, lymphokine-activated killer cells, 
and cytotoxic T lymphocytes) may impair the immune and cytotoxic functions of such 
cells thereby allowing tumour development. This contention is primarily based on 
previous findings that the prevalence of lymphoproliferative disorders appears to be 
increased in workers exposed to organophosphorous compounds [Blair et al., 1985; La 
Vecchia et al,, 1989; Alavanja et al., 1990; Hall & Rosenman, 1991] and the finding that 
ir MonEst activity is irreversibly inhibited by a wide range of such compounds [Saboori et 
al., 1991]. However, Newcombe 11992] neglects to add the fact that many enzyme 
systems (including by definition all serine proteases) that are also present in 
immunocompetant cells, are almost certainly simultaneously inhibited when exposed to 
organophosphates. As such, these hypotheses remain highly speculative even though 
they clearly deserve further investigation. 
In conclusion, the initial aims of this study were to undertake an extensive analysis of 
normal and leukaemic myeloid cell esterases in order to confirm the relationships between 
myeloid cell differentiation and esterase isoenzyme patterns, and to specifically analyse 
by chromatographic, molecular and kinetic techniques whether or not the esterase 
isoenzyme species that are expressed by granulocytic and monocytic cells represent 
different gene products or are variant post-translational forms derived from the same gene 
product. It is considered that the results of these investigations have comprehensively 
demonstrated the distinct nature of the ComEst and MonEst species and shown that these 
enzymes are almost certainly synthesised in granulocytic and monocytic myeloid cells as 
a result of differential gene activation following appropriate lineage commitment and 
differentiation. 
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CHAPTER 5 
Table 5.1 
Table 5.1 	 Sununary of the molecular, biochemical, kinetic and inhibitor characteristics of the 
myeloid ComEst and MonEst esterase species 
CoinEst 
	 MonEst 
Molecular Size (gel filtration). 
	 53 kDa 	 157 kDa 
Molecular Size (SDS-PAGE). 
	 68 kDa 
	 63 kDa 
60 kDa (deglycosylated) 
Molecular composition: 	 Monomer 	 Trimer 
pl range of isoforms: 	 63-7.9 	 5.5-6.2 
Glycan structure: " 	 Biantennary 	 High-mannose 
Con-A binding following endo H: 	 Yes 	 No 
Substrate hydrolysis: 
alpha-naphthyl acetate 	 +++ 	 +++ 
alpha-naphrhyl propionate 
	 +++ 
alpha-naphthol butyrate 	 0 	 +++ 
Inhibitor studies: r 
2OntM NaF 	 partial (reversible) 	 marked (reversible) 
1% SDS 	 marked (reversible) 	 marked (irreversible) 
5mM DEPC 	 marked (reversible) 	 marked (reversible) 
5n1M PMSF 	 resistant 	 marked (irreversible) 
0.05ntM DC/C 
	
resistant 	 marked (irreversible) 
5mM TPCK 	 resistant 	 marked (irreversible) 
a Biantennary indicates a mixture of biantennary N-acetyllactosamine-type (80-90%) and a-1,6- 
fucosylated biantennary N-acetyllactosamine-type 1(1-20% ) glycans: High-mannose indicates the 
presence of oligomannosidic-type glycans N-glycosidically linked to the protein. 
h  Indicates the effect of binding to Concanavalin-A following treatment with endoglycosidase H. 
c NaF, sodium fluoride; SDS, sodium dodecyl sulphate; DEPC, diethyl pyrocarbonate: PMSF, 
phenylmethylsulphonyl fluoride: DCIC. 3-4, dichloroisocournarin: TPCK, N-tosyl-L- 
phenylalanine chloromethyl ketone. 
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